1  | correl matern fetal plasma level glucos free fatti acid  correl coeffici determin level glucos ffa matern fetal plasma collect deliveri  signific correl obtain matern fetal glucos level matern fetal ffa level  size correl coeffici slope regress line appear fetal plasma glucos level deliveri strong depend upon matern level wherea fetal ffa level deliveri slight depend upon matern level 
2  | chang nucleic acid phospholipid level liver cours fetal postnat develop  follow evolut dna rna pl liver rat foeti remov fifteenth twenty first day gestat young rat newly born wean  observ follow fact  dna concentr  ug p th day decreas th day reach valu  ug  day wean   rna concentr  ug p th day decreas  period   pl concentr low th day foetal life  ug increas abrupt birth   ratio rna cytodna pl cytodna increas regular th day foetal life   nuclear rna pl content high throughout develop   result enabl us character three stage develop rat liver   th day th day foetal life stage growth hyperplasia without hypertrophi   th day foetal life rd day post nat life stage cellular reorganis   rd day post nat life stage growth hyperplasia hypertrophi 
3  | surfact fetal lamb tracheal fluid  lamb deliv cesarean section intact fetal circul fluid fill trachea  analysi reveal fluid contain materi high surfac activ lamb deliv near term less surfac activ prematur lamb  administr  per cent oxygen ewe  hour prior deliveri alter surfact properti fetal tracheal fluid  two analys fetal tracheal fluid reveal contain   mg lipid per  ml   per cent phospholipid part activ compon surfact  investig report offer model research possibl intrauterin factor pathogenesi hyalin membran diseas 
4  | placent cord blood lipid comparison set doubl ovum twin stillborn live born   determin phospholipid total free cholesterol triglycerid nefa made placent tissu cord blood set doubl ovum twin one stillborn one live born   similar occur fraction studi except cord blood triglycerid nefa level   serum stillborn infant contain one third much triglycerid  time much nefa live born infant   phospholipid content total lipid content stillbirth placenta highest studi laboratori includ determin  live birth   suggest made increas lipoprotein lipas activ cord blood may accompani intrauterin fetal death 
5  | free fatti acid concentr matern plasma fetal bodi fat content  subcutan inject  usp unit heparin femal sprague dawley rat produc larg sustain elev plasma free fatti acid signific chang blood glucos  group pregnant rat receiv inject heparin  time daili throughout pregnanc  fetus mother group   day gestat signific bodi fat fetus uninject mother  hypothesi present matern free fatti acid concentr part determin fetal fat accumul  propos bodi composit chang note babi mother diabet might thus ascrib abnorm high matern plasma free fatti acid concentr 
6  | concentr non esterifi fatti acid matern fetal plasma intact alloxan diabet x ray irradi rat  determin non esterifi fatti acid plasma pregnant rat show exist increas concentr depend pregnanc period th   nd day pregnanc  fetal plasma concentr non esterifi fatti acid amount     per cent matern valu  alloxan diabet produc  day prior test concentr matern plasma increas three  fivefold time signific rise absent fetal plasma slight increas averag valu  whole bodi x ray exposur dose r dose output rmin non pregn femal pregnant rat begin th day pregnanc result chang concentr non esterifi fatti acid immedi irradi 
7  | lipid metabol toxemia normal pregnanc  amount fatti acid composit total lipid extract serum examin normal pregnant women first second third trimest earli postpartum period patient mild sever preeclampsia essenti hypertens  placenta term also examin total lipid fatti acid composit  normal women total serum lipid increas pregnanc  rise less pronounc preeclampsia hypertens  serum palmit mild signific elev preeclampsia  total lipid arachidon acid elev placenta preeclampt women  find compar obtain anim develop eclampsia experiment basi 
8  | essenti fatti acid acid trans configur subcutan viscer fat newborn  made investig subcutan viscer fat newborn  estim content linol linolen acid acid trans configur spectrophotometr  abl show penetr acid placent barrier  essenti fatti acid content fat newborn low  immatur one   g rise trend
9  | acetoacet format liver human fetus age   week  slice homogen liver human fetus age   week low rate acetoacet format rais addit acet octano incub medium  possibl demonstr acetoacet format isol liver mitochondria  week old fetus probabl mitochondria injur isol 
10  | chang blood glucos non esterifi fatti acid foetal newborn lamb inject adrenalin  chang blood glucos non esterifi fatti acid intraven adrenalin measur foetal newborn adult sheep foetus immedi birth littl increas either blood glucos non esterifi fatti acid adrenalin  respons blood glucos adrenalin reach adult level twenty four hour age  respons non esterifi  ed fatti acid adrenalin increas gradual first week 
11  | electron microscop observat transfer fat human placenta  result previous present studi transport fat human placenta mean electron microscopi obtain follow conclus   neutral fat permeat human placenta without dissoci   almost process fat permeat seem due biolog activ  pinocytosi repres author newli found sever fact dissolution lik chang basement membran transport via stroma cell  author believ result bring clue explain mechan biolog transport materi placenta 
12  | content phosphatid triglycerid cholesterol placenta matern fetal new born liver white rat  thin layer chromatograph examin matern rat liver show differ rise triglycerid signific increas esterifi cholesterol howev strike chang content free cholesterol lipid phosphorus fraction examin lecithin colamin cephalin sphingomyelin lysolecithin  compar liver adult rat fetal liver contain littl less  per cent lipid phosphorus  differ condit concentr lecithin colamin cephalin  th day content triglycerid lower mother rat  refer dri weight result decreas phosphatid fraction well free cholesterol slight rise triglycerid th nd day  rise phosphatid concentr valu adult rat occur immedi birth influenc milk food moreov lead consider increas triglycerid valu  phospholipid  triglycerid concentr placenta correspond fetal liver  sole content free cholesterol higher end pregnanc  content triglycerid drop toward nd day 
13  | analysi mammalian len protein electrophoresi  len protein differ mammalian speci analyz two dimension starch gel electrophoresi  number fraction detect mean vari    a crystallin resolv two three compon b crystallin   y crystallin three five compon  techniqu provid sensit method fraction len protein analyz speci differ 
14  | autoradiograph studi cell migrat eye len epithelium normal alloxan diabet rat  lens normal alloxan diabet rat without cataract investig autoradiographi  hour  day  day intraperiton inject h thymidin  ucg bodi weight  rat made diabet  day prior inject thymidin age  week  posit label nuclei len epithelium note grain number count  diabet rat lower frequenc label nuclei control  hour grain count equal  frequenc diagram label nuclei given three experiment period  predomin peak appear  hour distanc   cell front begin nuclear arc  success shift toward area observ longer experiment period  shift peak restrict diabet anim  result may best interpret effect increas time cell generat  appendix histotechniqu eye len given collabor mrs gertraud moewi 
15  | len develop differenti embryon chick len epitheli cell vitro vivo  behavior len epitheli cell six day chick embryo studi three differ experiment situat explant sever differ fluid cultur media b explant follow reimplant lensectom embryon eye c explant follow reimplant embryon coelom caviti  specimen examin histolog total volum len materi specimen determin planimetri serial section  result interpret follow  small amount protein supplement cultur medium embryon len epitheli cell capabl limit amount independ cytodifferenti  without protein supplement fail undergo fiber format   return eye environ cultur epitheli explant respond resumpt growth cellular differenti least morphogenet chang necessari form len  embryon coelom support respons   initi format len fiber suffici complet autonom matur   intern architectur develop len determin overal shape 
16  | treatment activ chronic hepat lupoid hepat  mercaptopurin azothioprin   mercaptopurin azothioprin imuran use success  patient activ chronic hepat  lupoid hepat period  year  drug allow modif even abolit discomfort corticosteroid regim  action chronic hepat may analog anti immun action suppress homograft reject 
17  | treatment collagen diseas cytostat   patient collagen diseas  patient immunolog diseas treat cytostat antimetabolit purinethol  mercaptopurin imuran azathioprin averag period four month rang one eleven month  improv obtain  patient   patient long term glucocorticoid medic steroid therapi could perman discontinu  serious complic occur form two death pancytopenia sepsi  treatment requir care supervis patient institut strict indic altern long term glucocorticoid medic 
18  | bilater poplit cyst patient rheumatoid arthriti  case bilater poplit cyst multipl joint sublux patient rheumatoid arthriti corticosteroid medic mani year report  effect long term corticosteroid therapi periarticular connect tissu structur relationship articular diseas poplit knee cyst therapi discuss 
19  | system lupus erythematosus renal transplant report two case  two case system lupus erythematosus along termin uremia secondari lupus nephriti present  patient treat renal hemodialysi transplant  certain mechan infecti immunolog problem respons death  evid resurg lupus erythematosus either patient transplant kidney show evid lupus nephriti  renal transplant consid last resort treatment patient termin lupus nephriti 
20  | arter localis periost new bone format   three patient localis periost new bone format associ periost arter evid system lupus erythematosus describ   system steroid therapi valuabl manag condit 
21  | fine structur subtili phage sp   structur detail anomal form subtili phage sp  describ 
22  | genet transcript morphogenesi  messeng rnas bacillus subtili undergo sporul germin step down transit character compar  hybrid competit experi indic messeng deriv distinct genet loci  result consist hypothesi differenti transcript genom occur morphogenesi  data also complement previous observ chang morpholog enzymat activ sporul bacteria 
23  | renal amyloidosi clinicopatholog studi  clinic histopatholog data  case renal amyloidosi diagnos percutan renal biopsi present  twenty two case label secondari amyloidosi definit aetiolog factor respons renal amyloidosi could discov  predispos diseas state lead amyloid deposit kidney order frequenc fibrocas pulmonari tuberculosi bronchiectasi lung abscess ileocaec tuberculosi five case label suspect primari amyloidosi definit evid predispos diseas could obtain although skiagram chest reveal minim heal foci  caus could determin thirteen case therefor label primari amyloidosi  albuminuria constant featur case  case present nephrot syndrom  rest case present hypertens renal failur addit albuminuria  ancillari procedur viz congo r test gingiv liver biopsi prove limit valu diagnosi renal amyloidosi  import percutan renal biopsi diagnost tool emphasis 
24  | idiopath autoimmun hemolyt anemia idiopath thrombocytopen purpura associ diffus hypergammaglobulinemia amyloidosi hypoalbuminemia plasmacytosi  case report sixty nin year old woman sever idiopath autoimmun hemolyt anemia initi control splenectomi  relaps associ develop sever autoimmun thrombocytopen purpura fail respond larg dose prednison control variabl degre imuran  associ featur includ diffus hypergammaglobulinemia excess gamma u protein urin idiopath hypoalbuminemia great reduc total exchang albumin pool amyloidosi spleen organ diffus plasmacytosi bone marrow lymph node thorac periton fat  featur interrelationship discuss  defici synthesi specif neutral antibodi virus indic qualit immun defici exist  frequenc occurr thrombocytopen purpura case discuss prognosi  mechan action antimetabolit induc remiss autoimmun hemolyt anemia well etiolog diseas review 
25  | corticosteroid therapi amyloid nephrot syndrom  result treatment prolong adren corticosteroid  adult amyloid nephrot syndrom present  eight subject observ seri  addit case summar literatur  twenty two patient male four femal  diagnosi establish renal biopsi  instanc autopsi other  patient consid primari amyloidosi  secondari amyloidosi  major subject die renal failur averag surviv onset diseas  month  renal diseas indistinguish seen form nephrot syndrom possibl except high incid purpur skin lesion b low neglig incid hypertens time actual hypotens promin c rapid inexor progress azotemia despit persist clinic biochem characterist nephrot syndrom  amyloidosi found percutan renal biopsi  per cent  adult nephot syndrom  corticosteroid appear affect progress diseas neither benefici detriment  view high incid deleteri side effect prolong corticosteroid therapi avail potent diuret agent may help reliev edema disord felt corticosteroid contraind treatment amyloid nephrot syndrom 
26  | renal amyloidosi biopsi studi  relationship amount amyloid deposit kidney clinic pictur review  case renal amyloidosi diagnos renal biopsi  larg percentag patient nephrot syndrom  patient probabl reflect criteria renal biopsi institut  etiolog amyloid deposit seem clear correl either amount amyloid deposit kidney sever clinic renal diseas  patient deposit glomerulus heavier deposit sever renal diseas   patient biopsi bone marrow abnorm type number plasma cell  age rang primari amyloidosi appear amyloidosi secondari myeloma  amyloidosi suspect patient proteinuria nephrot syndrom renal failur 
27  | amyloid goitr case report  case amyloid goitr indian femal age  year occur sequela pulmonari tuberculosi report 
28  | amyloid starch gel electrophoret analysi protein extract amyloid  protein extract strong urea wash tissu patient amyloidosi secondari sever diseas associ famili mediterranean fever common major electrophoret compon  heart primari amyloidosi one compon common secondari amyloid may present  howev primari amyloid much difficult dissolv regular give compon observ secondari amyloid extract  big question remain constitu constitu compris fibril known part amyloid 
29  | select protein excret patient nephrot syndrom gel diffus precipitin techniqu commerci prepar antisera urineplasma ratio specif protein determin  individu protein clearanc express percentag transferrin clearanc plot ordin respect molecular weight log log graph  straight line evid graphic constant estim method least squar slope express  determin  slope line may said express degre glomerular select protein excret  sixty f determin perform  patient   satisfi usual criteria nephrot syndrom   patient primari renal diseas nephrot syndrom display high select type proteinuria  greater averag group   sd usual respond initi steroid therapi regardless acut subacut glomerular chang observ renal biopsi   patient chronic renal diseas nephrot syndrom display averag frequent low select type proteinuria   appear characterist type select given patholog group patient nephrot syndrom   degre select protein excret relat total daili amount protein excret one time remain fair constant despit fluctuat amount protein excret   slight correl borderlin signific degre select protein excret durat diseas initi para aminohippur acid clearanc   statist signific correl exist initi blood urea nitrogen inulin clearanc select type protein excret  patient azotem initi near norm inulin clearanc averag select type better   suggest adult patient initi azotem grossli abnorm inulin clearanc respons therapi unlik wherea blood urea nitrogen normal inulin clearanc near normal respons therapi cannot predict degre accuraci  studi adult patient nephrot syndrom requir substanti premis 
30  | aspect haemostasi open heart surgeri  synopsi two group patient undergo extracorpor circul hypothermia chang found coagul mechan probabl due dosag polybren administ  role heparin polybren concept activ coagul mechan product bleed perfus discuss 
31  | case interventricular septal defect dextrocardia situs inversus treat surgeri  case interventricular septal defect associ situs inversus dextrocardia twenti year old male patient present along discuss three type dextrocardi complex emphasi rariti occurr intracardiac anomali true mirror imag dextrocardia total situs inversus  comment also made kartagen syndrom exclud appropri radiograph procedur case  closur interventricular septal defect extracorpor circul success perform moder hypothermia 
32  | excret pattern urinari metabolit estradiol  c postmenopaus women benign malign diseas breast  studi excret pattern urinari metabolit estradiol  cj administ group  postmenopaus women  advanc mammari carcinoma prior endocrin therapi  benign mammari dysplasia report  chromatograph method employ determin estradiol estron estriol estrogen metabolit  urinari excret pattern defin extent excret isotop  success  hr collect period b percentag urinari radiometabolit enzymat hydrolyz c relat concentr sever metabolit hydrolyz fraction  wide subject to subject variat found  metabolit estradiol estron estriol compris larg portion total estrogen excret  signific lower amount estradiol note group women mammari carcinoma compar amount found group women benign mammari dysplasia suggest former group metabol rapid administ estradiol  although excret pattern patient fail respond estrogen treatment nonrespond differ greatest pattern associ benign diseas distinct pattern urinari excret isotop estrogen allow statist signific clinic use separ respond nonrespond subsequ estrogen therapi discov 
33  | local signific limit simultan visual form percept  patient present isol spell dyslexia impair pictur interpret simultanagnosia shown tachistoscop studi patholog limit simultan form percept  autopsi local lesion found within inferior part left occipit lobe  find discuss relat problem disord function under agnos alexia 
34  | visual anosognosia cortic blind anton symptom  denial blind case bilater hemianopia present acquaint ophthalmologist symptom well known neurologist rare seen opthalmologist 
35  | develop social attach infanc  report devot format develop social attach infanc  suggest core attach function repres tendenc young seek proxim certain member speci suitabl oper definit may found behavior individu depriv proxim  studi take form longitudin follow up  infant investig four week interv earli week end first year  month age  use attach scale base seven everyday separ situat follow three main paramet explor age onset specif attach intens attach number object attach form  measur fear of strang also includ  result indic age onset specif attach general found third quarter first year preced phase indiscrimin attach behavior intens specif attach increas first month follow onset thereaft fluctuat occur individu case make long term predict difficult multipl object found instanc begin specif attach phase becom rule remain case soon thereaft  correl attach variabl well fear of strang measur present examin also made condit elicit protest proxim loss manner protest express condit necessari termin protest  individu differ regard three main paramet explor subgroup  infant  number variabl examin relat individu differ suggest made regard condit affect manifest attach function  data discuss relat four theme emerg find natur attach function development origin development trend influenc social set 
36  | separ anxieti caus earli emot problem children  summari three case disturb behavior children discuss particular emphasi disturb feed sleep motil  hypothes present behavior develop signific attach behavior separ anxieti infant particular stress  difficulti mother care threaten child sens secur lead greater experi separ anxieti may reflect various disturb alter behavior  experi separ anxieti result earli life experi may reach patholog proport may account mani later problem children adult 
37  | product malign tumour nickel rat  powder metal nickel inject intramuscular rat produc tumour striat muscl origin well differenti 
38  | studi nickel carcinogenesi fraction nickel ultracentrifug supernat lung liver mean dextran gel chromatographi  chromatograph fraction perform ultracentrifug supernat homogen rat lung liver use column dextran gel sephadex g   major proport nickel tissu supernat demonstr firm bound macromolecular constitu  follow acut chronic inhal carcinogen level nickel carbonyl predomin increas concentr nickel observ macromolecular fraction  find consist previous demonstr nickel purifi prepar ribonucl acid rna sever rat tissu observ increas concentr nickel high molecular weight rna lung liver follow inhal nickel carbonyl 
39  | studi inhibitori effect ethylenediaminetetra acet acid thrombin fibrinogen reaction   ethylenediaminetetra acet acid revers inhibit thrombin fibrinogen reaction mean time depend diminut fibrinogen reactiv   alter fibrinogen due properti edta molecul unchel form due remov trace metal ion   possibl explan phenomenon discuss 
40  | intraderm test use cobalt chlorid  select group patient cobalt allergi nickel allergi well normal control test intraderm cobalt chlorid dilut    reaction wheal flare type appear first hour make  hour read mislead  papular respons cobalt chlorid  read   hour inject appear reliabl test cobalt allergi  patient combin nickel cobalt allergi exclud studi question group reaction discuss  nickel allerg give somewhat stronger reaction control slight impur cobalt chlorid  would prefer degre puriti cobalt chlorid ten time greater 
41  | measur nickel biolog materi atom absorpt spectrometri  atom absorpt procedur develop facilit quantit measur nickel biolog materi includ urin ribonucl acid rna serum protein  sensit detect nickel atom absorpt spectromet  ppm insuffici permit direct measur nickel normal urin  therefor necessari employ dimethylglyoxim extract procedur concentr nickel prior atom absorpt spectrometri  coeffici variat measur nickel urin human b  globulin   per cent respect  recoveri nickel ad urin averag  per cent rang   recoveri nickel ad human b globulin averag  per cent rang    mean concentr nickel  hr collect urin  normal subject  ug per  ml sd   rang    mean urinari excret nickel  ug per  hr sd   rang    mean concentr nickel  prepar ribonucl acid ultracentrifug supernat homogen rat lung  ug ni per gm rna rang    mean concentr nickel  prepar rna ultracentrifug supernat homogen rat liver  ug ni per gm rna rang    measur nickel perform upon fraction human serum protein prepar continuous flow electrophoresi cold ethanol precipit  highest concentr nickel found prepar serum b globulin 
42  | properti activ  nucleotidas human serum applic diagnosi  influenc mg  ni  l histidin purifi prepar bone intestin alkalin phosphatas  nucleotidas various mixtur enzym studi  extent find util quantit assay  nucleotidas serum evalu  result present possibl util l histodin simultan evalu serum alkalin phosphatas  nucleotidas activ 
43  |  iminoselenazolidin  on relat compound  seri  iminoselenazolidin  on selenazolidine  dion  alkylidenehydrazon synthesis  wide rang screen biolog activ fail reveal compound promis 
44  | influenc methemoglobinemia lethal toxic anion  azid  time cours extent methemoglobinemia induc intraperiton sodium nitrit p aminopropiophenon papp character femal mice  peak methemoglobin format   achiev  minut  compar level papp  mgkg achiev quick   minut declin rapid normal  nitrite  papp induc methemoglobinemia afford signific degre protect poison sodium azid administ appropri time sequenc  possibl circumst protect mice death fluorid cyanat thiocyan selen borat although prolong surviv time seen fluorid  format azide methemoglobin complex demonstr within intact mous red blood cell small amount complex identifi vivo antidot situat  think import protect action methemoglobinemia demonstr date establish inhibitor cytochrom oxidas 
45  | selenium trace element  account given discoveri selenium berzelius gahn toxic behaviour larg selenium quantiti soil upon veget anim man survey  review also given role trace amount selenium prevent myopathi anim  final recent theori import retin selenium vision mention 
46  | toxic inorgan selenium salt chick embryo  effect selenit selen treatment air cell inject mortal growth  day chick embryo   hour period studi  ld selenite s  ppm base weight egg content selenate s   ppm  growth depress evid treatment gross effect promin  treatment embryo selenit sulfat togeth caus greater mortal treatment selenit alon 
47  | lesion islet langerhan inject sodium selenit administ intraven  sodium selenit administ intraven rabbit dog repeat inject lead develop diabet syndrom rabbit  histolog examin pancrea poison anim dog rabbit shown exist lesion islet langerhan most b cell lose granul part complet  chang seem analog one produc alloxan two poison act first inactiv sh group lead defici b cell sensit 
48  | toxic sulfur  selenium tellurium avian embryo  continu intern irradi chick embryo sulfur  administ th th day incub produc abnorm similar observ selenium toxicosi avian embryo  highest level sulfur   uc inject egg contain  day embryo produc morpholog abnorm sever produc level radiosulfur administ  day embryo level stabl selenium toler  selenium level greater  ug kill embryo within  hour inject  near  time tellurium selenium requir kill embryo within  hour abnorm observ tellurium inject embryo 
49  | effect selenium upper respiratori passag  result report examin worker expos selenium special refer chronic chang respiratori passag  find report literatur  emphas occurr teleangiectasia uvula posterior palatin arc epigloti  describ occurr first poison selenium xyde countri  poison heal within day symptomat treatment  patient howev transfer anoth shop owe frequent symptom due toxic effect selenium  report also secondari find examin chronic chang emphas particular find profesion selenium extern otiti 
50  | influenc small selenit dose upon toxic fatti degener liver  sodium selenit  ugkg manifest lipotrop effect toxic rat tetrachlorocarbon  effect absent selenit dose increas  ugkg  level total lipid liver ethionin toxic signific influenc  ug selenitekg  increas  ug selenitekg
51  | selenium caus tumour    heterozyg rat administ  mg na seo per  kg food contain  protein surviv  month cancer liver metastas lung along sarcoma adenoma record  anoth seri yet incomplet experi anim fed higher quantiti protein selenium  toward   month three sarcoma note two sarcoma lymphat node one  mediastinum  suggest chang caus selenium compound extent due antagonist relationship methionin 
52  | blood bone marrow damag caus drug  drug side effect blood bone marrow briefli review  embrac wide varieti symptom pathogenet mechan recent year studi effect made import contribut knowledg immunolog biochemistri metabol blood cell 
53  | hypothermia physiolog effect clinic applic  survey background physiolog effect indic techniqu complic hypothermia present  applic techniqu straightforward safe use proper level proper indic 
54  | ehrlich ascit tumor cell agglutin interfer exert epsilonaminocapro acid eac acetyl deriv eaca  activ epsilon aminocapro acid eac acetyl deriv eaca studi antigen antibodi reaction membran antigen immun globulin  vitro eac eaca affect immun globulin alter membran antigen ehrlich ascit tumor cell inhibit agglutin reaction induc specif antiserum  inhibit partial due antigen alter observ repres promin direct interfer level antigen antibodi reaction  membran antigen altern induc drug nitrogen mustard compar take account toxic eac eaca found much activ specif nitrogen mustard 
55  | studi behavior tumor tissu diffus chamber penetr host cell tumor resist rat  tumour cell diffus chamber implant tumour resist rat destroy penetr immun host cell membran filter larg pore size use wherea filter small pore size tumour cell surviv remain virul 
56  | current status hypothermia  moder hypothermia recommend mani vari condit  today valu question light control group patient  moment use justifi certain cardiac oper circul may interrupt short period general surgic procedur massiv sudden blood loss may anticip neurosurg oper relax brain requir follow acut hypoxia seen cardiac arrest perhap therapi acut septicem shock  profound hypothermia associ extracorpor circul rest shakier premis valu major cardiac oper asystol requir certain neurosurg procedur complet interrupt circul indic  great hazard develop inadvert unrecogn hypothermia anesthet patient  monitor bodi temperatur import featur care patient oper theater recoveri room 
57  | hyperglycem coronari perfus effect hypothermia myocardi function cardiopulmonari bypass  seri  anim experi hyperglycem perfus heart gave signific protect anox heart  protect evalu ventricular function contractil forc studi observ aortic occlus    degre c  metabol data reveal consider myocardi glucos uptak higher coronari ph higher po lower pco glucose perfus group compar control  hypothesi protect effect may alter metabol pathway support myocardi enzym system associ high glucos concentr util 
58  | specif carcinoembryon antigen human digest system  wide varieti human adult fetal tissu studi immunodiffus techniqu agar gel determin whether contain tumor specif antigen previous found colon cancer  adult tissu demonstr ident antigen present test specimen malign tumor entoderm deriv epithelium gastro intestin tract pancrea absent test adult tissu  common antigen constitu therefor repres system specif cancer antigen human digest system  system specif cancer antigen previous demonstr human  experi fetal tissu demonstr ident antigen also present fetal gut liver pancrea   month gestat  compon name carcinoembryon antigen human digest system  basi present find recent work regard control express genet potenti various genet potenti various type cell conclud carcinoembryon antigen repres cellular constitu repress cours differenti normal digest system epithelium reappear correspond malign cell process derepressive dedifferenti 
59  | cours influenza virus infect mice organ tissu infect mice test electron microscop  use electron microscop presenc inclus could shown lung liver mice infect pr  strain  inclus contain particl size shape close resembl frequent seen form influenza virus  presenc inclus liver tissu might perhap speak possibl virus multipl organ 
60  | compar bone marrow studi use two aspir needl two biopsi site  bone marrow aspir wide use diagnosi hematolog diseas mani condit primarili affect blood system  number techniqu devis suitabl specimen marrow obtain relat littl discomfort patient  two needl set describ paper found equal reliabl obtain bone marrow microscop studi diagnosi  compar studi bone marrow aspir simultan iliac crest sternum  patient show signific differ  howev four instanc dri tap iliac site  fact addit observ less discomfort experienc patient sternum use might indic sternal area reliabl effici site obtain bone marrow  also observ studi patient experienc less discomfort univers illinoi needl use  major object use needl inabl obtain bone core biopsi 
61  | cell popul bone marrow normal guinea pig  quantit data obtain cell popul bone marrow normal g guinea pig base studi  anim  good agreement two independ group observ averag  nucleat cell per c mm found  total  lymphocyt  granulocyt precursor  nucleat erythrocyt precursor  whole bodi popul comput implic find discuss 
62  | pneumocysti carinii pneumonia case studi electron microscopi  paper deal clinicopatholog find  patient pneumocysti carinii pneumonia  first exampl  month old white femal infant without under diseas  second occur associ cytomegal inclus diseas lung  year old white woman receiv steroid therapi cytotox agent irradi thorax hodgkin diseas  electron microscop use studi morpholog organ tissu remov autopsi 
63  | effect dehydroepiandrosteron dehydroxycorticosteroid plasm various stage breast cancer mastopathi  depress effect dehydroepiandrosteron plasma corticosteroid averag shorten advanc breast cancer stage iv  lowest corticosteroid valu found three group patient  hour infus dehydroepiandrosteron phosphat  effect dehydroepiandrosteron still provabl  hour group suffer mastopathi breast cancer group stage iv time alreadi reach level initi valu  breast cancer group stage iv time alreadi reach level initi valu  breast cancer group stage iii behav intermedi  less last effect dehydroepiandrosteron attribut acceler transform advanc breast cancer 
64  | mean ph low temperatur extra corpor circul review temperatur gradient occur profound hypothermia made regard acid base chang general ph read particular  conclud term bodi mean averag core temperatur discard temperatur quot refer site measur  main circumst blood ph measur temperatur differ blood equilibr respiratori gase review describ chang occur tonometri experi  way fundament chang understood consid complic sequenc event take place live bodi  alter occur concentr protein bicarbon ion whole blood cool review togeth influenc correct factor  reason factor appli blood live bodi undergo hypothermia involv use extra corpor circul discuss  exampl numer valu blood ph two main method produc profound hypothermia one use autogen lung perfus pump oxygen given refer influenc pco upon valu  exist method acid bas measur appear suffici accur reflect metabol compon profound hypothermia 
65  | induc tumour resist rat  human sarcoma hs grown weanl rat treat cortison  growth modifi prior inject various tissu antigen  activ immun produc use human placenta embryon tissu antigen similar result obtain use suspens rapid grow human tumour  respons human tissu vari foetal muscl spleen activ wherea adult plasma inact except patient extens malign diseas  passiv protect produc use certain human sera time challeng hs  sera five women abort show characterist  pregnanc continu term antisubst found present puerperium two fifti case  group rat given rat embryon tissu antigen tumour challeng made walker tumour result variabl  benzpyrene induc tumour pure line wag rat effect obtain except isol case  experi mice use challeng irondextran induc mous sarcoma prior inject embryon mous liver placenta increas resist growth tumour tumour yet produc pure lin mous  hand mous experi use challeng crocker tumour prove negat  suggest immun reaction may play part caus abort 
66  | urinari steroid estim predict respons adrenalectomi hypophysectomi  clinic trial carri test use discrimin assess suitabl patient advanc breast cancer hypophysectomi adrenalectomi  patient posit discrimin submit hypophysectomi much better prognosi patient negat discrimin submit adrenalectomi  patient select adrenalectomi negat discrimin signific wors respons oper patient select random sampl  patient select hypophysectomi posit discrimin tend better respons oper patient select random sampl differ signific  adrenalectomi recommend patient negat discrimin 
67  | primari epidermoid cancer lung ultrastructur studi  earli epidermoid epithelioma human lung initi prolifer bodi cell whose structur analog medium cell andor modif basal cell normal bronchial wall  presenc desmosom tonofibril cell stratum germinativum bronchial epithelium cell deriv allow us better understand malpighian metaplasi wall give account epidermoid evolut bronchial epithelioma  certain nuclear cytoplasm modif suggest possibl causal virus 
68  | biosynthesi glycoprotein incorpor glucosamine  c liver plasma protein rat  shown glucosamine   c administ intraven fed rat rapid remov blood stream appear first trichloroacet acid solubl deriv tissu  follow convers macromolecul  least  administ compound recov tissu  liver far activ organ accumul glucosamin  rapid convert protein bound compon liver particul fraction microsom mitochondria releas plasma without appreci accumul solubl protein liver  conclud glucosamin transfer peptid chain glycoprotein stage protein releas liver particul fraction 
69  | acut experiment pneumococc type pneumonia mous migrat leucocyt pulmonari capillari alveolar space reveal electron microscop  preliminari studi experiment pneumococc pulmonari pneumonia mous leucocyt observ pass capillari interstiti tissu eventu alveolar space intercellular junction endotheli epitheli cell membran 
70  | light electron microscop studi develop respiratori tissu rat   light microscop observ develop rat lung shown presenc glandular canalicular alveolar stage   three stage identifi electron microscopi may present differ part lung one time eg   mm cr length   glandular stage lung tissu immatur appear light microscopi electron microscopi individu cell also immatur respect organell  glycogen present immatur cell   canalicular stage lung tissu becom vascular   throughout stage develop duct air space alway line continu complet epithelium blood vessel complet endothelium   lamel inclus bodi present epitheli endoderm cell earli stage develop   micropinocytot vesicl present larg number epitheli endotheli cytoplasm suggest foetus may indic absorpt amniot fluid alveolar space   mechan alveolar distens discuss natur remain uncertain   respiratori tissu rat fulli differenti birth import fact human infant discuss   adult blood air barrier consist epithelium zona diffusa endothelium vari thick  project perform whilst us receipt grant medic research council canada gratitud express  gratitud also express miss sylvia smith type manuscript 
71  | pathogenesi viral influenz pneumonia mice  pathogenesi influenz pneumonia mice studi electron microscopi  mice inocul  ld pr influenza virus kill vari interv inocul  observ light microscopi correl electron microscopi order evalu lesion produc  peripheri earliest lesion focal area edema alveolar line cell capillari endothelium interpos basement membran  caus appreci thicken blood air pathway  hypertrophi degener desquam alveolar line prolifer alveolar macrophag result complet consolid progress  week infect  central area lung affect somewhat differ   day infect noncili bronchiolar cell show consider hyperplasia endoplasm reticulum apic cytoplasm edema  viral particl matur lumen surfac cell releas bronchiolar lumen  bronchiolar cell ciliat noncili underw degener slough bronchiolar lumen  regener epithelium stratifi surfac cell elong flatten  peribronchiolar interstiti tissu gradual becam total infiltr cell most mononuclear type 
72  | studi age hors crystallin len gel contribut biomorphosi mammalian crystallin len  effect biomorphosi  dash continu materi chang chemic composit organ tissu  dash studi hors crystallin len respect amino acid content subject substanti variat cours life  shown electrophoret paperchromatograph method qualit composit hors crystallin lens remain quit within individu age stage occur quantit variat individu amino acid 
73  | role alveolar inclus bodi develop lung  develop alveolar epithelium man rat contain characterist inclus bodi heterogen structur basic consist system membran profil limit membran unit type  inclus bodi appear result focal cytoplasm degrad occur rapid chang cuboid alveolar epithelium  inclus bodi develop rat lung similar so cal lamellar transform mitochondria howev evid present suggest alter cytoplasm membran may involv process inclus bodi format  certain imag associ golgi complex interpret earli form inclus bodi  also evid inclus bodi enlarg accret membran final extrud alveolar space  inclus bodi form secret greater number late fetal life earli infanc ie time cuboid alveolar epithelium differenti matur flatten type  latter contain inclus bodi  basi morpholog characterist inclus bodi distribut acid phosphatas reaction conclud inclus bodi lysosom structur activ remodel develop alveolar epithelium  possibl interrelationship inclus bodi pulmonari surfact discuss 
74  | retin detach cataract keratoconus ocular symptom complex endogen eczema  refer person observ author describ ovular chang encount endogen eczema  besid cataract known occur alreadi long time retin detach keratoconus keratoconjunct still belong symptom complex 
75  | postur chang blood distribut relat chang cardiac output   cardiac output blood content indic sever part bodi measur  subject includ patient various diseas use extern radioisotop count techniqu  chang  paramet induc stand compar   averag chang blood distribut produc stand follow  decreas blood content lung    heart    increas thigh   statist signific  signific chang reveal head palm liver abdomen   cardiac output stroke volum decreas stand case  recent data ad report previous treat statist  averag decreas cardiac output    control case    case neurocirculatori asthenia    case hyperthyroid  differ signific control neurocirculatori asthenia  stand induc substanti increas cardiac output case idiopath nodal rhythm although remain doubt whether ordinari respons diseas   signific linear correl reveal per cent chang blood content thigh lung cardiac output stroke volum induc stand  minim blood shift observ latter extrem vice versa  impli follow reactiv heart might influenc postur transmur pressur vein capillari probabl adjust arteriol compens chang cardiac output
76  | compar studi glycogen content heart liver brain iodin treatment condit asphyxia  blood sugar level glycogen concentr heart brain liver rabbit treatment inorgan iodin depot insulin iodin insulin combin hostacortin hostacortin iodin combin examin  control group remain untreat  second test seri glycogen determin asphyxia trachea pinch three minut repeat  contrari brain glycogen content heart muscl depend upon blood sugar level  iodin treatment lower blood sugar becom notic also increas heart glycogen  liver glycogen show greater variat  level achiev test seri therefor show signific differ asphyxia signific lower glycogen three organ  preliminari treatment iodin succeed stop lower glycogen heart muscl brain  possibl caus phenomenon discuss 
77  | alter immunolog activ sarcoidosi  studi  patient sarcoidosi reveal evid immunolog alter impair delay hypersensit  transient impair respons lymphocyt cultur patient sarcoidosi phytohemagglutinin stimul found parallel clinic sever diseas  hemolyt activ serum complement increas  disproportion increas serum iga found characterist hyperglobulinemia sarcoidosi  observ indic alter immun respons may import pathogenesi sarcoidosi  simpl hypothesi specif kind interact infecti agent immun might result immunolog alter observ formul present 
78  | electron microscopi cytoplasm inclus within macrophag human tissu  fine structur inclus found within cytoplasm macrophag human lung spleen skin lymph node rectum describ  inclus appear concentr whorl lamella arrang around core  lamella construct discret parallel filament  inclus resembl current describ virus virus lik particl resembl asbesto bodi known atmospher pollut ingest  resembl lipid phase system well mast cell granul possibl inclus repres partial intracellular digest phagocyt tissu membran ingest mast cell granul respect  differ similar exist inclus bodi macrophag granul mast cell  variat could due alter mast cell granul morpholog macrophag ingest  cytolog distinct macrophag laden mast cell granul mast cell proper remain obscur requir addit experiment evid clear electron microscop differenti two cell type  exact natur high structur bodi remain specul
79  | histolog research len condit hypoxia chang mitot activ epithelium  effect hypoxia mitot activ cell len epithelium studi  rat strain weight  hypoxia obtain decompress chamber  result show mitot activ len epithelium depress examin altitud    particular mark reduct number prophas accumul metaphas observ  result examin statist standpoint discuss 
80  | rate chang carbon dioxid tension arteri blood jugular venous blood cistern cerebrospin fluid carbon dioxid administr   rate chang p arteri blood cistern csf measur follow  percent co administr eight anaesthet patient undergo routin air encephalographi  ventil maintain constant throughout procedur respir  three experi rate chang p jugular venous blood also measur   rise p vari   mm hg  final sampl blood csf taken   min start co administr five experi  time mean rise p  maximum rang   percent rise p  remain three experi final sampl taken  min rise p    percent arteri chang   increas p    percent arteri blood  chang p csf smaller jugular venous blood three experi  two experi final sampl taken  min start co administr increas p csf  percent  percent jugular venous blood  one experi final sampl taken  min increas p  percent rise p   delay follow start co administr rise p jugular venous blood csf  delay  min jugular venous blood csf vari   min mean    rise p blood csf exponenti  rise p experi consist fast compon time constant vari   min mean  slow compon time constant vari   mean   rise p p consist one compon  time constant chang jugular venous blood    min whilst csf vari   mean    probabl  percent increas ventil follow co administr due stimul area antero later surfac medulla sensit chang ph p mitchel et al   area superfici ventil affect chang p over csf  predict experi rise p co administr take  min complet  may explain slow rise ventil co breath compar rate rise arteri jugular venous p 
81  | studi compound lipid x ray irradi anim ii biolog biochem properti compound lipid x ray irradi rabbit organ  purpos clarifi caus x ray disturb seri experi conduct biolog biochem properti compound lipid extract normal x ray irradi rabbit organ special refer p  label compound lipid uptak inhibitori action l cell prolifer uncoupl oxid phosphoryl follow result obtain compound lipid lysophosphatid rich fraction isol x ray irradi rabbit organ found possess strong hemolyt action also action inhibit cell prolifer well acceler respir mitochondria rabbit liver spleen  also proven act induc mark swell mitochondria imped format high energi phosphat well act uncoupl oxid phosphoryl vivo  test see uptak p  label compound lipid various organ mark uptak observ spleen bone marrow liver irradi non irradi group  uptak p  label compound lipid rabbit given intraven inject compound lipid fraction  consecut day previous found greatest pancrea follow bone marrow spleen liver order mention male group wherea greatest spleen follow liver bone marrow femal group  result discuss conduct concern relat lipid metabol x ray disturb 
82  | cesium  uptak distribut human heart analysi cardiac scan  patient  proper use cesium  satisfactori agent studi cardiac morpholog photoscan believ use adjunct diagnost procedur patient result method evalu varianc clinic symptom cardiac diseas  studi report suggest perhap infarct subclin type size locat may occur earlier previous thought damag leav may detect mean autopsi techniqu scan  yet abl measur actual concentr cesium  heart autopsi cold cool area could examin histolog section 
83  | oxygen consumpt paralys men expos cold   oxygen consumpt carbon dioxid output measur human subject cool   min  two subject normal one almost complet paralys neck poliomyel two unconsci result intracrani damag observ without paralys dose muscl relax d tubocurarin gallamin   normal subject unconsci subject receiv drug cool oxygen consumpt carbon dioxid output rose   subject paralys diseas drug cool oxygen consumpt carbon dioxid output increas   observ consist view man increas metabol cool period  hr occur sole skelet muscl 
84  | heparin level hypotherm perfus   perfusion temperatur influenc rate heparin loss extracorpor circul therefor requir re heparin   heparin half liv approxim  hour  hour calcul perfus conduct averag temperatur   c respect   rate heparin loss extracorpor circul inconst individu variabl individu exact neutral requir accur estim heparin concentr present end perfus   protamin titrat test provid crude simpl satisfactori mean monitor free heparin level   complet neutral heparin import factor minim postop blood loss   protamin less effici neutral agent polybren dosag level  may effect divid dosag   rebound detect   case studi although one instanc degre like signific   signific prolong clotting tim result excess neutral agent evid studi 
85  | platelet sequestr man  method  current method label platelet chromium use ethylenediamin tetraacet edta anticoagul found caus rapid hepat sequestr near transfus platelet  return circul partial destroy spleen  less one third surviv  evid present indic edta injuri platelet  acid citr medium buffer plasma ph  use anticoagul   label platelet surviv averag   mark temporari sequestr occur  studi thrombocytopen person show circul platelet cr activ measur true surviv transfus platelet  surviv sequestr platelet studi normal subject  surviv data support concept platelet die chiefli process senesc  extern scintil scan various organ suggest normal major platelet destroy liver 
86  | acut leukemia associ phenylbutazon treatment review literatur report case  possibl toxic reaction phenylbutazon list review literatur haematolog complic shown  death attribut agranulocytosi aplast anaemia thrombocytopenia record  associ leukaemia phenylbutazon first suggest bean  amplifi report review  case histori present   patient acut leukaemia associ record possibl leukaemogen factor three three drug given short time leukaemia diagnos  howev remain nine histori phenylbutazon ingest may associ develop leukaemia  studi includ match control indic requir definit opinion given causal relationship drug diseas 
87  | absorb radiat dose excret cesium  human  data relat effect half lif absorb dose radiat excret rate cesium  present  cesium  excel materi cardiac scan sinc low amount radiat absorb  dash dose order one twentieth receiv diagnost x ray studi gastrointestin tract  absorpt radiat reduc administr thiazid type diuret probabl catharsi scan 
88  | radiocardiographi principl method  aa show import radiocardiographi method evalu cardiac output ventricular volum pulmonari blood volum  first paper particulari concern technic aspect import collect data  posit collim precordium inject isotop cathet behind ventricl near tricuspid valv select ratemet constant veloc paper record way read area curv special discuss  final present formula use calcul cardiac output ventricular volum pulmonari blood volum 
89  | reaction adren cortex control experiment hypothermia  stress reaction caus hypothermia studi rabbit subject control hypothermia immers icebath  anim re warm  anesthet anim pentobarbiton sodium nembut given intraperiton case follow ether anesthesia  stress reaction produc pentobarbiton alon studi five anim ether anesthesia alon three  anesthesia given three rabbit place refriger  variat distribut amount adrenocort lipid serv indic evalu stress reaction  hypothermia test occur chang distribut amount cortic lipid denot stress reaction brought hypothermia  rabbit barbitur seem inhibit stress reaction  may attribut part test anim part fact shiver extent alway occur hypothermia experi 
90  | use cross circul techniqu studi respiratori respons co  effect hypercapnia hypocapnia ventil investig cross circul dog recipi dog head neck region perfus blood donor dog  hypercapnia donor dog produc administ co  o  n gas mixtur inspir air  hypocapnia produc hyperventil donor dog aid respiratori pump  donor dog hyperventil ventil recipi maintain rest level independ arteri pco donor  donor dog apneic artifici hyperventil suspend respons abolish vagotomi  bilater vagotomi caus increas ventil recipi head perfus hypocapn blood  bilater remov carotid receptor influenc respons co qualit although reduct ventil recipi cephal hypercapnia  ventil recipi dog best correl ph pco cerebrospin fluid hypercapn hypocapn state 
91  | action phytohaemagglutinin vitro lymphocyt chronic lymphoid leukaemia  vitro action phytohaemagglutinin subject compar investig lymphocyt  normal subject  case chronic lymphat leukaemia  group cellular chang shown appear larg basophil nucleol cell show mitot activ  case lymphat leukaemia percentag cell undergo chang lower normal subject transform occur slowli  two phenomena strike higher initi leucocytosi  result suggest chronic lymphat leukaemia cell affect transform residu normal lymphoid element  leukaem lymphoid cell appear incap transform 
92  | demonstr ventricular aneurysm radioisotop scan  radioisotop scan cardiac blood pool intraven inject  label iodipamid carri  patient ventricular aneurysm   aneurysm could demonstr neither anteroposterior chest roentgenogram scan   aneurysm appar radiograph blood pool enter area suggest thrombus within aneurysm   aneurysm detect film also seen fill radioact scan  presum find show thrombus yet form  blood pool radioisotop scan appear anoth tool diagnosi ventricular aneurysm use also demonstr patient presenc absenc intralumin clot within aneurysm 
93  | propag lactic dehydrogenase elev virus cell cultur  primari cultur adult mous lung spleen liver mous embryo support multipl lactic dehydrogenase elev virus  cultur produc virus continu subcultur   time  correspond  week case lung spleen   week cultur embryo  viral multipl accompani cytolog alter cell chang rate synthesi nucleic acid protein  infect caus detect chang either product ldh releas cell 
94  | transform bovin cell vitro inocul simian virus  nucleic acid  cell bovin embryon lung tissu cultur inocul simian virus  sv  phenol extract high titer suspens sv   virus nucleic acid prepar induc prolif morpholog chang characterist sv  transform  non infect control cultur cultur inocul prepar nucleic acid expos dnase maintain condit infect cultur show regular fibroblast growth  cell line rapid grow transform cell obtain  attempt isol virus transform cell negat minut amount virus recov occasion passag 
95  | rapid transform human fibroblast cultur simian virus   risk system embol assess group  patient chronic rheumat heart diseas follow period  patient year  incid embol  per patient year whole group seven time higher atrial fibril sinus rhythm durat atrial fibril known found one third emboli occur within one month two third within  month onset atrial fibril  incid embol recurr  per patient year irrespect natur cardiac rhythm  recurr took place within  month initi embol episod  mitral valvotomi elimin danger embol  question whether reduc incid  anticoagul treatment reduc incid embol recurr 
96  | tissu reaction hyperbar oxygen  hyperbar oxygen damag tissu expos vitro sensit vari  exposur limit tissu may recov  effect appear depend oxygen tension rather rais pressur per se  tissu reaction may involv clinic applic hyperbar oxygen 
97  | attitudin factor congenit heart diseas  studi consid behavior implic congenit heart diseas pediatr patient sibl parent  effect diseas child sibl parent interplay among individu explor  impact physician diagnosi illustr induc signific chang famili attitud necessarili relat diseas sever child incapac  poorer adjust anxieti cardiac child relat high matern anxieti pamper degre incapac  matern protect pamper signific greater cardiac normal group highest cyanot group best predictor matern protect matern anxieti found addit variabl incapac child depend fail improv predict substanti  matern anxieti seem relat presenc rather sever heart condit 
98  | matern anxieti pregnanc adequaci mother child adjust eight month follow childbirth  fifti pregnant women administ batteri psycholog test  basi score obtain manifest anxieti scale pregnant women dichotom high anxieti group low anxieti group  eight month follow childbirth mother children seen psycholog assess  found women high anxious group evidenc signific negat childrear attitud  high anxious mother obtain signific higher score hostil control factor measur pari  basi examin rate mother person trait found women high anxious pregnanc receiv much less favor person rate time  month assess  moreov signific differ proport mother two group receiv favor rate examin basi observ mother child interact session  studi children mother found children low anxious mother receiv signific higher development quotient infant mental scale  keep find also obtain higher development quotient motor scale although aspect intellectu assess differ statist signific  also children low anxious mother tend receiv score indic favor general emot tone offspr high anxious mother  differ two group children statist signific  general find consist predict children rear women high anxious pregnanc would fare less well test intellectu develop indic emot adjust  find also keep predict high anxious women pregnanc would evid less desir parent attitud child earli develop would present less favor person pictur time approxim  month follow pregnanc 
99  | matern separ rhesus monkey  present studi involv separ eight monkey mother inf pair period two week measur behavior infant reunion mother mother reunion  infant show emot disturb respons separ drastic decreas play complex social behavior separ  clear infant moth separ produc emot disturb human macaqu infant pattern respons follow separ similar speci  result obtain studi monkey infant moth separ indic sheer physic separ crucial aspect matern separ monkey  undoubt factor associ separ mother vital import human children may account part absenc rariti detach stage seen human respons pattern separ monkey infant  overal result show consider similar respons human children infant monkey separ mother 
100  | ophthalmologist role manag dyslexia  dyslexia clinic entiti character subnorm read abil person averag averag intellig  diseas differ caus differ children  caus includ brain damag languag area hereditari predisposit ophthalm factor hyperopia muscl imbal aniseikonia visual immatur  emot disturb educ immatur cerebr domin may also play role etiolog condit  univers symptom poor read abil  howev case frequent associ symptom poor write difficulti read write number inabl read write music note disorient left right  mani patient develop person maladjust  visual field often reveal hemianopia  group poor reader larg percentag ocular neurolog psychiatr psycholog abnorm andor strong hereditari tendenc  degre read learn depend upon abil individu adjust psycho physiolog need present time reach read age school  compens abil present child reaction favor one may read well spite unfavor factor may becom poor reader  children recogn first year school  complet medic work up manag ophthalmologist  complet ophthalm examin first perform possibl visual anomali correct  ophthalmologist may want psychometr evalu neurolog opinion determin role organ brain damag psychiatr consult evalu emot disturb pediatr consult evalu status general health andor consult otolaryngologist determin patient hear abil  necessari inform hand ophthalmologist abl recommend correct medic therapi advis parent teacher avail remedi read aid  prognosi good patient sinc averag averag intellig near case help 
101  | unusu cours intern carotid arteri accompani bitempor hemianopia  case report bitempor relat hemianopia craniotomi show intern carotid arteri unusu cours correspond carotid siphon result chang shape optic nerv  abnorm carotid siphon could detect review carotid angiogram  evalu optic nerv relationship measur pneumogram indic optic nerv case expos compress abnorm arteri 
102  | frontal lobe vision  influenc frontal lobe vision discuss base present rather unusu case  oper right frontal brain abscess never led papilledema pronounc diminut visual capac patient gradual disturb regress point return full visual acuiti remain hemianop field defect  psycholog defect sens partial visual agnosia latter also regress well prompt discuss neuroanatom neurophysiolog observ pertin find patient  mani data fronto occipit connect subhuman primat point role frontal lobe area  develop visual disturb sens temporari hemianopia partial visual agnosia intellectu deficit  contrari singl observ anthropoid ape case would seem indic aforement combin symptom may origin frontal lobe hope prompt long term follow up studi similar patient  continu observ patient perhap other give possibl gain insight role frontal lobe vision assum anim 
103  | physiolog bitempor hemianopsia pregnanc  sever case bitempor hemianopsia occur late pregnanc present  patient illustr typic rapid progress cours rapid recoveri complet return visual field visual acuiti deliveri accomplish  presum patholog physiolog entiti briefli review 
104  | evok respons visual disord   erg ver record eyelid later occipit electrod respons diffus stroboscop stimul   normal subject ver found compos earli triphas potenti aris occipit region  wave present  percent subject wave ii  percent wave iii  percent later wave inconst contain compon vertex refer  overal asymmetri ver right left found normal subject although averag asymmetri smaller side compar larger  percent   monocular stimul contralater ver regular larger ipsilater reflect predomin retin represent tempor field   statist determin criterion  percent depress wave ii success identifi patient hemianop defect involv central  percent visual field tangent screen campimetri  latenc asymmetri six msec grossli asymmetr aberr wave form seen patient diffus cerebr diseas hemianop defect   sever diffus retin diseas associ alter loss erg ver stimul involv eye   optic nerv diseas indic bilater loss suppress ver stimul involv eye  erg normal   bilater prechiasm involv associ complet suppress ver  wave ii lost diseas probabl conclus demonstr   involv nasal retin fibr indic revers normal contralater preponder ver monocular stimul  chang observ chiasmal diseas   retrogenicul blind associ loss earli ver preserv late respons  nonspecif project felt contribut late cortic respons photic stimul 
105  | optokinet nystagmus occipit lesion  six case present invalid rule horizont symmetr optokinet respons indic vascular etiolog patient occipit lobe type hemianopia  convers rule experi still valuabl observ  asymmetri horizont optokinet respons accompani occipit type field defect strong indic mass lesion  optokinet nystagmus may help therefor corrobor evid diagnos occipit lobe tumor rule 
106  | anaphylactoid shock induc oral penicillin result gerstmann syndrom  anaphylactoid reaction oral penicillin  year old woman describ hour unconsci week confus left residu gerstmann syndrom  reaction less rare general suppos  symptomatolog treatment diagnosi mechan discuss relev literatur briefli review 
107  | disturb verbal bodi imag particular syndrom sensori aphasia   pto syndrom domin hemispher vari accord extent depth lesion angular supramargin area  mildest clinic syndrom consist vagu contralater sensori impair associ dyscalculia dysgraphia dyslexia difficulti name  extens lesion need caus wide varieti classic sign describ pariet lobe diseas among gerstmann syndrom usual found associ manifest pariet loss case   even extens corticosubcort lesion area lead complet disintegr name understand speech case      attent drawn difficulti aris lack differenti concret gnostic bodi imag abstract verbal bodi imag investig patient  aphas syndrom differenti disturb gnosi applic separ non verb method test elicit impair gnostic bodi imag  latter may well compens appar unimpair presenc aphas syndrom limit verbal bodi imag   disturb speech pto lesion investig along quantit scale impair repetit understand name show regular interrel  nomin affect understand less affect  repetit best preserv function case    interrel function found regard verbal bodi imag  howev understand name part bodi show far greater disintegr understand name categori word case present  aphas syndrom subsid finger aphasia minor disturb verbal bodi imag associ acalculia may persist case   thus gerstmann finger agnosia may repres partial impair verbal bodi imag limit finger aphasia   assum verbal bodi imag differ categori verbal symbol owe main propriocept vestibular tactil experi form specif physiolog background  telerecept experi minor import initi develop understand word defin bodi imag  patient describ select wors aphas impair verbal bodi imag compar categori word seem confirm assumpt 
108  | chromosom pattern cancer patient treatment  radiat damag chromosom human cell short term cultur white blood cell damag assess  patient cancer select studi larg portion blood form tissu irradi cours treatment  chromosom damag may quantit variat normal number  qualit therebi show structur aberr  count chromosom cell cultur grown prior therapi interv treatment enabl us determin variat  stain prepar examin microscop allow us recogn abnorm appar radiotherapi  damag appear larg random chromosom affect differ cancer specif aberr differ cell cell  howev seem correl appear persist aberr chromosom frequenc  peak incid plateau may remain unchang frequenc may chang 
109  | interest neurolog manifest migrain  migrain complex vascular phenomenon presum genet origin chang induc either vasoconstrict vasodilit produc interfer neurolog system result mani bizarr alarm clinic pictur  exampl interest neurolog manifest shown 
110  | visual neglect  clinic traine nurs psycholog boston colleg simmon colleg boston mass collect data observ patient direct author pilot program design measur visual spatial neglect develop rehabilit materi  measur exercis might also use nurs care patient cerebr vascular accid  divers daili activ patient becom involv hospit provid indic extent compensatori visual neglect therapeut effect  formal estim obtain re administ batteri visual neglect test period interv  nurs personnel adopt program therapeut must bear mind patient suffer cerebr insult usual less adapt nonbrain injur peer  develop new habit pattern slowli regress often follow appar fixat adapt level respons habitu  howev experiment inquiri shown dimens behavior differ brain injur adult normal adult one degre rather kind  dash differ skill nurs often reduc 
111  | respiratori chang open heart surgeri  patient undergo cardiac surgeri extracorpor circul develop signific alveolar arteri oxygen tension differ venous admixtur earli post op period   abnorm due anatom right left shunt lung remaind like due ventilation perfus inequ  chang appear complet revers  cardiopulmonari bypass procedur may respons initi under patholog sinc chang magnitud found cardiothorac surgeri patient techniqu requir
112  | cardiac malform associ ventricular septal defect  studi  necropsy prov case ventricular septal defect associ anoth anomali part recogn complex select  associ anomali classifi  obstruct posit anomali great vessel  anomali respons addit shunt  anomali caus intraventricular obstruct  aortic valvular insuffici  clinic find often ventricular septal defect find relat associ lesion frequent obscur  even special studi includ cardiac catheter angiocardiographi often failur arriv complet diagnosi  find led erron incomplet diagnosi present  complet diagnosi made preoper procedur lead outlin  diagnost approach vari malform may coexist ventricular septal defect observ aortographi select left ventricular angiocardiographi common help identifi occult malform associ ventricular septal defect  therefor recommend complet studi includ left sid cardiac catheter left ventricular angiocardiographi aortographi consid case clinic electrocardiograph right sid cardiac catheter studi entir typic isol ventricular septal defect 
113  | anatom type singl common ventricl man morpholog geometr aspect  necropsi case   necropsi case singl common ventricl man four major unrel ventricular malform found  absenc right ventricular sinus  case  percent design type  absenc left ventricular sinus  case  percent type b  absenc rudimentari develop ventricular septum  case  percent type c  absenc ventricular sinus ventricular septum  case  percent type  three type relationship great arteri present normal solitus interrelationship  case  percent design type  d transposit transpos aortic valv lie right dextro relat transpos pulmonari valv  case  percent type ii l transposit transpos aortic valv lie left levo l relat transpos pulmonari valv  case  percent type iii  none inversus interrelationship type iv display  three type viscer atrial situs found solitus normal  case  percent inversus exact appar mirror imag normal  case  percent heterotaxi uncertain viscer atrial situs associ asplenia  case  percent   case classifi segment accord anatomi three cardiac segment great arteri ventricular sinus atria  classic singl ventricl rudimentari outlet chamber found morpholog larg left ventricl right ventricular infundibulum sinus right ventricl absent type  myocardium right ventricular infundibulum right ventricular sinus left ventricular sinus identifi distinct gross morpholog characterist  plane atrial ventricular septa relationship great arteri semilunar valv measur project upon horizont plane relat anteroposterior line  approach cardiac anatomi present segment morpholog geometr  approach angiocardiograph electrocardiograph embryolog applic 
114  | congenit heart diseas adult  event natur cours  adult patient prove signific congenit cardiac anomali review determin incid longev complic caus death  atrial septal defect patent ductus arteriosus frequent encount lesion compris one third entir seri  ventricular septal defect pulmon stenosi made almost quarter group  twenty two instanc eisenmeng syndrom secondari varieti shunt lesion includ  bacteri endocard sudden death cardiac decompens greatest threat patient  symptom minim appear heart failur common caus death especi older patient  sudden death occur often patient ventricular septal defect  although clinic featur usual characterist congenit malform young adult acyanot congenit heart diseas often misdiagnos rheumat older patient present manifest frequent attribut arteriosclerot heart diseas  time associ acquir cardiovascular disord may alter basic syndrom  three quarter patient surviv continu observ abil mani live activ product live withstand stress surgeri cardiac non cardiac pregnanc impress  observ patient congenit heart diseas without surgic intervent essenti accur evalu long term efficaci cardiac surgeri 
115  | studi ventricular septal defect associ aortic insuffici  clinic electrocardiograph radiograph hemodynam find  children combin ventricular septal defect aortic insuffici present  left to right shunt determin small moder signific aortic insuffici document aortographi  patient  clinic indic aortic insuffici manifest aortic diastol murmur first appear averag age  year  patient concomit widen puls pressur   progress left ventricular hypertrophi note electrocardiograph progress cardiac hypertrophi aortic dilat x ray examin  patient  progress hemodynam disabl appear common childhood howev 
116  | ventricular septal defect aortic regurgit clinic hemodynam surgic consider  clinic hemodynam angiograph anatom find fifteen patient ventricular septal defect complic aortic regurgit present  combin malform aortic regurgit acquir result prolaps aortic valv leaflet septal defect  strateg locat septal defect relat aortic leaflet appear import develop complic size defect magnitud shunt  onset aortic regurgit occur earli childhood present tend becom sever  care observ patient defect indic follow appear aortic regurgit sinc rapid progress sever left ventricular failur uncommon  ventricular septal defect aortic regurgit must distinguish cardiovascular abnorm produc wide puls pressur continu to and fro murmur  cardiac catheter thorac aortographi diagnost procedur help differenti  oper treatment ventricular septal defect aortic regurgit review basi present previous report result suggest plan surgic manag present 
117  | current techniqu surgic approach aortic mitral valvular diseas   aortic mitral valv oper upon success total replac prosthet devic ball valv type good long term result  seventy four case report   aortic valvular diseas outcom immedi postop period influenc primarili presenc calcif aortic stenosi well presenc absenc diseas coronari arteri   signific decreas appear low output syndrom postop patient suffer sever mitral diseas leav papillari muscle chorda tendineae mur leaflet relationship intact  feel add strength contract   late death follow up period date thirti month patient replac aortic mitral valv ball valv prosthesi 
118  | effect aortic regurgit left ventricular perform direct determin aortic blood flow valv replac  volum regurgit blood flow effect perform left ventricl assess oper  patient vari degre aortic regurgit  instantan forward regurgit flow ascend aorta measur sine wav electromagnet flowmet simultan left ventricular aortic pressur  eight patient aortic regurgit without associ stenosi   percent total forward stroke volum regurgit succeed diastol  calcul regurgit orific area rang   cm  replac aortic valv starr edward prosthesi absenc regurgit flow prove everi patient record aortic blood flow close resembl seen patient normal aortic valv  net forward blood flow increas averag  percent total left ventricular stroke volum fell  percent mean aortic pressur rose  percent  pressur work left ventricl elev preoper five eight patient averag  g m strokem  fell signific averag  g m stroke valv replac  kinet ventricular work high seven eight patient compris  percent total work replac  percent afterward  similar observ made five patient aortic stenosi associ aortic regurgit rang sever   percent total forward stroke volum  four patient valv replac residu regurgit present afterward net forward flow rose averag  percent  kinet left ventricular work extrem high everi patient averag  percent total work preoper  percent valv replac  group pressur work variabl oper  studi describ provid definit inform concern effect aortic valv diseas left ventricular perform man document favor chang flow pressur left ventricular work immedi follow aortic valv replac 
119  | absorpt hepat uptak oral ingest radioact vitamin b hepato splen bilharziasi  absorb plasma radioact hepat uptak oral ingest vitamin b tag co measur  subject  normal  suffer bilharziasi  result present work indic absorpt hepat uptak vitamin within normal limit hepatosplen bilharziasi irrespect stage diseas size organ affect presenc absenc associ peripher neuriti 
120  | earli effect digitali central hemodynam normal subject  intraven administr lanatosid c  normal subject follow effect  earli signific reduct heart rate   signific transient reduct cardiac output   signific increas stroke volum initi accompani signific rise end diastol volum unchang systol rate empti  increas end diastol volum seem relat lengthen diastol fill period  later systol empti rate increas ventricular volum decreas suggest inotrop effect drug   signific increas pulmonari blood volum parallel increas stroke volum suggest passiv relat two variabl 
121  | measur pericardi fluid correl  cholografin ihsa heart scan   patient undergo open heart surgeri pericardi content accur measur  addit patient examin autopsi pericardiocentesi isotop photoscan heart made result correl  accur mean diagnosi pericardi effus found ratio maximum transvers cardiac diamet scan roentgenogram  patient less  cc pericardi fluid ratio greater  less case effus  cc  measur differ diamet visibl separ cardiac blood pool pulmonari vasculatur liver aid diagnosi  pericardi effus   cc greater detect isotop photoscan  although cardiac dilat andor hypertrophi decreas sensit techniqu somewhat definit diagnosi pericardi effus made even cardiomegali exist 
122  | aneurysm membran septum   aneurysm membran septum relat rare lesion presum develop congenit basi  aneurysm origin left ventricl immedi beneath aortic valv bulg right ventricl septal leaflet tricuspid valv right atrium   mani aneurysm produc symptom  other may caus right ventricular outflow tract obstruct may ruptur result septal defect  result shunt left ventricl right atrium ventricl   aneurysm membran septum may isol abnorm associ congenit cardiac defect particular aortic valvular insuffici  membran septal aneurysm may site bacteri endocard thrombus format   aneurysm resembl aris membran septum may occur part complex deform produc endocardi cushion defect  howev angiograph featur diagnost cushion defect still recogn   presenc septal aneurysm establish angiocardiographi  diagnost featur seen left ventricular angiocardiogram present 
123  | distribut transfus tritiat cytidine label leukocyt red cell bone marrow normal irradi rat  normal rat total bodi irradi  r x ray fate bone marrow label nucleat red cell transfus peripher blood observ autoradiograph  label nucleat cell lymphocyte lik cell readili migrat marrow parenchyma normal anim  cell  parenchym cellshr  follow irradi least   hr migrat appear relat increas  beyond time parenchym area difficult defin  label red cell rare observ enter parenchyma despit presenc nonlabel erythrocyt within parenchym structur irradi  vascular bed follow irradi increas great parenchyma diminish minimum less  percent control  hr  despit chang architectur marrow averag densiti label cell per area marrow correspond valu expect assumpt free flow circul  techniqu use present allow us distinguish time free flow circul intact sinusoid area sinusoid wall destroy 
124  | factor limit surviv circulatori occlus hypothermia hyperbar oxygen  thirti minut circulatori occlus mild hypothermia hyperbar oxygen ventil result mortal  percent anim  coronari perfus reservoir ad mortal rate  percent  ventricular fibril much easili revers coronari perfus  evid brain damag survivor lead conclus brain toler circulatori arrest better heart condit 
125  | effect hypothermia circulatori reflex human  total circulatori occlus releas result hemodynam phenomena provid index integr cardiovascular reflex  includ carotid sinus aortic baroceptor arteriolar vasomotor tone venomotor reactiv  baroceptor depress appear moder level cool sympathet vasomotor depress   degre c signific depress although probabl total abolish  level  degre c critic physiolog level may repres import limit clinic use hypothermia 
126  | studi perfus hypothermia special refer deep hypothermia circulatori arrest   perfus hypothermia produc larg temperatur gradient within bodi sinc organ cool rough proport basal blood flow  differ coldest warmest portion bodi  minut perfus exceed  c   averag bodi temperatur provid proper measur total bodi cool may calcul arterioven temperatur differ extracorpor flow rate   true deep hypothermia obtain reason period perfus alon   import rise core temperatur occur circulatori arrest hypothermia relat high averag bodi temperatur   high averag bodi temperatur lead continu product lactic acid muscl tissu wherea low core temperatur impair lactic acid metabol  thus metabol acidosi progress prolong perfus hypothermia accentu total circulatori arrest  progress acidosi may minim uniform profound cool combin extern perfus hypothermia   diluent appear littl effect total bodi heat exchang perfus cool   perfus warm differenti greater effect core organ  though readili brought normal rang much anim may remain cold 
127  | applic emiss spectrograph analyt need industri hygien laboratori  exampl uniqu applic principl emiss spectroscopi industri hygien problem provid  discuss qualit semiquantit quantit method spectrograph analysi present  method includ repres applic made analysi metal constitu bodi tissu fluid human anim subject industri process materi ore environment dust fume  brief descript sampl prepar techniqu requir success analys also present 
128  | nickel carbonyl detect potenti format  recent recommend control nickel carbonyl exposur consid design simpl sensit field method sampl nickel carbonyl air process gase  method involv collect dilut aqueous hcl ph adjust nickel complex develop alpha furildioxim extract chloroform  color intens compar visual greater accuraci spectrophotometr liquid standard  sensit order  ppm obtain  detail develop thermodynam associ format nickel carbonyl also present show maximum concentr nickel carbonyl may form wide rang co concentr temperatur pressur 
129  | polarograph determin heavi metal air sampl  polarograph possess requir sensit specif make method choic analysi varieti heavi metal air  two commerci polarograph compar found adequ basi analysi lead  determin may made antimoni copper lead cadmium chromium nickel cobalt manganes other 
130  | inorgan constitu human teeth bone examin x ray emiss spectrographi  x ray emiss spectrographi appli studi element composit human teeth enamel dentin bone  materi consist eight crush teeth enamel dentin powder separ eighteen teeth four piec buccal cortic mandibular bone  teeth fill  whole materi contain nineteen element main one calcium phosphorus  sampl tooth materi found ca p cl fe zn sr k bone also contain ni  time need semi quantit analysi compar favour need method 
131  | kinet studi nickelii complex sulfur contain amino acid rate express ethylenediaminetetraacet acid edta ligand exchang reaction nickelcystein rate  kcomplex  kedta complexedta  two term rate express characterist squar planar complex agre squar planar configur nicystein report basi spectral studi edta independ term rate express acid catalyz term written k h complex  valu kn  x  sec valu kedta order    sec  edta reaction nicystein methyl ester similar reaction nicystein  sulfur contain amino acid ligand contain thiol ether kinet differ strike  ligand exchang reaction edta triethylenetetramin diethylenetriamin nickel methionin complex sever order magnitud faster give product mixed ligand complex  result kinet studi amino acid complex contain sulfhydryl thiol ether sulfur group support studi equilibrium suggest sulfur coordin squar planar complex sulfhydryl group octahedr complex sulfur coordin thiol ether 
132  | action metal ion tobacco mosaic virus ribonucl acid  ad transit metal ion stabil secondari structur tobacco mosaic virus ribonucl acid tmv rna evidenc reduct absorb chang heat nucleic acid solut  spite stabil secondari structur heat presenc metal ion result loss biolog activ due hydrolysi phosphodiest bond  thus heavi metal ion iib first transit element studi caus rapid loss biolog activ tmv rna ph    calcium magnesium ion affect secondari structur  ph  caus rapid loss biolog activ  ph  room temperatur lead ion catalyz hydrolysi rna i  mononucleotid long stand nucleosid form 
133  | chromium lead cadmium nickel titanium mice effect mortal tumor tissu level   mice given throughout live  ppm cadmium lead chromium nickel titanium drink water fed diet defici cadmium low metal  tissu concentr compar man observ  sex differ appear  mortal femal unaffect  mortal male cadmium lead nickel increas compar chromium group cadmium lead compar control  longev oldest  sex less lead titanium group male cadmium group compar control  metal carcinogen incid tumor male cadmium lead femal given nickel decreas  bodi weight death greater titanium chromium lead group  larg increment titanium moder increment cadmium nickel lesser increment chromium lead observ  organ compar control  higher concentr cadmium titanium occur younger mice metal increas mark tissu age  metal except chromium exhibit one sign innat toxic 
134  | synergist effect antioxid selenium vitamin e  sever antioxid fed chick relat high level experiment diet ineffect prevent exud mortal combin defici selenium vitamin e  compound toxic evidenc sudden death subcutan hemorrhag  amount either selenit a tocopheryl acet individu littl effect symptom given antioxid sign defici mortal prevent toxic also elimin 
135  | express urin analysi result  dash observ use specif graviti correct  urin analys use measur extent exposur certain toxic substanc  type specimen obtain person employ industri effect concentr variat discuss  express result analysi shown concentr correct essenti  correct base specif graviti easiest appli  mean specif graviti person resid uk found around  figur consider lower mean  use mani worker particular usa  implic result urin analysi indic 
136  | activ inactiv p hydroxyphenylpyruv hydroxylas   p hydroxyphenylpyruv hydroxylas ec  revers inactiv dialysi storag purif involv ammonium sulfat fraction treatment oxid agent  inact enzym reactiv various reduc agent   metal chel agent inhibit enzym activ    phenanthrolin  diphenyl  phenanthrolin fe sensit strong inhibit  dimethyl  phenanthrolin cu specif   phenanthroline tr p hydroxyphenylpyruv hydroxyl  ase reactiv specif fe presenc reduc agent indic role fe enzym activ   nonoxid sulfhydryl reagent materi inhibit enzym activ various condit 
137  | respons b subtili atcc  streptomycin  observ detail influenc streptomycin growth sm depend type author chose b subtili atcc  made experi respons streptomycin special refer relat sm concentr spore format sm depend type togeth germin outgrowth spore form  result follow   among x cell wild type b subtili atcc   cell sm resist one cell sm depend found mutant   b substili atcc  show normal growth sm concentr  rml growth declin rapid sm  rml  rm l growth stop entir sm concentr  rml   sm resist type grow well sm  rml sm  rml growth declin rapid sm  rml   sm depend type show normal growth sm  rml  rm l growth get worth sm  rml cell shape elong sever time sm  rml cell becom filament form sever ten time length normal cell cell stop divid low sm concentr   germin outgrowth spore sm depend type slow declin sm concentr germin spore grow normal form sm concentr reach  rml germin becom much slower cell grow filament form irregular form  extrem low sm concentr germin outgrowth near stop 
138  | phospholipid bovin rabbit human len  phospholipid bovin rabbit human lens contain cephalin lecithin sphingomyelin distribut differ speci  suggest evid may also plasmalogen len repres minor phospholipid compon  fatti acid composit phospholipid differ speci differ center around    
139  | surgic aspect heart diseas pregnanc  ideal manag pregnant woman heart diseas medic feasibl  oper experi mitral valvulotomi pregnanc expand  procedur indic progress cardiac disabl develop first second trimest proven domin lesion mitral stenosi  lesion present especi requir pump oxygen perfus risk must care measur  damag fetus may result reduc placent blood flow 
140  | traumat lesion optic chiasma report four case  case histori four patient suffer sever head trauma result complet bitempor hemianopia present  optic chiasm visual one patient  mark swollen disintegr  appear consist multipl minut tear cross fibr median sagitt plane  theori explain bitempor field defect discuss 
141  | lung cancer evolutionari approach  lung cancer present exampl somat mutat  contrast previous theori follow defin major growth control mechan b mutat found cancer c environment chang lung patient smoke cigarett select mutant 
142  | effect electrophoret separ len protein len regener diemyctylus viridescen  present studi lens remov eye adult anesthet newt macer  borat buffer ph  separ starch gel electrophoresi  upon stain amido black  b seven distinct stain area appear block  three band move toward anod three toward cathod  addit seventh moieti repres smear materi move toward anod one millimet time five tenth millimet plug remov area place fresh lentectom eye  plug strong posit weak negat protein inhibit len regener  addit plug area contain weak negat protein induc either lens aberr polar doubl center lens center oppos polar  protein band signific effect regener  addit experi homogen proteinasedigest homogen lens inject eye follow lentectomi  three  ul sampl inject case six day period  inject plain homogen stimul len regener mark proteinas destroy stimulatori activ  theoret consider data discuss 
143  | enzym synthesi deoxyribonucl acid xviii repair partial single strand dna templat dna polymeras  partial single strand dna prepar limit digest strand exonucleas iii restor nativ fulli double strand structur escherichia coli dna polymeras  rate synthesi observ repair partial degrad primer polymeras system faster seen nativ dna  newli synthes dna coval attach primer  fulli repair dna resembl origin nativ dna judg appear electron micrograph cscl density gradi analysi denatur genet activ  dna synthesi follow repair phase produc structur coval link primer resembl nondenatur branch appear lack genet activ product obtain nativ dna primer schildkraut richardson  kornberg  
144  | mechan genet recombin transform bacillus subtili  molecular fate transform dna compet bacillus subtili studi  physic differenti transform dna genet materi recipi bacteria effect employ isotop n p  compet bacteria label n p allow incorpor n p label transform dna intracellular  dna isol recipi cell centrifug cesium chlorid  analysi drop fraction collect equilibrium show presenc radioact region densiti correspond recipi dna  materi contribut donor dna resid dna occur genet inert bacillus cereus dna substitut homolog dna  conclud radioact appear unlabel resid dna result degrad input  pdna subsequ incorpor normal metabol process  sinc single strand dna donor origin detect evid non specif aggreg donor recipi dna conclud observ physic associ transform recipi dna occur result genet recombin transform b subtili 
145  | physic biolog studi transform dna  bacillus subtili transform dna prepar method describ averag molecular weight  million  dna heterogen judg chemic composit thermo spectr pyenograph properti  properti use fraction biolog activ molecul show higher specif activ transform respect auxotroph 
146  | comparison mutat inactiv rate induc bacteriophag transform dna various mutagen  inactiv mutat rate measur phage bacillus subtili transform dna treat low ph nitrous acid hydroxylamin differ temperatur  frequenc mutant increas linear time three agent wherea logarithm surviv gave linear plot nitrous acid low ph  arrhenius plot show slope inactiv mutat rate treatment low ph nitrous acid latter agent slope remain unalt even dna treat denatur state  contrast mutat rate obtain exposur hydroxylamin differ great nativ denatur dna phage intermedi  treatment low ph nitrous acid interrupt genet linkag tryptophan histidin interrupt hit  frequent lethal hit independ temperatur 
147  | autolysi bacillus subtili glucos deplet  cultur minim medium rapid lysi cell bacillus subtili observ soon carbon sourc eg glucos complet consum  cell die ultraviolet absorb materi excret medium  result suggest cell lyse presenc autolyt enzym  presenc glucos damag cell wall caus enzym repair immedi 
148  | plasma  hydroxycorticosteroid  oxosteroid patient breast cancer normal women    hydroxycorticosteroid  ohc  oxosteroid measur plasma normal women patient earli breast cancer patient advanc metastat diseas   mean plasma  ohc level found normal earli stage diseas rais advanc diseas  group patient varianc signific greater normal women   mean plasma  oxosteroid level earli advanc breast cancer signific differ normal level varianc increas   signific correl plasma  ohc  oxosteroid normal women found cancer patient   patient advanc breast cancer level plasma   oxosteroid signific correl amount  deoxy   oxosteroid found urin  correl plasma urinari  ohc   physiolog signific find discuss 
149  | hormon therapi metastat breast cancer clinic respons urinari gonadotrophin  total urinari gonadotrophin output group post menopaus women metastat breast carcinoma undergo hormon therapi everi case initi consist treatment diethylstilboestrol des ca  mgd studi period vari seven month  year  correl gonadotrophin output clinic respons found except case show object regress urinari gonadotrophin remain low throughout remiss period  low level gonadotrophin output howev necessarili indic good clinic remiss  follow withdraw des independ period therapi recoveri pre treat level rule rather except  small group patient maintain lower dose des   mgd show degre suppress urinari output receiv  mgd sever exhibit object remiss  studi emphasis import site specif respons hormon therapi underlin difficulti relat clinic respons patient whole chang hormon environ 
150  | plasma androgen women normal non hirsut femal oophorectom adrenalectom patient   group  normal non hirsut femal age    non  hirsut patient vari genito urinari disord  oophorectom adrenalectom patient plasma testosteron measur method finkelstein et al   conjug androsteron conjug dhea determin modifi method migeon  plager    mean baselin valu normal femal   ug ml testosteron   ug ml conjug androsteron   ug ml conjug dhea  signific respons hcg could seen dexamethason affect conjug dhea signific seem affect conjug androsteron testosteron   non hirsut patient show essenti pattern  effect dexamethason level conjug androsteron demonstr   oophorectom women baselin valu conjug rang normal  testosteron howev low averag  ug ml  adrenalectom patient androgen detect 
151  | oophorectomi cortison treatment method elimin oestrogen product patient breast cancer  urinari excret oestron oestradiol b oestriol   hydroxycorticosteroid estim  premenopaus  postmenopaus women breast cancer various stage diseas therapi  deplet oestrogen excret caus oophorectomi combin cortison treatment studi patient metastasis breast tumour  premenopaus  postmenopaus subject  patient dissemin breast cancer excret signific larger quantiti oestriol healthi women age whether pre  postmenopaus  excret oestron oestradiol b similar cancer patient healthi women correspond age  oophorectomi reduc oestrogen excret premenopaus subject also quit number postmenopaus patient particular still excret signific amount oestrogen  decreas oestrogen output transient follow compensatori increas possibl adren origin  cortison administ within month oophorectomi dosag  mg per day rapid depress secondari rise oestrogen output level   ug h irrespect age patient  excret level unchang long cortison given adequ dose increas rapid cortison treatment discontinu  oophorectomi combin adequ cortison treatment seem offer altern extens surgic porcedur undertaken elimin oestrogen product breast cancer patient 
152  | reaction cytotox antibodi previous unknown mous isoantigen  antiserum produc chhe chst lymphosarcoma ched contain mixtur least two antibodi differ properti specif  anti h a hemagglutin antibodi remov absorpt red cell mani tissu  anti v cytotoxin react chst tissu ched red cell reciproc antiserum chst anti chhe sarcoma mcm complex  contain hemagglutinin anti h a varieti cytotoxin  one appear specif chhe tissu tumor mcm  anoth react antigen chgo carcinoma bp two addit cytotoxin may also present  immun sublin inbr strain result product varieti antibodi direct unrel antigen present even long transplant cell  signific
153  | valu thymectomi adult mice mean potenti immunosuppress action melphalan l phenylalanin mustard  thymectomi found ineffect mean potenti immunosuppress action melphalan adult cba p mice challeng a strain mammari carcinoma transplant  true thymectomi perform  day  week  week prior inject singl dose  mgkg bodi weight melphalan administ  hour prior tumour transplant also thymectomi combin multipl dose melphalan given tumour transplant  find discuss 
154  | studi kinet transplant immun  use paramet number tumor cell necessari produc sc tumor allogen anim vari interv antigen stimul immun found forc earli  day primari antigen stimul  reach peak   day larg subsid end month  method also appli quantit studi onset degre durat immun elicit skin graft  result obtain inocula larg number tumor cell  percent compar obtain massiv skin graft  differ degre antigen stimul result differ rout inocul studi  found intraderm id rout inocul result intens antigen stimul sc rout  rout inocul use simultan pattern growth sc tumor influenc id inocul id inoculum given   hr earlier caus mark suppress growth sc tumor id inocul preced sc inocul although appreci effect growth size growth curv  tumor alway parallel  correl cytotox activ degre immun forc given time 
155  | evid immunolog reaction host direct activ grow primari tumor  cell isol primari benzoapyrene induc fibrosarcoma rat pure line test abil grow autograft inject back autochthon host  autograft take primari tumor remov grew occasion anim major part tumor left  everi instanc sarcoma cell grew inject syngen recipi recipi growth sarcoma cell prevent retard mix vitro prior inject spleen cell anim immun tumor  autochthon spleen cell taken anim tumor behav test like immun anim long spleen taken  week remov tumor  spleen tumor remov time howev autochthon spleen cell behav like spleen cell immun anim interfer growth tumor  result autograft spleen cell experi suggest rat react activ grow primari tumor tumor exhaust suppli lymphocyt respons reaction  tumor remov concentr antitumor lymphocyt spleen build anim reject autograft  j nat cancer inst     
156  | comparison cytolog effect leurosin methiodid vinblastin tissu cultur  comparison degre durat arrest metaphas tissu cultur cell leurosin methiodid vinblastin made colchicin demecolcin includ refer purpos  four drug produc similar cytolog effect vinblastin activ remain activ longest period time 
157  | comparison central aortic peripher arteri pressur curv  brachial arteri central aortic pressur compar  consecut patient subject retrograd left heart catheter order re emphas fact two pressur necessarili ident   case system systol pressur peak exceed central aorta seven pressur equal  averag pressur differ  mm hg  greatest differ occur case aortic regurgit could extrem brachial arteri systol pressur exceed aorta  mm hg instanc  least differ occur case aortic stenosi signific differ occasion exist lead erron estim valv orific size system rather aortic systol pressur use 
158  | chang sphingosin fatti acid compon gangliosid develop rat human brain  rat brain increas weight birth three stage rapid first  week ii lower rate   week iii still lower rate  week  month  succeed period design iv maintain constant weight  year age  brain gangliosid content increas linear ii slowli iii diminish iv  appear measur amount brain sphingomyelin cerebrosid succeed gangliosid  ceramid c  sphingosin c fatti acid found larg proport three sphingolipid upon first appear measur quantiti  c fatti acid cerebrosid rapid declin neglig level gangliosid sphingomyelin declin slowli remain major fatti acid compon  cerebrosid sphingomyelin contain c  sphingosin almost exclus stage rat brain growth  gangliosid contain c  sphingosin almost exclus birth subsequ accumul c  sphingosin near equal quantiti base type  chang human brain gangliosid resembl rat  tay sach diseas gangliosid c  sphingosin predomin high content c fatti acid 
159  | studi general shwartzman reaction induc diet vi effect pregnanc lipid composit serum tissu  pregnanc induc profound alter lipid composit serum tissu   elev total serum lipid phospholipid triglycerid free fatti acid cholesterol  total lipid liver kidney increas depot fat decreas  palmit oleat increas serum liver  arachidon stearat decreas serum liver  placenta contain stearat organ pregnant rat also higher water content  decreas depot total fat elev serum liver kidney total fat elev serum free fatti acid suggest pregnanc induc mobil depot fat  increas proport liver serum palmit suggest pregnanc induc increas lipogenesi acet pool  appear increas amount long chain fatti acid liver may due increas intak dietari fat  decreas arachidon stearat serum liver suggest relat decreas mitochondri fatti acid synthesi
160  | electron microscopi bovin lung normal blood air barrier  lung  healthi matur cattl fix oso  embed polyest resin studi via electron microscopi  blood air barrier wide variabl thick consist  continu epitheli alveolar line  cytoplasm epitheli cell contain membrane bound aggreg granul may secretori structur  epithelium rest basement membran turn continu rest adjac capillari endotheli basement membran continu merg connect tissu  capillari endothelium fenestr continu cellular membran  epithelium endothelium contain numer caveola pinocytot vesicl  cell alveolar wall includ fibroblast lymphocyt macrophag occasion mast cell  littl elastin observ 
161  | sensit specif fluoresc assay tissu serotonin  sensit specif method estim serotonin biolog materi describ  method serotonin react ninhydrin form product whose fluoresc eight time intens nativ fluoresc serotonin strong acid solut  method possibl measur serotonin organ endogen serotonin previous detect studi subcellular distribut amin rat pineal adren gland 
162  | effect rumin insuffl cerebr circul metabol goat  effect nitrogen insuffl cannul rumen studi  goat  paramet measur includ cerebr blood flow mean carotid arteri pressur pressur confluenc sinus cerebrospin fluid pressur blood oxygen carbon dioxid content pack cell volum pcv hemoglobin concentr valu cerebrovascular resist cerebr util calcul  increas rumin pressur littl effect cerebr blood flow cerebrovascular resist  cerebr util decreas intrarumin pressur increas  decreas caus reduct arteri content consequ decreas cerebr arterioven differ  mean arteri venous sinus cerebrospin fluid pressur increas intrarumin pressur increas  increas pcv hemoglobin concentr relat elev intrarumin pressur  central nervous system sign goat acut rumin tympani may caus cerebr hypoxia  natur hypertens chang associ increas rumin pressur demonstr due influenc multipl factor fluid compart conclus could made mechan pressur respons  mechan factor howev may involv 
163  | comparison inhal dust dust recov human lung  experi loss dust particl breath indic total deposit respiratori tract subject result qualit argument may give inform alveolar deposit  measur insolubl dust recov post mortem human lung give absolut retent dust deposit alveoli subsequ shift probabl larg extent lymphat vessel lung  experiment result total deposit absolut retent discuss connect health risk due inhal insolubl particl plutonium dioxid 
164  | dual cation activ bovin len autolysi  autolyt activ bovin len extract  c ph  shown mark influenc simultan presenc mono  dival cation  cation test na   mm  mg   mm produc best activ  stimul synergist  basi result obtain laboratori suggest made combin cation may requir activ neutral proteinas len  presenc mg averag physiolog lenticular level na k  autolysi suppress basal level obtain presenc mg alon 
165  | nucleic acid metabol len iii effect x radiat  previous communic report increas vivo incorpor p  albuminoid rna fraction rat len  hour anim expos x radiat  r  present studi vitro uptak p  c  adenin albuminoid ribosom solubl rna fraction normal x  irradi rat lens measur  rna fraction extract sodium dodecyl sulfat  per cent nacl  specif rna fraction also hydrolyz chromatograph paper activ individu nucleotid well specif rna fraction determin  experi also perform capsul remov  hour incub period activ determin nucleic acid extract capsul three rna fraction remain len matter  result experi indic incorpor p  c  adenin albuminoid rna mark stimul  hour  r whole bodi radiat  signific effect ribosom solubl fraction  effect formaldehyd heat x irradi albuminoid rna much less albuminoid rna deriv control anim 
166  | chang dna rna protein synthesi develop len  len cell dna rna protein synthesi develop mous eye studi use tritium label thymidin uridin l  leucin autoradiograph techniqu  mous embryon len epitheli cell undergo dna synthesi found entir anterior len surfac  birth eye open percentag epitheli cell undergo dna synthesi rapid decreas  later percentag epitheli cell undergo dna synthesi near constant germin zone becam local len equat region  rna synthesi occur nucleat cell develop len embryon stage eyelid open  len matur h uridin incorpor rna superfici cell  similar pattern tritium incorpor seen h l leucin 
167  | amino acid transport len relat sugar cataract  steadi state distribut free amino acid len aqueous humor signific reduc diabet rabbit also rat fed ration contain high concentr xylos galactos  reduct level amino acid len appar direct effect high concentr sugar doubt whether relat cataract format 
168  | visco elast properti len  dynam visco elast properti human monkey rabbit lens measur dynam rheomet  valu appar elast modulus young modulus len found    dynecm human    dynecm monkey rabbit  valu loss tangent   human len   rabbit monkey lens  elast moduli loss tangent lens show poor depend temperatur    c frequenc oscil   c  lens show linear visco elast amplitud oscil  mm show nonlinear visco  elast amplitud exceed  mm 
169  | carbon anhydras distribut rabbit len  distribut carbon anhydras activ matur rabbit len determin  activ nucleus cortex epithelium anterior capsul anterior capsul posterior capsul respect                mole co kg wet tissu wt per hr  c  conclud basi avail evid carbon anhydras cannot play primari role cation transport system len 
170  | chang weight adenosin triphosph content len xylose f rat  xylitol sorbitol accumul len xylose f rat two day loss adenosin triphosph cataract chang appar  maximum degre cataract occur level polyol highest  regress cataract accompani decreas polyol concentr restor level atp  len xylose f rat usual increas weight 
171  | identif species specif organ specif antigen len protein  species specif organ specif antigen len investig gel diffus immunoelectrophoresi techniqu  found rabbit antiserum bovin len show cross reaction bovin tissu  cross react antigen b    y crystallin  two major minor organ specif antigen len  major antigen mobil identifi a crystallin len 
172  | electron microscop studi wolffian len regener adult newt  chang morpholog cell regen tissu transform pigment epithelium iri len adult newt triturus viridescen studi ultrathin section use electron microscop  addit quantit analys electron micrograph perform  cell normal iri character abund melanin granul extens smooth   surfac endoplasm reticulum irregular indent nuclear membran  len remov first visibl chang detect nuclei mediodors iri cell involv increas number primari nucleoli  later nuclei enlarg becom spheric promin nucleoli appear  nucleoli distinguish normal nucleoli presenc granular cortex surround fibrous core  pigment granul seem complet extrud intercellular space subsequ taken leucocyt  endoplasm reticulum disintegr gradual final almost disappear  signific increas ribosom cytoplasm  later cytoplasm matrix also acquir fibrous element  wide low densiti probabl correspond natur main compon normal len cell  chang transform cell discuss 
173  | growth sever human cell line newborn rat  inject intraven newborn rat eight human tissue cultur cancer cell line  dash hep  detroit  j  rp  rp  adeno cx  ovari  mac   dash grew progress lung organ  per cent anim common caus death   week  two human cell line  dash carcinoma hep  presum normal amnion b  dash grew less frequent rare caus death ill 
174  | human tumor egg host system iii tumor inhibitori properti tenuazon acid  ferment broth cultur alternaria tenui auct inhibit growth human adenocarcinoma  embryon egg aid studi egg tumor system activ agent isol identifi tenuazon acid  tenuazon acid produc number alternaria isol aspergillustamarii phoma sp  compar tenuazon acid molar basi  time much hadacidin  mercaptopurin  time much azaserin  much triethylenemelamin tem requir achiev inhibit  tumor growth egg  tenuazon acid effect  anoth transplant human tumor a   tenuazon acid compar puromycin specif inhibit tumor growth egg tumor system 
175  | occurr biolog crystal tumor nontumor cultur chhej mice  crystallin structur various type found primari tissu cultur neoplast non neoplast tissu chhej mice  cultur mammari carcinoma tissu contain crystal  crystal found vari incid cultur sever tissu except kidney  dialysi compart essenti format crystal  develop crystal acceler modif cultur medium 
176  | comparison fine structur cultur mac  hela cell  fine structur cultur mucoid adenocarcinoma cell human lung mac  describ compar fine structur hela cell  differ fine structur two strain primarili quantit  mac  cell differ howev follow respect spindle shap cell larger nucleus increas nuclear membran invagin consider larger amount perinuclear golgi apparatus  cytoplasm contain area low densiti undefin limit membran thought accumul mucin  two cell strain contain numer multivesicular bodi lamella various stage develop suggest organell may involv format lipide rich myelin structur observ hela mac  cell  number myelin bodi found invers proport ph medium 
177  | effect parathyroid human tumor tissu bone resorpt tissu cultur  mous calvaria grown tissu cultur combin singl multipl fragment varieti human tumor glandular tissu determin capac enhanc bone resorpt  singl fragment parathyroid adenoma tissu consist enhanc resorpt frontal pariet bone  except one squamous   cell carcinoma lung activ tissu test singl fragment enhanc effect  hand human tissu enhanc resorpt multipl fragment place halo around calvarium suggest presenc lesser amount resorption enhanc factor human tissu 
178  | limit growth period human lung cell line transform simian virus   summary  infect human cell strain simian virus  induc virus replic cell transform chang morpholog cytolog describ previous investig  although transform great enhanc growth potenti strain   transform cultur appear attain autonom growth  j nat cancer inst     
179  | bacteriophag lyse mycobacteria corynebacteria show cytopathogen effect tissu cultur renal cell cercopithecus aethiop preliminari communic  bacteriophag isol sputum resect specimen pa  tient suffer carcinoma lung found lyse coryne  bacteria mycobacteria produc cytopathogen effect certain cell tissu cultur  patient neoplast diseas bacteria isol describ coryne my  cobacteria bacteriolog featur share speci  bacteria either sensit mycobacterio  phage corynebacteriophag phage immun lysogen bacteria could induc produc lytic particl phagolyt activ corynebacteria mycobacteria cytopathogen effect hela cell renal cell cercopithecus 
180  | gel filtrat solubl protein normal cataract human lens  solubl protein normal cataract lens separ accord molecular size polysaccharid gel sephadex g   cataract well normal lens  differ compo  nent obtain  evolut cataract pre  ferenti decreas low molecular weight protein len  disappear complet matur hypermatur cataract  hand protein high molecular weight eg  crystallin resist patholog process  electrophoret pattern low molecular weight protein normal len revea  led sever fraction distribut larg mobil area  immunoelectrophoresi  differ precipitin line obtain 
181  | insolubl protein bovin crystallin len  insolubl len protein albuminoid adult bovin len cortex render solubl rais ph wash suspens  nacl  reduc ph   sediment constant dissolv protein  molecular weight estim    amino acid composit approxim solubl  crysta  llin fraction kinship also appar immunochemi  cal properti  suggest initi insolubl protein molecular aggreg  crystallin dissoci alkalin solut molecul exhibit sediment constant  
182  | glucos  phosphat dehydrogenas  phosphoglucon dehydrogenas len blood differ speci  activ glucos  phosphat  phosphoglucon dehydro  genas measur len erythrocyt man sever speci  wide variat individu speci seem correl activ either enzym len activ erythrocyt speci  wide rang activ glucos  phos  phate dehydrogenas  phosphoglucon dehydrogenas len blood differ speci  sever speci glucos  phos  phate dehydrogenas activ erythrocyt level consid defici man  sorbitol content len correla  ted glucos  phosphat dehydrogenas activ 
183  | nucleic acid metabol len iii effect x radiat  previous communic report increas vivo incorpor p  albuminoid rna fraction rat len  hour anim expos x radiat  r  present stodi vitro uptak p  c  adenin albuminoid ribosom solubl rna fraction normal x irradi rat lens measur  rna fraction extract sodium dodecyl sulfat  per cent nacl  specif rna fraction also hydrolyz chromatograph paper ac  tiviti individu nucleotid well specif rna frac  tion determin  experi also perform capsul remov  hour incub period activ determin nucleic acid extract capsul three rna fraction remain len matter  result experi indic incorpor p  c  adenin albuminoid rna mark stimul  hour  r whole bodi radiat  signific effect ribosom solubl fraction  effect formaldehyd heat x irradi albuminoid rna much less albuminoid rna deriv control anim 
184  | investig mitot control rabbit len epithelium  water solubl substanc inhibit mitosi rabbit len epithelium found present young old rabbit lens  high molecular weight relat stabl room tempera  ture  inhibitori factor associ y crystallin frac  tion exist throughout young len although activ nuclear region wet weight basi less half cortex epithelium 
185  | identif lysosom enzym bovin len epithelium  biochem studi describ isol lysosom identifi activ enzym cell bovin len epithelium  various fraction assay lysosom enzym show contamin mitochondri solubl cytoplasm materi two isol procedur employ 
186  | protein synthesi polyribosom calf len  cell fre system capabl incorpor amino acid protein isol calf len  polyribosom shown present ribosom fraction respons protein synthes capac fraction  polyribosom examin electron microscopi appear compos long strand ribonucl acid rang   con  tain larg number ribosom averag diamet  
187  | measur oxygen tension cerebr tissu rat expos high pressur oxygen  brain cerebrospin oxygen tension measur rat breath air various high pressur oxygen ohp  addit  percent co inspir oxygen rais cerebr oxygen tension rat expos  atm ab  inhibit  hemoglobin satur para aminopropriophenon lower cerebr po rat breath air rat expos ohp  rate rise cerebr po steadi level rapid compress found faster rate fall steadi level follow decompress  addit co inspir gas mixtur increas rate rise cerebr po  anesthet urethan pentobarbit sodium affect cerebr po rat breath air oxygen  atm  result discuss relat factor contribut oxygen poison high pressur 
188  | releas free fatti acid adipos tissu obtain newborn infant  summari role play mobil free fatti acid ffa adipos tissu produc typic high serum ffa level human infant studi  ffa concentr serum subcuta  neous adipos tissu gluteal region determin postnat develop  maximum level reach within  hr birth gradual fall  serum ffa level end  month still higher adult ffa level adipos tissu lower  month adult  incub small piec adipos tissu krebs ring phosphat buffer contain  albumin led releas ffa medium  releas could suppress addit glucos  mg ml tissu age group except youngest   hr birth
189  | detect pericardi effus radioisotop heart scan  mark differ cardiac silhouett six foot chest roentgenogram cardiac blood pool determin radioiso  tope scan shown consist pericardi effus andor thicken  also observ cardiac blood pool separ liver margin interposit peri  cardial fluid andor thicken  separ demonstr presenc normal pericardium  appreci featur  c radioiodin human serum albumin  c colloid radiogold use scan  former outlin blood pool latter demonstr posit liver 
190  | mechan erythropoietin induc differenti iv characterist erythropoietin action hemoglobin synthesi marrow cell cultur  characterist erythropoietin stimul hemo  globin synthesi rat marrow cell cultur studi  relationship cell number rate hemoglobin synthesi va  rious level erythropoietin sigmoid rather linear suggest cooper action among sensit cell  magnitud erythropoietin effect cell increas time contact hormon time one half maxim effect discer  nibl loss erythropoietin cultur medium  previous des  cribe lag time respons erythropoietin appear larg due condit cultur disappear cell pre   incub  h  replac larg fraction medium  h interv enabl cell continu hemoglobin synthesi addit  h 
191  | occurr megakaryocyt peripher blood dog  studi megakaryocyt buffi coat smear  dog reveal unusu characterist consist associ appea  ranc megakaryocyt peripher blood 
192  | moder hypothermia man haemodynam metabol effect  studi perform four patient undergo intracrani opera  tion induct revers surfac hypothermia  c  oxygen uptak decreas averag  per cent   c mean valu  per cent predict basal uptak  time cardiac output decreas  per cent result consist rise calcul mix venous oxygen satur mean   per cent  c  result effect cool oxygen dissoci estim tension oxygen mix venous blood remain virtual unchang  shiver allow occur two patient oxygen uptak increas approxim  per cent without concomit increas cardiac output  observ right atrial svc oxygen satur correl well calcul mix venous oxygen satur regard direct magnitud chang chang temperatur 
193  | spectrum lupus nephriti  fifti case sle collect ten year period incid clinic pictur ln review light publish data  lupus nephriti like sle variabl pattern wide spectrum renal involv  dash evalu therapi prognosi conduct background  lupus nephriti may present renal syndrom without manifest sle  renal involv sle common necessarili indic poor short term prognosi  peter bent brigham hospit seri sustain rais blood pressur onset renal insuffici influenc prognosi advers 
194  | comparison ultraviolet sensit bacillus subtili bacteriophag spo infecti dna  deoxyribonucl acid extract clear plaqu mutant temper phage spo infecti incub compet cultur bacillus subtili   relationship number infecti center dna concentr linear  sensit infecti dna ultraviolet light much greater free phage b subtili  use host  acriflavin inhibit host cell reactiv increas rate ultraviolet inactiv free phage approach inactiv rate phage dna  acriflavin littl effect surviv curv infecti dna  non host reactiv mutant hcr  b subtili  isol  surviv curv spo phage much steeper hcr mutant use host obtain hcr parent strain use host  ultraviolet sensit phage dna still greater free phage even b subtili hcr use host differ sensit much less differ obtain b subtili hcr host  possibl explan greater ultraviolet sensit infecti dna discuss 
195  | isol morpholog new bacteriophag specif bacillus acetobact speci  best natur habitat bacteriophag probabl semi solid medium contain activ divid host bacteria  condit provid bacillus acetobact speci rot grass appl respect  bacillus phage found includ one larg head contractil tail also so cal killer particl  head long contractil tail  particl properti kill multipli within sensit cell  new morpholog type virul bacillus phage also isol head oblong tail consist short needl plate one acetobact phage found resembl coliphag particular interest promin head capsomer three prong tail 
196  | character bacillus subtili bacteriophag  brodetski anna univers california los angel w r romig  character bacillus subtili bacteriophag  j bacteriol     a group six phage sp sp sp sp sp sp use marburg strain bacillus subtili host character  phage refer group  examin follow properti host rang plaqu morpholog stabil adsorpt kinet one step growth characterist calcium requir serum neutral thermal inactiv inactiv ultraviolet irradi  five unrel b subtili phage sp sp pbs sp alpha sp beta includ studi  first isol none group  phage abl replic effici b subtili sb mutant transform  b subtili   host rang mutant capabl growth sb isol group  phage except sp design star phage sp sp   character sb use host star phage anoth b subtili mutant b host sp 
197  | transduct bacillus subtili  compar examin shown temper subtili phage divid two group  b subtili strain nrs  adequ common host sensit examin temper phage  owe certain technic advantag strain found suitabl titrat subtili phage  ii cultur differ reveal among substrain b subtili  ind auxotroph maintain various laboratori  cell one cultur part capabl part incap use ammonia  ammonia assimil transduc ammonia negat bacteria  iii mitomycin c ultraviolet ray induct examin b subtili strain liber bacteriocin lik principl  find probabl analog seaman et al concern pbsx defect phage  basi bacteriocin product examin strain divid two group  iv sever temper phage isol laboratori presum ident phage pbs   phage sp  differ agent antigen structur host rang  v transduct lysat pbs  type phage observ frequenc order   consider less effect phage materi yield lysogen transduct  thus transduc phage activ order  prepar  vi transduct frequenc addit properti phage influenc physiolog condit bacteria  vii transduct indol histidin loci studi use deriv strain  ind 
198  | carrier state bacillus subtili infect transduc bacteriophag sp  bacteriophag sp may infect bacillus subtili form carrier system  infect bacteria give rise infect organ six success single coloni isol   spore deriv infect cultur yield clone produc phage spore retain abil produc phage even treatment antiserum heat   four hour incub carrier spore nutrient broth yield cultur  infect center per bacterium  cultiv infect organ medium contain sp antiserum lead loss phage loss immun phage infect  dna densiti characterist viral dna detect infect bacteria  extract infect bacteria contain phage induc deoxyribonucleas activ attack phage bacteri dna vitro  phage bacteri complex therefor best describ carrier state  dna phage b subtili chemic differ  enzymat prepar complementari virus rna homolog bacteri dna  lack homolog transduc phage dna dna host failur form truli lysogen relationship reinforc previous conclus transduc bacteri dna incorpor sp virus particl without recombin viral bacteri dna 
199  | infect dna isol bacillus subtili bacteriophag sp  sp newli isol bacteriophag bacillus subtili describ  sp close relat sp differ sp densiti denatur dna plate effcienc b subtili strain sb   dna isol phage recov molecular weight equival amount contain singl phage approxim  x  dalton  dna molecular weight half piec infect compet b subtili  respons plaque form abil dna concentr suggest four whole molecul requir initi infect center  recombin studi mix dnas two non allel temperature sensit mutant confirm exist obligatori co op infect process  second infect procedur util extract phage dna describ  system low concentr wild typ dna expos cell  concentr multiple ev natur phage dna infect preclud format unaid plaqu  howev subsequ superinfect dna infect cell temperature sensit mutant plate select condit genet rescu infect dna accomplish detect  infect center elicit marker rescu phenomenon direct proport dna concentr  time attain dnase resist phage dna infect center irrevers adsorb dna measur  phage dna infect center requir least  minut becom total dnase resist  reason failur singl phage dna molecul carri infect discuss term specif breakage reunion
200  | psycholog children dental treatment  communic deal influenc involv develop child attitud dental treatment  extrins educ etc intrins constitut hereditari  understand help determin correct psycholog polici manag child surgeri  aim psycholog appli dentistri discov mode treatment procedur would ensur child subject psychic traumat psychophylaxi  second aim manag call difficult child treatment  understand better child frame mind dental treatment situat surgeri dealt step step child experi sens psych  besid basic sens  dash hear see  dash other also affect touch pressur sensat smell tast  children dental treatment near alway state rais emot tension suscept anxieti reaction  accord degre fear manifest children may class categori cooper difficult patient  psycholog procedur treatment children group base principl summar section psychophylaxi dentistri  difficult children often necessari employ yet psycholog measures psychotherapi suggest etc  extrem exact case premed help sometim find contact child  experiment part work demonstr follow find  dental treatment consist seri interdepend traumat impuls  mani appear close analysi situat   advers respons similar elicit pain may due also sensori impress negat emot background   psychic traumat child dental treatment prevent relat simpl psycholog measur 
201  | relat emot chang pregnanc obstetr complic unmarri primigravida  studi design assess psycholog chang experienc white unmarri primigravida pregnanc relationship manifest anxieti clinic factor labor time mean birth weight person differ normal abnorm obstetr case  kent egi intellig scale taylor manifest anxieti scale mmpi administ  obstetr patient begin third trimest pregnanc mmpi taylor readminist post partum  reliabl group person chang observ pre  postdeliveri support content pregnanc time emot upset  follow deliveri patient classifi normal abnorm depend clinic cours parturit deliveri condit offspr  signific differ group respect age intellig  reliabl differ found howev manifest anxieti total labor time  addit posit relationship found manifest anxieti birth weight  person differ found predeliveri subgroup larg attribut abnorm group greater neurotic anxieti use rumin ego defens  post partum person characterist subgroup quit similar  group show greater person stabil follow deliveri strike chang predeliveri demonstr abnorm group  magnitud chang interpret emot labil relat obstetr complic activ various physiolog regul system 
202  | stranger separ anxieti infanc  anxieti respons stranger separ mother studi longitudin  infant age three  month direct observ interview mother  benjamin hypothes concern differenti immedi dynam infantil stranger separ anxieti support find  differ onset period highest intens termin ratio individu found two anxieti  test relationship two anxieti support deduct predict made benjamin  sex differ intens two anxieti found 
203  | mental retard relat hypercalcaemia   year number retard children adolesc observ show point strike similar  recognis well defin type clear distinguish form mental defici  therefor describ detail  children infantil hypercalcaemia assum aetiolog factor also involv  characterist faci usual congenit heart diseas ordin poor  constant failur thrive infanc episod vomit often constip  mental children also show great similar  iq   show outstand loquac great abil establish interper  sonal contact  stand background insecur anxieti 
204  | psycholog effect circumcis  order evalu psycholog effect circumcis small studi arrang twelv children averag low socio econom level given goodenough dam test cat rorschach two set stori prior oper follow  result test show circumcis perform around phallic stage perceiv child act aggress castrat  detriment effect child function adapt particular ego strength  weaken control defens mechan ego initi regress loosen previous hidden fear anxieti instinctu impuls render feel realiti  express follow oper primit archaic unsoci charact  defens control protect surg instinctu forc come within threat come outsid ego child seek safeti total withdraw thus isol insul disturb stimuli  result studi rais question concern certain psychoanalyt formul research suggest  possibl futur research also discuss 
205  | chang children behavior hospit dimens respons correl  chang  children behavior follow hospit evalu mean questionnair sent parent week discharg  factor analys reveal children respons hospit ill six type general anxieti regress ii separ anxieti iii anxieti sleep iv eat disturb v aggress toward author vi apathy withdraw  score six factor type respons well total score analyz univari case multivari analys varianc  four variabl  dash sex prior hospit degre pain experienc hospit birth order  dash essenti unrel type respons analysi  age durat hospit occup status signific relat one type respons  comparison mean factor total score full sampl level indic overal chang indic combin ill hospit psycholog upset experi children general result increas separ anxieti increas sleep anxieti increas aggress toward author 
206  | isozym lactic dehydrogenas sequenti alter develop  applic isozym various biolog context review  diagnosi sever diseas state facilit examin serum isozym pattern shown correl condit isozym pattern patholog involv tissu  physico chem studi human ldh isozym reveal differ among isozym affin given substrat  compar studi ldh isozym within erythrocyt various vertebr speci demonstr mark speci variat number ldh isozym distribut total ldh activ among electrophoret mobil  develop chick rabbit human tissu characterist sequenti alter ldh isozym pattern occur consist liver muscl loss rapid migrat anod band increas activ cathod band slower migrat anod band  heart revers chang observ  high enough ldh activ earli fetal tissu extract appli gel full complement ldh isozym observ howev lower concentr cathod band starch gel disappear rapid dilut anod band observ  species specif isozym pattern obtain long term cultur rabbit chick human cell  independ tissu origin occur cell cultur sequenti seri isozym alter character decreas intens rapid migrat anod band  shift toward promin cathod isozym fetal develop tissu cultur explain postul increas activ gene produc one subunit ldh concomit decreas activ gene produc second subunit  practic applic studi isozym tissu cultur discuss 
207  | establish cell line vitro case human lung cancer   one cell line establish pneumonectom specimen case lung cancer diagnos undifferenti cell carcinoma partial adenocarcinoma histolog find character intracytoplasm fat droplet   morpholog chang cell repeat stabil epitheli shape th transfer  cell atypi cultur remark  phagocytosi cell line observ  character intracytoplasm droplet found origin cancer cell maintain cultur cell even mitot stage throughout cultur cours   concern chromosom constitut diploid cell  per cent  rang chromosom number show sharp peak form two group near diploid near tetraploid rang   transplant cell cheekpouch golden hamster implant cell grew inoculum  cell condit anim show invas neighbour tissu metastasi organ 
208  | factor influenc develop tumor frog   studi  spontan tumor vermont frog show three patholog grade malign present aggress renal adenocarcinoma  per cent medium adenocarcinoma  per cent lower grade mix tumor undetermin origin remain  per cent   correl parasit infect trematod demonstr case kidney  hyperplasia neoplasia grade lung primari carcinoma found lung r pipien  temperatur  c protect anim lung well kidney diseas  higher temperatur disturb host parasit relationship led higher incid malign  bullfrog precanc clear associ worm attach disc   histolog type tumor vermont frog includ lymphosarcoma liposarcoma mesothelioma epithelioma adren cartilag tumor uncertain malign   improv method obtain tumor filtrat allow greater probabl induc malign direct renal inject   frog  per cent develop histolog provabl cancer rang three seven month  twenty six per cent show pre canc respons  per cent negat  within seri receiv filtrat high malign donor one group yield  per cent posit other   per cent respect   among anim inject low malign filtrat fewer tumor result  clear vesicular carcinoma could class lung tumor   improv tissu cultur method allow explant live liquid media perfor cellophan one year  slower growth aid lower temperatur  c improv microecolog cell type allow detail daili observ cell intranuclear intranucleolar physiolog extend time laps cine photographi   mechan malign transform relat increas activ product nucleolar dna rna  infect dna hypothesi classic virus theori offer detail support 
209  | mitot lymphocyt primari tissu cultur normal neoplast human lung  normal tumor tissu explant  resect human lung studi vitro  lymphocyt mitos observ tissu cultur deriv  lung  abil lymphocyt undergo mitot divis human lung tissu cultur report previous  autolog system use lymphocyt mitos much common cellular outgrowth deriv non neoplast tissu outgrowth deriv cancer bear explant  differ observ total number nondivid lymphocyt present non neoplast neoplast prepar  ritro system employ promis tool contribut alreadi well establish clinicopatholog relationship lymphocyt cancer cell  phase contrast time laps cinephotomicrograph record obtain mitot process special attent paid structur detail  certain find particular interest name format dens chromatin ring telophas variabl occurr cytoplasm bubbl death lymphocyt earli metaphas explod metaphas  elabor discuss find present 
210  | studi transform syrian hamster cell simian virus  sv acquisit oncogen virus expos cell appar unassoci viral genom  line syrian hamster lung liver cell origin expos primari cultur larg dose sv exhibit increas growth rate high plate effici morpholog transform instanc oncogen potenti unusu long interv  least two line acquisit oncogen potenti occur independ morpholog transform  none total  cell line studi detail conclus evid presenc sv genom obtain 
211  | eye kidney tissu reaction heterolog anti uv antibodi  uvea len capsul kidney glomerulus albino wistar rat common antigen compon  uvea len capsul pigment bovin eye also common antigen compon  result demonstr immunofluoresc techniqu  common antigen site uvea assum basement membran surround vascular tree tissu  possibl basement membran particip antigen sourc induc sympathet ophthalmia discuss 
212  | experi deal role play aqueous humor retina len regener adult newt   three group experi involv approxim  eye adult newt triturus v viridescen  devis examin role aqueous humor play len regener dorsal iri   mani daili inject aqueous humor normal eye made lentectom eye long  day case  control lensless eye daili inject holtfret solut  other aqueous humor mere withdrawn   procedur inject experi difficult control  howev success case show vari degre inhibit retard len regener   pair eye unit larg adjac wound open provid common reservoir aqueous humor bath lens dorsal iris  case eye place side bodi  other success union made fuse transplant eye right eye host   approxim three month oper one two larg len regener pair perfect fuse eye remov  six week later new larg len regener reappear lentectom unit presenc intact len unit  strong possibl normal amount neural retina present provid power retin factor len regener inhibit influenc intact len environ 
213  | correl mast cell histamin content eye cattl  author examin mast cell content eye cattl establish mast cell contain conjunctiva optic nerv ocular muscl fewer occur sclera iri least ciliari bodi choroid  cornea len retina contain mast cell  histamin content ocular tissu mast cell content general run parallel  howev cornea except histamin occur bound state form readili avail mild process extract tyrod solut  c 
214  | studi sickl cell anemia xxi clinico patholog aspect neurolog manifest  neurolog manifest frequent patient sickl cell diseas  manifest may earliest present sign symptom variabl patient may erron diagnos condit mening poliomyel subdur hematoma neoplasm subarachnoid hemorrhag lead enceph subacut bacteri endocard congenit malform brain  furthermor develop manifest cannot predict basi type crisi involv  prognosi follow neurolog involv unpredict recurr episod togeth abnorm electroencephalograph read suggest poor outcom  patient die victim rather sever neurolog deficit  neurolog examin patient suggest diffus involv cerebr hemispher  examin patholog materi howev often fail reveal thrombos  strike find infarct white matter perivascular hemorrhag  thesi abnorm neurolog find patient actual due sickl cell diseas support fact symptom appear associ clinic circumst known induc sickl  includ surgeri anesthesia fever infect 
215  | attenu curv human eye normal patholog condit  method describ allow determin attenu curv human eye  curv obtain plot critic depth modul cmd function critic fusion frequenc cff  routin experi carri  test field show sinusoid period variat lumin surround extens area lumin equal averag lumin test field  attenu curv obtain normal observ differ experiment condit number patient  shown method afford us inform cannot obtain mean classic method measur cff 
216  | central nervous system manifest periarter nodosa   case patholog prove periarter nodosa review  patient  percent symptom sign central nervous system cranial nerv involv  thirty nin patient cerebr manifest neuropathi  neuropathi alon  cerebr symptom sign  common cerebr manifest mental derang usual organ psychosi confusion state  headach convuls blur vision vertigo sudden unilater visual loss common symptom refer central nervous system  common abnorm examin retinopathi hemiparesi sign brainstem lesion  differ durat life onset diseas without central nervous system involv 
217  | see saw nystagmus unusu sign lesion near third ventricl  case see saw nystagmus child craniopharyngioma bitempor hemianopsia describ refer made previous case report  basi curious sign clear site lesion must consid region third ventricl sinc bitempor hemianopsia necessari part syndrom  sign common present point lesion near third ventricl 
218  | implic gerstmann syndrom   consecut patient subject standard batteri neuropsycholog test  one compon gerstmann syndrom   patient evid organ brain dysfunct addit gerstmann compon  number gerstmann compon increas respons brain lesion tend larger high destruct tissu caus greater neurolog impair  everi patient four gerstmann compon associ evid sever impair brain function lesion under diseas like compromis surviv patient  syndrom regard autonom entiti merg numer neurolog deficit notabl dysphasia agreement benton find justif singl four gerstmann compon separ syndrom unless one also prepar recogn arbitrari group concurr deficit also separ syndrom  least three  patient four gerstmann compon angular gyrus shown necropsi examin involv lesion  howev probabl left hemispher contain lesion increas number gerstmann compon probabl involv left posterior parasylvian area also increas increas number gerstmann compon  two three four gerstmann compon lesion never restrict angular gyrus tend spread wide pariet tempor occipit lobe  local signific gerstmann syndrom approxim degre cogenc dysphasia 
219  | alter visual evok respons presenc homonym visual defect  visual evok respons ver studi mean comput averag  normal subject nineteen patient without visual disord unilater cerebr lesion  patient homonym visual field defect  earli negative positive neg complex record later place occipit electrod vertex refer  latenc prolong hemianop patient  amplitud asymmetri note brain damag control pronounc patient visual defect  record hemianop patient differenti control group presenc aberr wave form  case prolong latenc  case amplitud depress greater  per cent posit wave abnorm side  case  patholog verif obtain three patient demonstr correspond alter ver presenc lesion geniculocalcarin system 
220  | cerebro vascular lesion livedo reticulari  extens livedo reticulari observ one man five women suffer seri cerebrovascular lesion  neurolog disabl includ aphasia homonym hemianopia hemiplegia remark degre recoveri occur  presum livedo found one patient without neurolog lesion relat cerebrovascular incid  investig fail show evid polyarter nodosa dissemin lupus erythematosus thrombocythaemia arter unrecogn type suggest etiolog 
221  | seesaw nystagmus case report elucid mechan  eighth record case see saw nystagmus report  featur case analyz evid suggest form nystagmus ocular rather central origin offer  see saw nystagmus unlik true vertic nystagmus indic brain stem lesion 
222  | supratentori paratransvers meningioma  author describ  case supratentori paratransvers meningioma  clinic develop tumour slow chief neurolog sign homonym hemianopia contralater hemiparesi speech disord tumour domin side radiolog carotid angiographi permit identif tumour easili  surgic tumour remov complet although  case transvers sinus resect caus damag  one patient oper twice whose histolog specimen second occas show meningioma malign die seven month second oper  patient well free neurolog deficit   year oper 
223  | life span lymphoma incid mice inject birth spleen cell across weak histocompat locus  newborn cogen c h mice receiv inject across weak h i h i  histocompat barrier exhibit life shorten high incid lymphomat diseas mid adult life  control experi h i h i  lymphomat diseas develop much later life  mous strain given inject new born manifest neglig incid lymphoma leukemia  find variabl interpret term oncogen virolog immunolog theori age cancer analog transplant diseas mechan 
224  | heterogen rheumatoid factor genet control polypeptid chain globulin   evid present rf protein heterogen antigen composit although occasion one homogen thus resembl paraprotein   studi point difficulti encount current avail prepar polypeptid chain genet map globulin describ 
225  | progynon depot prepar oestrogen action treatment prostat carcinoma  deriv natur oestrogen  dash oestradiol undecyl progynon depot  dash given depot form inject group patient prostat carcinoma  studi show progynon depot reduc excret androgen metabolit urin  result suggest prepar reduc testicular product androgen probabl adren gland  depot effect clinic action prepar describ briefli 
226  | urinari  ketosteroid excret studi radiat induc menopaus carcinoma breast   urinari  ketosteroid estim result given  patient subject radiotherapeut sterilis   high dosag level use case   result indic suppress ovarian function within  week sterilis 
227  | prostat cancer young person primari hypogonad  prostat carcinoma  year old man primari hypogonad present  endocrin environ relat estrogen excess suspect play lead part pathogenesi case 
228  | urinari excret neutral  ketosteroid pregnanediol patient prostat cancer benign prostat hypertrophi  urinari neutral  ketosteroid fraction pregnanediol excret  patient prostat cancer  patient benign hypertrophi  clinic well subject assay determin whether differ exist  patient prostat cancer benign hypertrophi excret signific less androsteron clinic well subject  disproportion lower level androsteron etiocholanolon result signific lower androsteroneetiocholanolon ratio group  specif find discuss  lower level androsteron excret patient benign hypertrophi associ extend period hospit  patient hospit less  day excret androsteron level signific differ clinic well subject  lower level androsteron excret patient prostat cancer explain presenc metastasi durat hospit loss appetit defin differ consid singl  possibl interrelationship clinic differ prevent assign lower excret level cancer state alon 
229  | urinari excret neutral  ketosteroid pregnanediol patient breast cancer benign breast diseas  urinari level neutral  ketosteroid fraction pregnanediol excret  women  premenopaus  postmenopaus determin  subject studi includ  premenopaus group breast cancer  benign breast diseas  sick control  well control   postmenopaus group breast cancer  sick control  well control   level androsteron etiocholanolon excret premenopaus patient breast cancer signific less level excret premenopaus group differ signific level excret postmenopaus patient breast cancer  disproportion lower level  desoxy  ketosteroid  oxy  ketosteroid excret premenopaus patient cancer result signific lower ratio found premenopaus group  ratio associ premenopaus patient cancer differ signific postmenopaus patient cancer  lower level androsteron etiocholanolon explain debilit 
230  | morpholog demonstr alveolar line layer relationship pulmonari surfact  presenc alveolar line layer histolog demonstr anim lung ultraviolet microscopi  layer appear thin fluoresc line air tissu interfac  fluoresc line layer could abolish lung section extract chloroformmethanol diminish digest clwelchii a toxin lecithinas suggest structur lecithin contain lipid  alveolar line structur also identifi use phosphatid polysaccharid stain suggest lipid phosphatid mucopolysaccharid compon might also present  bilater cervic vagotomi result diminut loss fluoresc alveolar line abnorm surfac tension properti lung extract  suggest presenc fluoresc materi associ surfac activ lung  alveolar line structur could demonstr electron microscopi even special stain techniqu 
231  | experiment emphysema basi review critiqu  normal lung structur describ rich capillari bed fine partit airspac uniqu surface act effect  morpholog criteria lesion human pulmonari emphysema includ evid destruct residu vascular remnant absenc signific amount fibrosi alter conduct airway without anatom obstruct  experiment studi relat pathogenesi emphysema review critic evalu  stress place necess control biolog factor influenc action specif etiolog agent 
232  | alveolar line cell pulmonari reticuloendotheli system rabbit  complet freund adjuv inject intraven rabbit cellular respons lung investig  popul cell within alveolar space contribut monocyt circul mesenchym cell alveolar wall epitheli line cell alveoli  abnorm epitheli line prolif phase result increas size number cell line normal alveoli  heal progress structur normal alveolar line found 
233  | time cours chang surfac tension morpholog alveolar epitheli cell co induc hyalin membran diseas  atelectasi hyalin membran produc exposur guinea pig  percent co found associ disappear lamellar bodi larg alveolar line cell granular pneumocyt associ decreas surfact indic rise minim surfac tension lung  process limit uncompens phase respiratori acidosi revers compensatori phase  parallel time cours chang surfac tension alter lamellar bodi granular pneumocyt provid addit evid identif latter cell respons secret surfact 
234  | cortison atyp pulmonari epitheli hyperplasia studi includ electron microscopi tissu cultur anim transplant long term observ  previous work rabbit show prolifer cell within pulmonari alveoli follow intratrach inject nitric acid prolifer great enhanc administr cortison anim  electron microscop observ indic morpholog larg alveolar line cell  tissu cultur studi damag normal lung without cortison show evid direct effect drug prolifer cell  observ togeth knowledg fibrosi delay cortison treat anim support thesi cortison effect indirect one  transplant damag lung tissu hamster cheek pouch fail reveal evid growth  within period observ   day evid prolifer subsid consider neoplasm develop
235  | observ myelin gli relationship etiolog cerebrospin fluid exchang lesion  present paper present cytolog observ develop kitten spinal cord spinal cord white matter react injuri also present recent experi mechan etiolog csf exchang lesion  draw various sourc author propos specif function cell type present spinal cord white matter 
236  | lactat pyruv brain rat hyperventil  experi anesthet curar rat artifici ventil show hyperventil lactat pyruv mark increas blood brain  lactatepyruv ratio remain blood control condit systemat decreas brain  hypoxia ventil  oxygen nitrogen lactat rise mark blood brain  lactatepyruv ratio strong increas blood show small rise brain  observ could indic differ mechan respons rise lactat brain hypoxia hyperventil  import augment lactat brain hyperventil give explan delay rise seen lactat level cerebrospin fluid condit 
237  | cistern fluid oxygen tension man  use beckman micro oxygen electrod studi oxygen tension simultan cisterna magna intern jugular vein arteri blood various condit  result suggest cistern oxygen tension degre reflect averag oxygen tension surround brain tissu besid reflect avail free oxygen brain registr chang short durat cerebr blood flow 
238  | ventricular septal defect prolaps aortic valv outflow tract obstruct  case ventricular septal defect combin aortic valvular lesion infundibular pulmon stenosi describ  right coronari cusp aortic valv protrud ventricular septal defect demonstr right ventricular angiocardiographi polyp lik mass right ventricular outflow tract  cardiac catheter angiocardiographi show progress right ventricular outflow obstruct 
239  | function adapt right ventricular outflow tract congenit heart diseas  function adapt right ventricular outflow tract discuss relat develop acquir pulmonari stenosi  conclud physic forc well structur abnorm may great influenc clinic pictur life histori mani patient congenit heart lesion  import serial haemodynam studi provid fuller understand natur cours mani lesion stress better advic prognosi optim time surgic treatment may given 
240  | mitral atresia associ pulmonari venous anomali  pulmonari venous anomali observ  among  specimen mitral atresia    anomal pulmonari vein took form anomal pulmonari venous connexion  remain case pulmonari venous anomali repres cor triatriatum   group mitral atresia prematur closur foramen oval coexist  anomal pulmonari venous connexion group provid collater rout flow pulmonari venous blood understood develop en respons obstruct foramen oval mitral valv atret  remain  group ii causat factor could invok  one latter group total anomal pulmonari venous connexion coexist common atrium  cor triatriatum coexist patent foramen oval  pulmonari venous obstruct occur  case 
241  | basal metabol rate cardiovascular surgeri  basal metabol rate respiratori equival patient determin  day convalesc cardiovascular surgic oper perform without cardiopulmonari bypass  result compar patient undergon oper differ diseas  metabol rate major case increas commensur bodi temperatur  patient particular requir open oper aortic valv rais metabol rate could explain sole pyrexia  type patient seri elev respiratori equival persist throughout convalesc  equival greater patient treat cardiopulmonari bypass patient treat without bypass 
242  | surgic treatment ventricular septal defect  surgic techniqu closur ventricular septal defect  case  case isol defect  case tetralog fallot discuss light follow up result  use patch closur reduc incid recurr  percent com  pare  percent direct sutur perform  incid heart block also decreas  percent direct sutur use  percent patch  transatri approach prefer isol ventricular septal defect ventricular approach prefer case tetralog fallot  case combin aortic insuffici small defect close aorta  larger defect close usual way first stage oper total valv prosthesi introduc second oper  oper mortal  percent isol ventricular septal defect compar  percent cyanot patient tetralog fallot 
243  | hemodynam observ congenit heart diseas special refer pressur curv ductus arteriosus  hemodynam observ  congenit heart diseas case made base data depart pediatr kyoto univers may  decemb   classifi  case accord malform hemodynam view point  case classifi follow group   ventricular septal defect  case small ventricular septal defect  moder ventricular septal defect  mark ventricular septal defect  ventricular septal defect pulmonari stenosi   patent ductus arteriosus   atrial septal defect  atrial septal defect  atrial septal defect pulmonari stenosi   pulmonari stenosi   tetralog fallot   aortic stenosi   aortic insuffici  aortic insuffici ventricular septal defect  aortic insuffici pulmonari stenosi  sonr small ventricular septal defect tri vasoact drug  phenylephrin inject slowli right ventricl via cathet rapid rise femor arteri pressur associ bradycardia intensiff systol murmur observ  administr amyl nitrit rapid fall femor arteri pressur associ tachycardia soften sys  tolic murmur observ  patent ductus arteriosus cardiac cathet withdrawn slowli aorta pulmonari arteri outstand pressur curv record ductus arteriosus  systol pressur curv ductus arteriosus systol pressur aorta diastol pressur curv ductus arteriosus diastol dip follow late diastol pressur peak  patent ductus arteriosus cardiac cathet withdrawn left pulmonari arteri right ventricl pressur curv reveal consider characterist rise pulmonari arteri pressur regard effect transmiss system pressur ductus arteriosus 
244  | studi direct inscript vectorcardiograph t loop left right ventricular hypertrophi   frank lead vectorcardiogram record  normal person  case hypertens acquir congenit heart diseas t loop classifi  type accord direct inscript  planar project  frequent observ type examin direct maxim vector   major normal case t loop inscrib counterclockwis horizont clockwis sagitt plane   left ventricular hypertrophi abnorm inscript t loop observ abnorm rightward superior deviat maxim vector t loop orient  horizont plane usual accompani abnorm inscript  percentag abnorm inscript higher case cardiac complaint   right ventricular hypertrophi direct chang t loop relat small chang inscript common  t loop alway inscrib abnorm case abnorm inscript qrs loop   concept polar vector found valuabl studi inscript direct t loop  signific chang inscript t loop discuss 
245  | pulmonari vascular plexiform lesion pathogenet studi  attempt made test theori pulmonari arteri hypertens plexiform lesion jet lesion beyond point arteri stenosi result nonspecif intim thicken   subject congenit communic associ pulmonari arteri hypertens lung studi histolog  addit element pulmonari venous obstruct  like absenc pulmonari venous obstruct adult patient congenit communic would develop plexiform lesion  three adult patient studi plexiform lesion identifi  among  infant children one subject show plexiform lesion  day old girl mitral atresia ventricular septal defect patent ductus arteriosus  find three adult subject support theori regard genesi plexiform lesion find one infant plexiform lesion appear contradict 
246  | renal hemosiderosi blue kidney patient valvular heart diseas  anatom evid intravascular hemolysi ie renal hemosiderosi found necropsi   patient die sever valvular heart diseas  aortic valv  patient heavili calcifi immobil portion calcif deposit direct contact blood  hemolysi patient attribut direct trauma erythrocyt travers stenot valv frequenc trauma increas associ regurgit flow  renal hemosiderosi observ patient isol mitral valv diseas combin mitral tricuspid valv malform 
247  | tumor scan radioact cesium  fourteen patient cancer scan  minut  hour inject radioact cs satisfactori scan tumor obtain seven  posit scan obtain larg superfici tumor pulmonari lymphoma carcinoma upper third esophagus  negat scan abdomin tumor  correl made data obtain extern count well scintil count biopsi specimen  two mode uptak suggest earli uptak due vascular probabl proport stabl cesium content b later uptak base upon greater alkali metal content tumor normal tissu 
248  | lung scan colloid risa  use colloid risa inject intraven particl size  micron follow lung photoscan offer practic atraumat method visual pulmonari arteri occlus dog fact particl relat short biolog half lif appear decreas radiat dose deliv durat occlus pulmonari capillari compar ceram microspher  work progress appli techniqu studi pulmonari arteri occlus human 
249  | multivari comparison result treatment chronic lymphocyt chronic granulocyt leukemia  result sever clinic trial analyz multivari procedur reli complet laboratori find involv score specif chang subject evalu  statist signific differ among drug three month therapi demonstr  relationship multivari method subject evalu demonstr indic subject evalu estim physiolog state prognosi patient complet object techniqu use 
250  | oxacillin  appar hematolog hepat toxic  bone marrow depress hepatocellular dysfunct develop allerg woman receiv  gm sodium oxacillin mouth daili near three month  discontinu drug administ corticosteroid antibiot result appar recoveri  toxic potenti oxacillin appreci 
251  | drug neonat jaundic  paper intend exhaust review bilirubin metabol mani factor may result exagger physiolog jaundic review interest reader refer excel articl zuelzer brown  brief mention made mechan certain drug may contribut develop hyperbilirubinemia  drug water solubl vitamin k deriv sulfasoxazol gantrisin salicyl novobiocin unequivoc shown affect advers newborn infant abil handl bilirubin  time compound definit incrimin  import rememb administr drug mother prior deliveri may result appreci concentr compound infant serum drug administ nurs mother may excret breast milk therebi absorb infant  care consider drug given newborn also mother therefor essenti avoid may term iatrogen hyperbilirubinemia 
252  | amput patient  year age  although patient  year age expect poor physic reserv mani co exist diseas observ show nevertheless subject surgic procedur without undu mortal  mortal rate maintain minimum surgeon consid factor contribut increas elder  necessit  care evalu patient treatment pre exist co exist diseas  proper control electrolyt  avoid infect  prompt correct postop hypotens  postop pulmonari ventil tracheal cleans  avoid prolong surgic procedur  group  patient past age  year underw amput lower extrem without undu mortal  death  lumbar sympathectomi consid advis age pa  tient  standard mid thigh oper question younger patient procedur choic remov gangren extrem patient  year age 
253  | radic oper ventricular septal defect infanc  ventricular septal defect common congenit anomali heart infanc poor prognosi  oper upon  infant one year age ventricular septal defect  success repair  case  present hypothermia surfac cool method prove superior artifici heart lung machin simplic good oper result use  addit earli oper infantil period caus less psycholog impact infant  advantag suffici us advoc radic oper ventricular septal defect infanc even includ sever ill children 
254  | specif suppress tumor growth isol periton macrophag immun mice  method present macrophag may isol periton cell popul mice  cell comparison periton lymphocyt lymph node cell test immunolog activ inject mixtur test cell tumor cell subcutan irradi mice  cell type obtain immun mice capabl suppress growth specif tumor cell  result discuss respect possibl specif immunolog function macrophag graft reject 
255  | effect heterolog antiserum complement glycolysi tumor cell  effect heterolog antiserum complement glucos metabol rat ascit tumor cell examin clarifi mechan cytotox effect antibodi   lactate product target cell inhibit cooper antiserum complement inhibit observ cell subject either antiserum complement alon  inhibit lactate product observ acrob anacrob condit  effect antiserum complement observ oxygen consumpt cell   amount antiserum necessari inhibit lactate product cell determin presenc definit amount complement found degre inhibit parallel concentr antiserum beyond certain threshold  hand parallel observ amount complement rate inhibit lactate product differ amount complement ad definit amount antiserum   similar inhibitori effect antiserum complement lactate product cell glucos fructose   diphosph pyruv suggest inhibit occur toward final step glycolyt process cell 
256  | solubl tissu antigen human brain tumor cerebrospin fluid  a  globulin antigen present human glioblastoma immunolog ident antigen present human brain liver spleen metastat carcinoma cyst fluid describ  protein antigen present plasma wbc normal csf  demonstr csf three  patient tumor central nervous system  present may repres specif tissu protein fraction contribut either tumor adjac cns tissu  major protein compon normal abnorm csf deriv least antigen ident plasma protein 
257  | appar immunofluoresc tissu mast cell  rat mast cell rat cosinophil exhibit fluoresc blue violet light treatment fitc conjug rabbit anti rat g globulin cell fluoresc immunolog nonspecif  wherea cosinophil fluoresc treatment fluorescein alon mast cell fluoresc treatment protein conjug contain g globulin  phenomenon observ cell differ organ fluoresc seen associ cytoplasm granul normal present cell 
258  | determin cerebrospin fluid po effect oxygen carbon dioxid breath patient chronic lung diseas  lumbar cerebrospin fluid po hypoxem hypercapn patient chronic lung diseas patient without chronic lung diseas  breath  oxygen  carbon dioxid increas lumbar cerebrospin fluid po breath  oxygen  nitrogen  chang cerebrospin fluid po close relat chang arteri pco relationship similar relationship arteri pco cerebr blood flow patient without hypercapnia  interpret observ must qualifi follow cistern cerebrospin fluid po differ lumbar cerebrospin fluid po respons breath oxygen carbon dioxid regul blood flow spinal cord nerv root known compar brain factor blood flow may contribut chang cerebrospin fluid po 
259  | behavior lymphocyt primari explant human lung cancer vitro  activ lymphocyt within outgrowth explant tissu fragment  human lung cancer studi  studi includ cancer bear tissu explant case noncancerbear lung tissu   case  five major categori lymphocyt behavior deriv studi name  emigr migrat lymphocyt explant  cluster lymphocyt around target cell  ameboid transform lymphocyt  lymphocyt congreg  emperipolesi  criteria differ lymphocyt activ amplifi introduc  find particular interest  frequenc via ble nonviabl lymphocyt within vacuol cell  observ consid absolut criterion recogni  tion emperipolesi  subsequ inclusionbodi appear dead lymphocyt observ   intim relationship ameboid form lymphocyt select cell result juxtanuclear frequent unipolar crowd one cell numer lymphocyt nearbi cell total devoid ameboid lymphocyt  reason given support impress phenomenon late sensit  also possibl phenomenon may indic lymphocyt condit   appar entri lymphocyt cell record timelaps cinematographi  lymphocyt relationship cancer cell infrequ found although explant   case produc identifi cancer cell lymphocyt emigr explant  case  appar limit studi whether signific find 
260  | ventricular septal defect aortic insuffici clinic hemodynam studi  prove case  eighteen patient combin ventricular septal defect aortic insuffici studi  nine also infundibular pulmonari stenosi  seventeen treat open heart oper  physic find typic ventricular defect murmur thrill togeth aortic insuffici blow wide puls pressur  systol murmur upper left sternal border thrill strong suggest addit lesion infundibular pulmonari stenosi presenc absenc infundibular pulmonari stenosi indic accur cardiac catheter inspect oper  suffici sever sign addit right ventricular hypertrophi appear electrocardiogram  retrograd aortographi serv demonstr sever aortic regurgit  problem surgic correct lesion subject separ communic 
261  | radioisotop photoscan diagnost aid cardiovascular diseas safe simpl method diagnos pericardi effus aneurysm  radioisotop scan safe simpl use method diagnosi pericardi effus aortic aneurysm  whole bodi radiat dose approxim  millirad   sodium iodipamid greater dose receiv standard posteroanterior chest roentgenogram blood volum determin  side effect complic procedur well toler patient  scan repeat interv assess progress diseas respons treatment  cardiovascular scan radioact isotop recommend use safe diagnost tool 
262  | studi hematolog bone marrow morpholog vitamin e defici pig  forty four pig use two experi whose purpos produc defici vitamin e  anemia chang bone marrow morpholog occur vitamin e defici state describ  hematolog disord includ low hemoglobin hematocrit valu leucocytosi granulocytosi  nuclear abnorm observ erythroid precursor bone marrow mani cell multinucl  giant multinucl cell megakaryocyt type frequent found 
263  | signific blood group homotransplant marrow dog ten dog given  r whole bodi irradi infus allogen marrow donor match respect six erythrocyt antigen  methotrex given reduc secondari syndrom  four dog surviv  similar experi  dog effort made match donor recipi three dog surviv  conclud match donor recipi six red cell antigen increas signific longterm surviv rate lethal irradi dog allogen marrow graft 
264  | radioautograph studi bone marrow lymphocyt vivo diffus chamber cultur  radioautographi tritiat thymidin util examin turnov rate origin small lymphocyt bone marrow guinea pig  marrow lymphocyt initi label singl inject tritiat thymidin thereaft number label lym phocyt rapid increas high maximum level  day  analysi label curv grain count indic popul marrow lymphocyt maintain dynam steadi state averag turnov time  day less  suspens bone marrow cell isol circul within intraperiton diffus chamber short term label tritiat thymidin vivo  although small lymphocyt label introduc diffus chamber consider percentag becam label subsequ cultur period  tritiat thymidin also administ intraven whilst exclud one hind limb applic occlus compress bandag  minut  label small lymphocyt found  hour tibial marrow initi occlud limb wherea normal high percentag label control tibial marrow  experi demonstr large scal influx small lymphocyt blood stream marrow parenchyma  suggest newli form small lymphocyt appear marrow result divis local situat precursor cell mechan intramedullari lymphocytopoiesi uncertain  transit cell intermedi morpholog blast cell small lymphocyt synthes dna activ prolif appear account fulli rate lymphocyt product  certain larg undifferenti label cell appear bone marrow result hematogen migrat  implic find discuss 
265  | autoradiograph studi origin fate small lymphoid cell dog bone marrow effect femor arteri clamp vivo avail h thymidin  origin fate small lymphoid cell dog bone marrow studi autoradiograph observ effect clamp femor arteri vivo avail h thymidin  heavili label small lymphoid cell appear bone marrow clamp leg  hour inject tracer increas number  day  label indic cell howev signific lower control marrow  possibl interpret dog bone marrow contain two popul small lympho id cell one migrat marrow via blood stream origin local precursor cell within marrow  evid transform migrat small lymphoid cell erythroblast first  hour inject h thymidin 
266  | lymphocyt guinea pig bone marrow  structur distribut lymphocyt bone marrow normal  g guinea pig studi mean light microscopi electron microscopi radioautographi  studi structur organ three techniqu confirm morpholog ident marrow small lymphocyt small lymphocyt situat afford ad proof presenc seri cell transit appear small lymphocyt blast cell  unlik small lymphocyt transit cell show evid dna synthesi  marrow small lymphocyt transit cell diffus scatter throughout parenchyma often situat close proxim sinusoid endothelium  also found characterist concentr within sinusoid term lymphocyt load  find discuss particular refer possibl origin interrelationship fate cell 
267  | surgic treatment atrial septal defect hypothermia  techniqu inflow occlus  c hypothermia adopt direct visual correct  consecut case atrial septal defect secundum varieti associ anomali  use extracorpor circul combin hypothermia reserv repair two case ostium primum defect  over al oper mortal   post op evalu show result good almost patient includ pulmonari hypertens  sinc ostium primum defect requir cardio pulmonari bypass closur pre op recognit defect high desir select patient oper plan procedur  inform deriv clinic examin appropri diagnost studi found consist accur pre op differenti primum secundum defect  therefor unexpect discoveri primum defect oper problem  experi open heart surgeri  c hypothermia repair atrial septal defect secundum type associ anomali safe practic techniqu effect correct anomali minim risk 
268  | intern cool general hypothermia  present offer advantag use intragastr temperatur control adjunct general hypothermia  devic describ accomplish end encount deleteri side effect minim technic involv minor expens  observ record rate temperatur chang accord sex weight type surgeri perform 
269  | late effect region renal hypothermia  summari one safe conclud deleteri effect creat dog observ period  year follow renal ischemia  hour durat protect hypothermia  blood pressur fail climb evid azotemia care microscop studi fail reveal histolog evid renal vascular cardiac damag  renal function demonstr creatinin pah preserv delay wound heal 
270  | mesenter vascular respons hypothermia   total segment resist studi mesenteri  dog effect hypothermia chang blood viscos epinephrin resist compar   cool  c caus increas mesenter resist  per cent anim approxim  per cent resist rise contribut arteri segment  small vessel resist increas  per cent  evid venous constrict  blood viscos appear play minor role   suggest hemorrhag necrosi bowel wall due intens vasoconstrict precapillari vessel subsequ distal anoxia cellular damag 
271  | respons dog perfus arrest circul near zero cerebr temperatur   twenty six dog cool whole bodi close chest perfus techniqu end perfus brain temperatur   c inclus   death group six dog end perfus brain temperatur  c higher    dog cool brain temperatur  c less nine death five occur quick cardiovascular failur four result gross neurolog disturb   evid aortic incompet whole bodi close chest hypotherm perfus   lower temperatur brain end cool perfus greater passiv transfer heat environ 
272  | effect grade hemorrhag cardiopulmonari function hypotherm dog  experi conduct anesthet dog subject moder hypothermia  c bled percentag estim blood volum  respiratori work influenc degre hemorrhag pulmonari ventil respiratori rate tidal volum influenc signific result blood withdraw  physiolog dead space percentag tidal volum increas hemorrhag  oxygen consumpt decreas hemorrhag made sever wherea carbon dioxid product unchang indic shift respiratori exchang ratio  cardiac output decreas  per cent control level  per cent estim blood volum withdrawn  system arteri pressur decreas mark heart rate chang result blood withdraw  comparison respons hemorrhag hypothermia normothermia discuss 
273  | hypothermia manag acut renal failur   prolong hypothermia begun period immedi follow infus epinephrin renal arteri appear give partial protect renal damag   shorter period hypothermia appear benefici   prolong hypothermia   c mortal rate  percent  percent 
274  |  effect dosag endotoxin induc chang reticuloendotheli system rabbit tissu remov rabbit   hr follow iv inject    ug endotoxin explant tissu normal inject anim grown coagul plasma medium medium contain  ugml endotoxin migrat growth cell observ follow week incub inhibit stimul cell reticuloendotheli system res differ host site endotoxin administr depend dosag known capac differ organ take circul endotoxin macro  phage migrat suppress cultur spleen remov  hr dose hibit  ug macrophag lymph node testi thymus show in  creas number extent migrat phagocyt activ widespread res stimul seen tissu remov  hr largest dose ad  dition restor cell activ spleen lung mark increas migrat larg phagocyt cell bone marrow well organ macrophag endotoxin inject anim sensit normal macrophag ad endotoxin vitro
275  |  vaccinia pneumonia mice light electron microscop viral assay studi swiss white mice   day age develop general vaccinia viral infect   day intranas inocul gross histolog evid pneumonia seen  approxim  mice virus re  cover relat high titer lung  pfu per g per  iod pneumonia develop viremia also present virus titer blood stream remain much lung histolog vaccinia pneumonia character larg swollen mononuclear cell give rise mark widen alveolar septa scatter neutrophil note usual associ cell necrosi exud edema fluid red cell al  veoli consid result viral replic cytopath effect cell compris alveolar septa various form vaccinia virus observ elec  tron microscopi within type type ii alveolar line cell capillari endotheli cell interstiti cell within alveolar wall infect inter  stitial cell probabl deriv fix macrophag note also around bronchiol virus particl similar observ bronchiolar epi  thelium surround smooth muscl cell earliest patholog ultrastruc  tural chang note virus infect cell intracellular edema evidenc low electron densiti background cytoplasm materi dilat endoplasm reticulum extens chang result cell necrosi releas virus particl extracellular space
276  |  electron microscopi bovin lung lattic lamellar structur alveolar lumen electron microscop studi sampl lung  normal cattl  high mountain diseas lattic lamellar structur obser  ved free alveolar lumen  normal cattl  high mountain diseas one specimen lattic lamellar structur ob  serv vacuol within alveolar epitheli cell other extracellular shape dimens lattic lamellar structur similar describ worker experi involv intratrach inject silicon oleic linol acid first report structur free alveolar lumen appar normal cattl
277  |  electron microscopi bovin lung blood air barrier acut pulmonari emphysema electron microscop studi experiment induc acut pulmonari emphy  sema  cow yield follow find alveolar epitheli edema cyto  lysi endotheli thin cytolysi excess elast collagen alveo  lar wall fibrosi hyperplasia alveolar wall smooth muscl numer intra  alveolar lattic lamellar bodi hyalin membran format hypertrophi endotheli perikaryon numer alveolar macrophag alveolar epitheli secret electron dens amorph mass postul lattic lamellar bodi result degener alveolar epitheli cell
278  |  ultrastructur lung lamb relat osmiophil inclus alveolar line layer fetal matur experiment produc respiratori distress lung  fetal newborn lamb studi osmiophil inclus bodi first appear  day gestat total number increas matur normal surfac activ lung extract detect day follow appear inclus bodi excretori natur type ii alveolar epitheli cell phospholipid natur inclus bodi content decreas number inclus bodi loss densiti associ respiratori distress loss normal surfac activ lung ex  tract provid strong evid inclus bodi sourc pulmonari surfact dens osmiophil alveolar line layer mammal describ sinc presenc layer well correl surfac tension valu number inclus suggest layer consist surfac activ substanc difficulti detect osmiophil layer mammal thought least part due speci differ compo  sition materi constitut pulmonari surfact cytolog immatur exist lamb fetus reach  day gestat consid basi suscept immatur lamb respiratori distress fibrin  period compon although small one hyalin membran lamb view fact matur fibrin appear bundl fibril rare  ly found suggest bulk hyalin membran matur fi  brin probabl consist polym fibrinogen serum protein
279  |  differenti exfoli broncho alveolar diseas desquam interstiti pneumonia three case present pulmonari diseas describ liebow asso  ciat name desquam interstiti pneumonia case support exist entiti content previous describ differenti diagnosi exfoli bronchoalveolar diseas desquam interstiti pneumonia submit clinic roentgenolog histopatholog mani  festat tabul condit differ em  phasiz addit symptom chang phenomena previous record introduc distinct differ  diseas found histopatholog manifest
280  |  lysosom rat sciatic nerv follow crush peripher nerv undergo degener favor materi studi type origin function lysosom follow lysosom describ autophag vacuol alter schwann cell within vacuol myelin much axoplasm enclos normal nerv degrad wal  lerian degener delimit membran vacuol appar form myelin lamella consid possibl sourc acid phosphatas golgi vesicl primari lysosom lysosom dens bodi type endo  plasmic reticulum lie close vacuol b mebran bodi accu  mulat focal myelin fiber zone extend   mm distal crush appear aris endoplasm reticulum demonstr acid phosphatas activ increas mark within  hour nerv crush c autophag vacuol axoplasm fiber proxim crush break  organell within vacuol may signific reorgan axoplasm preparatori regener phagocyt vacuol alter schwann cell myelin degener begin axoplasm expos appar engulf filopodia schwann cell degrad within phagocyt vacuol thus form e multivesicular bodi axoplasm myelina  ted fiber general seen near node ranvier
281  |  histochemistri surfac epitheli pleural mucin mammalian lung demonstr sialomucin alveolar cuboid epithelium sialo  sulfomucin demonstr histochem surfac layer lung pleura rabbit syrian hamster guinea pig mous man sialomucin predomin distal bronchial tree cover alveolar epitheli surfac possibl signific observ discuss
282  |  matur postnat human lung idiopath respiratori distress syndrom matur patholog alter lung  newborn infant die idiopath respiratori distress syndrom studi light and electron microscopi normal lung  fetus  new  born serv control infant idiopath respiratori distress syndrom respiratori bronchio  les alveolar duct usual present histolog pattern matur lung ie predomin line type cell also form epitheli compon blood air barrier well expand alveoli exhibit similar pattern wherea collaps alveoli line numer type ii cell par  ticip format poor develop blood air barrier capac type ii cell produc in  clusion bodi seem increas surviv beyond th hr age secret inclus bodi presum surfact alveolar space occur lung infant older  day how  ever process accompani reduct number type ii cell per alveolus nor  mal lung distribut patholog chang idio  pathic respiratori distress syndrom appear determin degre matur air sac structur matur air sac associ da  mage epitheli line hyalin membran forma  tion contrast collaps alveoli reveal intact epitheli line mark septal edema free hyalin membran find studi sug  gest transud plasma well develop  ed blood air barrier respons epitheli damag hyaline membran format air sac also suggest alveolar collaps presuma  bli lack surfact relat abnorm matura  tion epitheli line septal edema
283  |  lattic structur osmiophil bodi develop respiratori tissu rat osmiophil inclus observ lung rat particular  day rat embryo newborn  day post partum inclus present larg alveolar cell dens lamin  ate structur variabl size configur general consist concentr arrang membran appear myelin figur usual dens center osmiophil inclus fre  quentli seen direct contact cell membran alveolar space alveolar space contain numer osmiophil myelin figur thought origin intracellular osmiophil inclu  sion may extrud channel form in  side cell ruptur cell membran secre  tion materi may occasion seen cyto  plasm larg alveolar epitheli cell cell appear process degener cell surfac disrupt cytoplasm continu materi air space lattic structur alveolar space may origin cytoplas  mic secret materi cytoplasm secret ma  terial cell lattic structur air space disappear rat  day old
284  |  xanthogranuloma xanthoma choroid plexus origin foami xanthoma cell case  month old infant intens pro  lifer choroid epithelium foami cell second similar case  month old infant gener  aliz glycogen storag diseas case  year  old male bilater xanthogranuloma choroid plexus prolifer choroid epitheli cell discuss pathogenesi foami xanthoma cell stroma choroid plexus particular discuss author believ origin foami cell mode format xanthogranuloma explain prolif capabl phagocyt activ choroid epithelium choroid epitheli cell regard fix macrophag becom wander phagocyt detach disintegr foami cell releas lipid content interstitium provok re  spons macrophag multinucl giant cell foreign bodi type hemorrhag also consid factor involv format xanthogranuloma
285  |  mix hematopoiet pulmonari origin alveolar macrophag demonstr chromosom marker origin alveolar macrophag investiga  ted mous chimera hematopoiet cell could identifi marker chromosom chro  mosom analysi found normal lung lung expos irrit approxim two  third divid cell could recov lung wash aros hematopoiet system one third pulmonari origin
286  |  pulmonari alveolar proteinosi studi use enzym histochemistri electron microscopi surfac tension measur lung biopsi  patient pulmonari al  veolar proteinosi studi use histochem me  thod electron microscopi surfac tension mea  surement lipid rich intraalveolar fluid contain materi stain reaction ultrastructur phospholipid although mani alveoli line enzymat activ secret granular pneumonocy  tes extract proteinot tissu surfac activ fact inhibit normal surfact cell free intraalveolar materi de  generat slough granular pneumonocyt margin lesion lipid fil macrophag appear play role remov mate  rial observ indic alveolar protein  osi primari overproduct surfact consist concept alveolar clear  ing process defect diseas
287  |  surfac phenomena lung health diseas summari author attempt bring togeth multipl observ seem german understand surfac phenomena lung health diseas end contribut anatomist pathologist fine structur alveolar cell line fundament concept alveolar stabil requir special insight physiologist concern caus bubbl stabil relat particular problem pose lung sever million bubbl arrang parallel soon contribut chemist becam signific method identif assay al  veolar line materi interest clinician ask relev studi atelectasi occur diseas soon question surfac  tant appear develop occur concern prematur infant student metabol began focus lung site phospholipid synthesi tool seem promis time unearth possibl error metabol may express diseas surgeon undertak per  fusion isol lung ask requir organ respect nutrient environ alveolar cell anesthesiologist inquir possibl mechan injuri alveoli artifici respir problem pose review subject touch mani disciplin obvious doubtless pertin studi omit although uninten  tional other may misinterpret lack qualif spe  cialist specialti author hope provid evid forc surfac tension cannot ignor organ air liquid interfac  hope describ properti film alveolar air interfac oper produc stabil alveoli hold belief studi metabol alveolar line layer understand number diseas process may alter last hope much closer communic worker mani disciplin elucid remark subject best cooper studi
288  |  alter pulmonari surfac activ lipid ex  posur increas oxygen tension syndrom progress respiratori distress pulmonari edema increas pulmonari surfac tension induc  dog exposur oxygen tension greater  mm hg   hour pulmonari surfact extract endobronchi wash measur lipid composit surfac activ five dog develop respiratori distress without pulmonari edema dog endobronchi wash surfac tension normal slight increas total lipid distribut essenti normal esterifi fatti acid lecithin frac  tion consist alter reduct palmit total satur fatti acid three dog develop pulmonari edema increas surfac tension in  creas total lipid protein relat decreas total phospholipid endobronchi wash esterifi fatti acid lecithin fraction marked  ly alter palmit level  normal esterifi arachidon pre  sent attribut intra alveolar plasma electron micrograph lung oxygen exposur show thicken alveolar basement membran altera  tion structur lamellar bodi type ii alveolar epitheli cell
289  |  cistern fluid oxygen tension man measur cerebr oxygen tension man hamper technic dif  ficulti author present method beckman microelectrod introduc cisterna magna oxygen tension measur hypothesi measur oxygen tension fluid equilibr averag cerebr oxygen tension give reliabl measur cerebr oxygen tension subject inhal pure oxygen produc increas oxygen tension cistern fluid well arteri blood without alter oxygen tension bulb intern jugular vein wherea inhal  oxygen  carbon dioxid increas oxygen tension cistern fluid well arteri venous blood  carbon dioxid air produc increas cistern oxygen tension fall arteri blood pressur associ introduct suboccipit needl accom  pani decreas cistern oxygen tension rose simultan increas arteri blood pressur follow infus dextran intraven inject xanthinol niacin induc patient less pronounc fall arteri blood pressur time cistern oxygen tension fell administr aramin associ rise arteri blood pressur plus rise cistern oxygen tension
290  |  cerebrospin fluid man nativ high altitud csf ph shown prior report remain essenti constant  day acclimat  order evalu possibl role csf acid bas equilibria regul respir  peruvian andean na  tive studi altitud    subject  mean csf ph  pco  hco  na k cl  lactat  mg  ml arteri blood ph  pco  hco  na k cl  hematocrit  sao   subject    csf valu signific differ mean arteri pco   respect signific variat altitud expect lower pao   mm hg sao   increas hematocrit   respect nativ differ recent acclimat sea  level resid show less ventil higher pco respons ex  ist hypoxia less alkalin arteri blood differ appear relat peripher chemoreceptor respons hypoxia rather central medullari chemoreceptor
291  |  na k ca mg cl concentr choroid plexus fluid cistern fluid compar plasma ultrafiltr  cat concentr na k ca mg cl measur plasma ultrafiltr newli form choroid plexus fluid cisterna magna fluid choroid plexus fluid differ plasma ultrafiltr cl k concentra  tion contain higher na mark higher mg lower ca concentr ultrafiltr cisterna magna fluid differ ultrafiltr respect  electrolyt contain higher concentr cl na mg lower concentr k ca differ choroid plexus fluid con  tain higher concentr cl lower concentr k ca mg hco concentr calcul basi charg balanc  mmkg ho higher choroid plexus fluid cisterna magna fluid suggest ele  vate ph former site without measur potenti differ be  tween csf plasma definit conclus could drawn cation activ transport fact distribut ratio cerebro  spinal fluid ultrafiltr one dival cation opposit direct also true monoval cation taken evid mechan involv cation transfer quit selec  tive though proven activ transport consid like explana  tion find data suggest specif transfer mechan subserv homeostat function regard mg k cerebrospin fluid
292  |  cerebr hemodynam blood gase electrolyt breath hold valsalva maneuv continu record arteri intern jugular blood oxygen tension oxy  gen satur carbon dioxid tension ph sodium potassium togeth peco blood pressur electroencephalogram obtain compar effect inspiratori expiratori breath hold valsalva maneuv cerebr circul cerebr oxygen avail man inter  val toler breath hold  second less jugular venous oxygen tension increas owe increas cerebr blood flow result increas arteri carbon dioxid tension statist signific correl chang jpo paco prove less linear increas decreas paco  mm control level threshold found chang paco alter effect cerebr perfus cerebr venous po extrem small chang paco less  mm hg alter cerebr oxygen avail within   second valsalva maneuv consist reduct jugular oxygen tension found associ sudden fall arteri blood pressur reduct arteri carbon dioxid tension rapid chang cerebr hemodynam cerebr oxy  gen avail procedur briefli discuss
293  |  respiratori cardiovascular chang rapid spon  taneous variat ventricular fluid pressur pa  tient intracrani hypertens patient intracrani hypertens ventricular fluid pressur vfp curv character  main form spontan variat two form rhythmic natur call  per minut wave   per minut wave respect accord domin frequenc third form   irregular appear wave larg amplitud durat   call plateau wave accord usual shape fluctuat respiratori cardio vascular chang accompani variat vfp studi simultan record various combin vfp pulmonari ventil pco expiratori air arteri venous blood pressur puls frequenc found rhythmic vfp vari  ation  per minut type occur synchron respiratori peri  od cheyne stok breath synchron appear variat system blood pressur puls frequenc well conscious muscular tone limb also note respiratori midposit shift toward inspiratori side period hyperpnoea  per minut wave entir synchron variat system arteri blood pressur traube hering may type long sequenc wave observ vfp level consider elev plateau wave accom  pani correspond elev arteri venous system blood pres  sure simultan crest plateau wave sudden chang often occur puls frequenc bradycardia tachycardia res  piratori pattern sometim also degre conscious muscu  lar tone also long sequenc  per minut wave deep irre  gular breath seen stage induc consider hypocapnia preceed final critic fall vfp end plateau wave instanc how  ever fall begin sever minut appear hypo  capnia
294  |  central nervous system lesion rat expos oxygen high pressur adult femal rat paralyz repeat exposur oxygen high pressur found cns le  sion  type  focal necrosi individu neuron within certain nuclear group  complet partial necrosi nuclear group frequent damag mye  lin axon glia area involv type usual bilater symmetr lesion first type found consist superior olivari complex ventral cochlear nuclei nuclei spinal tract cranial nerv v lesion second type found consist substantia nigra globus pal  lidus frequent rhinencephalon never occur neocortex
295  |  electrod size tissu po measur rat expos air high pressur oxygen comparison made valu po record sever rat tissu  u  u flexibl gold electrod although qualit size elec  trode give similar result quantit valu po differ larg differ  enc found case electrod vari physic di  mension thought reflect amount trauma caus tissu in  vestig due electrod insert error po estim due tissu da  mage consid outweigh error due electrod calibr soft high vascular tissu liver kidney spleen show macroscop bruis quit larg area electrod insert show greatest differ estim po valu record tissu po made anim breath air compress   atm pure oxygen pattern respons tissu po exposur ani  mal high pressur oxygen describ
296  |  adrenerg effect splenic po rat air oxygen  atmospher oxygen tension measur spleen rat breath air exposur anim  atm ab oxygen hpo respons splenic po compress complex usual reach peak valu immedi com  pression fall lower valu form respons term hump respons adrenalectomi bretylium tosyl inject hump res  pons po compress almost abolish valu splenic po  atm consider higher control anim combin adrena  lectomi bretylium tosyl also mark reduc number hump respons unexpect signific lower splenic oxygen tension ani  mal ambient condit  atm oxygen cardiac rate blood pressur studi attempt find explan latter effect blood pressur adrenalectom rat control rat bretylium inject adrenalectomi potenti bradycardia produc brety  lium tosyl
297  |  effect antioxid high pressur oxygen toxic sever common use antioxid test effect poison  ing due high pressur oxygen ohp test use preconclus pe  riod surviv time mice  atm absolut oxygen lung damag rat ex  pose  atm oxygen  hr post ohp paralysi rat follow deep pentobarbital na anesthesia ohp  atm  min  bis  dimethyl  propyl hydroquinon gave excel protect ohp toxic test sever antioxid also protect ohp toxic potenc effect vari differ criteria oxygen poison test experi
298  |  glycolyt control mechan inhibit glycolysi acet pyruv isol perfus rat heart acet pyruv similar effect over al metabol glucos gly  colyt flux decreas presenc absenc insulin glucos oxid great decreas convers glucos glycogen lac  tate promot glucos phosphoryl decreas presenc absenc insulin hexokinas phosphofructokinas glyceraldehyd phos  phate dehydrogenas pyruv kinas far displac equilibrium enzym step glycolysi maintain either equilibrium fair close equilibrium differ metabol situat glycolyt flux may affec  ted step far displac equilibrium increas level hexos monophosph decreas level glycolyt inter  mediat fructos  diphosph pyruv addit  mm acet indic glycolyt flux decreas inhibit phosphofructo  kinas addit  mm pyruv fructos  diphosph triose  phosphat accumul result inhibit either glyceraldehyd phosphat dehydrogenas phosphoglycer kinas acet littl effect total con  tent oxid reduc di  triphosphopyridin nucleotid slight de  creas ratio nad nadh cytoplasm estim ratio lactat pyruv a glycerophosph dihydroxyaceton phosphat pyru  vate increas total content nadh nadph shown increas fluoresc intact heart tissu analys ratio nad nadii cytoplasm great increas result demonstr com  partment pyridin nucleotid cytoplasm mitochondria intact cell addit acet citrat intermedi citric acid cycl increas great amount oxaloacet level de  creas addit pyruv level citrat a ketoglutar ma  late oxaloacet great elev glutamic oxaloacet trans  aminas reaction measur total content reactant tissu remain close equilibrium chang concentr adenin nu  cleotid insuffici account inhibit phosphofructokinas result consist control step mediat citrat
299  |  oxygen tension human malign diseas hyperbar condit oxygen tension record continu tumour normal tissu  pa  tient pressur pure oxygen  atmospher absolut mean rise  mm hg  mm hg tumour normal tissu respect record patient breath air atmospher pressur   tumour elec  trode regist povalu less  mm hg compar   normal tissu electrod result obtain suggest oxygen polarographi meth  od determin po solid tissu vivo complic mani artefact   particular tissu damag due electrod trauma   reduc valu clin  ical research concern accur inform absolut po valu intact tissu
300  | cortic ph blood brain barrier method describ measur ph dc ac potenti concurr cerebr cortex adult cat condit control ventil kitten rabbit also studi cortic ph respons iv nahco acid accompani dc negat blood becam alkalin acid respons present rabbit kitten present number tissu cat includ dura cortic acid respons affect qualit iv acetazolamid prolong hypoxia  vv co reduc revers  vv co affect remov arachnoid membran cortic ph respons iv nh salt solut complex nhc produc alkalin respons cortic ph respons alkalin acid sodium phosphat solut augment chang direct follow treatment cortex n butanol result interpret term restrict hco  blood brain barrier co pass restrict probabl non specif inorgan ion perhap substanc appear relat low cerebr extracellular space independ substanti oxid metabol
301  |  brain damag paralysi anim expos high pressur oxygen   pharmacolog biochem observ singl exposur high pressur oxygen ohp   gaug pressur caus cns damag paralysi rat mice guinea pig rabbit man show sequela cns damag rat great increas cns de  pressant drug pentobarbit paraldehyd phencyclidin given ex  posur ohp cns lesion also potenti rais respir pco acetazolamid nhc whilst protect afford methaemoglobinae  mia tham   dinitrophenol serotonin barbitur co potenti ohp brain damag ohp induc brain damag modifi hypothermia cp electroconvuls shock treatment ohp cerebr x  irradi adrenalectomi cortison slow decompress rate spinal block local anaesthet condit rat ohp hyper  hypoglycaemia alter tissu histamin level result discuss relat pos  sibl biochem mechan theori oxygen poison
302  |  effect hypoxia oxygen consumpt cerebr cortex liver slice diaphragm vitro post  natal develop rat oxygen consumpt slice liver cerebr cortex cut dia  phragm determin rat age      day adult anim hypox condit gas phase  oxygen  nitrogen oxygen consumpt liver slice diaghragm decreas  age group hypoxia howev affect oxygen consumpt slice cortex  day old rat inhibitori effect appear later normal oxygen consumpt start rise inhibitori effect hypoxia greatest adult anim
303  |  hypoxic hypercapn interact subject bilater cerebr dysfunct analyz cerebr influenc modifi autonom respiratori respons author compar normal patient bilater pyramid tract diseas ventilatori respons hypoxia hypoxia hypercapnia eucapnia  group show similar hypox respons hypercapnia ventilatori respons hypoxia greater brain damag subject appar aug  mentat howev due entir anoxia interact abnorm fa  cilit carbon dioxid sensit compar normal brain damag patient pao  mm hg show  greater co respons paomm hg show  greater co respons sinc cerebr dysfunct facilit ven  tilatori respons hypoxia hypercapnia combin respons hypoxia alon result impli  respiratori stimuli interact central rather peripher
304  |  plasma free fatti acid blood sugar level newborn infant mother simultan plasma free fatti acid ffa blood sugar level determin fast newborn infant first  hour life cord blood mother deliveri follow observ made con  trol infant mean ffa level rose three time cord level birth accompani  drop mean blood sugar level thereaft mean blood sugar level remain relat constant mean ffa level vari   time cord level signific correl length matern fast prior deliveri infant ffa level howev signific negat correl length matern fast prior deliveri infant blood sugar level  hour age high ffa level occur infant obes mother low level observ infant delay respir infant preeclampt mother infant diabet mother
305  |  essenti fatti acid requir infant assess dietari intak linol serum fatti acid analysi content polyunsatur fatti acid serum total fatti acid relat dietari intak linol  infant two four month age  infant eleven twelv month age curv relat trien tetraen ratio dietari linol indic approxim  per cent total calori minim linol requir exponenti equat relat dienoic trienoic tetraeno acid dietari linol deriv comput method yield constant minim nutrient requir could calcul best estim obtain trien tetraen data two four month old infant found approxim  per cent calor intak nutrit status respect linol may estim mean logarithm regress equat equat two four month old infant log  dietari linol      di   tri  tetra data eleven twelv month old infant found greater scatter give lower trien tetraen ratio compar linol intak scatter displac consid due supplement solid food basic diet consid calcul dietari linol
306  |  analyt studi a  b lipoprotein micellar group nonesterifi fatti acid plasma normal pregnanc analyt studi made  patient use chemic method allow simultan detail evalu lipid a  b liproprotein fraction plasma addit non esterifi fatti acid titrat b protein uric acid assay numer indic deduc ratio made data obtain exist quantit dyslipidemia proven start gradual especi th th month pregnanc most  ly regard b lipoprotein preval slow subfract greater increas glycerid phosphatid cholesterol non proport in  creas b protein lower protein content moreov note preval rise free cholesterol fraction b lipoprotein reduct total esterif coeffici morpholog pictur lipid rate pregnanc show characterist accord author like seen lipid rate male presenil
307  |  behavior polyunsatur fatti acid physiolog pregnanc enzymat lipoxidas method macge et al author measur polyun  satur fatti acid pfa healthi pregnant women full term pregnanc labour blood   mg pfa ie   non pregn women labour pfa increas much   mg  labour
308  |  effect nutrit defici unsatur fat distribut fatti acid rat liver mitochondri phospholipid fatti acid composit liver mitochondri phospholipid rat render defici essenti unsatur fatti acid determin compar rat fed diet contain corn oil addit mark reduct amount linol arachidon acid esterifi b posit ethanol  amine  inositol  cholin glycerophosphatid defici result ex  tensiv chang distribut satur acid a  b posit palmitol oleic acid increas amount fat defici larg amount docosatrieno acid appear  phospholipid fatti acid sphingomyelin alter result essenti fatti acid defici data demonstr phospholipid uniqu way fatti acid moieti chang respons feed fat defici diet
309  |  interventricular septal defect aortic insuffici sanchez f villaran e coincid  malform permit diagnosi provid care evalu made hemodynam oximetr data basi specif auscultatori featur even differenti cardiopathi patent ductus arteriosus withwithout pulmonari hypertens aortopulmonari sep  tal defect interventricular communic truncus arteriosus aneurysm sinus aorta ruptur right caviti   simpl analysi cours syndrom togeth inform suppli phonocardiographi catheter angiocardiographi radiolog ecg order import indispens analysi made  case absenc ana  tomic confirm concret data obtain base diagnosi
310  |  measur aortic regurgit upstream sampl continu infus indic direct theoret valid method measur aortic regurgit involv record indic concentr left ventricl down  stream site aortic root inject howev method yield errat result appli man author laboratori use sudden in  jection techniqu therefor upstream sampl method use continu in  fusion indic evalu  patient aortic regurgit retrograd aortic transsept left ventricular catheter continu infus techniqu compar techniqu sudden inject  patient aortic valvulographi  patient measur forward flow obtain continu infus aortic root signific differ measur obtain sudden inject pulmonari arteri record indic concentr left ventricl continu infus aortic root demonstr readili evid equilibrium plateaus result measur regurgit flow high reproduc impair nonsimultan upstream downstream sampl percentag error estim  confid limit  measur regurgit flow  total flow  regurgit fraction total flow correspond  ing error estim sudden inject techniqu  time larger re  gurgit flow continu infus method rang   lmin total flow   lmin regurgit fraction total flow   rank patient magnitud regurgit total flow correspond rank angiograph criteria sever howev excel correl prevail angiograph grade regurgit fraction total flow demonstr variabl meaning express sever correl  angiograph grade regurgit fraction measur continu infus techniqu clear superior obtain sudden inject techniqu  mild regurgit equival regurgit fraction  moder regurgit fraction   moder sever regurgit fraction   sever regurgit fraction  conclud upstream sampl method con  tinuous infus indic sensit reliabl applic multipl measur valid presenc mitral regurgit use method quantifi aortic regurgit man
311  |  aortico left ventricular tunnel caus massiv aortic regurgit intracardiac aneurysm clinic roentgenograph hemodynam patholog find  year  old boy aortico left ventricular tunnel present accessori channel aorta left ventricl result massiv aortic regurgit portion tunnel travers ventricular septum aneurysm displac posterior wall right ventricl caus sever obstruct right ventricular outflow presenc associ cardiovascular anomali previous report case suggest malform congenit rather acquir clinic hemodynam manifest aortico left ventricular tunnel indistinguish observ common form aortic regurgit correct diagnosi establish thorac aortographi malform usual recogn childhood sinc aortic regurgit flow abolish simpl closur aortic ostium without aortic valv replac indic oper treatment differ appli aortic regurgit due valvular anomali
312  |  haemodynam implic bisferien puls bisferien carotid arteri displac puls record  patient sever aortic valvular diseas braunwald test indic moder sever sever gross aortic regurgit present absenc peak systol aortic pressur gradient certain case particular sever regurgit suggest freedom element stenosi anacrot wave peak aortic pressur puls found coincid percuss tidal wave simultan record carotid ar  terial displac curv suggest amplitud peak anacro  tic wave proport rate chang momentum eject blood amplitud correspond percuss wave displac modifi distens arteri depth shape trough two peak thought depend upon magnitud slope two wave rather upon venturi effect suggest condit arteri wall dia  stolic blood pressur stroke volum influenc puls suffici preclud use simpl guid natur aortic valv lesion
313  |  left ventricular function follow replac aortic valv hemodynam respons muscular exercis evalu left ventricular myocardi function carri  patient   mth stenot regurgit malform aortic valv correct valv replac circulatori respons exercis judg increas cardiac output relat increas oxygen consumpt normal mild reduc  patient  patient relationship chang left ventricular end diastol pressur alter stroke volum also normal fall increas left ventricular end diastol pressur less  mm hg accompani increas stroke volum  patient howev abnorm increas left ventricular end diastol pressur occur exercis  left ventricular end  diastol pressur increas level  mm hg variabl alter stroke volum accompani increas end diastol pressur suggest  patient exhibit simultan increas left ven  tricular end diastol pressur stroke volum chang either mani  festat frank starl mechan primarili result posit inotrop influenc  patient exhibit increas left ventricular end diastol pressur chang fall stroke volum propos distinct depress left ventricular perform present thus cardiac output respons adequ meet stress exercis major patient studi follow aortic valv replac determin relationship left ventricular end diastol pressur stroke volum permit detect abnorm function left ventricl
314  |  pulmonari atresia intact ventricular septum pulmonari valv atret ventricular septum intact right ventricl usual consist small chamber thick wall capabl de  velop high pressur patholog pictur associ clinic find similar tricuspid atresia cyanosi decreas pulmonari flow left ven  tricular preponder electrocardiogram earli death diagnosi may confirm heart catheter select angiocardiographi in  jection right ventricl risk great surgeri never suc  cess past equal hopeless prognosi medic treat  ment attempt continu made anastomosi superior vena cava right pulmonari arteri appear offer hope success futur
315  |  intra atri pressur measur electrocardiographi detail diagnosi atrial septal defect discuss possibl limit differ method identifi anatom type atrial septal defect author suggest use new method consist simultan record pressur curv endocavitari electrocardiogram withdraw cathet left right atrium ostium primum type septal foramen infe  rior margin point cathet retract unlik ostium secundum type rest intermedi section atrioventricular septum endocavitari electrocardiogram zone passag two atria show typic pattern intermedi section atrioventricular septum pressur curv may show pattern atrial intravalvular type
316  |  ventricular septal aneurysm report two case two case ventriuclar cuptal aneurysm report one membran one muscular portion diagnosi made select left ventricular angiogra  phi suggest case repres spontan closur ventricular septal defect weak aneurysm format due high left ventricular pressur asymptomat hemodynam within normal limit surgic repair aneurysm consid necessari
317  |  electrod cathet diagnosi ebstein anomali tricuspid valv success surgic treatment ebstein anomali call accur pre ope  rativ assess natur sever tricuspid valvular lesion increas risk cardiac catheter condit match in  creas experi intracardiac techniqu provid examin skill hand patient ebstein anomali investig way serious congenit heart lesion surgeri con  templat diagnost valu electrod cathet discuss intra  cardiac electrocardiograph featur ebstein anomali illustr fals posit fals negat record demonstr mechan product explain conclud though help intracardiac electro  cardiograph evid regard confirmatori rather diagnost record made electrod cathet cardiac catheter con  sider along clinic electrocardiograph radiolog featur case reli upon definit method diagnosi ebstein anomali
318  |  unusu aneurysm membran interventricular septum case patient huge aneurysm membran interventricular septum present believ first patient undergon success resect
319  |  laevocardia situs inversus case report review literatur case levocardia invers cham  ber heart transposit great vessel situs inversus describ gross cyanosi club present due veno arteri  al shunt right sid superior vena cava open  ing arteri atrium passag venous blood aorta ventricular septal defect case complic right sid hemiplegia develop liver abscess review literatur prognosi possibl etiolog condit also made
320  |  postop aneurysm right ventricl twelv patient postop aneurysm right ventricular outflow tract correct surgeri pulmon valvar stenosi ventricular septal defect tetralog fallot report literatur review pathogenesi discuss differ diagnost test evalu stress role roentgen examin import care follow up interc chest roent  genographi
321  |  ventricular septal defect aortic regurgit medic patholog aspect thirty four patient ventricular septal defect aortic regurgit repre  sent less  patient ventricular septal defect discuss loud systol murmur characterist ventricular septal defect note dur  ing infanc wherea evid aortic regurgit protodiastol murmur wide puls pressur usual appear time   year age clinic catheter data indic princip hemody  namic load aortic regurgit wherea ventricular septal defect usual result larg pulmonari blood flow high pulmonari arteri pressur  patient signific pressur gradient across right ven  tricular outflow tract exist detail patholog studi indic ventricular septal defect high anterior encroach greater lesser degre membran bulbar septum right coronari cusp one sever involv prolaps caus aortic regurgit noncoronari cusp alway less sever affect anatom basi pressur gradient ob  serv across right ventricular outflow tract alway clear
322  |  natur histori arrhythmia follow septal defect reapir repair  atrial ventricular septal defect   review determin incid prognosi arrhythmia relat oper case includ  ventricular septal defect  atrial defect ostium secundum type  ostium primum varieti nodal rhythm second degre block complet heart block flutter fibril persist complet oper analyz intermitt ectop beat sinus tachycardia bundl branch block exclud fifteen per cent patient ventricular defect  ostium primum defect  ostium secundum defect develop abnorm rhythm associ repair  patient whose arrhythmia began oper  death fatal occur  patient develop arrhythmia postop period seven death associ complet heart block one second degre block although one half patient develop arrhythmia pulmonari arteri pressur greater  mm hg systol fatal occur group four death follow surgeri use pump oxygen children  month age thirty eight per cent abnorm rhythm began postop period nodal flutter fibril common follow repair atrial secundum defect patient  yr age occur younger patient death heart block occur first  day follow oper except one  month later survivor complet heart block revert less serious arrhythmia normal rhythm within  month
323  |  left ventricular angiocardiographi studi ventricular septal defect sixty f case ventricular septal defect studi left angiocardiographi left ventricl enter retrograd arteri catheter cathet j shape tip procedur appear littl hazard right sid angiocardiographi ventricular septal defect may divid  type depend locat ventricular septum anatom radiolog featur septum septal defect describ select in  jection contrast materi left ventricl opacifi blood pass defect septum permit preoper local defect rela  tion identifi anatom landmark multipl defect septum well de  monstrat inform may consider valu surgeon under  take repair septum left ventriculographi often combin supraval  vular aortographi use indic differenti mitral insuffici ventricular septal defect detect cardiac ano  mali whose manifest mark septal lesion tech  niqu well suit postop studi patient follow repair septal defect follow up studi patient oper upon clarifi natur histori defect differ portion ventricular septum
324  |  free fatti acid metabol chines hamster normal chines hamster cricetulus griseus mean concentr free fatti acid ffa serum vari group group  consist   time greater rat dog man  slight higher syrian hamster  two  four fold higher fast alloxan diabet rat epididym adipos tissu chines hamster  initi concentr ffa compar rat syrian hamster  releas time interv    fold ffa vitro tissu rat  higher concentr ffa incub incub tissu rat retroperiton periren adipos tissu chines hamster less ac  tive releas fatti acid vitro epididym howev activ epididym adipos tissu rat characterist ffa metabol chines hamster appar attribut speci age diet sex chines hamster weight epididym adipos tis  sue per gram bodi relat high appear speci rate releas fatti acid adipos tissu great lead high ffa concentra  tion serum chines hamster rat adipos tissu vitro glucos in  sulin separ reduc rate releas ffa amount ffa tissu glucos insulin togeth produc greatest reduct net reduct ffa releas glucos insulin vitro greater tissu chines hamster insulin mark increas glucos uptak adipos tis  sue speci possibl relat result spontan diabet chines hamster discuss
325  |  chang serum non esterifi fatti acid level spon  taneous oxytocin induc labour nonesterifi fatti acid nefa concentr serum rise progress cours normal labor rise appear relat durat labor use oxytocin induc stimul labor alter normal pattern rise nefa provid given physiolog dosag level nefa umbil vein umbil arteri deliveri compar alway signific lower matern level maternalfet ratio vari     seri follow deliveri nefa level begin fall almost immedi rate fall   deliveri valu st hour   within  hr   within  hr
326  |  effect combin glucos insulin infus lipoid carbohydr metabol parturi woman fetus infus glucos insulin deliveri use author pri  marili order determin whether util glucos enhanc condit want investig whether increas unesteri  fie fatti acid cord blood take place sole glucos infus mother could caus low capabl glucos util fetus infus deliveri consist applic  ml  glucos  u insulin period  min brought greater decreas unesterifi fatti acid parturi woman compar infus glucos exclus reason result thought due better utili  zation glucos favor influenc insulin infus glucos insulin increas valu lactic pyruv acid took place parturi women probabl due acceler glycolysi increas product lactic acid caus higher share anaerob metabol cord blood likewis increas valu lactic py  ruvic acid reflect higher valu substanc mother format product metabol breakdown fetus howev signific increas infus glucos insulin investig paramet valu includ level unesterifi fatti acid found cord blood similar amount infus glucos alon re  sult cannot reliabl prove passag insulin placenta especi continu studi metabol valu newborn proof passag insulin placenta could establish possibl intak insulin increas unesterifi fatti acid cord blood could caus relat insuffici insular apparatus fetus probabl reason increas unesterifi fatti acid differ depo  sition metabol unesterifi fatti acid cours intrauterin life
327  |  glucos nonesterifi fatti acid level matern cord plasma author establish  healthi women moment deliveri content glucos free fatti acid blood mother umbil cord concentr substanc signific higher mother infant relat free fatti acid   glucos   relat glucos fatti acid mother signific differ infant
328  |  epinephrin infus normal toxem pregnanc ii plasma glucos nonesterifi fatti acid epineph  rine norepinephrin alter seven control  preeclampt patient infus differ amount epinephrin plasma nefa glucos catecholamin determin epinephrin infus toxem patient respond metabol effect infus epinephrin manner similar normal pregnant patient increas level nefa pregnant patient explain com  plicat biochem mechan involv increas avail cortisone lik steroid slight increas amount thyroid hormon etc result alter carbohydr util studi lead conclus epi  nephrin etiolog agent toxemia pregnanc
329  |  lipid mobil substanc serum pregnant wo  men probabl placent origin substanc capabl induc free fatti acid ffa releas found sera   pregnant women rat epididym fat pad use bioassay substanc circul late pregnanc disappear within  day post partum present crude placent extract remov deprotein nondialyz applic pituitari extract procedur placenta yield activ fraction pituitari growth hormon usual found accord fact hypothesi concern part metabol chang occur preg  nanci pronounc follow describ substanc diminish matern glu  cose consumpt elev plasma free fatti acid direct in  hibit glucos uptak permit preferenti shunt glucos fetus time increas plasma free fatti acid level would serv altern matern energi substrat elev matern insulin level late pregnanc stabil degre matern lipid mobil contrainsulin properti substanc capabl mobil free fatti acid inhibit mater  nal glucos util would pose diabetogen challeng face com  promis matern insulin reserv provok overt worsen exist diabet mellitus
330  |  metabol free fatti acid perinat life lamb rapid rise free fatti acid blood plasma birth newborn lamb studi confirm rise caus augment mobil acid tissu norepinephrin easili mobil free fatti acid adult ewe newborn lamb special effect lack though cardiovascular re  spons clear demonstr block sympathet nervous system newborn lamb inhibit rapid rise free fatti acid birth com  patibl concept increas activ sympathet nerv birth import factor free fatti acid mobil intrauterin life ampl studi carbohydr organ use energi sourc hypoglycaemia result sudden carbohydr depriv birth demonstr rise free fatti acid change ov tissu fat main sourc energi
331  |  effect glucos infus lipoid carbohydr metabol parturi woman fetus  parturi women given glucos infus expuls stage labor author abl observ unusu hyperglycemia decreas unesterifi fatti acid uefa uefa level usual increas regular deliveri likewis valu esterifi fatti acid efa show in  creas normal present level women receiv glucos in  fusion expuls stage labor result show deliveri hyperglycemia increas lipoid predomin due energi demand organ howev also evid hitherto un  known factor may play role fetus infus glucos lead in  creas glucos retent infus howev bring decreas contrari expect increas uefa valu general reaction found subsequ period life inves  tigat conduct order find explan paradox uefa  reaction shown analysi lactic acid pyruv acid valu increas uefa probabl attribut impair fetal metabol condit administr physiolog salin infus  parturi women equal condit reveal caus uefa  increas appar neither found hemodynam chang due infus chang electrolyt balanc rather adapt insuffici fetal islet cell respect differ fat mobil fat deposit
332  |  plasma free fatti acid composit blood glucos normal diabet pregnant women new  born blood glucos plasma ffa content composit newborn normal women gestat diabet insulin depend diabet analyz normal matern ffa level twice fetal valu  hr age ffa in  creas  fold initi valu normal infant infant gestat diabet  fold rise insulin depend diabet  fold blood sugar time decreas invers relationship be  tween blood glucos normal infant ffa relationship alter infant diabet mother gas chromatographi plasma indic higher ratio unsatur satur ffa mother compar infant pattern differ note normal diabet mother except latter higher oleic acid initi  hr life pattern chang although differ note infant diabet mother normal observ suggest  metabol interrelationship glucos ffa normal infant differ infant diabet mother latter infant state physiolog hyperinsulin  plasma ffa fetus deriv fetal fat synthesi well placent transfer  infant diabet mother differ normal regard ffa com  posit
333  |  lipid human placenta chloroform methanol solubl compon  human placenta isol rubber membran dialysi gas chromatographi analys two third total lipid consist phosphatid lecithin main compon  colamin cephalin  sphingomyelin  free cholesterol form  ed  total lipid cholesterol ester account  trigly  cerid  investig phosphatid fatti acid gas chromatographi show content  satur  simpl unsatur  polyunsatur acid fatti acid triglycerid consist  satur  simpl polyunsatur acid polyeno acid  cholesterol fatti acid high content linol acid one quarter total acid
334  |  experiment studi sensit nickel sensit effect epicutan applic nickel sulfat  guinea pig confirm appear eczematiform lesion skin test nickel sulfat mainten anim good general condit necessari add vit c antiinfect agent diet reason allergen ni salt augment use adjuv freund complet adjuv alum adjuv act stimul res method sensit guinea pig metal salt work propos studi mechan sensit biolog disturb involv possibl exist cross sensit
335  |  remark nickel dermat non occup contact dermat repres  skin diseas observ allergolog outpati depart dermatolog clinic milan disord frequent women prefer thigh girdl key wrist watch incub period general long peculiar papulo vesicular follicular lichenoid erupt often follow
336  |  studi bind protein nickel special refer role nickel sensit reaction nickel protein studi use techniqu equilibrium dialysi experi crystallin bovin serum albumen use nickel protein complex low stabil quantiti nickel bound protein depend concentr free nickel ion ph particular protein use site bind nickel ion primarili carboxyl amino group author conclud unlik nickel behav hapten capabl initi allerg respons
337  |  experiment nickel contact sensit man   male prison contact typ delay hypersensit induc experiment repeat applic  nicl  sodium lauryl sulphat solut skin test reaction  nicl occlus found irrit experiment sensit subject demonstr clinic sensit metal environ
338  |  hand eczema clinic aspect  case hand eczema review clinic type defin nummular eczema nickel allergi atop dermat hyperkeratot dermat palm hand eczema post partum mycot eczema contact dermat occup eczema idiopath eczema result patch test influenc psycholog psychiatr factor effect water cleanser diagnosi treatment prognosi discuss  signific causat factor could found mani case causat factor could identifi probabl contributori superimpos upon under idiopath eczema
339  |  steroid aerosol spray contact dermat prophylact use particular refer nickel hypersensit proper use topic aerosol dexamethason decadron spray afford complet protect patient nickel sensit clinic result confirm result patch test nickel sensit patient  nickel sulfat solut nickel coin combin dexamethason isopropylmyrist film necessari success prophylaxi individu compon alon protect patient clinic patch test result indic moder degre protect afford patient paraphenylenediamin sensit patch test result indic spray protect poison ivi ragwe oleoresin potassium dichrom certain rubber acceler monobenzyl ether hydroquinon afford moder protect formaldehyd test done patient formaldehyd hypersensit fair degre protect obtain use spray housew eczema presum due irrit present soap deterg
340  |  pathogenesi contact eczema due deterg domest use thesi maintain eczema due household deterg pathogen link allerg contact sensit metal salt especi chromium nickel seri  case contact eczema attribut deterg exist sensit metal demonstr patch test likewis analysi  sampl differ deterg use wash chromium nickel found present proport either metal vari   ppm
341  |  studi nickel carcinogenesi subcellular partit nickel lung liver follow inhal nickel carbonyl wistar rat expos inhal nickel carbonyl either concentr  ppm  minut  mg nicolair repeat  ppm  mg nicol air  minut  time week  year kill  hour final period exposur nuclear mitochondri microsom supernat fraction isol lung liver homogen measur nickel nitrogen rna cont subcellular fraction made greatest ratio nickel nitrogen nuclear fraction liver lung increas amount nickel also found microsom supernat fraction liver lung mitochondri fraction lung
342  |  studi nickel carcinogenesismetastas pulmonari tumor rat induc inhal nickel carbonyl combin seri studi   rat nb  surviv  wk expos nickel carbonyl develop pulmonari carcinoma metastas lesion includ common type pulmonari cancer squamous cell carcinoma adenocarcinoma anaplast carcinoma pulmonari lesion found   mth initi exposur nickel carbonyl amount nickel found capabl induc lung cancer rat compar amount nickel inhal person smoke less  cigarett per day period year mean weight rat chronic expos nickel carbonyl found consist less control rat throughout entir  year period studi
343  |  influenc age sex glandular extirp muscl carcinogenesi rat carcinogen effect singl intramuscular inject nickel sulphid aqueous suspens penicillin g ad compar male femal castrat hypophysectom intact rat differ age respons seem mark intact femal inject  mth old castrat hypophysectom  month old femal less respons one month old intact male respons  month  month old intact male  month old castrat male  month old intact femal data would requir firm conclus could drawn result
344  |  studi trace metal metabol electron paramagnet reson manganes ribonucl acid electron paramagnet reson spectrum pattern manganes readili detect sampl rna reson pattern indic manganes present rna dival state suggest manganes locat center distort octahedron oxygen atom intens nomin forbidden reson crystal field split paramet estim  cm  
345  |  metal chelat potenti reactiv organ phosphat poison acetylcholinesteras part studi investig metal chelat possibl reactiv phosphat poison acetylcholinesteras shown chelat act inhibitor enzym addit copper nickel chelat  pyridinealdoxim catalyz decomposit dfp sarin compar  pam howev chelat poor reactiv probabl improp align oxin oxygen chelate enzym complex
346  |  effect nicl isol ranvier node attempt made explain extrem prolong nodal potenti   mm nicl term ionic theori effect nicl room temperatur similar temperatur reduct decreas maximum rate rise action potenti lengthen action potenti durat elev threshold increas tendenc repetit activ addit amplitud action potenti slight increas long last plateaus respons obtain combin influenc nicl temperatur reduct shorten cathod polar strong anod polar decreas na plateau prematur termin short anod puls critic amplitud short cathod puls reduc durat plateau gradual increas puls strength increas k prolong plateau durat steep repolar phase normal termin plateau replac long last after depolar stepwis potenti declin amplitud k depolar influenc nicl temperatur reduct  mm nicl chang relat maximum rate rise steady st polar potenti chang requir  sodium inactiv mv normal ringer solut mv presenc  mm nicl  c  mm nicl increas time constant delay rectif measur na poor solut  c factor  decreas action potenti cathod polar slight delay nicl conclud prolong nodal action potenti nicl due delay reduc inactiv na permeabl delay increas k permeabl part nicl effect could explain assum competit ni ca specif site membran
347  |  carcinogen activ n hydroxy  acetylaminofluoren metal chelat function retent inject site carcinogen activ sc administ n hydroxy  acetylaminofluoren n hydroxy aaf varieti metal chelat indic greater activ local associ longer retent chelat site inject slow releas n hydroxy aaf surround tissu tumor obtain site  inject n hydroxy aaf  mg inject    rat develop sarcoma site   inject respect nickel cobalt ferric cupric chelat induc moder high incid sarcoma   inject case one half administ n hydroxy aaf retain inject site   day mangan zinc chelat potassium salt less activ inject site half retent time rang  hr  day compar half retent time n hydroxy aaf  hr inject metal deriv c short half retent time result higher incid mammari tumor inject deriv half retent time  day administ food cupric chelat n hydroxy aaf induc spectrum tumor n hydroxy aaf incid lower prolong retent materi inject site may account greater carcinogen activ metal chelat serious consider must also given possibl import chelat carcinogen metabolit cellular constitu
348  |  generat action potenti singl ranvier node isol frog nerv fibr influenc nickel cadmium ion russian experi singl ranvier node frog isol nerv fibr shown along mark prolong repolar phase action potenti ap ni cd ion also caus rise critic membran depolar level increas ap amplitud somewhat reduc steep ascend phase ni cd ion restor ap generat node ranvier alter  procain solut excess potassium ion mm kcl slight mechan injuri dissect reduc na concentr medium restor ap could achiev ni cd ion consider slow weaken cathod rise critic level ap reduct cystein       elimin effect mention ion suggest made bind sh group nerv fibr protein nickel cadmium reduc rate inactiv increas potassium permeabl depolar also weaken initi inactiv increas potassium permeabl depolar well weaken initi inactiv membran i h whenev happen rais previous influenc
349  |  agnost alexia construct apraxia regress evolut child  yr age acut encephalopathi etiolog could determin boy  yr  mth age develop syndrom agnost alexia construct apraxia remark pure intellectu function normal determin iq test speech disturb either child could read copi text fulli abl write freeli dictat patient could read written show characterist featur agnost apraxia motor activ perform normal child extrem difficulti construct geometr form even elementari either spontan copi remark syndrom disappear involut follow
350  |  symptomatolog pariet cerebr syndrom domin hemispher pariet dyslexia conduct aphasia comprehens studi patient begin pronounc gerstmann syndrom autotopagnosia part face dyspraxia construct apraxia dyslexia autotopagnosia mild left right disturb show mark regress actual hemianopsia observ tachistoscopi reveal percept right field vision poor audiometr examin show conduct deaf disturb binaur word synthesi disturb examin meticul test symptom relationship becam evid various factor concern creativ abil
351  |  observ colour agnosia  year old right hand man follow format left posterior subdur hematoma develop spell dyslexia impair pictur interpret resolv color agnosia persist latter impair use color inform name color may explain disord impair recollect format associ color name type inform result interfer task color name place specif context altern view willbrand  limit dysphasia sittig  recognit defect simultan present cannot exclud present previous report case causat lesion seem posterior locat domin hemispher borderland area receiv visual input languag verbal record area
352  |  bitempor hemianopia two stage distinguish develop bitempor hemianopia hypophys tumor first stage consequ direct pressur tumor lower side chiasma henc start upper quadrant field defect stage visual disord amen prompt complet restor progress growth tumor second stage follow consequ constrict circl vessel stage nerv fiber destroy therefor pressur reliev oper restor occur limit extent
353  |  ophthalm manifest bilater non occipit cerebr lesion twelv patient describ neuro ophthalm symptom result bilater cerebr lesion area occipit lobe symptom sign categor follow group show predomin disturb visual object recognit visual agnosia disturb visual spatial local group iia defect voluntari control eye movement ocular motor apraxia group iib persist palsi conjug gaze although symptom may present extent unilater lesion much profound less abl compens bilater lesion evid present case suggest biparieto tempor local lesion caus visual agnosia disturb spatial local ocular motor apraxia frontal local lesion caus prolong paralysi conjug gaze
354  |  speed read basi clinic function test easili comprehens measur capabl read author recommend determin read speed supplement ocular function test method question constitut senso motor effici test valu apprais haemianopia paracentr central defect visual field squint amblyopia spontan nystagmus
355  |  problem visual agnosia critic assess ancient modern theori visual agnosia origin descript subject world patient also given visual agnosia rare disord led comprehens discuss instanc fact problem normal visual percept alway involv bay view deni exist agnosia separ phenomenon percept disord especi dealt affirm case describ literatur visual agnosia decid pure isol phenomenon most also disturb intellectu interpret visual data often metamorphopsia asthenopia local prestriat gnostic center visual impress older concept higher lower level percept percept disord also critic visual percept passiv activ process neurophysiolog psycholog aspect involv disturb lead various degre visual percept disturb
356  |  dysbar among hyperbar personnel survey effect hyperbar exposur  medic personnel expos  compress decompress reveal case perman ill effect pain ear sinus common symptom could often amelior avoid valsalva techniqu forc insuffl nostril occlud serious symptom encount  episod transient homonym hemianopsia classic symptom decompress sick extrem pain bend pulmonari substern distress choke skin dysesthesia occur rare mild fleet requir treatment reduct symptom without increas decompress time may obtain inhal  oxygen decompress stop pressur  pound per squar inch gaug psig
357  |  visual static agnosia special refer liter agnos alexia report  right hand adult visual agnosia predomin liter alexia recognit letter poor nonexist patient simpli view materi static method letter slowli develop abl identifi dynam method one patient vascular patholog consid involv occipit lobe nd patient surgic remov left occipit lobe angioma
358  |  optic agnosia semeiolog pathogenet aspect author discuss classic concept agnosia make survey pathogenet factor determin phenomenolog origin tradit concept term impli loss capac recogn object function sens organ undamag psycholog studi percept modern physiolog vision allow avoid dichotomi sensat percept affirm ident cortex recptor close bound function unison everi cortic alter thus reflect sensori function therefor practic semeiolog ground possibl obtain congruous inform correspond cortic function explor sens organ carri suitabl mean sinc confront function chang explor method must fit evalu dynam aspect percept connect tempor spatial stimuli method quit numer often complex particular stress laid local adapt flicker fusion tachistoscopi account signific suitabl method possibl show function deficit patholog disturb sensori function also behind patholog visual recognit fluctuat extinct alter percept movement real appar chang adapt light dark phenomena detect instrument time may determin import onset agnos behaviour complex latter hand cannot alway explain sensori disturb mechan function complementari less indispens dynam percept process may interven interfer basi latest neurophysiolog data attent call ocular motil propriocept centrifug innerv sensori receptor vestibular affer particular clinico pathogenet signific attach author associ later visual disturb alter propriocept kinesthet inform correspond half bodi associ fact near alway present among factor respons strict spatial error agnos patholog light pathogenet consider well suitabl semeiolog find author deem conveni divid case  categori distinct clinic featur case alter visual behaviour may relat chang visual function complementari mechan b case hemianopia associ homolater deficit somat propriocept c case chang behaviour chiefli due dissolut symbol sphere
359  |  clinic observ hemianopia japanes clinic find  case hemianopia analyz hemianopia caus frequent vascular lesion central nervous mianopsia tumor wilbrand prism sign general taken evid optic tract lesion posit one case pariet lesion case show cogwheel movement eyebal optokinet nystagmus posit  case one prove parieto occipit aneurysm etiolog factor could identifi remain  case macular spare found symptomat occipit lobe lesion incongru  field observ  case occipit lobe lesion prognosi hemianopt field defect remain stationari case vascular lesion hand perfect recoveri visual field defect occur case occipit lobe tumor hypophys hypertrophi caus pregnanc visual acuiti hemianopt patient fair good deterior occur observ period  year one patient present seri die result suggest favor vital prognosi accord hemianopt subject
360  |  import campimetri carotid vertebr angiographi thrombosi posterior cerebr arteri author report case thrombosi posterior cerebr arteri present later homonym hemianopia stress import campimetri carotid angiographi besid vertebr angiographi
361  |  hemianopsia glaucoma discuss bibliograph refer observ simultan occurr hemianopsia glaucoma author state basi experi follow point homonym hemianopsia occasion take place glaucoma although direct relat establish former glaucoma point howev older patient exampl retin detach neuriti etc likewis subject repeat exact perimetri hemianopsia occur found lesser rate glaucoma homonym hemianopsia taken consider also event sudden impair visual field glaucomat patient hemianop defect superven addit visual field defect due glaucoma case binas hemianopsia simultan presenc glaucoma rare incid whether binas hemianopsia result gradual develop glaucomat visual field nasal defect whether constitut independ symptom certain extent cannot alway clarifi individu case obvious condit basal cerebr vessel play certain role develop glaucoma even role cannot clear defin yet case binas hemianopsia glaucoma rule radic diagnost therapeut measur carri
362  |  disord oculomotor function lesion optic pathway parieto occipit level signific topic diagnosi paresi ocular movement hemianop side describ  patient acut vascular lesion parieto occipit region  case paresi dissoci type inabl follow move finger ocular movement verbal state direct quit normal remain  patient oedema extend frontal region complet paresi conjug movement conjug paresi reced hand in hand pariet symptomatolog even hemianopia persist oculomotor disord refer never observ lesion extend beyond occipit region conjug paresi case drawn attent presenc hemianopia unobserv patient led accur topic diagnosi
363  |  binocular anomal retin correspond patient anomal retin correspond demonstr complet bitempor binas hemianopia test binocular vision exotrop binas suppress esotrop bitempor suppress contrari prevail concept function peripher retina anomal retin correspond  refer
364  |  thioguanin treatment certain autoimmun immunolog relat diseas therapeut effect  thioguanin evalu past  year  patient divers syndrom patient sever debilit diseas unrespons convent therapi treat remiss occur   patient system lupus erythematosus  patient dermatomyos necrot angiiti  patient psoriasi   patient atop diseas improv occur patient diseas   patient neurodermat two patient scleroderma experienc equivoc benefit signific toxic attribut drug observ  patient assess eventu valu agent therapi requir studi hypothes regard mechan action agent signific clinic respons discuss
365  |  natur collagen diseas particular system lupus erythematosus sle special refer renal lesion japanes result examin  autopsi case collagen diseas rheumat fever polyarter nodosa pn consid diseas hypererg natur show pronounc specif manifest particular organ reactiv becom lower specif local becom less signific mani organ becom affect sle may accord suppos sle diseas hypersensit one occur state exhaust reactabl prolong sensit moreov sle lik syndrom aris end stage parasepsi nephriti nephrosi case prolong sensit mycotb also pnpssdm rheumat may therefor conceiv sle syndrom rather separ entiti import consid whether sle lik symptomatolog may regard process equal auto immun whether key morpholog elucid auto immun phenomenon may lie hidden problem
366  |  therapi lupus nephropathi  mercaptopurin corticosteroid therapi improv general prognosi sle detect effect nephropathi actual main caus death new therapeut method present use  mp purinethol leupurin produc  remiss  consecut case total  case sever nephropathi definit remiss emphas  case report definit npn elev accord consid hopeless
367  |  lupus erythematosus fatal hemorrhag liver lesion resembl periarter nodosa malign hypertens immunocytochem observ firm establish case lupus erythematosus histolog characterist periarter nodosa fatal hemorrhag present immunocytochem studi done explor possibl vascular lesion immunolog type immuno fluoresc techniqu y globulin human serum complement albumin fibrinogen demonstr vascular lesion y globulin renal glomeruli associ complement conclus lupus erythematosus primarili immunolog diseas complex auto immun mechan oper
368  |  earli experi azathioprin ulcer coliti note caution azathioprin administ  patient ulcer coliti classifi sever moder sever  relat mild  patient conjunct standard therapi adren corticosteroid   patient possibl benefici therapeut effect azathioprin small seri cannot evalu definit concurr medic preliminari uncontrol observ howev clinic improv appar   patient  patient favor cours occur absenc steroid therapi  addit patient favor cours maintain administr azathioprin follow discontinu prolong steroid therapi  patient administr azathioprin associ amelior arthriti pyoderma gangrenosum respond use steroid medic immuno suppress observ limit establish delay hypersensit respons reflect various skin test unchang administr azathioprin azathioprin discern toxic effect upon kidney liver  patient  postnecrot cirrhosi serum hepat gastro intestin symptom anorexia epigastr discomfort nausea occur  patient mild moder leukopenia develop  patient  individu accompani thrombocytopenia temporari alopecia occur  woman hematopoiet effect develop within   wk therapi azathioprin dosag level   mgkgday azathioprin exert rapid benefici effect ulcer coliti note corticotropin adren corticosteroid therefor use sever ulcer coliti requir intens therapi probabl undesir azathioprin basi initi observ may consid moder sever ulcer coliti circumst permit control prolong therapeut trial adjunct medic care supervis prevent toxic especi leukopenia
369  |  effect fluoropyrimidin delay cutan hypersensit abil express delay cutan hypersensit assess  patient carcinoma evid present  fluorouracil  fluoro  deoxyuridin paradox potenti paramet immun respons
370  |  data etiolog pathogenesi treatment result surviv period  patient cirrhosi liver statist compil total  case chosen random cirrhosi liver figur refer age sex patient well etiolog hepat morpholog date death  subject known possibl calcul surviv time diagnosi made  surviv time diagnosi  year   year   year figur show modern therapi liver cirrhosi succeed prolong life major victim mani case howev possibl larg extent reliev patient suffer improv appetit general condit elimin ascit period hemorrhag stupor particular attent paid prophylaxi diseas studi surviv time assess therapeut report method select subject
371  |  chronic renal diseas pregnanc review review given reciproc relationship chronic renal diseas pregnanc short review import chang renal function due normal pregnanc diagnosi chronic renal diseas discuss subsequ follow complic pregnanc discuss individu chronic pyelonephr chronic glomerulonephr lupus erythematosus nephrot syndrom diabet nephropathi polycyst diseas kidney paper conclud discuss influenc pregnanc differ renal affect
372  |  occurr cytomegalovirus infect childhood leukemia report three case cytomegal inclus diseas cmid present follow clinic find three children acut leukemia persist high temperatur cough vomit diarrhea hepatosplenomegali rale termin icterus pancytopenia present includ two children leukem remiss roentgenograph evid pneumonia appear third week onset symptom abnorm liver function test late find intranuclear inclus seen urin sediment two patient neither patient intranuclear inclus demonstr sputa virus cultur urin done one patient cytopathogen chang characterist cytomegalovirus cmv demonstr cmid caus death three children receiv chemotherapi agent known immunosuppress properti
373  |  chorea lupus erythematosus cerebr arter woman age  develop chorea  yr onset system lupus erythematosus sle experienc asymptomat interv  yr abnorm movement persist  mth subsid short term administr  mercaptopurin  previous descript chorea patient sle   autopsi case extens cerebr lesion due diffus arter found cns chang quit similar found chorea minor
374  |  pharmacolog action cellular immun follow chapter interest field drug immun process includ manifest cellular immun state reduc immunolog reactiv present status pharmacolog immunosuppress test suscept tuberculin reaction pharmacolog action test suscept transplant immun pharmacolog action compar suscept tuberculin skin homotransplant reaction pharmacolog action
375  |  chromosom aberr human cell follow treatment imuran five women various collagen diseas studi bone marrow aspir obtain patient   day start imuran azothioprin therapi fifti metaphas sampl count patient nos   increas cell structur abnorm therapi signific aberr found most break chromatid chromosom type abnorm chromosom seen among ring chromosom patient  chromatid exchang seen three cell
376  |  autoimmun hepat   patient cirrhosi caus uncertain  case clinic pictur activ chronic hepat could recogn   character lupoid hepat relationship activ chronic hepat lupoid hepat sle studi  group  case comparison made possibl etiolog factor system manifest surviv rate histolog appear biochem test autoimmun reaction result immunosuppress drug studi concept emerg accord proport case cirrhosi occur adequ nourish individu attribut end result autoimmun reaction
377  |  comparison effect select cytotox agent primari agglutinin respons rat inject sheep erythrocyt compar studi made effect sever cytotox agent given maxim toler dose primari agglutinin respons rat immun sheep erythrocyt given intraperiton antigen given begin middl  day cours drug treatment chlormethin mechlorethamin  fluorouracil  fluoro  deoxyuridin suppress primari respons signific methotrex  mercaptopurin  mercaptopurin robosid  amino   methyl  nitro  imidazolyl thio purin prolong induct time suppress peak titer maxim immun perform one three day prior drug treatment vinblastin affect peak titer prolong induct time antigen given  day prior drug treatment cyclophosphamid mark prolong induct time suppress peak titer irrespect time antigen administr antimetabolit appear suppress maxim intermedi stage primari respons cyclophosphamid appear suppress stage
378  |  analysi mechan immunosuppress drug renal homotransplant dammin g j long term studi mechan action immunosuppress drug complet bilater nephrectom dog kidney homotranspl  test anim  differ drug protocol analyz increas number long surviv anim pose mani question regard status treat host current drug protocol azathioprin diazoacetylserin azaserin produc   day survivor   day survivor follow observ document anim prolong drug therapi immunolog compet drug therapi stop success anim long surviv kidney appar protect way new environ second donor kidney reject first surviv retransplant long surviv kidney back origin host lead decreas renal function long surviv kidney success retranspl back origin donor reject transplant third parti non drug treat recipi immun paralysi account prolong surviv second donor kidney constitut doubl dose antigen reject first continu surviv absorpt metabol drug account variat result two kidney separ donor reject differenti drug treat host host sensit recipi sensit continu even anim success wean drug addit analys relationship skin homograft kidney homograft reveal follow skin homograft univers reject within  day host treat drug regimen protect kidney homograft sometim perman skin kidney homograft donor place simultan skin surviv prolong kidney surviv shorten paradox effect probabl explain product antibodi skin absorb reject kidney addit observ indic drug treat anim male femal fertil multipl reject process produc general immunolog pictur host similar autoimmun diseas process
379  |  myocardi toxic contrast agent use angiographi myocardi toxic mani current experiment contrast agent studi dog use previous unreport method occlus retrograd coronari venographi well familiar techniqu select coronari arteri catheter follow conclus appear justifi light experi iodine contain radic contrast agent often identifi acetrizo diatrizo iothalam etc also final salif product appear respons wide diverg degre myocardi toxic contrast agent point differ  ent salt compound behav entir differ agent chemic biolog result seem indic domin sodium ion andor protect effect methylglucamin salt respect myocardi toxi  citi current radiopaqu media report yet unexplain electrocardiograph chang occur within one two second begin massiv caval high pressur inject appear find causal relationship myocardi ir  ritabl induc distent coronari vein myocardi infiltra  tion intent enhanc retrograd inject techniqu pe  culiar trait share vari degre radiopaqu agent test abil increas coronari blood flow clinic signific phenome  non howev remain establish studi re emphas limita  tion standard toxic studi conduct anim clear result report agent administ coronari circul demand investig regard potenti toxic method describ herein variat thereof fact similar test carri or  gan subject radiograph examin via vascular bed author hope present stimul renew investig particular view grow clinic applic select cardiovascular opacif tech  niqu
380  |  studi cardiac dimens intact unanesthet man descript techniqu valid ii effect respir iii effect muscular exercis method describ permit measur relat chang exter  nal dimens individu cardiac chamber throughout cardiac cycl intact unanaesthet man consist sutur multipl radiopaqu silver tantalum clip surfac heart time cardiac oper postopera  tive period cineradiogram obtain distanc clip mea  sure individu frame techniqu found safe employ  patient without complic result studi  patient util biplan serial exposur effect rotat heart sagitt plane cardiac respiratori cycl determin precis clip proper place heart possibl error result rotat found quit small inspir right ventricular dimen  sion increas opposit occur expir val  salva manoeuvr left ventricular dimens exhibit littl chang normal respir deep slow inspir chang dimens left ventricl lag behind right ventricl   general   car  diac cycl magnitud chang dimens left ventricl smaller occur right ventricl effect ventricular dimens light muscular exercis perform supin posit studi  patient end diastol dimens decreas averag  con  trol right ventricl averag  left ventricl end sys  tolic dimens decreas averag  control right ventricl averag  left ventricl decreas consid approxim one half rest stroke volum  patient rate right ventricular pressur rise determin continu exercis re  sult elev dpdt ventricular end diastol dimens decreas data interpret indic increas myocardi contractil occur muscular exercis man
381  |  radioact isotop determin myocardi blood flow surfac count ratio formula wilkinson result present larg scale error larg scatter author recommend clinic use method at  tempt coronari portion flow rate curv exist chang present instrument need allow use techniqu sevelius johnson defin coronari portion flow rate attempt made evalu possibl sourc error
382  |  risa ventriculographi risa cisternographi general experi author risa ventriculographi risa cis  ternographi relat conclud former techniqu may particular use detect intraventricular tumor intern hydrocephalus well assess effici surgic shunt latter techniqu may use studi normal csf circul well case csf leak arachnoid extern hydrocephalus
383  |  measur cardiac output ventricular volum radiocardiographi cardiac output measur extern count inject radioisotop rihsa erythrocytes cr result  subject includ  normal present compar result method cardiac output rest exercis compar  subject principl ventricular volum measur radioisotope cardiographi discuss result measur ventricular volum  normal subject  patient measur ventricular volum  patient present
384  |  aberr left coronari arteri five case aberr coronari arteri present emphasi angio  graphic featur differenti endocardi fibroelastosi clinic electrocardiograph featur may suggest proper diagnosi angio  graphi conclus demonstr continu pulmonari arteri left coronari arteri case blood flow pulmonari arteri coronari arteri forward  case coronari arteri pulmonari arteri retrograd  diagnosi aberr coronari arteri suspect select left sid angiocardiographi angiograph procedur choic differenti endocardi fibroelas  tosi myocardiopathi usual problem studi may difficult intraven angiocardiographi latter type studi coronari arteri general visibl persist thin la  teral aspect left ventricular wall suggest proper diagnosi sub  sequent confirm left sid inject advis
385  |  detect heart shunt mean  extern scintil detect pure dilut curv origin right ven  tricl pursu investig mani yr use soft photon  offer improv method determin allow excel collim  mechan  small half valu layer  cm tissu  uni  direct part due all or non photoelectr absorpt photon compar pluridirect due compton scatter case   normal individu extern detect dilut curv right heart ventricl arteri dilut curv obtain arteri punctur compar five hundr microcuri  inject antecubit vein amount radiat absorb  uc dose adult  kilo   mrad inject form  iodid use  orthoiodohippu  rate advis due short biolog half period integr whole bodi radiat exposur decreas  fold comparison  iodid shape right heart curv similar arteri dilut curv   excess count origin outsid right ventricl area descend segment right ventricl curv minimum count rate   peak curv compar arteri curv   mean  descend slope right ventricl   sec right heart curv   sec arteri curv clinic use procedur  patient atrial septal defect  patient ventricular sep  tal defect analyz seem possibl perform select right heart radiocardio  graphi mean extern precordi detect  method simpl reproduc
386  |  clinic applic quantit radiocardiographi result normal subject chang age techniqu describ routin determin bedsid blood volum cardiac output pulmonari blood volum mean method quantit radiocardiographi instrument simpl techniqu easi perform caus littl troubl patient one inject  uc rihsa need thirty nin patient age   yr free cardiovascular re  spiratori disord studi result obtain close agreement previous report cardiac index show signific decreas age reduct blood volum pulmonari blood volum slight close statist correl found pbv sv interpret depend pbv sv
387  |  demonstr myocardi infarct photoscan heart man intraven inject radioiodin oleic acid incorpor heart muscl suffici concentr permit record photoscan heart man  fatal case massiv septal myocardi infarct inject radioiodin  ate fatti acid rifa made life necropsi photoscan excis heart show discret area absent radioact correspond infarct interventricular septum photoscan heart made life  pa  tient  suffer recent myocardi infarct definit area deceas radioact correspond locat infarct judg electrocardiogram  probabl area decreas radioact   case myocardi infarct technic present employ approach limit definit infarct acut case modif biochem principl develop y camera may bring method level diagnost use
388  |  y angiocardiographi record made simultan y cardiogram pulmonari an  giogram mean collim place left scapular region carotid angiogram collim center axi extern auditori canal  curv yield interest inform chronolog various car  diac cycl pattern pulmonari carotid y angiogram valuabl sever patholog condit logic measur cardiac output carotid curv y cardiogram especi shunt pulmonari curv allow rectif time constant empti left caviti heart regard chronolog inform cardiac cycl atten  tion drawn fact pulmonari circul long short circuit demonstr characterist time measur time radioact materi appear left caviti time leav carotid interv   systol repres time neces  sari left circular fill valid calcul cardiac output stewart hamilton formula discuss valid collim cover small volum princip channel remain shown calcul valid larger caviti  caviti radioact materi pass success differ c function well tissu seen collim yet irrig radioact blood area recircul alreadi start aspect applic pulmonari angiogram discuss detail author techniqu y angiogram especi valuabl correc  tion time constant decreas left peak base lengthen curv serv basi determin left ventricular volum
389  |  valu quantit radiocardiographi studi hemodynam six normal subject  patient mitral stenosi studi quantit radiocardiograph investig rihsa perform accord donato method stroke volum well cardiac output found decreas mitral stenosi right ventricular evacu ratio diminish pul  monari circul time prolong result pertain diastol right ventricu  lar capac right ventricular rest blood volum pulmonari blood volum prove inconclus
390  |  local aortic shunt develop precordi registr  inject aorta differ level techniqu local shunt aortic origin describ base analysi precordi record  inject differ aortic level seven patient patent ductus arteriosus pda  coronari av fistula  ventricular septal defect vsd  atrial septal defect asd  mitral regurgit  aortic regurgit  system hypertens studi retro  grade arteri catheter selding techniqu perform patient well right sid catheter congenit cardiopathi transsept catheter valvulopathi dose   uc na  inject level aortic root ascend aorta aortic arch origin left subclavian arteri ductus level descend aorta post  ductus level precordi curv obtain mean  inch thallium acti  vate nai crystal focus rd left intercost space sternal margin shunt outlet detect obtain simultan venous dilut curv right chamber pulmonari arteri latter techniqu use  patient pda  coronari av fistula  vsd curv obtain continu withdraw blood flow well scintil counter crystal puls carri ratemet work follow time constant   sec precordi curv  sec venous curv direct record  mmsec paper speed use normal precordi curv inject aortic valv obtain patient arteri hypertens mitral regurgit asd vsd swift downslop fell near baselin level recirculatori area observ
391  |  use tc pertechnet cardiac scan technetium pertechnet util aa laboratori scan cardiac blood pool delin heart pool surround vasculatur compar obtain standard  compound use author hand tc follow advantag sinc routin util tc brain thyroid scan avail elimin purchas shelf decay materi three  mc quantiti may administ relat low patient radiat dosag associ high count rate permit rapid scan identif pericardi effus enhanc radio  activ stomach case becom abnorm separ cardiac blood pool
392  |  use technetium clinic tracer element physic properti metabol radiat dose tc discuss compar     shown tc highest vivo count rate obtain given intern radiat dose mea  surement high statist accuraci may safe made y ray energi near optimum scan observ transient allow light weight collima  tor use tc tag albumin consid superior risa ap  plicat brain scan placentographi measur cardiac output  becom avail prefer thyroid scan
393  |  studi central arterioven shunt precordi record radioalbumin dilut curv precordi dilut curv  patient studi  without cardio  vascular diseas  central arterioven shunt  various cardiac diseas collim use allow minim quantiti radioact materi   uc  tag albumin util precordi focus zone critic factor techniqu applic differ discrimina  tion factor among ratio minim concentr latter  an index propos   made possibl diagnosi   patient shunt method shown sensit classic oximetri done cardiac catheter curv pure valvular stenosi show similar chang shunt hand chang shown certain val  vular regurgit fact becom import limit factor diagnosi central arterioven shunt cardiac failur preclud diagnosi provid one exclud valvular regurgit mean method thus spite limit extrem valu diagnos central arterioven shunt especi result analyz togeth clinic
394  | inform  primari epidermoid cancer lung electron micro  scopic studi electron microscop studi made  squamous cell  undifferenti  alveolar carcinoma lung biopsi specimen embed methacryl  ate squamous cell carcinoma found contain cylindr cell glycogen granul scanti mitochondria reticular endoplasm chiefli vesicular numer free ribosom bundl confluent fibril desmo  some author also observ center tumor node cell richer tonofibril envelop nucleus cell cytoplasm organell almost disappear except tonofibril cell pack keratohyalin even lipid granul sometim arrang lamellar format myelin type pictur whole often seen optic microscop tumor foci form slight differenti cell peripheri becam differenti one approach center undifferenti  ate cell resembl intermedi bronchial cell basal cell paper describ undifferenti alveolar carcinoma
395  |  loss neoplast properti vitro ii observ kb sublin ten sublin kb cell line obtain number differ laboratori reexamin respect chromosom number heterotransplant syrian hamster cheek pouch twelv clonal cultur deriv  sublin similar examin three sublin differ one anoth kb cell line origin studi heterotransplant inocula circa  cell  sublin could heterotranspl inocula less   cell  heterotransplant inocula     cell  fail heterotranspl even inocula   cell similar differ heterotransplant observ among clonal deriv  sublin although modal number sublin clonal deriv basic similar rang   line chromosom sufficient  ly distinct morpholog serv marker howev appar correl minor karyotyp differ heterotransplant possibl differ non heterotransplant heterotransplant sublin respect pattern variabl cytoplasm protein cyto  plasmic ribonucl rna content per cell remain studi detail seri articl see exc medica cancer  abstr 
396  |  establish tissu cultur strain jtc  actino  mycin induc ascit sarcoma biolog charact cell line jtc  maintain  yr subcultur  time cell th subcultur subcutan inject mice produc tumor ident produc origin cell judg time taken kill mice intraperiton inject tissu cultur cell malign origin tumor cell passag anim cell easili re establish cultur vitro
397  |  microcinematograph studi mechan cancer invas cultur normal tissu combin malign cell normal myocardium newborn ch mice cultiv vitro contact homolog sarcomat cell strain n strain nctc studi micro  cinematographi  day found tumor cell tend move apart vigor rapid movement call commando make way group normal cell arrest wherev meet compact group cell demonstr one hand direct aggres tumor cell group defenc normal cell
398  |  presenc lymphocyt long term cultur newborn mous thymic epithelium thymic epitheli cell deriv newborn mous thymic fragment cultur vitro  mth subcultur start transfer minut cell sheet obtain mechan scrape origin cultur  mth old older lymphocyt mani morpholog appear plasma cell seen subcultur intact lymphocyt well mitot figur seen within cytoplasmat vacuol epitheli cell possibl bear observ origin thymic lymphocyt briefli discuss
399  |  four separ tumour clone deriv transplant pleo  morphic carcinoma lung heterozyg mous metastasis pleomorph adenocarcinoma lung untreat hetero  zygous male mous success transplant  brother plate techniqu henderson rous plate multipl small graft air bell subcutan tissu new host possibl select  differ clone transplant tumour studi histolog peculiar differ part origin tumour reproduc differ clone ii iii b retrospect studi primari tumour metastas provid interest clue rout metastasi select surviv malign cell conclud clone transplant cell first serial passag valuabl inform histogenesi potenti malign primari tumour obtain last high malign charact  clone tumour cell appar deriv familiar clinic benign adenoma mous lung may interest point view prognosi base histolog
400  |  in vitro cultur pulmonari tumor hamster caus adenovirus  known adenovirus   provok malign tumor new born hamster author made studi histogenesi tumor examin specif chang brought cell virus infect malign presenc viral antigen reaction superinfect new born hamster inocul chest adenovirus  malign tumor develop one two month  anim  tumor present epitheli aspect bronchiolo alveolar origin transplant  abl vivo cultur vitro consist first cultur macrophag fibroblast epithelium subsequ passag progress disappear macrophag fibroblast case cultur seven passag pure epitheli natur reimplant hamster time gave rise rapid develop epitheli tumor tumor cultur adenovirus could demonstr could cultur pulmonari tumor cultur normal hamster lung infect adenovirus appear lung hamster organotyp  ical cultur constitut mean choic malign transform adenovirus 
401  |  demonstr purif partial character ab  normal hsl antigen stabl human cell line exist abnorm human stabl line hsl antigen common number stabl human cell line absent normal human tissu normal human diploid cell strain tissu cultur demonstr agar gel microimmunodiffus hsl detect hela sj hela mba hela  chang conjunctiva syverton embryo esophagus chang liver j iii detect henl human intestin detroit  absent two normal diploid strain wi  sj dhl found varieti concentr extract fresh human organ hsl associ contamin pleuropneumonia lik organ pplo cell line purest hsl prepar obtain hela sj ammonium sulfat fractiona  tion yield absorpt spectra characterist protein inactiv trypsin sephadex chromatographi indic particl weight approxim  hsl sediment  x g  po buffer activ virtual complet elimin  minut  c  minut  c  minut  c preliminari studi fluoresc anti hsl globulin indic hsl surfac antigen rabbit antisera purifi hsl fraction cytotox hela cell best prepar hsl still contain trace common human antigen appear consist multipl compon activ immunoprecipit electrophoresi indic in  homogen materi
402  |  compar studi two isogen cell line autolog origin one tumor produc singl explant normal lung tissu adult femal mous cbl provid  cell line one remain normal refer pg becam malign design pt success vitro passag tryp  sinize tumour induc capac pt line consider decreas tumour produc capac well acrob glycolysi coeffici pg line show appreci chang result chromosom studi de  scribe prove inconclus similar experi also carri cell line deriv pt line result discuss
403  |  characterist human adenovirus type  induc hamster tumor cell tissu cultur characterist human adenovirus type  induc hamster tumor serial pro  pagat vitro describ includ small cell size epithelioid appear  anc rapid growth rate resist superinfect a  transplant  abil weanl hamster cell grew either monolay ball aggreg cell detach glass depend whether calf serum hors serum ad eagl medium attempt demonstr virus activ subcultur supernat fluid lyse cell hela cell mix cultur human hamster cell electron microscopi inocul newborn hamster irradi tumor cell negat
404  |  trial heterotransplant human cancer rabbit kleisbauer trial transplant human tumour  almost carcinoma pleural caviti larg rabbit  month old flander weigh  kg gave negat result also cortison treatment associ though cortison treat anim necrosi tumour less massiv examin graft tumour carri differ time   day transplant also control radiograph examina  tion detail descript giant cell reaction around tumour adjoin lung
405  |  solitari mast cell granuloma histiocytoma lung histopatholog tissu cultur time laps cinemato  graphic studi pulmonari histiocytoma  year old woman studi intens histo  patholog techniqu abund mast cell found within lesion previous unreport find tissu cultur studi suggest process reactiv rather neoplast plasma cel granuloma lung may mast cell histiocytoma
406  |  valu fluoresc cytolog cytodiagnosi pulmonari cancer paper discuss test result  tissu sampl sent cytodiag  nostic lung cancer compar method ao fluorochrom method prepar mean appli ao fluorochrom rate er  roneous posit find could reduc rate erron negat find  ing somewhat higher total diagnost precis   higher method appli
407  |  pitfal clinic histolog diagnosi broncho  genic carcinoma necropsi studi  case extrathorac carcinoma reveal pulmonari metastas occur almost  case bronchial metastas   case  seri clinic featur simul bronchogen carcinoma   case cytolog andor histolog confirm carcinoma pancrea present greatest sourc diagnost error account one third  case primari site second frequenc carcinoma kidney bronchial metastas chiefli respons clinic cytolog histolog find compat diagnosi bronchogen carcinoma secondari growth lung may present roentgenolog solitari tumor indistinguish primari lung cancer metastat lesion lymph node bronchi lung may exhibit pleomor  phic featur simul squamous cell carcinoma diagnosi bronchioloalveo  lar carcinoma resect lung tissu presumpt conclus inasmuch ident morpholog featur may reproduc metastas duct glandular carcinoma simul bronchogen carcinoma metastat tum  or occur suffici frequenc challeng diagnost accuraci death certifi bronchogen carcinoma necropsi exclus primari site
408  |  effect arginin depriv ultraviolet radiat x radiat cultur kb cell cytochem ultrastructur studi cultur kb cell deriv human oral carcinoma grown monolay injur one three agent starvat arginin depriv treatment high dose either ultraviolet radiat x radiat differ agent produc chang nucleolar structur vari accumul triglycerid glycogen three agent produc increas number size lyso  some studi acid phosphatas prepar view light electron microscopi occasion vital dye esteras aryl sul  fatas prepar ultrastructur alter lysosom suggest residu bodi develop varieti way ie endoplasm retic  ulum multivesicular bodi autophag vacuol follow three agent endoplasm reticulum assum form rough smooth whorl two agent arginin depriv ultraviolet radiat acquir cytochem demonstr acid phosphatas activ near connect endoplasm reticulum lysosom rais possibl kb cell least injur endoplasm reticulum involv format lysosom transport acid phosphatas
409  |  simultan use extracorpor circul hypothermia surgeri heart oper techniqu cardiac surgeri condit deep hypothermia simultan use pump oxygen cardiopulmonari bypass describ major case patient cool water  c perfus volum reduc  hypothermia other gradient  c blood water maintain perfus volum reduc less  data present show neither techniqu lead hypox chang cerebrum intern organ provid mean arteri pressur kept   mm hg perfus overal mortal author  case   congenit heart diseas     case tetralog fallot   cyanot   vsd close take flap tissu crista supraventriculari group mortal 
410  |  cardiac perform hypothermia experiment studi left ventricular power oxygen consumpt effici dog multipl cardiac paramet measur  dog cool  c aortic blood temperatur paramet express absolut valu percentag normotherm valu normothermia dog close chest ascend aorta flow  left ventricular extern power  correspond valu dog open chest ascend aorta flow left circumflex coronari arteri flow reduc  normotherm level  c aortic arch mean pressur reduc  normotherm level  c total peripher resist increas  normotherm level  c left ventricular extern power decreas  normotherm level  c left ventricular oxygen consumpt decreas  nor  motherm level  c mechan effici left ventricular myocardium decreas  normotherm level  c
411  |  toler dog deep hypothermia control maintain pump oxygen advantag hypothermia  c  hr induc maintain extracorpor circul  min compar partial bypass durat normothermia normotherm group  dog  live hypotherm group  dog   surviv perfus high flow  cckgmin eleven dog   surviv flow rate reduc  cckgmin temperatur  c death high flow group due main postperfus lung chang even low pulmonari venous pressur assur vent left atrial chamber me  tabol acidosi occur group though greater high flow low flow intermedi former normotherm group chang great degre explain lung chang
412  |  bleed tendenc associ profound hypothermia technic neurolog surgeri forty thre patient bleed intracrani aneurysm oper deep hypothermia aid extracorpor circul open thorax method use  case closed thorax method  follow point made  closed thorax method consid superior open  thorax method sever respect  meticul hemostasi essenti control ooz occur extracorpor circul profound hypothermia heparin antagonist becom effect bodi temperatur return normal  signific thrombocytopenia may develop extracorpor cir  culat inhibit thrombin fibrinogen reaction factor heparin may caus major coagul defect may also mimick he  parin effect lead excess use heparin antagonist  patholog chang microcircul extracorpor circul may determin hemorrhag tendenc
413  |  use hypothermia dehydr treatment sever cerebr hypoxia ration use hypothermia cerebr dehydr suppress re  vers progress delay cerebr damag hypoxia suggest damag natur result injuri astroglia oligodendroglia especi former experiment clinic evid favor lower bodi temperatur immedi episod hypoxia accompani impor  tant damag brain ration use dehydr insecur result uncertain treatment probabl reserv case rais cerebrospin fluid pressur prove measur especi hypothermia either avail fail
414  |  select cerebr hypothermia physiolog technic safe suitabl techniqu produc select brain cool perfus method describ  dog  surviv salient featur aid surviv discuss use direct vasodil papaverin perfus reliev vasospasm mark reduc cool time repres signi  ficant technic advanc previous describ method acid base analysi util siggaard andersen curv nomogram perform  dog signific acidosi note select brain cool definit arterioven lactic acid differ develop hypotherm temperatur indic brain may metabol substanc prefer glucos lower brain tempera  ture reason discuss rate disappear physi  calli dissolv oxygen po measur brain follow ischemia dif  ferent temperatur averag rate disappear  c  rate  c discrep find vitro oxygen utili  zation rate temperatur discuss
415  | cardiac activ cranio cerebr hypothermia onset hypothermia rare alter heart rate deepen   rate slow level   usual amount half origin va  lue  develop bradycardia observ warm  normal heart rate restor oper abdomin organ heart rate slight modifi appear solitari extrasystol rare usual associ stimul diaphragm mark chang heart rate observ oper heart especi exclud circul idioventricular rhythm may develop heart stop beat remov ligatur vena cava nor  mal rhythm restor temperatur fall excit myocardium increas conduct resist areflexia continu even direct sti  mulat reflexogen zone surgic stage cranio cerebr hypothermia clear signific degre energi hemodynam insuffici deve  lop whether experiment condit oper patient opera  tion well mark stabil contractil power myocardium may observ
416  |  respir hypothermia respiratori pattern acid bas balanc blood mongrel dog light pentobarbit anesthesia made hypotherm im  mers ice water normotherm warm water cours cool respiratori rate pulmonari ventil initi increas reduc rectal temperatur fell spontan respir ar  rest rectal temperatur   c alveolar pco increas initi slight lower progress hypothermia arteri ph standard bicarbon jorgensen astrup decreas alkalin blood coh ch winterstein decreas mark hypothermia find suggest respiratori metabol acidosi mechan concern cours rewarm chang disappear rapid complet though venti  latori stimul observ initi transitori phenomenon cool fail occur
417  |  studi blood viscos signific anesthesia principl measur blood viscos discuss although blood behav newtonian manner data obtain vitro measur use modifi simpl method measur blood viscos relat nor  mal salin describ essenti differ viscos be  tween fresh blood heparin blood plasma serum viscos vari quantiti natur protein plasma cellular concentra  tion halothan thiopent sodium reduc blood viscos seem indicat  ed condit hemoconcentr tendenc red blood cell aggreg cyclopropan hypothermia norepinephrin tend rais blood viscos would seem contraind microcircul fail
418  |  flow consider region cerebr hypothermia suggest low flow danger may caus anoxia either direct interf cool sixti dog subject local cerebr hypothermia method femor carotid cool arteri blood per  fusion predetermin pressur rather predetermin flow rate cir  cuit describ advantag clinic use mention togeth in  accuraci method scientif investig chiefli concern mainten system blood pressur may requir inject pressor agent evid reduct flow low temperatur discuss evid present due increas viscos activ spasm manifest rewarm hump occur cool graph mean carotid flow rate determin revolut counter attach pump fix stroke volum output link per  fusion pressur thus determin resist place ad co discuss particular relat fall partial pressur accompa  nie cool blood addit  co increas total carotid flow halothan use anesthet sympatholyt ac  tion increas flow  abolish rewarm hump rheomacro  dex use prime fluid instead blood produc increas flow averag  abolish spasm suggest cool faster  c per minut intrins danger spasm prevent high flow maintain method describ
419  |  select brain cool produc cerebr ventricular perfus hypotherm cerebr ventricular perfus appli dog shiver appear  ed direct relat cns temperatur rather peripher bodi temperatur select heat brain stem produc pant rewarm bodi retard initi heat loss mechan control cen  tralli hypertherm perfus use shiver disappear pant unaffect pentobarbit anesthesia cool one frontal area anterior part third ventricl signific affect respiratori circulatori system brain stem hypothermia produc distinct respiratori circulatori reaction suggest cool rd th ventricu  lar area may util anesthet purpos
420  |  optim coronari flow bypass normotherm hypotherm heart seri experi conduct dog bypass flow temperatur direct coronari perfus pressur vari coronari flow coronari ven  ous satur myocardi oxygen consumpt mvo coronari vascular re  sistanc assay coronari flow percentag total bypass flow vari appreci vari level bypass flow induct hypothermia total bypass flow constant result decreas coronari flow induct hy  pothermia maintain constant bypass pressur result increas coronari flow temperatur  c cool caus reduct flow use isol coronari perfus  mm hg coronari flow fell resist rose first  min bypass use isol coronari perfu  sion  mm hg induct moder hypothermia  c caus increas coronari flow venous satur decreas cardiovascular resist mvo condit induct hypothermia  c produc similar chang caus myocardi hemorrhag ventricular fibril pro  found hypothermia probabl lead excess fragil capillari bed reduc  tion perfus pressur  mm hg near normothermia reduc coronari flow slight reduc venous satur mvo reduct perfu  sion pressur  c produc similar less mark chang reduct  mm hg  c mark reduc coronari flow venous satur mvo initi partial recoveri later data acut experi dog coronari perfus use moder hypothermia  c  mm hg slight pulsatil mean pressur appear optim
421  |  extracorpor hypothermia without thoracotomi ex  periment studi use cold neurosurgeri cancericid perfus paper includ minor clinic note open heart surgeri cancer perfus contain experiment inform neurosurgeri cancer perfus method closed chest hypotherm perfus  dog report author util drainag superior inferior cava graviti volum venous drainag sometim enhanc transfus  low molecular weight dex  tran determin flow rate cool maintain quit variabl period appar general unspecifi esophag temperatur perfus time va  rie  min  hr anim low flow perfus longer high  er incid ventricular fibril low surviv rate eleven ani  mal surviv pre cool flow rate  mlkgmin good flow rate perfus  ventricular fibril flow rate surviv increas anim receiv low molecular weight dextran four  teen  anim ventricular fibril defibril electr  re  gain adequ cardiac function  surviv interest data region cool lower half bodi present author conclud without suffici evid import factor mortal hypo  thermic perfus abil maintain flow rate approach estim normotherm cardiac output anim
422  |  profound hypothermia aim hypothermia protect vital cerebr structur hypoxia aneurysm repair profound hypothermia also valuabl oper certain cardiac defect cannot repair even whole bodi perfus sinc time need aneurysm repair often exceed safe limit   minut without circul afford surfac hypothermia   c author investig drew open chest technic closed chest method isol cerebr perfus drew technic consist substitut two pump heart patient lung act oxygen disadvantag larg amount blood need morbid due intra  cardiac cannul median sternotomi closed chest method develop use mayo gibbon vertical sheet pump oxygen provid perfus extracorpor cool without requir thoracotomi cerebr perfus blood taken one arteri pump heat exchang return anoth arteri author describ anesthet technic offer comparison three method give instruct pertain product hypothermia list problem encount manag case
423  |  system hypothermia via gastric cool eight dog underw gastric cool system hypothermia dog cool balloon fill safe volum base weight  mlkg subject cool balloon fill maxim safe pressur  mm hg consist latter procedur far effici averag  time rapid degre hypothermia decreas core temperatur  c re  quir averag  minut comparison clinic report hy  pothermia induc usual gastric cool improv effici two fold three fold still note
424  |  dubious haemopoiet stem cell function lym  phoid cell blood autoradiograph studi dog migrat fate turnov lymphoid cell blood bone marrow irradi non irradi dog studi serial autoradiographi co  ping hind leg plasma clearanc time h thymidin inject anterior vein irradi dog h thymidin inject procedur car  rie earli recoveri phase follow  r whole bodi x irradi conclus evid transform hematogen bone marrow lymphoid cell hemopoiet precursor found howev light individu grain count transform lymphoid cell hemopoiet cell cannot rule data obtain dog earli recoveri phase follow whole bodi irradi strong indic transform
425  |  studi growth cytomorphosi thymo lympha  tic system   special refer influenc thymus thyroid guinea pig migratori stream lymphocyt differ part thymo lymphat system evalu comparison lymphocyt popul thoracic  duct lymph arteri venous blood especi thymic venous blood re  cord organ weight sham oper thymectom guinea pig treat thyroxin untreat import thymus thyroid growth regener thymo lymphat system studi main result follow consider venous output lymphocyt low mito  chondrial content small lymphocyt thymus normal young guinea pig explain much higher incid small lymphocyt blood tho  racic duct lymph neonat thymectomi caus lymphat hypotrophi defi  cienci lymphocyt pyroninophil cell relat reticular one bodi growth surviv anim affect thymus exogen thyroxin probabl promot differenti larg basophil cell small lymphocyt result increas output small lymphocyt lymph node thyroxin promot differenti larg pyroninophil cell transit cell immatur matur plasma cell effect thyroxin dif  ferenti follow increas growth thymo lymphat organ character increas incid larg basophil cell increas weight lymphat organ growth thymus lymph node preced red splenic pulp delay splenic respons due transform increas number immigr thymic lymphocyt neonat thymectomi prevent thyroxin stimul occurr larg basophil cell red splenic pulp thyroxin stimul growth lymphat system ac  compani increas output larger lymphocyt thorac duct result increas number larger lymphocyt blood postnat thymectom anim normal normal amount circul small lymphocyt thyroxin produc drastic decreas number small blood lymphocyt indic decreas deliveri andor increas disappear  anc cell blood respect decreas number small lymphocyt seen sham oper anim judg studi organ weight thyroxin stimul growth regener lymphat tissu influenc antagonist thymectomi synergist local factor involut tissu
426  |  origin macrophag bone marrow rat skin window subcutan coverslip appli rat studi design identifi tissu precursor macrophag prolifer lympho  cyte deplet either chronic drainag thorac duct  rad x  irradi fail suppress emigr macrophag reduc pro  portion becam label inject tritiat thymidin x  irradi  rad suppress emigr label exud macrophag restor normal tibial marrow shield irradi radioactively label cell suspens obtain thorac duct lymph lymph node thymus spleen bone marrow transfus syngen recipi emigr label macrophag coverslip could demonstr recipi label bone marrow spleen cell label monocyt found blood rat receiv inject label bone marrow conclud rat bone marrow lesser extent spleen major sourc macrophag emigr foci acut non bacteri inflamm
427  |  studi leucocyt compart guinea pig bone marrow acut haemorrhag sever hypoxia evid common stem cel larg acut hemorrhag absolut le  vel neutrophil eosinophil basophil guinea pig bone marrow consider reduc stage differenti involv declin myelo  blast promyelocyt particular mark exposur sever hypoxia also temporarili depress number marrow granulocyt bone marrow lymphocyt slight reduc singl he  morrhag later stage sever hypoxia number great reduc assum suppli stem cell bone marrow unlimit de  creas marrow granulocyt lymphocyt follow  ing mark erythropoiet stimul appear favor monophylet theori hemopoiesi heavi demand stem cell differenti erythron may temporarili restrict number enter leukon hypox anim show consider loss bodi weight notabl reduct marrow lymphocyt later stage hypoxia may specif relat general atrophi lymphoid tissu use h thymi  dine evid activ dna synthesi guinea pig metamyelocyt although dna synthesi found metamyelocyt normal marrow hemorrhag cell form much larger proport total synthes cell granulocyt compart also ratio label metamyelocyt myelocyt consider increas microspectrophotometr measur feulgen dna cont metamyelo  cyte hemorrhag show  popul cell one group valu typic rest nonsynthes cell nd group show complet rang dna valu level characterist found divid cell certain small mononuclear cell minim deepli basophil cytoplasm dis  tinctiv group dna synthes cell marrow af  ter hemorrhag morpholog appear complet sequenc cell procrythro  blast
428  |  relat abil parent marrow repopul lethal  ly irradi f hybrid lethal irradi cbl x f mice inject mixtur  million cbl  million  bone marrow cell repopul  bone marrow cell experi cell mixtur indic  marrow relat nine time effici cbl marrow repopul lethal irradi cbl x f mice result addit strain combina  tion suggest behavior donor marrow determin sole h  factor cbl marrow frequent regress irradi f mice shown relat less capabl repopul recipi regular retain parent marrow differ relat abil parent mar  row repopul f mice cannot yet fulli explain might corre  late physiolog differ parent marrow micro  environment advantag one hematopoiet cell type anoth irradi recipi immunolog physiolog factor might favor select growth discuss
429  |  pluripot stem cell function mous marrow lymphocyt bone marrow normal polycythem mice filter glass wool column remov cell lymphocyt given number nucleat cell filter marrow effici origin marrow repopul spleen isogen recipi previous expos lethal irradi prolif capac filter unfilt marrow suspens ap  pear constant function number small medium lymphocyt present cell type
430  |  effect unilater limb shield  ing haemopoiet respons guinea pig gamma irradi guineapig expos  r  irradi whilst approx  total bone marrow protect  ed shield  limb quantit cell count shield irradi marrow combin observ thymus spleen blood recoveri period compar effect whole  bodi irradi follow whole bodi irradi  r thymus show delay secondari cellular deplet coincid mark splenic hyperplasia phenomena elimin limb shield lymphocyt irradi marrow partial shiel  ded anim continu show overshoot secondari fall number character recoveri whole bodi irradi  r initi fall number erythroid granulocyt precursor shield marrow show temporari increas granulocytopoiesi coincid abort phase granulocytopoiesi irradi marrow evid effect colon irradi marrow cell shield marrow signi  ficanc find discuss
431  |  studi intraven transfus thymus cell lymphnod cell iii influenc transfus thymus cell lymphnod cell bone marrow rabbit transfus thymus cell lymphnod cell peripher blood bone marrow studi transfus thymus cell caus peripher lymphocytosi diminut lymphoid cell bone marrow young adult rabbit transfus lymphnod cell result peripher lympho  penia initi increas subsequ diminut lymphoid cell bone marrow suggest lymphoid cell bone marrow may lympho  cyte store discharg accord varieti condit further  thymus cell thought mobil lymphocyt bone marrow peripher blood
432  |  studi hypoxia iii differenti respons bone marrow primari secondari hypoxia twenty f adult male guinea pig place decompress chamber simul altitud  feet  day kept ordinari air  day final return decompress chamber subject hypoxia second time period rang   day period secondari hypoxia quantit studi made chang blood bone marrow secondari primari hypoxia signific increas nucleat red cell marrow secondari hypoxia howev mark increas marrow lymphocyt wherea primari hypoxia lymphocyt fall marrow reticulocyt remain fair constant level despit mark fluctuat erythropoiesi
433  |  investig lymphocyt product guinea pig bone marrow evid varieti experi indic lymphocyt produc guinea pig bone marrow certain condit number produc appear consider recoveri irradi numer telophas marrow smear appear form small lymphocyt moreov mani lymphocyt still found shield bone marrow rest bodi in  clude convent lymphoid tissu receiv lethal supra leth irra  diation almost  cell form irradi final bone marrow cultur periton caviti host whose lymphocyt product suppress irradi small percentag newly form small lymphocyt found marrow
434  |  repopul bone marrow mice number type cell requir post x irradi protect fraction cell mous bone marrow autolog mous spleen indi  cate cell respons bone marrow repopul x irradi protect resembl small lymphocyt experi inject differ number bone marrow spleen cell observ surviv obtain fraction irradi entir bodi extirp shield spleen irradi indic approxim  x   cell type requir provid  surviv approxim number migrat shield extrem spleen mous per hour slight faster spleen slower bone marrow
435  |  hyperbasophil cell indic prolifer bone marrow transplant irradi dog studi made hyperbasophil cell appear follow transplant bone marrow  irradi mongrel dog sex main seri experi anim irradi dosag  r use four tub rum  x ray machin voltag  kv current  filter  cu mm   mmal target distanc  cm rate   rmin   day irradi suspens bone marrow cell dosag      x   nuclear cell administ iv marrow obtain aspir various skelet bone compress sternum rib bone studi made morpholog composit blood bone marrow irradi        day irradi transfus bone mar  row thereaft   day interv smear blood marrow stain azure ii eosin found distinct cell basophil proto  plasm frequent incid immatur nucleus present blood dog follow irradi  r transplant bone marrow hyper  basophil cell appear blood     day transplant attain maximum     day later thereaft number diminish rapid trend number hyperbasophil cell coincid donor element leukocyt erythrocyt hyperbasophil cell found acut radia  tion sick dog given inject bone marrow found  mth transplant bone marrow nonirradi puppi   day age irradi dosag increas   r number hyperbasophil cell increas attain peak sooner  r dosag cell form donor cell
436  |  autoradiograph studi lymphoid cell blood bone marrow nor  mal irradi dog migrat fate turnov lymphoid cell blood bone marrow  irradi  non  irradi dog studi serial autoradiographi clamp hind leg plasma clear  anc time h thymidin inject anterior vein irradi dog h thymidin inject pro  cedur carri earli recoveri phase  r whole bodi x irradi result  irradi  normal dog describ de  tail migrat lymphoid cell blood marrow parenchyma confirm irradi dog con  clusiv evid transform cell hemopoiet precursor found relat number larg lymphoid cell label index whole popul lymphoid cell small lymphoid cell increas irradi marrow initi label small lymphoid cell could also observ data indic pattern pro  lifer lymphoid cell chang irradi re  generat bone marrow
437  |  lysozym bone marrow periph  eral blood cell mean indirect histochem techniqu intracellular lysozym form element peripher blood bone marrow estim evi  denc present monocyt well matur neutrophil precursor extend back progranulocyt contain signific amount en  zyme rare matur eosinophil demonstr trace lysozym activ evid lyso  zyme activ basophil erythrocyt megakaryo  cyte platelet plasma cell tissu mast cell bone marrow reticuloendotheli cell
438  |  prolif activ lymphat tissu rat studi tritium label thymidin cytokinet data present employ quantit hdna lymphat tissu normal rat serial sacrif htdr administr mark differ pattern initi label label loss observ thymus peripher lymphat tissu data compat indica  tion rapid cell renew thymus suppress initi uptak htdr dna larg lymphocyt progenitor cell thymus appa  rentli feedback thymidin contain materi small lympho  cyte thymus deplet thymus small cell oper stress whole bodi x ray lead mark increas uptak htdr dna larg thymocyt find agreement previous find sugino et al suggest transfer thymin nucleotid small thy  mus lymphocyt precursor cell may may relat appar transfer dna label thymic cell evid latter consist curvilinear dilut dna label thymus prolifer cell popul relationship rate dna label dilut larg cell dna small cell thymus dna label progenitor cell thymus lymph node enter small cell popul subsequ dilut grain divid cell follow slope loss radio  activ entir lymph node long retent hdna label divid lymph node cell popul suggest loss radioacti  viti divid cell small cell popul whole occur e  qualli pattern prevail regardless whether percentag larg small cell alter experiment find explain inter  chang dna nuclear label small lymphocyt larg lymphocyt could occur process phagocytosi pinocytosi trans  format small lymphocyt larg divid cell data fit best latter possibl mechan would lead equilibr dna label larg small cell find prevent assign  ment finit life span lymphocyt basi dna label kinet ne  vertheless appear least two differ type lymphocyt one thymus typ lymphocyt found thymus cortex bone marrow ger  minal center lymphoid follicl type found abund wide  spread peripher lymphat tissu show prolong retent dna la  bel believ recircul immunolog commit cell describ other cell appear enter thymus cortex
439  |  free glucuron acid bound  hydroxy corticosteroid plasma patient cancer breast iv infus acth seventeen patient advanc mammari cancer given infus  u acth  hr  other infus  u determin made plasma  hydroxy corticosteroid free bound glucuron acid infus rapid grow carcinoma high initi valu found free corticosteroid  ug ml plasma ratio free bound corticosteroid stage iv patient  averag approxim  mix form stage iv  ratio alter acth shift ratio free bound corticosteroid acth treatment seen depend initi valu free corticosteroid administr  u enough  hr valu  relat maxim stimul  u
440  |  reduc estriol excret patient breast cancer prior endocrin therapi urinari quotient estriolestron  estradiol beq measur chemic women without breast cancer in  dex ratio noncarcinogen imped es  trogen mammari carcinogen estrogen  control median eq   menopaus  patient sub  normal  breast cancer patient without endo  crine treatment recent surgeri median eq   respect  pa  tient subnorm major surgeri hormo  nal therapi   patient subnor  mal remiss observ unless eq rose toward normal match  control patient pair age ovarian status wilcoxon test indic decreas eq ex  crete untreat cancer signific  confid level mark increas eq induc castrat androgen estrogen corticosteroid therapi suggest normaliza  tion precancer metabol imbal be  tween imped activ estrogen deriv ovarian adrenocort sourc contribut arrest growth estradiol depend metastas
441  |  urinari excret estron estradiol estriol pa  tient breast cancer benign breast diseas premenopaus patient breast cancer benign breast diseas appear ex  crete signific lower percentag total estrogen estron signifi  cant higher percentag estriol women premenopaus control group signific differ excret total estrogen cancer group control good health postmenopaus patient cancer excret higher level estriol postmenopaus control group increas estriol excret cannot explain debilit
442  |  system effect androgen estrogen hormon advanc breast cancer system effect diethylstilbestrol  patient testosteron propion  patient hormon  patient studi treatment six week three month advanc breast cancer postmenopaus women serious complic includ induc hypercalcemia fluid re  tention physiolog effect urinari incontin diethylstilbestrol viril testosteron nausea vomit necessit disconti  nuanc treatment androgen therapi stimul erythropoiesi observa  tion system reaction hormon agent definit contribut evalu sex steroid therapi
443  |  effect dehydroepiandrosteron  hydroxycorti  costeroid plasma various stage cancer diseas breast reduc effect dehydroepiandrosteron plasma corticosteroid averag shorten advanc stage iv case breast cancer  group patient lowest corticosteroid level found  hr infus dehydroepiandrosterone phosph patient mastopathi effect still detect  hr later patient breast cancer stage iv initi level reach time case stage ii lesion find intermedi shorten attribut intens transform dehydroepiandrosteron advanc case breast cancer
444  |  urinari excret estron estradiol estriol patient prostat cancer benign prostat hypertrophi hopkin ce urinari estron estradiol estriol fraction excret  patient prostat cancer  patient benign hypertrophi  clinic well subject assay determin whether differ exist absolut level estron estradiol estriol fraction signific differ excret relat lower level estron estradiol relat higher level estriol patient prostat cancer compar clinic well subject result signific lower proport total estrogen excret estron estradiol differ proport estrogen frac  tion patient benign hypertrophi clinic well subject signific except signific higher percentag total estrogen excret estron patient benign hypertrophi differ group cancer group also signific clinic variat  group within cancer hypertrophi group preclud assign signific differ prostat dystrophi alon cancer patient experienc inanit due loss appetit excret signific lower level estron patient report loss appetit signific lower level estron excret patient benign hyper  trophi hospit  day compar patient hospit  day less signific higher urinari estrone androsteron ratio present cancer group clinic well group believ howev arbi  trari ratio use suggest intern estrogen androgen imbal
445  |  enzym synthesi steroid sulfat ii presenc steroid sulfo  kinas human mammari carcinoma extract extract human primari secondari mammari carcinoma shown contain steroid sulfokinas everi case examin examin normal breast tissu surround tumor reveal weak steroid sulfokinas activ instanc thought due fibrous natur poor cellular normal breast tissu normal ovarian tissu specimen obtain cancer patient undergo oophorectomi general contain enzym trace level detect   specimen examin steroid without necessarili show convers steroid sulfat observ increas incorpor s sulfat one product form enzy  mical incub breast tissu extract s adenosine  phosphate   phosphosulf
446  |  steroid excret earli breast cancer patient advanc breast cancer subsequ fail respond adrenalec  tomi hypophysectomi found excret abnorm amount urinari metabolit androgen cortisol similar measur carri patient earli breast cancer found approxim half case present mastectomi also excret abnorm amount steroid subsequ follow up show case tend poor progno  sis trial therefor start abnorm cor  rect addit seem possibl defici adrogen excret may preced onset diseas problem investig trial involv urinari steroid estim  normal women measur compar subsequ develop breast cancer
447  |  excret oestron pregnanediol pregnanetriol breast cancer patient excret spontan menopaus urinari excret oestron pregnanediol pregnanetriol determin seri postmenopaus breast cancer patient receiv endocrin treat  ment steroid excret studi relat age patient well relat time elaps sinc last menstrual cycl result indic initi slow decreas age menopaus onward excret oestron preganediol increas new maximum found group   yr menopaus excret pregnanetriol howev remain relat constant rapid fall first year menopaus
448  |  excret oestron pregnanediol pregnanetriol breast cancer patient ii effect ovariectomi ovarian irradi corticos  teroid urinari excret oestron pregnanediol pregnanetriol determin breast cancer patient differ stage endocrin treatment result demonstr corticosteroid substitut dose cortison  mg daili prednison  mg daili divid  daili dose effect depress excret  steroid postmenopaus patient agreement clinic impress easili toler small dose corticosteroid therapeut effect adrenalectomi patient breast cancer result indic ovari may contribut product oestrogen mani year menopaus product depress ovarian irradi agreement clinic observ ovarian irra  diation therapeut valu postmenopaus women breast cancer
449  |  estim urinari  ketosteroid diagnosi car  cinoma prostat  patient histolog confirm carcinoma  patient confirm benign hyperplasia prostat amount neutral  ketosteroid estim  hr sampl urin result reveal contrari report literatur diagnost method quit unreli rais  ketosteroid level found also high percentag control subject moreov estim  ketosteroid labori biochem method involv relat great experiment error
450  |  influenc small dose corticosteroid excret pregnanetriol oestron seri patient breast cancer excret oestron pregnanetriol determin administr corticosteroid oestron excret postmenopaus women diminish  decreas pregnanetriol ex  cretion valu observ well evid low oestron excret patient subject corticosteroid therapi due depress adren function
451  |  urinari ii deoxy  oxosteroid british japanes women refer incid breast cancer japanes women excret andosteren relat aetiocholanon b british women live tokyo mean ab ratio former  latter  mean differ signific ratio mark affect thyroid function thyroid diseas report affect incid breast cancer japan one eighth white women north america great britain
452  |  plasma  ketosteroid  hydrocorticosteroid women breast cancer  women menopaus breast cancer mean level plasma   ketosteroid  ks  hydroxycorticosteroid  ohc signific higher normal women equival age  young women level plasma  ohc signific higher normal menopaus women breast cancer whether treat correl level plasma  ks  ohc
453  |  urinari porter silb chromogen follow intraven metho  pyrapon acth patient breast cancer urinari porter silb chromogen measur  group patient breast cancer intraven methopyrapon acth administr control group consist femal free diseas  year follow mastectomi studi group document metastat diseas signific differ urinari porter silb chromo  gen found  group day cours studi within rang normal measur laboratori conclud function reserv capac pituitari acth secret adreno  cortic steroidogenesi patient advanc metastat breast cancer rela  tive normal
454  |  amyloidosi autopsi materi patholog depart tuberculosi institut warsaw   autopsi materi patholog depart tuberculosi institut   includ  postmortem examin patient die tuberculo  sis  case tuberculosi complic amyloidosi   amy  loidosi account  case   percentag  differ incid men women differ two sex peak tuberculosi fatal curv men   year age group amyloidosi   age group women greatest number death tuberculosi   age group amyloidosi   age group
455  |  certain featur haemogram patient pulmonari tuberculosi complic amyloidosi russian regress amyloidosi earli stage seem possibl reason russian clinician explor possibl find mean earli diagnosi complic author studi  complet clinic blood analys made  patient viz  chronic fibrocavern cirrhot form tb com  plicat amyloidosi  form tb without amyloidosi detail serial studi haemogram patient pulmonari tb possibl diagnos associ amyloidosi intern organ initi stage presenc amyloidosi intern organ infer follow chang blood pictur appear normochrom hypochrom anaemia patient various form tb except tb kidney intestin tract larynx caseous lymph node b progress increas leucocyt count neutrophil shift left correspond phase quiescenc main diseas c consist high esr absenc activ process thrombocytosi phase subsid flare up also chang thrombocyt formula tend toward appear de  generat form old matur thrombocyt
456  |  diffus tracheo bronchi amyloidosi rare variant protean diseas patient diffus tracheo bronchi amyloidosi describ brief clinic detail supplement publish previous report prows follow account necropsi find histolog appear site amyloid deposit literatur review argument advanc favour common aetiolog amyloidosi form act immun mechan suggest variat site strength durat frequenc antigen stimulus antibodi respons may determin natur distribut amyloid deposit
457  |  modern method treatment viscer amyloidosi patient pulmonari tuberculosi russian immedi long term result treatment    patient pulmonari tuberculosi complic amyloidosi studi hormon corticosteroid therapi pathogenet treatment viscer amyloidosi indic proteinur earli edema hypoton phase amyloidosi function capac kidney liver still adequ azotem phase amyloidosi hormon corticosteroid therapi indic sinc lead rapid deterior patient condit sinc hypoxemia one main factor pathogenesi amyloidosi oxygen therapi ration patho  genet therapi patient pulmonari tuberculosi complic hypoxemia symptom proteinur edema hypoton phase amyloidosi without ascit form subcutan introduct oxygen oxy  geno peritoneum patient pulmonari tuberculosi surgic interven  tion account main process indic earli stage amyloi  dosi pronounc function disord kidney liver absent co  joint therapi use protein vitamin particular ascorb acid hormon corticos  teroid prepar oxygen desensit agent elimin foci infect indic treatment pulmonari tuberculosi even earliest sign amyloidosi
458  |  use needl biopsi liver diagnosi viscer amyloidosi patient pulmonari tuberculosi russian result  punctur biopsi liver  patient pulmonari tuber  culosi  men  women age   yr purpos diagnos amyloidosi report punctur perform amyloidosi suspect basi case histori destruct process   year durat clinic sign form enlarg liver spleen edema chang blood pictur blood protein formula chang urin proteinuria cylindruria isohyposthenuria amyloidosi diagnos presenc surmis punctur  patient punctur biopsi confirm diagnosi  refut   patient without clinic symptom amyloidosi diagnos basi punctur biopsi alon  case fatal out  come post mortem find coincid result bioptic punctur  patient amyloidosi detect biopsi  moder dystroph chang  mark dystroph chang  case patho  logic chang found  patient later develop amyloidosi find support content liver amyloidosi link dystroph chang epitheli cell mark dystroph chang preced amyloidosi may occur simultan moder dystroph chang quit common patient exacerb tubercul process lung wide applica  tion bioptic punctur liver indic case increas knowledg morpholog chang take place liver tb
459  |  role certain addit factor develop amyloidosi prophylaxi patient pulmonari tuberculosi russian patient chronic fibrocavern tuberculosi lung toxic aller  gic side reaction antibacteri therapi chronic foci infect diseas allerg compon contribut develop amyloidosi earli detect clear chronic foci infect effect measur even mild pronounc toxic allerg side reaction prime impor  tanc prevent amyloidosi unsystemat prolong administra  tion antibacteri prepar along toxic side effect tend in  creas incid amyloidosi patient chronic fibrocavern pulmon  ari tb individu constitut factor great import develop side effect side reaction chemoprepar case hypofunct liver kidney autonom dysfunct promot develop dys  trophic process confirm high frequenc toxic allerg reac  tion patient fibrocavern pulmonari tb later develop amyloidosi administr desensit drug patient show side reaction there  fore help prevent amyloidosi case chronic fibrocavern tb chemo  therapi automat combin administr desensit stimulatori drug class case
460  |  decreas steroid urin cours lung tb therapeut valu increas calciferol quantit determin urinari steroid  patient extens ul  cero cas pulmonari tb confirm  ketosteroid alway decreas case calciferol form one ampoul vit  u everi  day combin activ tuberculostat drug major case lead increas urinari  ketosteroid    mth appear calciferol exert action proteolysi stimul liquefact evacu caseous materi proteolyt effect relat mineralocorticoid phlogist proteolyt sub  stanc calciferol offer advantag substanc affect electrolyt well toler organ reason good result may expect administr case extens pulmonari tb myc tuberculosi remain sensit administ tuberculost drug nevertheless proceed toward recoveri mark caseous lesion case calciferol treatment lead rapid pronounc decreas radiolog shadow improv general condit also modifi steroid metabol render abnorm diseas
461  |  develop amylosi less  month cours primari tb infect case report previous healthi young north african male post primari ulcero infiltr tb less  mth led develop viscer amyloidosi could confirm biopsi kidney liver treatment antibiot hepat amyloidosi regress parallel improv tb biolog sign renal amyloidosi dis  appear except pronounc proteinuria persist render long term prognosi high doubt
462  |  relat lupus erythematosus diseas lympho reticular system case report patient led age  year develop secondarili lymphoblast sarcoma sarcomat degener lympho  reticular system becam appar serolog immuno hematolog test typic led negat interpret observ  patient lymphogranuloma lymphosarcoma leukemia malign tumor sar  coidosi tuberculosi investig serolog immunohematolo  gical antinuclear factor found serum  patient lymphogranulo  one patient anaplast carcinoma one patient metastas mix parotid tumor ident antinuclear antibodi found led could prove differ method import certain diseas lympho reticular system product antinuclear factor dis  cuss
463  |  valu signific prednisolon test diseas kidney twelv normal subject  case tubulo interstiti nephropathi  case glomerular nephropathi  case renal disord investig patient given prednisolon test urin cultur test mani instanc determin urinari osmolar urinari sediment examin sternheim malbin stain techniqu peroxydas stain investig urinari cytolog criteria adopt test negat normal posit  case chronic pyelonephr  remain case unequivoc non  infecti renal diseas increas urinari bacteri count cortico  steroid administr investig various compon urinari sediment also suppli use diagnost inform contrari stern  heimer malbin stain urinari sediment prove littl use
464  |  tumor amyloidosi lung incident find necropsi woman age  tumor lik mass  x  x  cm lower lobe left lung detail structur may suggest angioma hamartoma stroma vessel contain amyloid amyloid uncommon stroma tumor summari  tumor amyloid case report other includ
465  |  experiment amyloidosi immun much interest mechan experiment amyloidosi result parenter introduct foreign protein center around natur link lead cytolog biochem chang tissu bodi fluid author suggest link may immunolog natur howev clear cut proof either favor theori immunolog origin amyloid sinc inject protein perinat period prevent immun respons anim subsequ challeng antigen author studi amyloidosi caus casein mice treat birth protein mice expos soon birth casein ac  quir immun toler antigen demonstr absenc circul antibodi measur disappear i label casein circul mean passiv hemagglutin test ascit fluid toler control anim develop amyloidosi extent result impli pathogenesi amyloidosi rest upon classic immunolog basi exclud possibl diseas may due auto immun process
466  |  electron microscop studi six case human renal amyloidosi studi particular concern basal membran differ stage b intercapillari space earli stage conclus may put follow  amyloid substanc seem fibrillar structur start  wall peripher capillari loop thicken volumin amyloid deposit hyalin aspect primit basal membran persist structur alter presenc multipl amyloid fibril  hand initi stage amyloid fibril cannot seen lamina densa basal membran appear epitheli endo  thelial surfac membran suggest amyloidosi repres abnorm precipit extrins origin rather transform situ basal membran  earli stage amyloid infiltr glomeruli fibrillar substanc found first intercapillari space later reach peripher capillari wall
467  |  morpholog develop infectious tox affect kidney pulmonari tuberculosi russian kidney  patient dead tb lung  rabbit pulmonari tb examin first lesion develop glomeruli follow chang stroma tubul infectious tox affect kidney complex prolong process involv organ immun reaction lymphostasi venous stasi final nephrosclerosi infectious tox lesion found one third patient die pulmonari tb chang produc clinic manifest basi follow affect diagnos nephriti nephrosi amyloi  dosi antibacteri therapi pulmonari process reduc renal lesion how  ever sever infectious tox affect kidney may develop recoveri pulmonari tb
468  |  diffus nodular amyloidosi lung  year old man  yr previous ceas work aluminium factori die respiratori insuffici postmortem examin reveal dissemin nodul lung nodul sharpli defin greyish color doughi consist could easili remov capsul diagnosi amyloidosi made basi histolog find stain qualiti materi intrasept periarteriolar local exist plasmocyt infiltr foreign bodi giant cel granuloma amyloid deposit also found spleen kidney coronari branch regard pathogenesi suggest exposur aluminium product  yr might constitut predispos factor
469  |  bacteri induct homograft sensit ii effect sensit staphylococci microorgan heat kil strain staph aureus staph albus induc guinea pig state alter reactiv skin homograft indistinguish result sensit homolog tissu group streptococci challeng suitabl prepar recipi st set skin homograft obtain unrel random select donor elicit white graft reaction accelera  ted reject graft bacteria test includ lancefield streptococc group b c e g h l pneumococcus type ii iii xiv rough strain c xerosi b subtili e coli aerogen typhimurium pr vul  gari n catarrhali h influenza  human virul strain myc tuber  culosi none microorgan activ induct homograft sensit guinea pig pretreat recipi gram neg bac  terial suspens associ slight increas mean surviv time st set skin homograft result studi suggest presenc staphylo  cocci well group streptococci antigen relat biolog ef  fect tissu transplant antigen
470  |  structur function cross link dna revers denatur bacillus subtili transform reaction nitrous acid dna result coval linkag complementari polynucleotid strand result materi denatur revers retain biolog activ bacteri transform
471  |  mechan messenger rna replic bacteria transform bacillus subtili sb his tryp bi two link genet mar  ker action hybrid molecul dna investig molecular hybrid obtain thermal denatur anneal mixtur two dnas one extract singl auxotroph strain h his and  tryp  format heterozyg dna doubl helic prove special experi  ment transform procedur exclud dna synthesi recipi cell prior format enzym histidin tryptophan synthesi found heterozyg molecul dna abl transform condit doubl auxotroph cell prototroph one mean strand dna doubl helix serv templat m rna synthesi possi  biliti secondari replic m rna outsid chromosom action rna polymeras use rna primer discuss
472  |  molecular basi histidas induct bacillus subtili bacillus subtili grow  glutam carbon sourc induc form histidas l histidin enzym convert histidin urocan acid isol purifi form high sensit conveni assay induc enzym describ appli show histidas appear cell  min addit induc histidase synthes capac appear  min decay exponenti addit actinomycin inhibitor dna depend rna synthesi half tim valu histidase synthes capac  high compar half tim valu messeng rna histidas format addit actinomycin due protein synthesi direct accumul m rna also convers enzymatical  ly inact protein present moment actinomycin addit product specif m rna activ enzym exist enzym pre  cursor shown mean experi perform presenc chlor  amphenicof final numer valu steadi state histidas synthesi reach  min addit induc calcul basi ki  netic histidas synthet capac precursor enzym format cell contain suffici precursor form approxim  molecul histidas cell produc approxim  molecul histidas per min cell ac  quir lose everi minut capac make  molecul histidas per minut maxim enzym level  molecul per cell
473  |  symposium fine structur replic bacteria part ii bacteri cytoplasm comparison fine structur cytoplasm bacteri cell cell general reveal import differ lead conclus bacteri cytoplasm littl differenti separ function en  titi nuclear membran fine fibril appear extend nucleo  plasm cytoplasm may expand direct cytoplasm necessarili intersect membran profil special configur born e coli b gram neg organ membran profil special configur present gram posit b subtili appear differenti clear defin endoplasm reticulum golgi substanc microbodi etc mitochondria kinetosom presenc centriol perhap like experi tellurit re  duce cell suggest structur base flagella reduct capac howev upon applic tetranitro blu tetrazolium technic b subtili stain presum ident basal granul membran structur b subtili call chondrioid author probabl one function site respiratori enzym chain gram neg p vulgari probabl site respiratori chain structur differ bacillus clear whether membran involv structur morpholog even b subtili chondrioid differ fundament mitochondria built composit membran extens plasma membran may complet close system regard last point observ chondrioid may possibl stand open connect cell environ sinc lumen separ cell wall plasma membran although yet noth known seem preclud membran organell may function also intracellular transport system contrari porter idea er chondrioid extens nuclear envelop plasma membran hand nuclear area direct contact nucleoplasm therefor perhap need carri interior dna becom known ordinari mitochondria chromatophor vesicl simpl structur connect plasma membran cover singl membran thus resembl granum disc much smaller tissu cell im  portant function er support protein synthesi ribosom bound surfac evid accumul activ complex poly  peptid synthesi bacteria also membrane bound seri ribo  some use messeng rna molecul remain contradictori situ  ation particl obtain releas cytoplasm protoplast dilut rather crude fix media identifi ribosom could recogn thin section ryter kellenberg fix protoplast point much need clarif even cytoplasm thin section protoplast state dispers brought artifici still appar various micrograph basic cytoplasm network presum linear array mani interconnect due fibrillar system fibril nucleoplasm penetr deepli cytoplasm presenc fine fibril various thick electron densiti orient make high resolut studi cytoplasm detail intrigu prospect much fundament inform gain organiz pattern ultrastructur level bacteria reveal fundament similar divergen  cie cell general
474  |  molecular mechan genet recombin bacteri transform mechan dna incorpor recipi cell chromosom in  vestig b subtili transform system recipi cell auxo  trophic  link marker hybrid dna use transform heterozy  gous one marker differ transform activ found effect nativ hybrid dna compar accord author observ easili explain accept complementari strand donor dna incorpor recipi chromosom equal probabl result segreg genet charact pro  geni transform cell also consist model independ incorpo  ration dna strand calcul done probabl integr singl dna strand carri particular genet marker probabl recombin lead doubl transform
475  |  multipl bacteriophag reproduct bacteriophag requir particip bacteri metabol  ism synthesi viral protein compon accomplish me  chanism ordinarili produc bacteri protein howev synthesi nucleic acid dna rna enzym may requir present non  infect bacteria format induc virus fundament biolog process replic transcript translat discuss context
476  |  mechan histidas induct format bacillus subtili role induc l histidin synthesi histidas l histidin am  monia lyas b subtili investig found induc cell poison actinomycin inhibitor rna synthesi lose capac forma  tion protein precursor histidas rate independ presenc absenc induc result show induc increas intracellular level histidase specif messeng rna prevent des  truction major portion materi fraction engag pro  tein synthesi possibl exclud induc exert effect bring stabil messeng rna still attach dna yet becom attach ribosom altern induc may actual stimul synthesi histidase specif messeng rna conver  sion precursor activ enzym appear involv polymer mono  mer rather releas ribosome bound inact enzym
477  |  synthesi phage host dna establish lysogeni method extract describ prevent excess fragment bac  terial dna larger bacteri dna separ phage dna sucros gradient relat amount phage host dna made various time infect typhimurium phage p lead lysogeni determin phage specif dna synthesi begin  min continu increas   min decreas complet repress attain  min autonom phage dna synthesi remain repress bac  teria specif synthesi proceed decreas rate  min almost complet inhibit reach dna synthesi recov in  fect cell host specif materi made new speci dna made phage dna synthes detect possibl implica  tion find understand lysogen interact discuss
478  |  lag period character entri transform deoxyribonucl acid bacillus subtili kinet appear transform function time exposur dna studi short lag period approxim  min  c evi  dent transform termin deoxyribonucleas length lag independ genet trait transfer moreov lag unaf  fect transform dna concentr presenc homolog unmark dna shear cross link transform dna lag show strong invers temperatur depend energi activ  kcal lag abolish transform termin wash instead addit deoxyribonucleas result taken indic immedi adsorpt dna cell follow deoxyribonuclease sensit period  min time genet trait enter cell result make feasibl investig configur assum dna molecul entri cell
479  |  configur transform deoxyribonucl acid entri bacillus subtili correl obtain map distanc length lag period preced appear pair genet trait addit dna compet cultur b subtili result taken indic dna enter compet cell lengthwis fashion smallest length transform dna particip recombin event number nucleotid pair enter cell per unit time estim evid indic part lag period devot transport dna cell signific result respect mechan entri dna cell discuss
480  |  chemic inactiv reactiv transform dna russian kinet inactiv link unlink genet marker mean hno uv light studi close link marker inactiv simul  taneous unlink marker inactiv independ seem chemic attack dna impair larg part macromolecul includ mani cistron shown genet experi chemic inactiv prac  tical influenc process dna inclus compet cell mean viscos measur shown molecular weight macromolecular properti dna signific chang chemic inactiv mean hno two explan inactiv trans  form activ dna discuss  structur deterior prevent integr dna molecul genom recipi cell  delet chain unit dna chain result wrong read code triplet previous describ literatur extens inactiv lead state dna appar resist initi one inactiv con  firm exponenti kinet author discuss code mistak hypothesi explan remark fact extens hno uv light action re  sult multipl lesion dna molecul lead reactiv delet restor correct read code larg part dna molecul basi explan reactiv chemic injur dna mean fusion anneal homolog genet inact dna slight fragment dna mean ultrason vibrat may expect attempt achiev reactiv method gave posit result
481  |  separ transform viral deoxyribonucl acid transduc bacteriophag bacillus subtili author use transduc b subtili phage ps  present fol  low experiment data dna isol ps  effect transform compet b subtili cell ps  dna distinguish b subtili dna higher densiti csso gradient lower thermal denatur temperatur transform activ present dna ps  denatur temperatur characterist b subtili dna rather viral dna transform activ ps  dna band csso gradient bacteri dna data indic bacteri dna incorpor phage ps  without integr viral dna incorpor bacteri dna involv transduct
482  |  repair damag induc monofunct alkyl agent transform ultraviolet sensit strain bacillus subtili uv sensit transform strain b subtili uvr  unabl carri host cell reactiv virul bacteriophag spo ratio slope kuvr kuvr uv inactiv curv   cell whole phage  indol transform dna spo phage dna measur transform system whole phage inactiv nitrogen mustard show greater surviv uvr cell uvr  differ whole phage inactiv methyl methanesulfon whole uvr cell recov uv induc damag determin increas extract transform activ period incub net dna synthesi occur uvr  cell unabl reco  ver uv induc damag recov methyl methanesulfon induc damag similar experi densiti label hn methyl methanesul  fonat treat uvr cell incub hn medium contain h thymidin show  ed  fold increas extract transform activ format new dna molecul determin pyknometr analysi repair damag in  duce uv irradi differ least one step repair damag in  duce methyl methanesulfon
483  |  biosynthesi  hydroxymethyldeoxyuridyl acid bacteriophage infect bacillus subtili phage e contain  hydroxymethyluracil dna place thymin infect b subtili enzym chang occur host organ account synthesi abnorm base deoxycytidyl deaminas increas least  fold product action deoxyuridyl acid convert direct deoxynucleotid  hydroxymethyluracil hydroxymethylas enzym activ thymidyl synthetas also use deoxyuridyl acid substrat decreas rapid phage infect
484  |  death anxieti children fatal ill author report studi seri  children hospit fatal ill due leukemia form cancer postul younger children would experi separ anxieti older children would like experi death anxieti general hypothesi support result studi evid indic younger children perceiv death anxieti deal symbol form older children felt boy tend react death anxieti act behavior girl tend becom depress
485  |  theori practic famili diagnost ii theoret aspect resid educ famili intervent observ prove use  area st observ psychosoci context patient admiss mental hospit phenomenon extrus separ  ation famili evid need studi interact patient famili milieu vital nd area famili inter  view major role resid educ tra  dition medic educ ill prepar stu  dent consider multifactori problem emot disord balanc mem  ber group may issu rather extern pathogen famili interview offer uniqu point observ factual evid emot con  vinc group data addit observ famili phenomena mutual understand other problem creat final famili interview serv instrument data collect hypo  thesi seek relat individu psychopatholog famili adapt patient famili time admiss deal crisi some  time traumat unexpect loss young marit partner unexpect ill financi revers common howev development natur part life cycl characterist development task involv deal crise postpon one see famili age specif ap  propriat time task crisi emerg dis  ruptiv inevit biolog matur person decis social expect primari concern leader determin life task face famili mental ill member mere deal vicissitud life unabl cope crisi be  caus feel arous life cri  sis lead particular constel effect given famili includ primarili sad anger guilt may well specif affect con  stellat appropri differ development task patient inabl cope life crisi due particular adapt style deal feel employ member famili
486  |  studi person ii bio psycholog experiment approach problem human adapt modern societi experiment determin fixation ambival measur relat anxieti estim obtain  ed project test group male adolesc shown  fixat increas increas corpor injuri anxieti ambival kept con  stant  ambival increas increas separa  tion anxieti fixat kept constant  extrem hetero fix subject show presenc intens guilt absenc aggress toward mother one ef  fect system organ seem suicid tendenc  extrem ambival subject in  tens separ anxieti one effect seem suicid tendenc combin high ambit impair cognit capac
487  |  earli indic outcom schizophrenia case materi  person seen child guidanc center child  hood adolesc later hospit schizophrenia examin intens studi concentr especi differ associ chronic vs hospit releas follow  factor signific relat chronic  psychot schizoid patholog mother person  se  parat kind pathogen famili  pre il histori poor so  cial sexual adjust  failur continu treatment childhood least  mth  less act communiti  neither disorient confus admiss  symptom depress psychosi  premor  bid schizoid person  clear precipit event  concern die acut phase ill  length onset  mth  schi  zophren reaction patient hered item    deriv earli life histori data thought new literatur prognosi schizo  phrenia remain  factor score hospit data alon cite previous prognost studi
488  |  format object rel identif kibbutz child issu relev earli stage object relat format identif kibbutz children discuss purpos child rear milieu kibbutz child describ clinic illustr given relationship mother seen main object rel educ transient interchang need satisfi relationship basi retrospect analyt materi appear cours develop two relat well two respect origin distinct object represen  tation synthetis one condit communal educ character  ise doubl object rel format birth seen factor in  tensifi normat crisi infanc especi transit symbio  tic separation individu stage object rel develop
489  |  mean cri multipl mean cri review particular stress laid tear respons type separ loss
490  |  death parent case depress ill death either parent prior child reach  ing age  seem correl signific contributori factor except statist studi suggest death mother first  yr child life oppos father potenti etiologi  cal factor futur develop psychos delinqu psychoneuros case histori  boy lost father given instanc distinct evid psycholog symptom behavior disturb  anc attribut larg measur effect death upon child case symptom choic correl specif cir  cumstanc surround death father case unresolv grief reaction mother help perpetu disord child re  solut mother therapi led improv child func  tion instanc improv occur especi child ceas preoccupi close identif dead father boy involv close mother grief reaction one disturb brief treatment given boy mother appear respons consider amelior symptom result ther  apeut intervent worthwhil especi instanc unresolv grief reaction mother
491  |  child concept death translat paper first appear  shown accord freud far child appreci dead differ true signifi  canc death mean revers decreas life function interrupt time like sleep time may mean temporari separ alway man power chang concept child unconsci find licens sadism cruelti anim death wish person close appear overcompens exagger piti dead creatur belief man power life death
492  |  mother child interact separ individu stage normal autism st week extrauterin life infant pass symbiot phase gradual emerg stage dual uniti end th mth th mth next phase separ individu begin four characterist subphas separ individu process describ differenti practic period associ stage character unfold complex cognit function relat mother child throughout subphas studi illustr clinic materi poor relat mother child  subphas necessarili usual preclud impress chang better next subphas
493  |  emot need children hospit hospit child physic reason bring separ pa  rent sibl familiar surround well probabl subject frighten pain procedur unless step taken prevent modifi result stress behavior disturb may aris may result per  manent damag develop person
494  |  earli childhood separ everi child long term studi child rear show signific reaction ordinari separ  yr age similar pattern respons group children suggest biolog determin caus cling reaction appear child becam mobil abl move away mother re  gardless frequenc durat separ major mother understand natur phenomenon regard cling cri  year old evid spoil regress behavior pediatrician help mother anticip explain separ respons indi  cate univers give specif recommend gradual chang modifi reaction
495  |  chang development quotient two condit matern separ development scale administ  group infant sub  sequent temporari period institution although group experienc matern separa  tion  group subject depriv receiv much less stimul result longitudin test program show score depriv group period separ signific lower nondepriv group progress de  terior score took place cours institution immedi follow return home score nondepriv group re  main constant depriv infant jump level group  theori regard mechan under associ depriv development retard exam  ine suggest explan moti  vation term best fit result obtain
496  |  separ anxieti factor object relat schizophren patient thesi advanc special vulner separ anxieti crucial factor schizophren difficulti establish maintain satisfactori interperson relationship  major reason lack autonomi lack object constanc without stabl autonom capac self regul adapt inordi  nate depend upon other help protect direct without object constanc unabl maintain stabl represent need person latter absenc evid present intens psychotherapi schizophren patient mani vicissitud doctor pati relation  ship center patient separ anxieti attempt defens includ cling perceptu cognit distort design deni separ recours substitut object promi  nent mani effort attempt revers passiv victim activ masteri practic implic thesi treatment schiz  ophren patient discuss
497  |  separ experi health record group normal adult   ostens normal ss report recent separ experi defin studi frequenc visit dis  pensari symptomat complaint signifi  cant higher among report separ among data suggest appar associ relat high cornel medic index score histori separ experi may understand term cause  effect relationship separ experi ill
498  |  separ attempt suicid  group psychiatr patients at  tempt suicid suicid urg non  suicides ther signific attempt suicid among patient histori childhood anteced separ control childhood signific differ found primarili period birth  yr signific interact childhood antecend separ suicid attempt suicid urg
499  |  investig len protein microelectrophoresi hydrosolubl protein senil cataract investig len protein agar microelectrophoresi hydro  solubl protein normal lens affect senil cataract re  veal follow fact  opaqu lens diminut total protein solubl protein take place well increas amount in  solubl protein decreas quantiti solubl protein higher increas insolubl protein point transform solubl protein insolubl varieti also disappear protein fraction len chang quantiti solubl protein accompani decreas protein slow fraction electropherogram even disappear fraction increas amount protein fraction medium veloc develop cataract matur phase cataract process becom distinct respect strong parallel exist protein chang clinic pictur senil cataract  qualit quantit chang occur protein normal lens advanc age show charact similar senil cataract howev less pronounc instanc de  creas quantiti solubl protein likewis close associ diminut protein content slow fraction electropherogram  chang solubl protein content len alter protein amount slow fraction alway accompani former play princip role age process len develop senil cataract  investig seem indic age process lens well develop senil cataract similar charact differ intens  undoubt process transit slow fraction solubl protein faster one transform part solubl protein insolubl protein like associ process well partial disappear total protein len seem play import part mechan pertain develop cataract
500  |  studi solubl protein bovin len immuno  chemic analys protein fraction lyophil solubl len protein dissolv  phosphat buffer ph  solut subject column chromatographi deae die  thylamino ethyl cellulos elut accomplish chang ph ionic strength elut buffer compon fraction stepwis elu  tion len protein separ  fraction column chromatogra  phi fraction compar b crystallin electrophore  tic mobil antigen puriti fraction examin immunochemi  calli result show fraction complet pure purer b crystallin fraction f  a b c correspond crystallin f  a b c e f correspond b crystallin f        crystallin
501  |  studi y crystallin calf len ii purif properti main protein compon four protein belong y crystallin group purifi chromatographi sulphoethyl sephadex phosphate cellulos column protein homo  geneous gel immunoelectrophoresi experi could crystal molecular weight n termin amino acid sequenc antigen structur similar amino acid composit sulphydryl group con  tain show certain dissimilar probabl  protein possess small differ primari structur associ antigen site may arisen mutat evolut
502  |  studi subunit a crystallin recombi  nation earlier investig shown presenc high concentr urea a crystallin bovin len split number subunit apparent  ly differ electrophoret mobil similar molecular weight recom  binat subunit remov urea studi ultracentri  fugat immunoprecipit techniqu found maxim recombina  tion obtain ionic strength remov urea high  wherea low ionic strength molecul half molecular weight nativ a crystallin much lower sediment coeffici obtain complet recoveri structur nativ a crystallin never obtain even high ionic strength evid electrophoret quantit preci  pitin analys subunit fraction chromatographi deae cellu  lose presenc  urea purif follow polyacrylamide  gel electrophoresi remov urea high ionic strength  fraction obtain show reaction partial ident nativ a crystallin immunodiffus test fraction show complet ident differ electrophoret mobil fraction presenc urea persist remov urea fraction much higher sedimen  tation coeffici absenc urea presenc although valu urea tr unfraction a crystallin obtain remov urea reach even high ionic strength amino acid composit fraction found differ observ suggest a crystallin com  pose number chemic differ relat subunit approxim size bound togeth nonspecif noncoval bond pos  sibli hydrophob bond moreov isol subunit abil associ form molecul high molecular weight
503  |  fraction b crystallin calf len gel fil  tration b crystallin isol calf lens combin gel filtrat sephadex g  vertical column zone electrophoresi subdivid  fraction subsequ gel filtrat dextran gel low cross linkag fraction show  major peak ultracentrifug sediment coeffici     fraction i iv respect howev  fraction contain addit minor compon reveal sediment immunoelectrophoret analys fraction procedur may valu first step isol individu protein b crystal  lin group
504  |  properti cold precipit protein fraction len solubl protein fraction precipit aqueous solut temperatur  c isol rat len fraction appear re  sponsibl revers cold cataract seen develop young mammal expos temperatur  c rat age concentr protein fraction decreas fraction com  plete disappear even lens  year old rat although molecular speci compris fraction appear homogen ultracentrifug disc electrophoresi immunodiffus shown heterogen mixtur a  b  y crystallin subunit abil cold precipit protein ccp fraction precipit cold depend upon concentr ionic strength ph solvent solut ph  aggreg  cpp occur form  compon longer precipit cold abil protein fraction precipit cold may depend hydrophob bond influenc conform protein
505  |  effect radiat lenticular epitheli enzym young rabbit mitochondri fraction solubl fraction epitheli cell len  week old new zealand white male rabbit expos  r whole head x irradi evalu glucos  phosphat dehydrogenas isocitr dehydrogenas malat dehydrogenas glutathion reductas glyceraldehydephos  phate dehydrogenas purin nucleosid phosphorylas nadph diaphoras nadh cytochrom c reductas activ increas enzym activ note irradi lenticular tissu purin nucleosid phosphorylas nadph diaphoras nadh cytochrom c reductas decreas activ glucos  phosphat dehydrogenas malat dehydrogenas glutathion reductas gly  ceraldehydephosph dehydrogenas observ lenticular tissu ir  radiat anim activ isocitr dehydrogenas ir  radiat control anim
506  |  convers a crystallin bovin len insolubl protein vitro a crystallin convert insolubl form treatment alloxan small extent iodoacet reagent hcl naoh reduc glutathion hydrogen peroxid mercaptoethanol abl convert a crys  tallin insolubl form alloxan treat insolubl a crystallin could made solubl treatment  urea product thus made solubl electrophoret mobil a crystallin show cross reaction a crystallin ouchterloni plate proteolyt activ alloxan effect produc cataract rabbit len small amount inject aqueous
507  |  structur studi a crystallin a crystallin isol cortex ox len isoelectr precipit follow chromatographi deae cellulos amino acid composit agreement report a crystallin prepar differ method one thiol groupg protein  order magnitud sub  unit molecular weight disulphid bond absent thiol group alkyl radioact iodoacet presenc urea partial acid hydroly  sis alkyl protein give accord condit main  radioact peptid near exclus one radioact dipeptid dipeptid n seryl  s carboxymethyl cystein ser cmci  peptid probabl tri  peptid relat ser cmci simplest interpret result sequenc around cystein residu common structur featur sub  unit a crystallin
508  |  subunit a crystallin a crystallin isol total water solubl len extract prepar zone electrophoresi starch pevikon c block purifi densiti gradient centrifug sephadex chromatographi prepar treat urea sodium dodecyl sulphat submit electrophoresi polyacrylamid gel contain either urea sodium dodecyl sulphat wherea  urea larg number zone detect three band observ  sodium dodecyl sulphat hand sediment coeffici valu media author re investig n termin amino acid content starch block prepar compar result obtain prepar isol accord new procedur concentr dinitrophenyl glutam acid lower purifi sampl urea tr sampl concentr n termin glutam acid wherea concentr trace end group chang sedimentation diffus equilibrium analyt ultracentrifug reveal slight heterogen purifi sampl electron micrograph electrophoret purifi sampl similar neutral slight alkalin ph show almost uniform spheric aggreg substructur observ acid ph coil filament rather small globul could demonstr
509  |  separ solubl protein bovin lens polyacrylamid gel solubl protein bovin lens separ gel filtrat polyacryl  amid gel presenc ethylenediaminetetra  acet buffer found essenti achiev good separ len homogen four fraction   b c ultracentrifug electrophoret immunochem analys use compar fraction solubl crystallin fraction len fraction compar a crystallin fraction b c b crystallin fraction y crystallin distribut four protein fraction nuclear cortic part calf cow lens determin oxidation sensit protein fraction calf lens separ fraction b se sephadex column
510  |  deaggreg bovin len a crystallin sediment equilibrium studi len a crystallin neutral ph indic materi compos number differ size speci studi effect alkali upon a crystallin indic progress deaggreg ma  terial increas ph sediment equilibrium studi perform ph  well guanidin hydrochlorid  urea succinyl materi condit molecular heterogen observ data indic independ speci coexist dissoci condit weight averag molecular weight succinyl alkali  urea  guanidin hydrochloride tr materi found integr relation  ship     respect sinc constant ratio mw found conclud spread distribut molecular speci occur deaggreg condit result guanidin hydrochlorid could evalu manner small concentr depend conclus impli weight averag molecular weight  urea actual molecular weight individu speci urea one half valu found alkali one quart succinyl materi
511  |  problem albuminoid albuminoid main constitu insolubl fraction len protein albuminoid cortex ox len fraction deae cellulos  urea peptid map fraction similar corre  spond fraction a crystallin albuminoid regard insolubl a crystallin undilut ground len clear becom turbid dilut albuminoid present normal len caus turbid even cellular structur disrupt perhap like albuminoid form dilut len mush high concentr protein len especi nucleus entail high degre order destroy dilut phenomenon may well connect precipit albuminoid
512  |  autoradiograph studi len epithelium normal x irradi rat eye cell prolifer migrat len epithelium normal x irradi rat eye studi mean autoradiographi label tritiat thymidin cell normal len epithelium requir  hr pass begin synthes period complet mitosi interv partit follow period approxim  hr g slight less  hr mitosi  min follow divis label daughter cell migrat germin zone postequatori row  week tracer inject mani radioact nuclei found len bow epitheli cell irradi dna synthesi phase undergo degener begin approxim  hr exposur onset cell death correspond time cell would normal prepar mitosi indic die abort divis small percentag origin label cell surviv  day irradi  ation  week number fell almost zero loss radioact cell occur rapid equatori zone
513  |  chicken len develop epitheli cell product migrat earliest stage chicken len develop cell divis occur entir len cell divis first stop posterior side len vesicl cell differenti primari len fiber annular pad develop cell divis occur part anterior surfac epitheli cell short hatch thereaft germin zone consist narrow band epitheli cell adjac annular pad develop cell germin zone migrat slowli differenti first annular pad cell len cortex fiber estim  year period slow migrat cell len discuss relat failur adult chicken de  velop radiat cataract
514  |  selenium content fish flour relat kwashiorkor dental cari fact fish flour shown rich sourc dietari selenium  ppm may import implic ie deleteri effect teeth treatment prevent protein malnutrit indic diseas syndrom man may manifest selenium defici recommend role play selenium protein malnutrit given serious consider research worker
515  |  selenium content fresh egg studi effect trace se dental cari author determin element egg whole egg contain appreci amount se found chiefli yolk mean valu   ppm   ppm white
516  |  selenium content human milk possibl effect dental cari selenium appear factor capabl increas suscept dental cari children rat area consid nonselenifer milk collect  mother   yr old low socio econom class mean selenium content  ppm standard error 
517  |  mode action selenium relat biolog activ tocopherol dietari selenium level  ppm partial benefici effect upon nutrit muscular dystrophi ineffect detriment higher level role selenium improv effect vitamin e due least part fact dietari selenium increas retent a tocopherol especi d a tocopherol shown chemic determin plasma tocopherol also trace activ tritiat tocopherol selenium serum various fraction serum protein chick receiv nutrient alon combin se h a tocopherol activ follow close serum protein studi indic vitamin e may carri selenolipoprotein fraction associ serum y globulin thus one biolog role selenium appear lie selenium contain compound act carrier vitamin e may function absorpt retent prevent destruct perhap transfer across cell membran d a tocopherol therebi enhanc biolog activ blood perhap cell throughout bodi
518  |  effect sodium selen acut poison thallium experi perform wistar rat weigh   g thallium ad  minist sc dose  mgkg  mgkg sodium selen given per os dose  mgkg  hr poison  mgkg daili next  day result indic sodium selen protect anim death bind thallium ion increas deposit organ comparison level thallium organ treat rat show selen increas liver  kidney  bone  influenc selen excret thallium urin found fecal excret thallium increas averag  treat anim
519  |  inhibit activ transport sugar rat intestin vitro ii action mepacrin atractylosid selenit shown mepacrin atractylosid selenit regard inhibitor intestin absorpt glucos inhibitor activ transport sugar sac evert jejunum rat wilson wiseman method mepacrin  x       inhibit   respect activ transport galactos atractylosid       inhibit   selenit        general inhibitor effect within order magnitud similar vivo vitro atractylosid rather effect vitro vivo mepacrin rather less easier achiev total inhibit activ transport sugar vitro intestin absorpt isoton solut vivo
520  |  analog parasympathet neuroeffector ii compar pharmacolog studi acetylcholin thio seleno analog hydrolysi product acetylthiocholin acetylselenocholin exert acetylcholine lik effect guinea pig ileum frog rectus abdomini prepar latter prepar respons acetylthiocholin acetylselenocholin contrast acetylcholin enhanc addit anticholinesteras attribut relat high activ hydrolysi product cholinethiol cholineselenol acetylthiocholin acetyselenocholin undergo enzymat hydrolysi approxim rate acetylcholin hydrolysi product acetylthiocholin acetylselenocholin effect guinea pig ileum compar parent ester readili oxid air relat inact cholin disulfid cholin diselenid respect observ help explain mani appar contradictori statement literatur regard action acetylthiocholin
521  |  cytotox organophosphorus compound compar activ trimethyl deriv thiophosphor selenophosphor acid veget pisum root human hela cell  compound studi seleno compound cytotox hela cell thio analogu wherea activ pisum root cell equal parent phosphor acid deriv wider activ rang hela cell seleno thio deriv studi progress
522  |  poison sodium selenit chronic poison na selenit drink water caus hepat cirrhosi usual atroph type rat rabbit seem definit diabetogen action attempt demonstr action dog far given inconclus result differ  speci perhap due techniqu use differ space inject practic reason action selenit pancrea discuss point se replac sh group thus render latter ineffect effect liver pancrea se seem resembl alloxan
523  |  tissu distribut se  selenouracil se  selenourea selenium analogu thiouracil thiourea label se inject rabbit high radioact appear lung liver kidney anim lung could visualis photoscan qualiti poor neither compound recommend trial lung adren scan man
524  |  sodium selen toxicosi patholog pathogenesi sodium selen toxicosi sheep pathogenesi selenium toxicosi studi  ewe fed subtox toxic level sodium selen   mth seventeen  die selenium toxicosi sever consist patholog chang found myocardium lung myocardi alter focal diffus degener necrosi earli replac fibrosi pulmonari chang consist edema interstiti hemorrhag typic degen process character passiv congest lung result left ventricular insuffici atrophi lymphoid center spleen lymph node common degen chang occasion found liver kidney gastrointestin tract
525  |  sodium selen toxicosi distribut selenium within bodi prolong feed toxic quantiti sodium selen sheep distribut selenium bodi tissu adult sheep fed subtox toxic quantiti sodium selen daili   mth vari tissu type level durat selenium consumpt selenium concentr highest liver follow descend order kidney lung spleen myocardium skelet muscl brain
526  |  studi selenium toxic chondroitin sulfat taurin biosynthesi chick embryo fourteen day old chick embryo use vivo experi toxic selenit treatment caus reduct extent sulfate  incorpor chondroitin sulfat taurin reduct observ tissu level metabolit rather taurin level signific greater embryo receiv selenium extent incorpor selenite s metabolit low signific
527  |  reaction seleno  sulfoamino acid hydroperoxid reaction methionin cystin selenium analogu hydrogen peroxid organ peroxid studi methionin react rapid hydrogen peroxid selenocystin caus decomposit react much slowli organ peroxid result suggest selenocystin may act biolog antioxid
528  |  selenium toxic domest anim articl extens bibliographi compendium avail inform selenium toxic domest anim literatur reveal evid organ bound se biolog activ given oral domest anim inorgan se salt also variat toxic organ se analog expos rumin digest consider reduct se salt relat biolog inact element se may result fecal excret se much  singl oral dose fluorin molybdenum chromium vanadium cadmium zinc cobalt nickel uranium increas se toxic arsenic tungsten give protect bromobenzen benzen napthalen mobil tissu se stimul excret sinc se prepar design topic applic treatment skin diseas avail use man dog literatur report case poison misus prepar selenium proper use valuabl therapeut agent though certain salt se must regard potenti toxic howev consider latitud therapeut andor nutrit toxic dose salt
529  |  studi specif transplant antigen rous sarcoma mice mice allograft differ sarcoma induc schmidt ruppin variant rous sarcoma virus rsv sr show resist subsequ isograft  differ rous sarcoma transplant resist could also induc rous mous tumor cell x irradi  r cell fre tumor extract contain demonstr virus transplant resist could demon  strat allograft pretreat various polyoma tumor non vir tu  mor allograft pretreat rous tumor induc demonstr resist isograft polyoma tumor inocul rsv sr rous chicken sar  coma suspens adult mice gave clear cut resist isograft  ing mous sarcoma neither allograft rous tumor virus chicken sarcoma inocul adult mice could virus neutr activ demonstr sera result demonstr presenc common speci  fic transplant antigen differ rous sarcoma mice speak ident transplant antigen viral antigen
530  |  anaphylact test model tumour antigen investig efficaci anaphylact test detect tumor antigen serum investi  gate simpl model tumor antigen studi carri use rat tissu rat serum bovin y globulin byg act mock cancer antigen found byg absolut dosag  ug form  antigen mix  ture use sensit readili detect present concentr   serum use challeng invari detect concentra  tion   byg absolut dosag  ug form approxim  sensit mixtur infrequ detect even present challeng  ing serum concentr   conclud anaphylact test use context high sensit discriminatori capac
531  |  effect lymphoid cell lymph specif immunis sheep growth primari sarcomata rat growth primari fibrosarcomata induc rat  benzpyren retard inject lymphocyt obtain effer duct lymph node sheep immun piec tumor treat action heterolog lym  phocyt specif particular tumor use immun suggest reaction tumor  specif antigen involv cell respons believ medium s pyroninophil lymphocyt may stimul immun system host react autochthon tumor
532  |  treatment canin neoplasm autogen vaccini prepar inbr mice transplant sarcoma carcinoma treat im  plant tumour grown strain mice normal resist tumour complet regress transplant tumour note  treat mice  life span doubl untreat control one dog spontan scirrhous mammari carcinoma anoth lymphosarcoma treat implant tumour growth cortisone tr mice regress spontan neoplasm follow case suggest growth neoplasm foreign host alter mole  cular structur neoplasm make antigen return origin host antigen produc also effect origin lesion
533  |  studi protein nucleic acid metabol virus in  fect mammalian cell format virus specif antigen kreb ii ascites tumour cell infect ence  phalomyocard virus kreb ii mous ascites tumor cell infect encephalomyocard virus found contain addit matur virus virus specif protein antigen assay base abil antigen block neutral purifi virus specif antiserum develop antigen present cul  ture fluid  hr infect cell virus intracellular titer increas time viral capsid protein synthes within cell most local solubl cell sap contrast virus anti  gen agglutin sheep erythrocyt immunolog properti destroy digest trypsin ribonucl acid detect concentrat  ed prepar antigen titer antigen affect ribonucleas antigen sediment coeffici   approx diffus co  effici determin method allison humphrey   x   sq cm sec  particl weight antigen henc   capsid protein purifi encephalomyocard virus could degrad treat  ment ethanolamin protein sediment coeffici   approx antigen similar treat yield protein similar size howev smaller antigen detect virus infect cell conclud non hemagglutin antigen repres polymer form basic viral capsid  protein molecul synthes cytoplasm infect cell may either intermedi by product process viral capsid protein syn  thesi
534  |  immunolog compet induct neoplasm polyoma virus thymectomi  day age sever inbr strain mice f hybrid result strike increas frequenc neoplasm follow infect polyoma virus age suscept extend least  day age high resist cbl mice usual stigmata associ thymectomi birth found  day thymectom mice nonetheless method use restor immunolog defici thymectom neonat also effect restor capac resist polyoma virus tumor induct adult syngen spleen cell thymus tissu millipor diffus chamber syngen thymus graft growth curv polyoma virus kidney salivari gland liver quit similar thymectom intact litter mate hemagglutination inhibit antibodi deter  mine period  day infect also similar group result discuss term concept involv virus specif tumor antigen immunolog status anim
535  |  antigen analysi sera patient malign tumor immunodiffus method immunoelectrophoresi ouchterloni method use antigen analy  sis sera  cancer patient  normal non tumor case serv control immunoelectrophoresi show abnorm precipitin line could demonstr normal sera abnorm antigen demonstr a  b globulin fraction distribut antigen differ individu case relat histopatholog classif site tumor howev antigen increas parallel growth tumor disappear mark decreas surgic remov tumor tissu almost sera patient myeloma leukemia malign lymph  oma form one characterist line b globulin region could dif  ferenti pattern case carcinoma
536  |  isoantigen properti tumor transgress histocompat barrier h  system sublin capabl transgress h  histocompat barrier deriv strict strain specif tumor  passag newborn host foreign genotyp  passag adult h  incompat recipi pretreat isoantisera direct tumor cell nonspecif charact induc procedur usual express number differ h  incompa  tibl recipi chang respons convers nonspecif growth appear proceed stepwis fashion express nonspecif charact requir exposur foreign host environ  day stage subsequ  transfer generat revers strain specif growth occur back transf strain origin  passag foreign host nonspecif charact perman establish howev could revert prolong passag origin host genotyp growth rate strain specif tumor nonspecif sublin compar strain origin differ found one tumor strain  specif line grew better nonspecif sublin anoth differ detect homozyg strain origin differ semi isolog f hybrid line grew better homozyg strain f hybrid howev comparison made concentr h  isoantigen surfac determin strain specif tumor nonspecif sublin quantit absorpt techniqu vitro nonspecif sublin lower concentr h  isoantigen strain specif tumor suggest nonspecif tumor develop result immunoselect variant resist homograft reaction character lower concentr h  antigen
537  |  particip antibodi enhanc resist methylcholanthrene induc tumour serum factor respons enhanc resist methylcholanthrene  induc tumor syngen system mice studi found part serum immunoglobulin system activ compon specif anti  tumor serum alway contain y  y m fraction activ detect fraction sera given dose enhanc growth tumor graft enhanc activ present fraction serum higher former sera given dose influenc interact organ tumor produc resist tumor graft fraction activ activ fraction higher fraction
538  |  effect immun sex antigen tumour graft contain sex antigen tumor bp  induc benzpyren cbl male mice contain sex antigen sex antigen lost growth tumor immun direct antigen tumor howev becom resist immun content sex antigen decreas
539  |  factor influenc induct enhanc re  sistanc methylcholanthrene induc tumour syn  geneic system activ immunolog enhanc growth methylcholanthrene induc tu  mor demonstr syngen system mice enhanc detect   wk preimmun irradi tumor suspens succeed th wk develop resist tumor analysi mean adopt passiv transfer show true immunolog phenomena enhanc resist transfer serum lymph node cell preimmun mice threshold dose tumor cell found satisfactori detect resist enhanc system
540  |  antigen properti human tumour preliminari studi antigen properti human tumour carri use heterolog antisera prepar rabbit number differ cancer normal tissu repeat absorpt antisera obtain react tissu antigen antisera ab  sorption normal tissu react tumour seventy two tumour  normal tissu extract studi mean ouchterloni agar gel doubl diffus techniqu result show presenc antigen antigen human malign tumour detect normal tissu foetal tissu hela cell addit loss normal tissu antigen tumour attempt made isol character tumour normal tissu antigen
541  |  incorpor sv genet materi adenovirus  measur intranuclear synthesi sv tumor antigen strain adenovirus  free detect infecti sv virus induc sv tumour antigen demonstr fluoresc antibodi stain green mon  key kidney rabbit kidney hamster embryo human embryo kidney cell cultur green monkey human cell cultur cytopath effect cell contain sv tumour antigen type cultur adenovirus  viral antiserum neutral sv tumour antigen induc abil strain virus anti sv monkey serum serum sv tumour bear hamster adenovirus  prepar propag exclus human tissu induc sv tumour antigen sv tumour antigen entir localis within cell nuclei appear transmit daughter cell mitosi
542  |  fluoresc antibodi human cancer specif dna nuclear protein specif antigen demonstr certain cancer studi obtain adenocarcinoma colon ewe sarcoma homogen prepar male rabbit immun anim bled death  day last inject test includ fluoresc antibodi method agar gel horizont double diffus precipitin test pattern reaction antibodi various cancer seem depend upon sourc cancer dna bound protein salt concentr use isol human cancer specif cross nuclear antigen seem cross react rather ident structur cancer specif antibodi could remov absorpt immun globulin cancer tissu salt solubl human dna bound protein adenocarcinoma colon ewe sarcoma induc format cancer specif antibodi show posit fta re  action maximum titer   cancer tissu studi cancer specif antibodi gave similar fta reaction cell nuclei normal appear liver parenchyma adjac metastat carcinoma colon nor  mal appear colon near metastat carcinoma colon normal appear colon near carcinoma colon long stand case chronic ulcer coliti evid shown find possibl may repres serolog detect earli latent cancer chang morpholog normal cell cancer specif antigen identifi round intranuclear dna  bodi nuclear protein specif destroy dnase trypsin
543  |  immunolog cancer cell tumour specif antigen broad histor survey immunolog studi cancer review given evid show antigen present normal cell miss malign cell aris tissu evid consid con  junction delet hypothesi carcinogenesi author emphas view key event carcinogenesi enzymat delet antigen gain intensif cours spontan chemic viral carcino  genesi review togeth experi demonstr exist tumour specif antigen question pose tumour specif anti  gen evid reject scanti occasion spontan re  gression point host resist rariti suggest toler general develop consider given applic immunolog method therapi although current achiev field limit new immunolog stratagem might yet transform pictur final plea made integra  tion disciplin immunolog cellular differenti prospect rais synthet holist approach might discov suscepti  biliti cancer cell re differenti re recognit
544  | effet de la carenc potassiqu chez le rat sur le squelett le cholesterol plasmatiqu lhistologi des surrenal r habib j lefebvr et p royer potassium defici male rat time wean provok increas weight supraren atrophi glomerular zone lipoid hypertrophi fascicula caus rise level blood cholesterol reduc phosphat level blood increas phosphat urin blood calcium level alter hypocalciuria note lead sever osteopathi investig radiographi microradiographi histolog bio  chemic studi skeleton follow charac  terist  arrest osseous growth delay matur arrest chondrogenesi format dens metaphys line line arrest osteoporosi fact discuss compar analog chang found syndrom chronic idiopath hypo  kalaemia hyperkaluria infant
545  | vergleichend renal phosphatelearance untersuchungen beim hyperparathyreoidismus und beim sog phosphatdiabet analysi function kidney give contribut pathophysiolog two differ diseas general osteopathi whose pathogenesi etiolog still clear point phosphat clearanc pre  postop one patient hyper  parathyroid show remov adenoma parathyroid renal reabsorpt phosphat improv tempo  rari secondari form hyperparathyroid alreadi present patient phosphatdiabet clearanc examin show high dosag vitamin reabsorpt phosphat increas base result continu therapi vitamin certain indiffer compar renal clearanc examin carri  patient show disturb calciumphosphate metabol
546  | unreli titan yellow method determin magnesium patient receiv intraven calcium glucon glucon found interfer determin magnesium titan yellow method method fals low result found serum urin patient receiv intraven calcium glucon interfer prevent ash specimen
547  | absorpt excret toxogonin alkyl phosph antidot intramuscular inject man toler absorpt urinari excret stu  die toxogonin bis  hydroxyiminomethyl  pyridine  methyl ether dichlorid specif anti  dote poison esterase block organ phosphat made  men intramuscular inject  mg ca  mgkg drug given self inject ampoul inject made automat ampoul autul caus local irrit certain facial symptom report time regard resorpt side effect toxogonin maximum blood level  ugml record within  minut even four hour level still   ugml concentra  tion ampli suffici ensur reactiv blood esteras inject dose  excret urin two hour  eight hour toxogonin appear pass bodi un  chang
548  | studi osteoporosi osteomalacia radiolog evid strong suggest osteoporosi possibl except acut immobil osteoporosi may irrever  sibl condit chang therefor expect calcium balanc osteoporot treat small compar often seen osteomalacia method obtain accur calcium balanc need show small chang especi high calcium intak use method continu mark stool chromium sesquioxid seem provid method use method far prove imposs obtain prolong larg posit calcium balanc osteoporosi either high calcium intak anabol hormon sodium fluorid two altern therapi vitamin explor use vitamin d resist osteomalacia atp found inneffect intraven phosphat alon ineffect produc posit calcium balanc effect complement vitamin certain condit
549  | aetiolog treatment urinari calculus investig laboratori base hypothesi calculus format primarili process crystal super  satur solut rather one adsorpt specif protein matrix postul boyc colleagu boyc king  crystal primari factor strong suggest recent studi vermeulen lyon gill  author produc artifici concret close resembl urinari calculi immers rotat wire loop normal urin sever day slowli ad appropri stone form element hypothesi correct factor primari interest urinari stone format respons supersatur nucleat crystal poison much remain learnt various factor inter relationship relat import signific urinari colloid protein muco protein polysaccharid calculus format still clear probabl play import secondari role bind crystallin precipit form non friabl calculus sinc time import factor crystal growth non specif bind protein would increas chanc stone growth retent within upper urinari tract
550  | control idiopath hypercalciuria paper discuss caus hypercalciuria describ  case differ origin present similar renal stone diagnosi idiopath hypercalciuria made exclus effect dietari restrict calcium sodium bicarbon cortison sodium phosphat sodium phytat cellulos phosphat demonstr calcium phosphorus balanc techniqu shown urinary calcium low effect final chlorothiazid derivative  nam bendrofluazide  wa also demonstr hypocalciur effect mode action discuss
551  | effect parathyroid hormon protein vitro mitochondri metabol appar addit parathyroid hormon sever non hormon basic protein stimul mitochondri respir ion transport atpas inhibit pi atp exchang reaction thus effect may uniqu measur biolog action parathyroid hormon previous report suggest rasmussen et al  also isol parathyroid extract protein inert vivo stimul mitochondri transport phosphat vitro postul protein might yet anoth biolog import factor produc para  thyroid gland latter specul may warrant view uncertain specif protein effect mitochondria test complet date show non hormon parathyroid protein c c unrel either biolog immunolog chemic amino acid analysi parathyroid hormon rigor studi necessari precis determin whether effect parathyroid hormon mitochondria valid reflect mechan action hormon whether sound use vitro test bioassay tool
552  | treatment phosphat encrust cystiti alkalin cystiti nalidix acid phosphat encrust cystiti caus persist infect b proteus ps pyocyaneus associ alkalin urin incid may increas may follow megavoltag therapi bladder tumour incid post radi case  per cent mandelamin often fail reliev condit seri ten patient fail respond mandelamin eight respond treatment nalidix acid side effect treatment note seri nalidix acid valu treatment b proteus infect urinari tract drug choic treatment phosphat encrust cystiti
553  | role liver glycoprotein mobil properti parathyroid extract studi carri de  termin action hepatectomi glycoprotein action pte well pte induc renal calcif deposi  tion glycoprotein data show hepatectom rat pte longer caus elev serum glycoprotein how  ever hepatectomi alter forma  tion glycoprotein tubular cast produc pte administr data suggest liver major sourc ele  vate serum glycoprotein found rat re  ceiv pte addit possibl pte may direct stimul action biosynthesi glycoprotein kidney
554  | distribut excret radioact parenter administr radioact polydiethylstilbestrol phosphat rat cow polydiethylstilbestrol phosphat psp water solubl polyest phos  phoric acid diethylstilbestrol in  ject rat cow distribut excret radioact follow speci subcutan intramuscular inject bulk radio  activ accumul site injec  tion disappear radioact depot slow late  day inject rat  administ radioact still accumu  late site inject liver effect remov label materi circul blood twenty four hour intraven inject rat  radioact recov organ distribut radioact cow indic polym prefer accumul organ contain reticuloendotheli cell
555  | studi phosphat excret stop flow techniqu de myttenaer stop flow techniqu appli dog attempt rule tubular secret phosphat locat site action parathyroid hormon pth renal tubul experiment condit use signific inward transtubular movement p could demonstr rule tubular secret phosphat stop flow experi perform parathyroidectom dog pth administr demonstr inhibit phosphorus reabsorpt hormon addit stop flow pattern indic phenomenon took place main distal part proxim tubul
556  | stupor hypercalcemia carcinoma renal pelvi sinc albright suggest tumor might produc parathyroid hormon hy  percalcemia associ malign tumor with  boni metastas record increas  ing frequenc transitional cel carcinoma renal pelvi ad list neoplasm hypercalcemia may accompani
557  | anod aluminium grain label radiophosphorus medic purpos g b fasolo r malvano u rosa e zimmer interstiti b therapi implant tissu radioact sourc wide appli treatment certain form human malign among radio el propos therapeut techniqu yttrium  gold  general use radiophosphorus p show attract featur suitabl half lif  day rather high energi b emiss maximum energi  mev use radionuclid limit diffi  culti found prepar safe solid sourc techniqu found literatur report riechert munding rame moravek use respect small plastic capsul fill phosphomolybd acid solut capo grain label phosphorus  method requir delic prepar work moreov larg b self absorpt effect expect case new simpl method prepar grain label phosphorus  basic consist ad  sorb label po   ion activ aluminium oxid film produc anod oxid aluminium wire adsorpt capac oxid film po   ion quit high process revers phos  phorus  activ partial desorb even seal boil water label wire kept isoton sodium chlorid solut
558  | effect parathyroidectomi ferric dextrin upon calciphylact sensit uremia experi rat indic calciphy  lactic sensit achiev bilater nephrectomi intraven administr ferric dextrin prepar fe din induc select calcif buccal mucosa esophagus trachea mediastinum nephrectom rat although produc chang intact control anim convers fe din prevent cardiovascular calcif normal elicit nephrectomi parathy  roidectomi protect nephrectom rat fe din induc calciphylaxi henc may conclud  autolog parathyroid hormon amount secret gland act calciphylact sensit  fe din high effect protect cardiovascular system urem damag
559  | mediastin parathyroid adenoma case hyperparathyroid hypercalcem crisi present tumor well differenti encapsul parathyroid adenoma un  usual locat anterior mediastinum lie within without pericardi sac surgic approach direct sternum mediastin explor postop cours unev gratifi complet correct symptom abnorm laboratori find
560  | clinic experi primari hyperparathyroid evalu treatment forty four patient oper proven hyperparathyroid evalu decid  whether diagnosi could substanti postop observ gross anatom diagnosi oper specimen  long term valu oper treatment would found immedi signific fall urinari phosphorus excret best document diagnosi primari hyperparathyroid interv  year follow up patient suggest favour respons diseas oper treatment
561  | dilut test measur renal function niobium poison rat control femal albino rat given water load  mlkg excret  per cent load urin within   minut teu administr singl intraperiton dose rang   mg nbkg result    fold increas teu valu  hour niobium inject niobium complex ascorb acid prior inject teu valu within control limit howev rat given singl intraperiton dose niobium given  dose ascorb acid interv    hour show teu valu mark differ observ rat given niobium increas teu valu observ rat given singl intraperiton dose uranyl nitrat   mg ukg mercur chlorid  mg hgkg sodium tripolyphosph  mgkg
562  | influenc parathyroid activ ion exchang various tissu  balanc data three patient hypoparathyroid given parathyroid extract present metabol respons complex data demonstr loss phosphat magnesium sodium potassium account destruct either bone non oss tissu preferenti deplet miner bone loss non oss tissu must presum  exchang ca mg p spectrum rat tissu studi sham oper parathyroidectom parathyroid extract treat rat effect parathyroidectomi develop magnesium defici determin  four hour parathyroidectomi increas transport calcium bone kidney intestin liver brain muscl found six day parathyroidectomi equilibrium reestablish exchang rate ident sham oper anim  administr parathyroid extract associ de  creas transport ca mg p bone ca exchang kidney reduc tissu exchang ca mg in  creas p exchang intestin kidney mard increas anim receiv extract  parathyroidectomi great minim manifest mag  nesium defici young rat magnesium defici diet  result suggest parathyroid hormon may affect trans  port exchang calcium magnesium phosphat perhap sodium potassium tissu usual consid target organ
563  | effect alkalosi plasma concentr urinari excret inorgan phosphat man acut respiratori metabol alkalosi shown depress plasma phosphorus con  centrat normal man fall plasma phosphorus concentr greater respiratori compar level extracellular meta  bolic alkalosi fall attribut in  creas renal excret migrat red blood cell evalu low serum phos  phorus concentr alway carri knowledg ph total co content plasma
564  | relationship vitamin parathyroid hormon marit von stedingk effect parathyroidectomi parathy  roid hormon administr upon concentra  tion plasma calcium phosphat measur vitamin d defici rat re  sult compar observ d fed ani  mal also influenc dietari calcium phosphat content upon respons investig parathyroidectomi d fed ani  mal result rapid fall plasma calcium biphas plasma phosphat respons initi fall follow strike rise contrast parathyroidectomi d defici rat fol  low signific chang plasma calcium immedi rise plasma phosphat prevent administr para  thyroid hormon dietari phosphat restrict abolish effect parathyroidectomi group anim administr dose  u hormon intact d defici rat littl influenc upon plasma calcium dose  u in  creas plasma calcium dose  u suffi  cient increas plasma calcium d fed anim result discuss relat effect vitamin parathyroid hor  mone upon mitochondri metabol
565  | decreas serum urinari phosphorus man cours pyrotherapi fever peak occur hour in  jection urinari phosphorus dis  appear entir fact cannot account parallel decreas gfr serum phosphorus level sp increas would expect retent occur contrari declin mark degre possibl chang sp could brought increas util glucos also consid intraven glucos toler  anc test method macho licko  carri anoth group patient control day day pyrotherapi five hour pyrogen administr increas rate glucos util observ tabl  howev differ opinion found literatur cours glucos toler test conn  comparini  observ lower rate glucos util febril subject malizia  found accentu rate declin serum phosphorus glucos toler test subject high temperatur glycem respons differ ob  tain control without fever subject test whether util purpos fact remain massiv transfer phosphorus serum tissu take place fever
566  | relationship maxim tubular phosphat reabsorpt filtrat rate dog maxim renal tubular rate reabsorpt phos  phate tmp demonstr normal dog dog man consider variabl tmp often occur variabl remain unex  plain direct relationship glomerular filtrat rate gfr tmp demonstr gfr vari wide rang relationship suggest glomerular intermitt may exist dog
567  | human growth hormon clinic measur respons hypoglycemia suppress corticosteroid standard test growth hormon secretori ca  paciti base radioimmunoassay plasma growth hormon insulin hypoglycemia describ normal subject standard insulin toler test caus  ing averag blood glucos drop  per cent rest valu produc mean rise growth hor  mone  millimicrogm per millilit one hour total rang   millimicrogm per mil  lilit respons observ  hypopituitari subject compar hypoglycem stimul glu  cocorticoid tr patient show mark in  hibit growth hormon respons relat dose subject receiv  mg cortisol equival per day show mean plasma rise  millimicrogm per millilit rang   millimicrogm subject receiv   mg cortisol equival per day show mean rise  millimicrogm per millilit rang   millimicrogm inhibit human growth hormon also affect durat glucocorticoid treatment be  ing greater long term short term ad  ministr
568  | obes plasma level insulin growth hormon studi serum level glucos free fatti acid insulin growth hormon prolong fast suggest insulin growth hormon respons certain metabol abnorm accompani obes
569  | hypophysectomi replac therapi toler euryhalin killifish fundulus heteroclitus hypoton media hypophysectom fundulus heteroclitus previous report surviv day transfer salt fresh water surviv time fish test  week  month hypophysectomi gradual dilut extern medium produc failur averag salin    salin compar caus failur abrupt transfer although failur associ hypochloremia daili inject balanc salt solut  nacl shorten surviv daili inject teleostean neurohypophysi peptid arginin vasotocin   pressor mu per gram isotocin   oxytoc mu per gram prolong surviv extract caudal neurosecretori tissu urophysi male tilapia mossambica benefici action dose  ug per gram everi day purifi ovin prolactin  mu per gram altern day maintain surviv   fish durat  day test period fresh water irrespect period pretreat salt water purifi bovin prolactin prolong surviv   fish maintain  day purifi bovin growth hormon ineffect monkey growth hormon contain  u per milligram prolactin activ administ dose  ug per gram equival  mu per gram prolactin activ prolong surviv human growth hormon contain  u per milligram prolactin activ dose  ug per gram equival  ml per gram prolactin activ also prolong surviv   fish maintain  day abil pituitari prepar protect hypophysectom f heteroclitus failur fresh water appear relat prolactin activ content neurohypophysi peptid suggest adenohypophysi hormon resembl mammalian prolactin essenti surviv fish hypoton extern media carp pituitari prepar protect hypophysectom f heteroclitus although f heteroclitus pituitari known effect
570  | resist human growth hormon pituitari dwarfism clinic immunolog studi thirteen pituitari dwarf treat human growth hormon hgh growth acceler dose   mgweek observ one patient therapi   year old girl grew rate  cmmonth  month thereaft despit larger dose growth hormon  mgweek growth rate fell  cmmonth rate growth persist stop hgh retreat  occas acceler growth occur antibodi hgh absent serum treatment repeat demonstr serum high concentra  tion hgh bind capac  mg treatment compar titer anti  bodi found  patient receiv long term hgh treat  ment specif human anti hgh serum differ rabbit anti hgh serum wherea monkey growth hormon mgh hgh effect inhibitor bind hgh i rabbit antiserum hgh effect inhibitor human antiserum like manner crude placent extract effect in  hibitor rabbit antiserum ineffect human anti hgh serum
571  | influenc alloxan diabet growth hormon content rat hypophysi homog  enat adenophypophysi tissu obtain alloxan  inject adult male rat vari durat sever diabet well diabet rat maintain insulin replac regimen assay immatur hypophysectom femal rat abil crude hypophysi extract encourag tibial cartilag width ex  pansion gain bodi weight depress hematocrit blood area level determin signific decrement abil increas epiphysi cartilag width abil depress hematocrit note   day follow inject alloxan increas intens diabet state associ decreas growth promot potenc hypo  physial prepar well decreas abil influenc hematolog indic hypophysi extract taken insulin tr diabet rat contain growth hormon equival amount tissu obtain control rat conclud adenohypophys diabet rat contain diminish amount growth hormon insulin repair encourag greater normal ac  cumul somatotrophin anim
572  | pheochromocytoma without hypertens patient develop symptom pheochromo  cytoma  year diagnosi eosinophil adenoma pituitari gland predomin symptom profus sweat tachycardia hypertens hyperglycemia glycosuria absent relat quan  titi relat composit catechol amin symptomatolog discuss specul regard etiolog import hypersecret growth hormon pheochromo  cytoma seem order
573  | hypoglycemia growth retard probabl isol growth hormon defici  year old child heretofor unreport associ defect name hypoglycemia growth retard defici serum growth hormonelik activ  year old child describ human growth hormon hgh  mg day  day doubl fast blood sugar prevent postprandi hypoglycemia revers sensit tolbutamid leucin treatment  mg hgh  time week produc growth  inch  month compar growth  inch previous  month sinc protein bound iodin respons methopyrapon normal blood level growth hormon low case present probabl isol growth hormon defici
574  | product secret avail insulin precis understand metabol phase diabet mellitus requir reliabl inform concern synthesi manner releas transport insulin well behavior agent interfer action hormon inhibit destruct shall deal varieti problem might help outset outlin first present understand chemic structur insulin sinc mani use hint flow consider natur molecul
575  | growth growth retard various attempt made year defin growth standpoint review growth physiolog accret new tissu reflect acquisit protein water process almost instanc lead increas size length weight volum activ progress fertil ovum period sexual matur million cell present state advanc organ time growth less inde may becom negat insofar cell lost
576  | long term treatment hypopituitari achondroplast dwarfism human growth hormon treat  year old hypopi  tuitari dwarf intermitt hgh wilhelmi  year  mg  time week month growth rate  inch treatment continu becam resist increas dosag  mg  time week age  induc month growth rate  inch growth promot effect least great report li raben prepar also treat  year old sever de  form achondroplast dwarf year  mg  time week grew  inch first month spurt growth subsid  mg  time week grew anoth  inch month growth main  tain
577  | acromegali effect various steroid hormon insulin induc growth hormon respons peter h forsham avail sensit assay human growth hormon made possibl direct measur effect various agent purport alter growth pattern acromegal patient present special problem earli diagnosi therapi abl measur growth hormon patient provid accur index activ precis measur therapeut effect attempt determin whether pituitari block growth hormon secret feasibl condit studi made effect estrogen androgen glucocorticoid administr growth hormon respons standard insulin toler test patient activ acro  megali dosag schedul use studi possibl suppress either basal growth hormon secret blunt respons normal physiolog stimulus hypoglycemia
578  | practic human growth hormon prepar clinic use human growth hormon prepar acetone dri pituitari powder hot glacial acet acid extract subsequ precipita  tion sodium chlorid cold aceton yield  per cent prepar call practic growth hormon recognit complement corticotropin treatment two dwarf practic growth hormon aqueous solut   mg intra  muscular altern day acceler growth rate physic sign laboratori indic adren stimul advers effect prepar recom  mend safeti simplic relat good yield
579  | hypophysectomi lipolyt action epinephrin vitro respons normal adipos tissu epinephrin  ugml incub medium complet abolish hypo  physectomi donor rat treatment hypophysectom rat crude whole rat pituitari extract restor lipolyt ac  tion epinephrin normal posterior pi  tuitari extract corticotropin replac without effect thyrotropin inject produc partial growth hormon treatment full restor lipolyt action epinephrin treatment hypo  physectom rat cortisol cortico  steron reestablish sensit adipos tissu epinephrin relat larg dose hormon given physiolog dose triiodothyronin  ugratday howev restor nor  mal respons epinephrin conclud sever endocrin factor influenc lipolyt action epinephrin physiolog import cannot yet quantit
580  | c acetyl bovin growth hormon procedur describ label bovin growth hormon human albumin c acetyl label molecul biolog antigen similar unlabel bovin growth hormon follow administr label hormon anim label appear remain attach growth hormon molecul least  hour administra  tion label hormon promot growth hypophysec  tomiz rat increas free fatti acid concentr rabbit serum degre compar seen follow administr unlabel growth hormon rabbit anti  bovin growth hormon serum neutral rat growth respons acetyl hormon immun rabbit alter isotop dilut increas serum free fatti acid intraven inject label hormon
581  | growth hormon growth hormon influenc protein fat carbohydr miner metabol promot nitrogen retent growth cartilag transport amino acid cell wall incorpor amino acid protein factor mo  biliz free fatti acid adipos tissu increas serum concentr substanc long term administr hormon follow deplet bodi fat store inhibit fatti acid synthesi diabet subject growth hor  mone administr follow hyper  glycemia glycosuria ketosi effect carbohydr metabol normal sub  ject subtl sodium potassium inorgan phosphat retain follow administr growth hormon hypercalciuria also accompani treat  ment effect mediat para  thyroid gland human growth hormon may detect serum use radio  immunoassay hypothalamus inti  mate involv control secret releas growth hormon pituitari correl avail glucos me  tabol plasma concentr growth hormon glucos unavail  abl growth hormon releas order provid substitut sourc energi fatti acid administr growth hormon patient hypopituitar fol  low growth mani instanc usual effect promot growth individu abnormali  tie acquir resist effect growth hormon accompani de  velop antibodi direct protein
582  | recent advanc physiolog bone part introductori textbook summar knowledg biochemistri physiolog bone calcium metabol  lectur outlin import advanc appear sinc time refer origin literatur need repeat object bring subject investig up to d present new problem laboratori research hypothet new hormon calcitonin copp cameron discuss detail dr mclean lectur parathyroid gland bone
583  | hyperplast lesion mous mammari gland treatment  methyl  cholanthren hyperplast lesion present mammari gland mice treat  methylcholanthren exogen hormon lesion similar found gland expos mammari tumor virus probabl product mammari gland hyper  plastic lesion could serv measur effect chemic compound carcinogen agent mammari gland
584  | bone growth metabol studi prematur infant treat human growth hormon influenc exogen human growth hormon growth metabo  lism prematur infant observ possibl regist in  creas linear bone growth hormon administr concomit urinari hy  droxyprolin excret chang signific nitrogen balanc studi indic sharp increas nitrogen retent due reduc urinari excret infant calcium phosphorus balanc rose three four prematur infant treat growth hormon characteris  tic sth calciur action sth observ furthermor sth fail in  duce signific increas nefa serum concentr prematur infant may therefor conclud metabol respons prematur infant sth differ consist normal observ matur subject
585  | growth hormon action rat liver rna polymeras effect growth hormon activ rna polymeras measur system shown tabl  seen hypophysectomi rat result decreas activ rna polymeras inject  mg human growth hormon rat  h death increas enzym activ hypophysectom rat normal rat howev stimul effect growth hormon seen absenc high concentr ammon  ium sulphat rais ionic strength assay medium abolish growth hormon effect mention addit growth hormon vitro presenc absenc ammonium sulphat signific effect label rna nuclear prepar
586  | mammari growth rat treat somatotropin pregnanc andor lactat group rat receiv daili inject  mg somatotropin sth either day   pregnanc day   lactat anoth group rat receiv grade increment   mg sth everi  day pregnanc lactat group rat serv pregnanc lactat control mammari gland deoxyribonucl acid dna content determin rat milk yield determin rat carri day  postpartum signific increas mam  mari dna occur rat treat sth irrespect dose schedul in  jection compar gestat control signific elev mammari dna lactat control level also evid rat receiv hormon carri day  lactat milk yield rat treat grade increment sth signific greater control lactat milk yield rat re  ceiv constant daili dose hormon differ control
587  | growth retard accompani diabet insipidus addit mechan consider may divid patient nephrogen diabet insipidus least two categori  fail respond current avail therapeut product well presum normal secret adh  similar similar unrespons treatment presum reduc secret adh adh growth hormon theori may well account part growth retard later group
588  | studi growth hormon secret rat hypophysi autotranspl kidney capsul secretori capac pituitari gland autotranspl kidney capsul studi special regard secret growth hormon gh bodi weight bodi length tibial epiphys width mammari gland develop testosteron stimul studi bodi growth tibial epiphys width mark reduc rat transplant hypophysi much hypophys  ectom control inject  mg testosteron propion daili  day group alveoli seen mam  mari gland transplant rat observ show consider defici gh rat pituitari gland auto  transplant kidney capsul howev develop alveoli mammari gland favour theori small amount gh secret transplant pituitari tissu inject purifi vasopressin prepar pitressin rat autotranspl hypophysi influenc bodi growth tibial epiphys width mammari gland develop effect pitressin seen tibial epiphys cartilag rat intact pituitari gland report del vecchio et al  hiroshig  itoh  experi therefor support view vasopressin act gh releas factor
589  | effect human growth hormon hypopituitari dwarfism human growth hormon hgh raben use dosag  mgmday  mgm twice week dosag probabl certain rang physiolog replac therapi standard five day metabol hgh test hypopituitari dwarf retain n children without gh defici test valuabl diagnost help hypopituitari dwarfism prolong treatment hgh acceler growth hypopituitari dwarf children without gh defici growth rate induc treatment first averag later averag averag age decreas respons hgh typic general phenomenon catch up growth caus develop  ment antibodi  hypopituitari dwarf treat least  month  growth resist begin spite high n retent preced hgh test resist caus develop high titr specif hgh antibodi first month treatment antibodi suppress effect hgh metabol growth unexpect occasion induct man antibodi homolog protein hormon great interest possibl antibodi might activ homogen also endogen hormon could far reach biolog import
590  | effect short term administr hysiolog dose human growth hormon three patient turner syndrom h e sjoberg effect appar physiolog dose human growth hormon investig three patient turner syndrom short term metabol balanc studi subject present abnorm sex chro  mosom constitut increas level sulphat factor activ serum two dose level hormon use appear anabol respons correl dose obtain paramet use except urinari magnesium retent greater higher dose sulphat factor activ serum in  creas hormon administr one case studi respect urinari excret hydroxyprolin within normal rang two patient studi respect alter growth hormon patient increas urinari excret creatin present cannot explain creatinuria diminish growth hormon treatment mechan behind retard growth discuss suggest major factor might defect center linear growth ie epiphys would make less respons factor normal stimul growth process epiphys zone
591  | effect growth hormon kidney transamidinas hypophysectom mous role growth hormon certain endocrin factor re  gulat kidney transamidinas investig mous kidney transamidinas valu low follow hypophysectomi growth hormon administr dose   ugday ovin nih restor enzym activ toward normal bioassay growth hormon suggest base determin total kidney transamidinas intact mice given relat larg dose triiodothyronin low enzym activ enzym valu alloxan tr mice normal
592  | influenc hormon tumor growth plasma prolactin level rat bear pituitari mammotrop tumor effect estradiol cortisol acet thyroxin thiouracil tumor growth organ weight plasma prolactin level determin rat bear furth pituitari mammotrop tumor mttf tumor known secret larg amount adrenocorticotropin somatotropin prolactin follicle stimul hormon lutein hormon thyrotropin dose level use estradiol signific suppress tumor growth without influenc bodi growth partial inhibit enlarg adren atrophi thymus cortisol acet signific reduc tumor bodi growth thyroxin signific effect tumor growth enhanc somatotrop effect indic increas bodi growth organ weight thiouracil signific effect tumor bodi growth although signific increas thyroid weight estradiol cortisol acet thyroxin increas plasma prolactin level tumor bear rat
593  | studi human growth hormon ten dwarf patient whose short statur vari aetiolog studi investig metabol effect human growth hormon  mg administ daili period   day patient maintain constant diet preliminari control period receiv hgh  patient   day post hgh period hgh produc reduct serum cholesterol rebound withdraw  delay clearanc fat blood fat load  appear pre b lipoprotein fast state measur paper electrophoresi fall serum cholesterol rebound withdraw hgh relev observ hypercholesterolaemia occur hypopituitari patient even absenc hypothyroid chang observ test thyroid adrenocort function short term high dosag administr hgh hypopituitari patient show consider retent nitrogen hgh administr confirm work prader colleagu provid valuabl diagnost test growth hormon defici measur urinari nitrogen excret withdraw hgh also promis use investig differenti diagnosi short statur nitrogen excret withdraw phase hypopituitari children return slowli pre hgh level two non hypopituitari dwarf children excret much nitrogen withdraw period retain hgh period one primordi dwarf show neglig chang urinari nitrogen excret hgh post hgh period
594  | hormon modif distribut  amino  cyclopentanecarboxyl acid  c rat four hormon examin abil alter distribut rat new model amino acid  aminocyclopentanecarboxyl acid  c although total tissu concentr amino acid consider less found previous a aminoisobutyr acid chang produc hormon much amino acid hydrocortison elev liver level  aminocyclopentanecarboxyl acid within  hr bovin growth hormon acceler entri amino acid skelet muscl liver hypophysectom rat within  hr testosteron propion elev distribut ratio kidney skelet muscl wherea b estradiol signific increas uptak model amino acid immatur uterus growth hormon produc signific chang serum level  aminocyclopentanecarboxyl acid condit use
595  | insulin insulin antagon said earlier simpl answer yet emerg larg amount research direct toward determin natur substanc substanc respons diabetes induc insulin antagon action anterior lobe pituitari gland ascertain mechan action growth hormon corticotropin certain qualifi factor increas mobil fat plasma albumin bound free fatti acid idea yet incomplet character insulin antagonist pancrea may liber blood influenc growth hormon may play role process growth hormon diminish activ insulin promot util glucos attract still remain confirm
596  | relationship growth hormon steroid relaxin transform pubic joint cartilag ligament hypophysectom mice histolog chang occur pubic joint hormon treat intact hypophysectom mice studi estrogen treatment result bone resorpt transform cartilag cap pubic bone fibrocartilag intact mice hypophysectom mice furthermor relaxin fail influenc appear pubic joint estrogen prim hypophysectom mice wherea induc develop long interpub ligament intact mice growth hormon sth administ hypophysectom mice pubic joint respond estrogen bone resorpt transform cartilag cap fibrocartilag sth treatment also restor abil pubic joint hypophysectom mice prolifer long interpub ligament estrogen relaxin administ progesteron specif inhibit ligament format due relaxin inject without alter histolog chang associ estrogen treatment intact mice sth maintain hypophysectom mice
597  | effect testosteron propion growth hormon growth chemic composit muscl tissu hypophysectom male rat effect testosteron propion growth hormon growth muscl bone pelt viscera semin vesicl studi hypophysectom male rat testosteron  mgday stimul growth levat ani muscl semin vesicl effect tissu studi growth hormon  mgday acceler growth tissu except semin vesicl testosteron enhanc growth promot effect growth hormon tissu except levat ani muscl growth hormon stimul deposit myosin sarcoplasm protein collagen alkali solubl protein thigh muscl hypophysectom rat composit muscl treat control hypophysectom rat normal rat growth hormon also increas collagen keratin clastin globular protein content pelt effect growth hormon protein muscl pelt enhanc testosteron testosteron given alon effect chemic composit content muscl pelt hypophysectom rat
598  | growth hormon diabet mellitus sinc advent insulin vascular neurolog lesion replac ketoacidosi major problem diabet although good control hyperglycemia glycosuria diet insulin may influenc favor develop ocular angiopathi remain high incid lesion result blind despit good control growth hormon may major factor pathophysiolog diabet mellitus effect may reflect genet disturb import first realiz classic experi houssay young reveal diabetogen effect experiment anim associ acromegali diabet long time major argument support hypothesi diabetogen effect growth hormon man
599  | experi contribut somatotrophin prenat growth rat hypophyseoprivus fetal rat induc decapit fetus utero retard fetal growth effect prevent inject somatotrophin observ substanti support view normal rat short birth fetal somatotrophin develop hypophysi govern part prenat growth occur time although complet hypophysectomi pregnant rat retard growth fetus manner action obscur individu litter combin hypophysectomi mother hypophyseoprivus fetus retard fetal growth greater extent hypophysectomi mother without hypophyseoprivus fetus intact fetus inject somatotrophin armour acceler fetal growth presum ampl fetal somatotrophin develop hypophysi present
600  | insulin protein metabol present status protein synthesi within cell outlin protein form absenc insulin net format protein acceler insulin effect insulin protein metabol take place independ transport glucos amino acid cell glycogen synthesi stimul high energi phosphat format case protein metabol certain studi pathway glucos fat metabol observ reveal strike intracellular effect insulin mani tissu within tissu effect insulin appear find express predomin microsom level incident hormon affect protein metabol growth sex hormon appear act microsom fact insulin exert effect protein metabol intracellular site well independ effect lead one agre action consist stimul multipl seem unrel metabol event fact immedi effect insulin protein synthesi independ immedi need extracellular glucos amino acid mean sustain function cell likewis independ biochemist fulli awar metabol defect diabet alter insulin vitro demand vari period pretreat anim also known diabet protein enzym may defici other may produc excess absenc insulin suggest physician desir least two kind relat fundament studi patient one possibl relat defici insulin action patholog process tissu yet examin method describ need accur measur metabol disord control thing urinari blood glucos develop futur improv place insulin protein biosynthesi must kept mind
601  | influenc blood glucos plasma concentr growth hormon berson md sensit specif assay method use demonstr acut chang plasma hgh normal diabet subject hgh secret suppress glucos administr mark stimul hypoglycemia interfer intracellular glucos util high level hgh also observ prolong fast exercis four six hour follow oral glucos administr abnorm hgh secret found associ acromegali obes follow section hypophys stalk half time disappear endogen plasma hgh twenti thirti minut
602  | failur thrive diencephal syndrom infanc childhood present case patient astrocytoma optic chiasm demonstr featur diencephal failure to thr syndrom overact overalert emaci signific symptom patient roentgenogram characterist demonstr normal bone growth good muscular outlin absent subcutan fat increas growth hormon found may factor disturb lipid metabol
603  | increas statur fact patient respond growth hormon administr linear growth indic growth hormon defici hypopituitar yet appear main factor led author assum patient suffer hypopituitar conclus children growth retard subject short trial period treatment growth hormon singl defici growth hormon therefor question valid rather limit suppli human growth hormon appear much stringent criteria administr human growth hormon advoc everi effort made uncov patient might benefit growth hormon util reliabl test pituitari function perfect suitabl growth hormon assay suggest evid hypopituitar growth hormon defici treat care evalu respons long term treatment
604  | languag disord young children reorgan think current question confus use term aphasia refer young children seem often reflect semant problem accru profession habit think term etiolog patholog label argu term aphasia general simpli refer inabl interfer develop languag comprehens use task evalu group describ well possibl detail specif impair function child task common requir use extens period diagnost teach wherein care taken explor sensori motor modal work whether integr various stimuli take place current idea discuss refer descript impair causal factor fair uniqu childhood thought neurophysiolog human languag system psychosoci factor import language learn special attent given various relat term tempor resolv power sensat sensori integr scheme model suggest may prove fruit experiment design attack problem prelanguag premean level argu proport unknown reduc care studi base inform impair function within sensory integrative motor complex without particular regard site extent lesion
605  | therapi hearing impair children comparison usa europ canada still earli stage develop rehabilit servic speech hearing impair children adult avail larg canadian citi opinion author servic made avail hear impair everi canadian communiti specialist rehabilit communic problem along member medic paramed social servic recogn vast varieti communic problem occur person age tremend handicap problem repres individu loss handicap person repres societi press need effici effect rehabilit practic hope articl made reader awar vast varieti rehabilit procedur avail today hear impair better understand problem defect hear hope reader profession non profession join mutual support establish vital need servic respect communiti
606  | babi habit genesi ontogenesi adam may look upon personif paleolith man  generat primit human animal whos evolut vast import understand ontogenesi behavior babi noth deuteronomist reiter rememb day old consid year mani generat
607  | speech therapi select patient congenit velopharyng inadequaci paper describ clinic speech problem three patient without cleft palat velopharyng inadequaci pharyng flap surgeri perform patient speech therapi found ineffect follow systemat trial therapi continu follow surgeri youngest child first grader realiz normal speech follow surgeri therapi two children continu aberr improv speech
608  | stimulus overload action cycl complet gradient systemat inquiri origin certain emot disturb infant show consist matern care vital child normal physic psychic social develop inde surviv elementari precondit consist matern care physic presenc mother substitut howev becom increas appar children develop also stunt suffer damag vari extent attent close contact mother dispens seem wrong kind mother model mother babi interact propos explic dynam wrong kind mother consequ proposit mutual exchang mother babi consist give take action reaction two partner requir activ passiv respons respons form seri chain singl link consist call action cycl complet time anticip next link design seriat respons exchang precursor dialogu primal dialogu dialogu act vector babi develop influenc direct stimul adapt effort psychic growth follow inappropri mother quantit well qualit result refer time derail primal dialogu control experi anim find experiment psycholog last clinic find illustr mechan derail dialogu sequela case review surfeit stimul psychic overload result derail dialogu overload prevent subject complet action respons initi long last overload result cumul incomplet action cycl sequela cumul profound chang behavior individu chang manifest departur norm individu social behavior pattern maladapt individu asynton societi asoci derail dialogu trigger perhap even caus natur social set one set over popul extens discuss connect anim experi implic human communiti examin
609  | children kelbourn kelbourn school glasgow educ spastic aphas children first school kind administ local educ author aphas depart larg experiment natur contain children age three eight spastic depart  children sever physic handicap age rang   school celebr golden jubile last year origin maryhil hall public school defect epilept children open   pupil premis hmi report four year later imposs speak favour report continu public hall use frequent even public entertain lack proper cloakroom bare appear general comfortless use purpos inspector word go unheed seven year later children transfer other new build perci street special school name chang kelbourn school two world war school provid educ physic mental handicap children  new unit ad spastic children admit first time gradual emphasi shift children physic mental handicap cerebr palsi final entir build becam avail spastic two year ago aphas children join school miss ef hamilton headmistress
610  | deaf method detect diagnosi manag deaf children depend entir knowledg process involv communic speech acquisit skill propos consid first found practic step taken deal patient flow natur knowledg
611  | pharyngoplasti speech adequ palat repair undertaken  year indic pharyngoplasti well age pharyngoplasti indic support oper result palat repair assess  year plus speech result prove disappoint figur  pharyngoplast  case appli known speech result april  follow follow up recent primari case pharyngoplasti may well necessari hyne pharyngoplasti prove satisfactori
612  | verbal effect intermediate s transport problem preschool children given intermediate s discrimin problem told respons reward medium stimulus    step transposit test train group group ii told big littl one group iii told anyth verbal given test group ii learn initi discrimin faster group iii transpos group iii distanc effect three group result data suggest defici verbal control motor behavior young children aris defici decod encod process
613  | acquisit formal featur languag children differ group learn use function languag everi child must learn formal featur code languag thus creat constant everi languag acquisit situat
614  | mongolism som clinic aspect review  mongoloid seen  year nebraska psychiatr institut one half sampl evalu second birthday eighteen per cent case birth weight data avail weigh less   lbs doubl nation rate prematur bi mod distribut mother age birth mongoloid child pregnanc labor deliveri complic report almost one half case seven per cent breech deliveri case mr frequent type moder frequent mention characterist general hypotonia  case psychiatr disord  case abnorm eeg  case hear loss  case
615  | learn problem children ii emot aspect last meet tri deal general over al approach problem learn consid mere problem read learn general begin birth hope deal problem relat high level want emot problem dealt manner rather term diagnost criteria child learn problem compartment term organ nonorgan subject talk emot issu learn
616  | manag communic problem infant children earli detect referr child hear speech languag problem feasibl case critic consult obtain child place train program gear need
617  | format cleft palat unit  preliminari report cleft palat surgic field chang techniqu better manag patient whole render inexcus oper procedur mere drag togeth edg defect leav cosmet function crippl child adapt best may harsh competit outsid world iron problem congenit defect increas compet deal advanc past case struggl take place marriag market skill rehabilit procedur becom like perpetu disabl sinc signific number show hereditari tendenc
618  | acquisit languag although work bullowa jone bever greatest promis light may shed develop function languag children promis cannot realiz unless author give great deal explicit attent framework analysi may case phonolog grammat develop anyth like satisfactori bodi linguist theori method termin state good deal may learn without theori necessarili must learn sinc work progress cannot suspend unpredict millenium still would piti chanc lost interact acquisit data improv theoret notion let complet discuss develop argument two way briefli state natur problem regard termin state verbal develop b indic present futur contribut field anthropolog sociolog social psycholog may abl make solut problem
619  | speech product spoken languag deaf distinct made speech product spoken languag analys oral output hear impair brief review studi area undertaken includ report new electron visual monitor devic glossal transduc postul deaf utilis uniqu visual to motor convers within brain speak monitor conscous tactile kinaesthet control recent studi relat syntact featur speech deaf show deaf creat telegraph speech reduc sentenc length omiss essenti word functor speech deaf seem contain most noun verb limit number word use expand verb form
620  | cognit function earli infantil autism examin four case mean wechsler intellig scale children result communic obtain examin mean wechsler intellig scale children four case earli infantil autism case develop way reliabl investig mean mental test becom possibl accord full scale iq four case fell within categori dull normal intellig less show consider discrep verbal perform iq perform iq much higher valu composit autist test profil character larg variabl subtest score discrimin autist group signific non autist control group subtest score diverg respons larg variabl show distinct pattern specif autist group whole group could consid distinct group particular mark tendenc achiev poor far subject averag level subtest comprehens vocabulari achiev superior far level subtest block design object assembl specifi mental function condit success four subtest occupi extrem posit within autist test profil conclud autist patient appar abl achiev well even superior task could perform pure perceptu level fail soon appeal made think proper thought due disabl deal imaginari thing imaginari situat word incap objectifi actual present subject concret situat propos impair could reduc lack symbol mean correl defect insuffici develop languag patient propos children suffer earli infantil autism might abl later stage reach level languag develop word use symbol repres absent thing absent situat
621  | otolog care cleft palat case purpos studi review ear patholog  patient whose cleft palat previous repair despit concern speech regress tonsil adenoid surgeri carri  patient care done accomplish consider overal improv particular benefit conduct hear loss sixteen case exact document result virtu speech record accur audiometr record
622  | congenit heart diseas deaf mut associ somat malform occur sever member one famili md patrick h lehan md uniqu famili describ mother four eight children pulmonari stenosi two four affect children deaf mut one addit pulmonari valvular stenosi idiopath hypertroph subaort stenosi affect children sever associ somat malform genet nongenet factor role develop malform discuss suggest cardiac defect transmit singl non sex link genet factor domin autosom inherit presenc normal karyotyp appear singl dose either point mutat small delet transloc like caus
623  | histidinemia review publish report histidinemia indic condit variabl clinic biochem express three children histidinemia born consanguin marriag report blond hair blue eye speech defect mental retard peculiar eeg abnorm also exhibit characterist biochem find diseas elev blood urin histidin increas urin imidazolepyruv acid sustain high rise plasma histidin follow oral histidin toler test howev reduct skin histidin a deaminas activ observ children condit test determin heterozygot famili success parent consanguin normal skin a deaminas activ set children apart report case first lend support hypothesi histidinemia inherit autosom recess trait second support idea genic fault result reduc histidin a  deaminas activ express differ degre differ tissu children seem repres variant histidinemia liver histidas activ reduc skin histidas activ present
624  | interpret within metaphor analyt investig use metaphor first given impetus ella freeman sharp  explor symbol mean particular metaphor phrase refer bodi libidin need current interest becom focus upon use metaphor self consci ration therapeut techniqu communic particular valu patient reach borderlin saniti ekstein  ekstein wallerstein  emphas use metaphor regard essenti techniqu gradual establish communic initi insight borderlin schizophren patient must regard treatment techniqu preliminari approxim final therapeut act ultim consist classic interpret level secondari process use metaphor deriv primari valu maintain contact patient constant danger inund break through primary  process materi
625  | evolut characterist speech disord juvenil cerebr lipidosi juvenil cerebr lipidosi diagnos increas frequenc countri especi school visual handicap manifest rapid develop loss vision seizur muscular rigid ataxia retin pigmentosa eeg abnorm well known disord speech disord describ loll stammer speech mention sjogren  comprehens descript juvenil amaurot idioci emphas recent descript report base upon analysi  case describ evolut characterist form speech patholog invari present juvenil cerebr lipidosi initi speech abnorm seen earli disord hesit speech occasion repetit word time dysarthria becom evid slur nasal impair phonat similar seen pseudobulbar palsi addit dysarthria high characterist persev speech appear often close resembl true stutter stuttering lik speech observ   case time cours ill speech pattern deterior patient becom less communic final laps mutism speech disord often disabl aspect syndrom
626  | relat cri activ earli infanc speech intellectu develop age three year rosenfeld cri  infant age   day measur outburst frequenc activ  sec period cri cri score show signific correl  stanford binet iq  year borderlin correl  cattel iq   month nonsignific trend speech rate  year although correl adequ individu predict infant cri deem worthi investig possibl indic intellectu potenti
627  | labial support applianc patient repair cleft lip palat associ displac defici premaxilla present problem may concern plastic surgeon speech pathologist orthodontist prosthodontist upper lip may appear flat retrud relat lower lip maxillari anterior teeth miss either congenit natur mix dentit period neglect upper lip may appear roll premaxilla lower lip usual assum characterist pouti appear complex tissu deform also may import articul speech sound fricat plosiv difficult produc correct malposit lip may interfer direct air current contact tongu alveolar ridg normal contact lip correct procedur design improv labial profil establish normal relationship intraor structur procedur employ individu combin may includ othodont movement maxillari segment dental prosthesi cheiloplasti anoth recent develop adjunct involv autogen osscous implant cleft area
628  | heterogen cleft palat popul research design primari point made paper must reject notion inher univers common among individu born cleft lip andor cleft palat must recogn various pertin subgroup within popul mean howev one must alway recogn smallest subgroup given studi contrari would defend use fewest possibl subgroup consist specif research purpos nevertheless feel time spent consid purpos studi subgroup need identifi tend minim number contradictori result assist us interpret observ insight technolog make possibl
629  | cineradiograph comparison normal noncleft subject velopharyng inadequaci cineradiograph studi normal subject compar studi noncleft subject demonstr velopharyng inadequaci follow conclus made signific differ soft palat length normal velopharyng inadequaci group b signific differ depth nasopharynx normal velopharyng inadequaci group c differ mean soft palat length depth nasopharynx normal velopharyng inadequaci group signific thick soft palat greater normal abnorm group e  normal velopharyng inadequaci group height soft palat elev palat plane f  normal group height velopharyng closur took place palat plane none subject velopharyng inadequaci group obtain velopharyng closur g signific correl amount gap voic qualiti h signific correl amount gap intellig speech differ vital capac read velopharyng inadequaci group nose occlud unocclud j correl coeffici qualiti judgment intellig judgment high signific
630  | spontan verbal rehears memori task function age distinct made  altern hypothes explain often report defici verbal mediat perform earli childhood  verbal respons made tend mediat perform mediational defici hypothesi  verbal respons tend made production defici hypothesi studi describ attempt meet ideal criteria test production defici hypothesi method use direct observ ss spontan verbal hypothesi confirm find kindergarten less like older children rehears stimulus name nonverb serial recal task
631  | earli experi social cognit mode children paper deal question cultur depriv act shape depress resourc human mind argument present first behavior lead social educ econom poverti social earli childhood second central qualiti involv effect cultur depriv lack cognit mean mother child communic system third growth cognit process foster famili control system offer permit wide rang altern action thought growth constrict system control offer predetermin solut altern consider choic research group compos  negro mother  year old children select four differ social status level data present show social status differ among four group respect cognit function linguist code offer exampl relat matern child behavior congruent general line argument laid
632  | recoveri mycoplasma studi human leukaemia malign numer report publish concern necess test presenc mycoplasma interpret experi perform cell cultur test especi import presenc virus suspect sinc recent evid indic mycoplasma capabl elicit transmiss cytopath effect addit mycoplasma virus share properti size filter morpholog electron microscopi sensit ether abil haemagglutin caus haemadsorpt interfer virus replic vitro lack inhibit certain common use antibiot inhibit growth homolog antiserum thus absenc ordinari bacteria mould prepar elicit cytopath effect cell cultur unreli criterion viral identif great caution exercis classifi new agent virus especi myxo  virus without adequ test exclud ident mycoplasma
633  | pneumonia due mycoplasma pneumonia incid membership co op medic group ruth mcmahan edmund r clark william maccol j thoma grayston total  case pneumonia occur  person member medic co op period decemb   decemb   annual rate pneumonia  per  isol mycoplasma pneumonia throat swab attempt half case report pair blood specimen obtain one third basi laboratori examin specimen incid clinic recogn pneumonia due pneumonia   person per  per year although peak rate pneumonia occur five year age  per  pneumonia due pneumonia uncommon age group common children five nine year old frequent caus pneumonia adolesc ten nineteen year age rate children primari school twice averag incid pneumonia pneumonia also differ pneumonia etiolog occur throughout year season excess wherea total pneumonia show predomin winter typic clinic syndrom pneumonia pneumonia isol one promin system manifest headach fever respiratori symptom occur except cough upper respiratory tract complaint elev white cel count much frequent pneumonia patient pneumonia pneumonia almost never hospit suffer signific absente came larger famili usual children school age report physician usual correct diagnos pneumonia atyp viral
634  | establish turkey flock free n strain mycoplasma mycoplasma n strain frequent isol turkey poult affect airsaccul free mycoplasma gallisepticum research n strain imped presenc high proport turkey poult airsaccul breed flock examin difficulti cultur identifi mycoplasma strain lack practic serolog test communic describ establish small nucleus n free turkey commerci breed flock known carri n mycoplasma hen tom product n free poult select parent flock serolog cultur
635  | septicemia due mycoplasma homini type  viola young phd sheldon wolff md febril ill follow therapeut abort accompani presenc mycoplasma homini type  blood describ patient upon recoveri exhibit specif antibodi respons mycoplasma isol blood well anoth strain serotyp find regard addit evid pathogen homini type  organ particular situat favor dissemin femal genit tract
636  | infecti door mycoplasma homini bij een pasgeboren mycoplasma homini infect newborn child   in babi born difficult forcep deliveri abscess began form neck day birth mycoplasma homini recov pus
637  | intraspeci differ antigen surfac certain live human cell surfac antigen sever type live cell human origin partial character hyperimmun antisera prepar rabbit live hela cell live uncultur full term human amnion cell hemagglutin mixed agglutin direct indirect immunofluoresc fab techniqu employ techniqu fraction absorpt procedur common specif cell antigen detect surfac sever human live cell uncultur primari amnion two establish human cell line rp  u amnion presum normal origin two hela hep  presum malign origin human erythrocyt none antigen found nctc  mous cell human cell possess species  relat antigen demonstr hemagglutin remov hemagglutinin absorpt human erythrocyt antibodi high titer homolog cell detect fab method addit chang antigen surfac amnion cell primari cultur observ final antigen found hela hep  cell use anti hela serum absorb human erythrocyt rp  cell found either human erythrocyt uncultur amnion cell cell two establish amnion cell line dilut use test antibodi abo blood group isoanti  gen forssman hapten adsorb serum protein could account antigen detect possibl mycoplasma sp antigen respons reaction inconsist result specif fab method live cell confirm
638  | coombs posit hemolyt anemia general amyloidosi mice follow transmiss subcellular leukem materi follow transmiss cell fre supernat fluid virus ex  tract leukem tissu plasma vari  ous type murin plasma cell leukemia diseas develop character hyper  gammaglobulinemia weight loss anemia mark splenic renal hepat amyloido  sis plasma cell infiltr lung diseas also transmiss placenta milk infect mice dba male incid diseas much higher  sur  vival shorter anemia much sever case dba femal dba x cba f mice sex propos develop lesion mediat auto  immun mechan creat antigen effect virus transform host cell
639  | ph  antigen strain pasteurella pseudotuberculosi relat biolog activ may conclud part p pseudotuberculosi strain synthes ph  antigen wherea properti seem share strain p pesti case p pesti three kind biolog activi  tie relat presenc ph  antigen isol strain p pseudotubercu  losi
640  | serolog relationship among human mycoplasma shown complement fix gel diffus robert chanock antigen relationship among human mycoplasma studi complement  fixat agar gel diffus techniqu four recogn human speci mycoplasma homini type  homini type  salivarium fermentan antigen distinct test addit pneumonia eaton agent etiolog agent cold agglutinin  posit atyp pneumonia differ four speci although speci distinct evid share antigen compon obtain complement fix agar gel diffus test sinc rabbit immun mycoplasma grown rabbit muscl infu  sion broth supplement rabbit serum case pneumonia infect chick embryo lung suspens possibl heterolog reaction result antibodi growth medium compon could exclud four recent mycoplasma isol oro  pharynx analyz three shown close relat homini type  fourth close relat salivarium although recent isol could dis  tinguish relat prototyp human speci complement fix differ could detect agar gel diffus techniqu
641  | mammalian cell cultur contamin pleuropneumonia lik organ ii effect pplo cell morpholog establish monolay cultur occurr cytopathogen chang monolay cultur pplo contamin mammalian cell shown relat defici arginin medium effect seen cell cultur medium deplet pplo prior applic pplo fre cell cultur even though viabl pplo longer present fact pictur result absenc pplo either arginin glucos omit medium would indic defi  cienci creat condit describ specif cellular chang could well result omiss deplet mam  malian cell growth requir import surveil cell line presenc pplo avoid misinterpret cytopathogen effect stress
642  | suppress rous sarcoma virus growth tissu cultur mycoplasma oral agent produc cell destruct human diploid chick embryo fibroblast isol wi  strain human diploid fibroblast shown mycoplasma multipl rous sarcoma virus rsv rous associ virus rav inhibit wi  wi  chick embryo fibroblast infect mycoplasma mycoplasma isol design strain  react strong complement fix test antiserum mycoplasma oral ch isol obtain human oral caviti cytopath effect mycoplasma strain  could elimin grow mycoplasma artifici agar medium inocul chick embryo fibroblast serial passag chick embryo fibroblast restor cytopathogen agar grown mycoplasma howev growth rsv rav inhibit tissu culture grown agar grown  strain also ch strain produc cytopath effect
643  | method direct demonstr pleuropneumonia lik organ cultur cell direct microscop observ pleuropneumonia lik organ pplo cell cultur easili accomplish follow  ing hypoton treatment air dri stain orcein rapid techniqu use fl human amnion cell inocul su  pernat suspect cultur de  scribe demonstr pplo con  tamin  cell line rapid method complet agreement re  sult pplo agar techniqu
644  | fatal septicem diseas infant puppi caus cytopathogen organ characterist mycoplasma pathogen organ iso  late  outbreak fatal septicem diseas infant puppi dog kidney cell degener spontan iso  late indistinguish serolog possess characterist mycoplasma pathogen organ cytopathogen dog kidney cell cultur inocul puppi produc patholog chang resembl seen natur case le  sion consist princip necrosi hemorrhag isol cultur serolog distinct recogn canin mycoplasma speci
645  | chromosom chang pplo infect fl human amnion cell characterist chromosom chang observ pplo infect fl human amnion cell chang includ gradual reduct chromosom number increas chromosom aberr appear  new varieti although aberr appear earli infec  tion chang develop slowli period sever month
646  | studi mycoplasma pneumonia infect sweden sera  case pneumonia  case milder respiratori infect examin cf test pneumonia antigen thirty f patient pneumonia  patient bronchiti serolog evid pneumonia infect case signific antibodi rise cf test also show correspond rise fluoresc antibodi test pneumonia isol   serolog posit case cold agglutinin demon  strat   case  per cent pneumonia infect pneumonia infect occur season year common older children young adult clinic featur case pneumonia infect studi re  sembl describ similar investig countri
647  | spontan genetisch veranderungen zellstamm l earl chromosom constitut clone cell strain l studi repeat chromosom analys within  year result stabil cellular clone regard test featur durat one year maxim number chromosom amount   later test spon  taneous doubl chromosom number maximum  chromosom ascertain caus phenomenon could yet clear new chromosom pattern remain unchang subsequ examin period  month prove observ present cultivation condit cell popul retain stabil vitro certain period defin substanc howev still impli unknown factor may mutagen effect sudden chang cell popul may result respect physiolog featur hard known yet
648  | chromosom chang human diploid cel cultur infect mycoplasma communic show mycoplasma may also chang cell chromosom therefor emphas need caution interpret experiment result without adequ test presenc mycoplasma chromosom damag similar describ induc virus cell cultur blood cul  ture chromosom abnorm also report blood cultur bone marrow leukaem patient
649  | evalu tylosin prevent egg transmiss mycoplasma gallisepticum chicken inocul mycoplasma gallisepticum infect yolk left posterior thorac air sac lay chicken result infect produc rate egg infect satisfactori experiment purpos cultur live embryon egg well dead infertil egg necessari determin rate egg infect tylosin either inject subcutan administ drink water employ egg dip solut great reduc complet elimin egg infect  egg dip trial  isol gallisepticum ob  tain  tylosin dip egg compar  isol  control egg
650  | epidemiolog mycoplasma pneumonia infect famili ruth mcmahan transmiss clinic manifest in  fection mycoplasma pneumonia studi  famili case atyp pneumonia pneumonia isol throat cultur index pneumonia patient  famili trans  mission famili member occur   famili  famili  children  adult infect index case includ total  patient family contact infect  lower respiratory tract symptom  pharyng alon  children asympto  matic  probabl unrel symptom time interv case within famili suggest median incub period  day treatment tetracyclin seem neither cure symptom com  plete abolish carrier state often last one three month
651  | case salping due pleuro pneumonalik organ case acut salping follow diagnost curettag aspir pouch dougla describ case resist penicillin streptomycin therapi pure cultur pleuropneu  monia like organ pplo grew pus remov secon  dari pyosalpinx aspir organ sensit tetra  cyclin cure adnex infect pplo found vagin discharg pplo frequent isol vagina healthi infect women howev  case pelvic inflammatori diseas pure cultur pplo report possibi  liti growth pplo intern genitalia follow use antibiot therapi discuss infect pplo consid pelvic inflam  matori diseas prove resist common antibiot
652  | serolog differenti mycoplasma strain pleuro  pneumonia lik organ various sourc complement fixat test rabbit antisera use differenti  cultur mycoplasma man mammalian cell cultur laboratori rat mice cattl goat poultri embryon egg sewag seventeen serotyp distinguish  man  mammalian cell cultur  rat mice  cattl goat  poultri one saprophyt correspond recogn speci mycoplasma  human origin repres  strain navel  tissu cultur  strain may repres new speci r one serotyp rat could distinguish speci arthritidi probabl antigen variant rather distinct speci two speci hitherto recogn distinct arthritidi homini type  could distinguish appear constitut singl speci find illustr necess viewpoint taxonomi compar mycoplasma strain serolog method serotyp human anim origin larg host specif except inclus arthritidi rat homini type  man singl serotyp find bovin organ among strain isol goat saprophyt strain rat relat aetiolog diseas man anim isol endogen mycoplasma embryon egg use passag infect materi illustr import identifi organ serolog demonstr mix mycoplasma infect lesion two rat show necess adequ purifi cultur mycoplasma examin
653  | spiramycin treatment experiment mycoplasmosi day old chick turkey poult day old chick turkey poult experiment infect gallisepticum treat time infect spiramycin administ subcutan inject drink water medic dose  mgkg bodyweight subcutan inject  per cent concentr drink water continu three day elimin infect bird remain free air sac lesion react slide agg  lutin haemagglutin inhibit test
654  | studi agent isol tissu cultur inocul human leukaem bone marrow wood mycoplasma isol tissu cultur inocul bone marrow leukaem patient cultur show cytopath effect contain mycoplasma evid mycoplasma control cultur mycoplasma isol seem biolog serologic  alli one strain differ previous report isol human sourc although relationship rodent mycoplasma pulmoni mycoplasma cannot readili distinguish virus electron microscop relationship mycoplasma leukaemia yet clear
655  | microbiolog studi reiter diseas attempt made demonstr virus pplo bodi fluid synovi tissu patient various rheumat diseas attempt demonstr virus negat pplo look  specimen  patient rheumat non rheumat diseas wherea organ readili isol genito  urinari specimen found none  synovi fluid specimen could grown synovi tissu biopsi patient rheumatoid arthriti ankylos spondyl gout gonococc arthriti psoriat arthriti traumat arthriti arthriti accompani ulcer coliti present one possibl two eight synovi tissu specimen patient reiter diseas complement fix test negat nine patient reiter diseas includ two whose synovi tissu pplo thought isol
656  | recoveri pleuropneumonia lik organ pplo genitalia femal albino rat genit organ seventy seven nonproduct breeder femal rat examin grossli histolog bacteriolog cultur uterus ovari made three seventy seven anim show purul salping oophor pleuropneumonia lik organ isol uterus ovari  anim examin cultur obtain genitalia compar pplo isol middl ear anim two appear ident intraperiton inject pplo cultur young rat mice produc oophor salping mice rat
657  | chronic respiratori diseas mice rat chronic respiratori diseas crd mice rat embrac two separ entiti name infecti catarrh caus mycoplasma pleuropneumonia lik organ enzoot bronchiectasi virus two syndrom discuss regard etiolog patholog manifest transmiss particular attent paid relat mycoplasma infecti catarrh morpholog cultur characterist catarrh type organ consid standpoint differenti diagnosi import crd mainten breed coloni use anim experiment purpos stress method establish specif pathogen fre coloni mean control briefli outlin togeth observ cesarean deriv line swiss mice
658  | observ lymphoma african children  cytopathogen filtrabl agent frequent encount cultur embryon human kidney cell follow inocul supernat fluid primari human amnion cultur previous expos extract tumor specimen east african children malign lymphoma kind describ burkitt other result seem noteworthi suggest intim associ agent diseas also natur isol involv two phenomena initi induct peculiar spindl twist amnion cell fig  subsequ destruct chang kidney cell inocul fluid alter amnion cultur direct inocul embryon kidney cell extract tumor bone marrow never caus cytopathogen effect isol transmiss agent capac induc amnion lesion nevertheless two effect close associ clear relat specimen cytopathogen agent later cultiv protein rich media found characterist mycoplasma fail induc tumor varieti anim serolog test serv antigen gave suggest inconclus evid relationship diseas mycoplasma also fail induc amnion lesion caus specimen
659  | mycoplasma speci man present six distinct speci mycoplasma known infect man certain biolog ecolog properti agent defin one speci pneumonia definit shown import respiratory  tract pathogen anoth speci homini type  may play role respiratory tract genital tract diseas
660  | pleuropneumonia lik organ despit small size pplo carri full complement chemic com  pound enzym contain larger bacteria cell contain dna rna independ metabol essenti like free live cell contrast virus independ metabol outsid live host cell sever strain pplo cultiv mucous membran appar normal human subject espe  cialli respiratori urinari tract recent howev definit evid associ pplo clear  ly defin clinic diseas human sub  ject lack  becam evid so cal eaton virus origin isol eaton associ  patient primari atyp pneu  monia realiti pleuropneumonia lik organ typic pplo coloni pro  duce cell fre agar medium enrich addit blood serum yeast number strain pplo identifi recognit uniqu characterist classi  fie separ order mycoplasmatal genus mycoplasma
661  | problem diseas parathyroid gland biochem test indic unequivoc function parathyroid tumour usual adenoma remov reliev symptom prevent damag organ kidney  per cent case oper particular difficult anyon experi thyroid surgeri tumour seldom great size usual less half inch diamet care search expect posit close apposit posterior surfac thyroid lobe usual reveal adenomata usual brown colour normal yellow gland  per cent case one gland may aberr possibl absent super  numerari gland may present usual one lower pair gland occupi ectop posit explain outlin embryolog develop may accompani thymus mediasti  num rather vast area seek small tumour explor cannot light undertaken evid indisput burden must shoulder correct polici believ first carri thorough explor neck prove un  avail inspect mediastinum sternum split incis two week later rather complet major undertak one session
662  | age factor experiment hypertens dca type rat rat age   day sensibilis unilater nephrectomi week later given  mg g dca everi third day  week  nacl solut drink younger rat react greater increas blood pressur male rat hypertrophi heart kidney mortal supress growth also evid younger age group male rat given steroid hormon start day  show perman suppress growth
663  | respons serum glycoprotein tissu injuri necrosi  respons necrosi hyperplasia tumour growth serum glycoprotein rat underw  fold increas  day growth walker tumour increas affect rat treat terramycin protein increas greater rate rat subject ischaem necrosi one kidney two  third liver boil kidney tissu hand littl effect upon protein respons kidney hyperplasia none suggest protein increas respons substanc liber damag necrot cell
664  | natur histori autoimmun diseas nzb mice comparison pattern human autoimmun manifest mice nzbbl strain spon  taneous develop serolog patholog evid autoimmun dis  eas adult life nzbbl strain develop dr mariann bielschow  sky dunedin new zealand inbreed  ing outbr coloni mix coat color sever inbr strains  nzb nzc nzo nzw nzi other evolv dunedin origin col  oni evid autoimmun diseas nzb strain first report bielschowski helyer howi found evid autoimmun hemo  lytic anemia dunedin group use presenc agglutinin ficin tr red cell index diseas
665  | remain kidney irradi survivor wilmss tumor intraven urogram  patient surviv  year irradi wilmss tumor studi kidney size configur diseas kidney remov nephrectomi remain kidney sub  ject vari dose ioniz radia  tion time area diseas kidney irradi none evid atrophi within rang expect normal size enlarg
666  | cellular prolifer deoxyribonucl acid synthesi compens kidney mice effect food water restrict compensatori enlarg kid  ney occur unilater nephrectomi mice fourteen day remov one kidney surviv renal tissu  weigh  per cent singl kid  ney sham oper anim hyperplast respons cortex second postop day  time greater seen zone kidney sham oper anim  day surgeri mitot index cortex return control valu outer medulla also underw hyperplasia second day follow unilater nephrectomi increas signific increas mitot activ found inner medulla surviv kidney statist signifi  cant starvat  hour water restrict  hour prevent hyper  plastic respons remain kidney  day unilater nephrectomi water given  hour unilater nephrectomi  hour water restrict signific increas mitot activ note cortex remain  ing kidney fourth fifth post  oper day howev even free access food allow  hour without food signific increas mitot frequenc remain kidney found deoxyribonucl acid synthesi con  trol kidney mice highest cor  tex lowest inner medulla reveal radioautograph studi fol  low inject tritiat thymidin two day follow remov one kidney label index cortex remain kidney increas  fold statist signific increas deoxyribonucl acid synthesi note either outer inner medullari region remain kidney
667  | compensatori renal enlarg hypertrophi versus hyperplasia unilater nephrectomi mous compensatori growth remain kidney character increas rna protein synthesi within first hour dna synthesi remain un  chang  hour rise maximum  hour end fifth day dna synthesi pass peak declin cellular hyperplasia account one fourth increas kidney weight thus shown cell hypertrophi primari predomin respons earli phase compen  satori renal enlarg
668  | cell prolifer experiment hydronephrosi compensatori renal hyperplasia mitosi count autoradiograph count nuclei label tritiat thymidin made renal cortex male rat left uret ligat compar correspond count remain kidney left nephrectomi sham  oper control    hour oper cortex kidney obstruct side show greater number tritium  label nuclei mitot figur kidney undergo com  pensatori hyperplasia epitheli interstiti cell respond simul  taneous obstruct side wherea remain kidney nephrectomi epitheli respons preced slight interstiti re  spons  hour contralater kidney rat subject ureter ligat show respons conclud earli respons increas dna synthesi cell divis obstruct kidney mediat humor factor local probabl differ mechan prolif respons occur compensatori renal hyperplasia
669  | renal factor pathogenesi hypertens renal arteriographi modern diagnost procedur provid mean establish close relationship high blood pressur renovascular diseas mani case amen surgic cure present time singl test definit diagnosi renal hypertens care intens studi mandatori select case suitabl surgeri sinc hypertens mani etiolog factor involv mani complex sometim obscur mechan aortographi intraven urographi split funct test among import method definit diagnosi plan appropri surgic procedur oper common observ caus renal arteri con  striction elder atherosclerosi wherea younger patient hyperplasia intim muscular coat renal arteri branch renovascular surgeri may requir varieti technic procedur success case strike perman reduct blood pressur accuraci blood pressur read emphas sinc hypertens usual discov first time cours routin physic examin
670  | cell prolifer compensatori renal growth rat one kidney remov show progress increas weight remain kidney six week period autoradiograph radiochem studi h thymidin indic increas new kidney cell format maxim forty eight seventy two hour unilater nephrectomi earli respons chiefli due product new cell renal cortic tubul normal rate tubul cell turnov achiev two week oper glomerular tuft contain fewer new cell peak product delay one week period slow declin thereaft rat forty eight hour unilater nephrectomi chosen model studi effect various substanc magnitud new cell format number dna synthesis cell stimul kidney reduc treatment hydrocortison acth  dimethyl  benzanthracen  benzanthracen number increas administr deoxycorticosteron aldosteron
671  | effect adrenalectomi parathyroid nephrectom rat rat parathyroid studi nephrectomi com  bine nephrectomi adrenalectomi earli  hour nephrectomi morpholog indic increas para  thyroid activ form increas glandular volum enlarg cell nuclei correspond chang combin nephrectomi adrenalectomi less mark total serum calcium higher nephrectomi observ suggest adren could induc chang calcium homeostasi opposit parathyroid
672  | pathogenesi polycyst kidney microdissect confirm previous de  scription uncommon varieti poly  cystic kidney found newborn period character symmetr enlarg caus saccular cylindri  cal increas size collect tubul number relat length differ generat collect tubul normal nephron present normal number attach collect tubul normal pattern nephron nor  mal except minim local area dilat interstiti connect tissu increas intrahepat bile duct in  variabl cystic sibl may affect believ kidney be  havior ampulla branch ureter bud normal secondari hyperplasia interstiti portion branch respons great in  creas renal size
673  | concurr hyperplasia neoplasia parathyroid gland concurr parathyroid hyperplasia neoplasia group six patient re  port two patient long stand renal diseas azotemia hyperphosphatemia hypercalcemia develop observ found parathyroid adenoma well hyper  plasia gland third patient follow appar similar cours one pa  tient primari hyperparathyroid due larg mediastin adenoma display hyper  plasia gland associ moder  ate renal insuffici two patient pri  mari general parathyroid hyperplasia found superimpos neoplast lesion multipl adenomat nodul one adenocar  cinoma observ add new dimens diagnosi therapi parathyroid disord indic necess examin four parathyroid area time surgeri also emphas hypercalcemia develop patient chronic renal diseas manifesta  tion autonom parathyroid function
674  | experimentell nierenvergroberung nach unilateral nephrektomi bei ratten untersuchungen mit h thymidin paper attempt clarifi certain question mechan compensatori renal hypertrophi mean histolog cytolog autoradiograph examin nephrectomi experi young grown rat base result investig process compensatori renal hypertrophi must imagin follow earli two hour unilater nephrectomi distinct increas mitosi index without simultan increas dna synthes cell observ remain kidney assum cell divis polyploid cell involv prolong premitot rest phase latent period  hour dna synthes cell divid cell start increas maximum regen process reach rd th day nephrectomi twenti day unilater nephrectomi regen process larg conclud tubul section particip compensatori renal hypertrophi although regen process mark central section one cannot speak develop actual indiffer zone regener kidney young test anim compensatori renal hypertrophi determin mitot cell divis older test anim polyploid process result investig provid certain indic assumpt amitot nuclear divis play major part compensatori renal hypertrophi prolifer process extent local run parallel regener parenchyma also observ cell connect tissu renal vessel
675  | abscop effect whole bodi x irradi compensatori hypertrophi rat kidney weight dna content normal grow ie intact hypertrophi ie follow uninephrectomi rat kidney obtain sever hundr sprague dawley white rat effect whole bodi x irradi  rad local irradi kidney  rad determin follow rate degre hypertrophi dna content kidney calcul basi bodi surfac area constant ratio kidney weight kidney dna found normal non  hypertrophi kidney   week old rat  day hypertrophi valu increas approxim  per cent normal rat   week old time nephrectomi anim   week old time nephrectomi correspond increas  per cent follow uninephrectomi x irradi  rad exterior remain kidney  week old rat whose bodi lead shield irradi show bodi weight growth retard signific differ dna content kidney small signific decreas weight increment hypertrophi kidney  day rat expos  rad x ray kidney shield irradi compar nonirradi control show bodi weight growth retard reduct dna content kidney reduct amount kidney hypertrophi  day follow uninephrectomi still greater inhibit kidney compensatori hypertrophi increas dna content kidney occur  rad whole bodi irradi food restrict nonirradi  week old rat result bodi weight growth retard elicit mark reduct kidney weight dna content hypertrophi kidney  day uninephrectomi conclud reduct kidney hypertrophi follow whole bodi x irradi  rad due measur abscop indirect effect secondari decreas bodi weight
676  | radiat effect renal enlarg mous three hour follow unilater nephrectomi weanl femal cf  mice subject local abdomin total bodi exposur either   r group given  r half abdomen without prior nephrectomi signifi  cant decreas renal weight gain compar control obtain  r total bodi group local irradi ani  mal given  r renal weight chang compar basi ratio renal weight bodi weight per cent increas   seen anim subject nephrectomi alon final valu irradi nephrectom group similar rang   result suggest irradi dose rang exert direct inhibitori effect renal weight increas limit bodi weight gain influenc kidney weight
677  | renal hyperplasia neoplasia rat given dimethylnitrosamin multipl foci hyperplasia neoplasia induc kidney rat dose oral dimethylnitrosamin younger rat male sex greater incid renal tumor hyperplast neoplast lesion classifi two group basi histogenesi name tubular epitheli origin interstiti cell origin dimethylnitrosamin recommend use chemic compound studi renal carcinogenesi
678  | role age x irradi kidney function mous femal mous kidney show declin respect age abil concentr urin  hour water fast x irradi earli life measur long term effect process kidney cortex slice old femal mice concentr p aminohippur acid concentr gradient equal well slice young mice loss abil cortex slice young old femal x irradi mice uncertain whether compensatori renal hypertrophi unilater nephrectomi declin age nonirradi mice x irradi caus reduct degre compensatori renal hypertrophi age mous reduct may repres loss abil kidney cell undergo cell divis administr testosteron propion old mice compen  satori renal hypertrophi result increas hypertrophi increas relat irradi nonirradi mice indic lack long term effect x irradi reduc abil target organ respond hormon over al conclus studi respect radiation induc age x irradi femal swiss mous earli life pronounc effect kidney function late life may long  term effect process concern cell divis
679  | hyperaldosteron hyperplasia juxtaglomerular complex normal blood pressur dwarfism report case patient syndrom hyperal  dosteron hyperplasia juxtaglo  merular complex dwarfism normal blood pressur report detail patient aldosteron secret rate in  creas signific serum potas  sium rose slight sodium depriva  tion low sodium diet urinari sodi  um fell zero spironolacton low  sodium diet rais serum potassium nor  mal infus albumin howev resul  ted rapid increas serum potassium fall aldosteron secret rate uniqu featur patient re  spons albumin lower uri  nari sodium zero respons low  sodium intak essenti case resembl two previous report case treatment subtot adrenalecto  curat
680  | juxtaglomerular cell kidney zona glomerulosa adren cortex sodium lose hypertens form viril adren hyperplasia patholog biochem observ present two case viril ad  renal hyperplasia one sodium los type hypertens type examin kidney reveal hyper  trophi juxtaglomerular cell case exhibit excess sodium loss adren cortex show hypertrophi zona glomerulosa hypothes chronic state sodium loss caus chang intravascular compart led compensatori activ juxtaglomerular cell result stimula  tion zona glomerulosa examin hypertens case known involv differ enzym defi  cit show hypertrophi zona glom  erulosa without hypertrophi juxta  glomerular cell intrins overproduc  tion sodium retain steroid associ genet defect clinic form could account hypertens absenc hypertrophi juxta  glomerular apparatus
681  | studi eperythrozoon infect sheep intraven inocul blood sheep parasi  taemic stage eperythrozoon infect produc detect parasitaemia recipi sheep within  day parasitaemia last   week accompani anaemia occasion icterus symptom develop control experi hogg signific differ weight gain infect control anim concurr attack tick born fever led disappear eperythrozoon circul blood suggest phenomenon may caus pyrexia incub period follow inocul infect blood ten   week old lamb vari   week eight anim symptom less sever adult sheep two smallest lamb develop profound anaemia fail gain weight cultur organ sheep blood agar sheep kidney monolay unsuccess attempt transmiss infect mice transfer ked lice infect uninfect sheep fail transmit infect sheep infect intraven inocul ground up lice infect anim characterist histopatholog chang infect sheep lymphoid hyperplasia malphigian corpuscl spleen deposit haemosiderin cell proxim convolut tubul kidney cortex
682  | age differ cellular prolifer rat kidney hyperplast respons unilater ne  phrectomi  hour cortex medulla remain kidney weanl young adult rat studi mean autoradiographi tritiated thymidin destin exclus nucleoprotein synthe  sis administ  control  ex  periment rat  hour prior sacrific label tubular cell rare control tissu especi medulla per  centag differ great two age group cortex control cell three time frequent weanl rat adult signific increas per  centag label cell control level found region remain kidney age group percentag increas greater medulla cortex pronounc medulla young adult rat
683  | phospholipid sexual segment kidney indian hous lizard hemidactylus flaviviridi ruppel indian hous lizard hemidactylus flaviviridi breed seas  onal sexual matur male lizard octob may follow year secondari tertiari collect tubul kidney hypertrophi form sexual seg  ment develop sexual segment synchron testicular cycl maximum develop occur period test spermatogen activ sex  ual segment develop femal season year complet regress male sexual quiescenc june juli inject  mg testosteron propion two week stimul regress sexual segment hyper  trophi male quiescenc also femal apic portion cell sexual segment load granular secret stain baker acid hae  matein phosphomolybd acid stann chlorid indic presenc cholin   contain phospholipid composi  tion phospholipid sexual segment uniqu featur lizard snake unknown preliminari communic describ isol quantit estim phospholipid present sexual segment indian hous lizard hemidactylus flaviviridi ruppel
684  | erythropoiet effect differ tissu suspens stimul effect erythropoiesi regener liver hyper  trophic kidney tissu partial hepatectomi unilater nephrectomi respect studi rat mean erythrocyt count haemo  globin determin reticulocyt count fe util reticulocyt count fe util increas signific treatment normal liver renal tissu strong regener liver hypertroph kidney tissu effect seen treatment sera rat undergon partial hepatectomi unilater nephrectomi
685  | hemihypertrophi medullari spong kidney congenit hemihypertrophi over  growth one side bodi associ asymmetri beyond ex  pect rang distinguish hemiatrophi atrophi wither one half bodi occur usual be  caus neurolog lesion condit hemihypertrophi though rare frequent associ congenit abnorm includ sever urogenit tract hypospadia cryptorchid unilater renal hypertrophi increas incid wilm tumour
686  | chemic aspect compensatori renal hypertrophi effect unilater nephrectomi size composit remain kidney investig rat normal rat right kidney averag signific heavier left higher total content dna rna  kidney almost ident ratio rnadna proteindna unilater nephrectomi surviv kidney increas steadili wet dri weight st  day oper accompani much slower increas total dna content dramat increas rnadna ratio rnadna ratio kidney also affect diet higher high protein low protein intak moreov rise rnadna ratio follow unilater nephrectomi greater anim fed high protein diet chang kidney weight total content dna rna protein lipid phosphorus result feed high protein diet found approxim magnitud remain kidney  day unilater nephrectomi rnadna proteindna ratio also greater rat fed diet contain  urea increas much less remain kidney unilater nephrectomi
687  | antidiuret mechan hydrochlorothia  zide treatment diabet insipidus chang water electro  lyte balanc hydrochlorothiazid therapi  patient vasopressin  defici diabet insipidus studi  ed  case fix daili so  dium intak urinari sodium excre  tion mark increas first day treatment urinari volum began fall second day per  sist low  day discontinua  tion drug case urinari volum mark decreas daili sodium intak strict  ly limit decreas hydrochlorothiazid therapi sodium intak restor return pretreat level despit con  tinu use drug antidiuret action hydro  chlorothiazid treatment dia  bete insipidus believ relat sodium deplet state bodi brought increas output decreas intak sodium sodium water reabsorpt proxim convolut tubul kidney in  creas amount glomerular filtrat reach distal convolut tubul decreas thus final urinari volum fall
688  | action oral diuret diabet insipidus chronic administr chlorothiazid thiazid analogu diabet insipidus result strike reduct urinari volum increas urinari osmol curious antidiuret action first describ crawford  kennedi  though sinc wide confirm pituitari nephrogen form diseas precis mechan remain obscur number investig sought explain phenom  enon entir basi renal action drug earley  orloff  goodman  carter  whilst other contend abat polyuria may secondari central effect thiazid decreas thirst robson  lambi  skadhaug  past two year conduct detail in pati studi action various diuret drug thiazid seri group  patient pituitari diabet insipidus
689  | investig thiazide induc antidiuresi patient diabet insipidus plasma sodium osmol serum chlorid togeth creatinin clear  anc studi thiazid treatment  patient diabet insipidus diuresi reduc   urin osmol increas   averag decreas plasma sodium  meqi plasma osmol  mosmkg serum chlorid  meqi observ one pa  tient creatinin clearanc re  duce signific thirst feel reduc even first day treat  ment diuresi minim third fourth day diuresi correct extra electrolyt ex  cretion initi thiazid antidiuresi found oper full extent even first day treatment conclud antidiuresi main secondari natriuresi certain degre due decreas thirst  feel seem also direct renal action involv least reduc  tion glomerular filtrat rate pronounc antidiuresi found water depriv test thiazid treatment one patient
690  | salt water antidiuret effect thiazid thus result induc sodium deficit fall serum osmol may contributori reduc thirst deplet bodi sodium self limit major hazard use thiazid potassium deplet treatment patient vasopressin insuffici type diabet insipidus thiazid indic intoler hormon replace  ment nephrogen diabet insipidus thiazid import therapeut applic
691  | nephrogen diabet insipidus chlorothiazid found valu establish maintain adequ hydra  tion patient exact mechan action known antidiuret effect chlorothiazid analogu studi six patient ndi two infant less six month age dehydr infant show dramat respons treatment unabl achiev optim fluid intak prior treat  ment initi benefici respons asso  ciat increas fluid intak follow  ing initi antidiuret respons vari  abl degre escap resist action drug common occur de  spite unpredict prolong anti  diuret respons therapeut trial chloro  thiazid ndi seem warrant diet alon suffici maintain hydrat must rememb howev drug po  tential toxic
692  | fluid electrolyt metabol nephrogen diabet insipidus bodi fluid volum fol  low two infant nephrogen diabet insipidus without treatment patient low extracellular fluid volum ecv normal low  normal total bodi water tbw follow thiazid therapi case  fluid depriv test case  reduct ecv tbw found untreat patient reveal se  vere hypernatriemia without increas urinari aldosteron excret first patient cerebr atro  phi rightsid hydronephrosi higher diuresi lower concentr capac found side patient treat continu thiazid ordinari hous diet given drug could maintain normal electrolytemia combin spirolacton consider increas height psychic develop took place combin treatment note nephrogen diabet insipidus may present infant unexplain fever vomit absenc polydipsia polyuria urin may even hyperton
693  | diuret pediatr practic clinic note comment develop potent oral diuret recent year drug look upon limit use pediatr receiv clinic applic per  mit new approach manag edemat state given oral signific advantag par  ticular coupl relat lack toxic although number patient pediatr age rang requir agent relat small valuabl adjunct manag chronic renal diseas refractori heart failur hyper  tension discuss review pharma  colog clinic indic
694  | role aldosteron vasopressin postur chang renal excret normal subject patient idiopath edema effect upright postur leisur walk  hour half  hour urin volum excret sodium creatinin studi  normal subject  patient idiopath edema drank   ml  per cent sodium chlorid solut everi half hour  hour walk compar preced recumb period  hour group found show signific antidiuresi upright administr ethanol last half hour recumb abolish fall urin flow free water clear  anc first hour walk normal subject signific re  duce fall patient edema sodium excret normal subject slight signific lower upright recum  bent edemat patient signific lower upright fell progress  hour period ad  ministr spironolacton d  amphetamin increas sodium excret recumb group increas sodium excret upright edemat patient equal normal subject creatinin excre  tion chang either group postur drug therapi similar studi perform  patient un  treat diabet insipidus  pa  tient adren insuffici treat hydrocortison alon lack al  dosteron adren insuffici increas amount sodium ex  crete normal subject recumb prevent oc  currenc signific sodium retent upright postur howev lack adh diabet insipidus delay antidiuresi upright  minut result indic adh releas probabl respons reduct urin volum first  min  ute assum upright postur thereaft excess magni  tude orthostat antidiuresi idiopath edema probabl result caus adh releas sinc complet overcom ethanol reduc na excret  hour upright postur occur absenc circul aldosteron abnorm magnitud na re  tention patient idiopath edema probabl result hyperal  dosteron
695  | use mode action ethacryn acid nephrogen diabet insipidus use diuret agent treatment nephrogen diabet insipidus re  port result decreas urin volum decreas clearanc free water studi use ethacryn acid potent saluret agent institut patient nephrogen diabet insipidus attempt achiev signific antidiuret respons allow liber sodium diet intraven ethacryn acid result de  creas urin volum decreas clearanc free water decreas rpf gfr prolong oral administr ethacryn acid promot signific antidiuret re  spons daili sodium intak limit  meq effect ethacryn acid renal function potassium chlo  ride excret uric acid metabol discuss
696  | treatment pituitari respons diabet insipidus evalu therapi diabet insipidus import note alter ten per cent reabsorpt function kidney kidney function case diabet insipidus effici activ biolog test purpos therapi patient conveni economi normal function societi diabet insipidus alter life span howev secondari factor may introduc health problem lysyl  vasopressin nasal spray effect offer maximum conve  nienc produc untoward reaction expect ineffect treatment extrapituitari pituitari unrespons diabet insipidus
697  | antidiuret effect hydrochlorothiazid diabet insipidus chiuan lu  case diabet insipidus studi hydrochlorothia  zide therapi fix diet symptom blood pressur urinari volum blood urinari electrolyt plasma volum electrocardiogram hyperton salin intraven drip test compar treat  ment daili dose   mg brought urinari volum  pretreat valu initi antidiuret effect note  hour medic maxim effect fourth fifth day owe kaluret action drug   gm potassium salt also given day satisfactori re  sult obtain dietari sodium ion  meq daili ingest excess tabl salt fre  quentli diminish even destroy therapeut effect physic sign blood pres  sure ecg essenti un  chang plasma volum alter treatment hyper  tonic salin test improv patient low salt syndrom fre  quentli encount therapi continu  month even secondari failur could pre  vent time use intermitt altern regimen therapeut mechan indic side effect drug briefli discuss drug might possibl act mechan salt deplet contract extracel  lular fluid volum decreas renal glomerular filtrat consequ urinari volum decreas thirst allevi
698  | effect hydrochlorothiazid water intak plasma osmol diabet insipidus rat fall plasma osmol accompani reduct urin volum rat hypothalam diabet insipidus given hydrochlorothiazid otherwis normal diet plasma concentr reduc high sodium intak although urin volum still fell normal rat hypo  thalam obes rat increas water turnov hydrochlorothiazid yet plasma concentr fell moreov antidiuret respons vasopressin pure renal also accompani plasma dilut although self evid rat drink less less thirsti reduct thirst hydrochlorothiazid may direct result chang plasma osmol previous shown patient kennedi hill  high sodium intak increas free water clearanc diabet insipidus interfer reduct polyuria hydrochlorothiazid wherea high potassium intak reduc free water clearanc prevent effect drug urin volum
699  | antidiuret properti chlorothiazid diabet insipidus dog chlorothiazid found decreas urin volum increas urin con  centrat diabet insipidus dog chang gfr rpf tmpah plasma volum extracellular fluid total bodi water one con  sistent alter function decreas free water clearanc diazoxid mercuhydrin antidiuret believ antidiuret action depend chlorothiazide induc saluresi although mechan antidiuresi clear de  fine seem best explain postu  late decreas filtrat reach distal nephron give decreas final urin volum coupl inhibit solut reabsorpt distal tubul prevent select reabsorpt solut distal tubul nor  malli seen account increas urin concentr possibl role mineralocorticoid antidiuret respons chlorothiazid therapi investig diabet in  sipidus adrenalectom dog ad  ministr sodium retain steroid diabet insipidus dog re  produc urinari chang associ chlorothiazid therapi addit antidiuret respons chlorothia  zide alter adrenalectomi spironolacton administr there  fore presenc sodium retain  ing steroid essenti anti  diuret respons chlorothiazid diabet insipidus
700  | stabl strontium human bone geograph age differ unit kingdom correl level strontium  re assess made publish data worker sr sr human bone differ part great britain mean ratio stabl sr ca adult human bone rang  ugg extrem valu found even close  mile apart carlisl v westmorland perinat level stabl sr correl adult level estim placent discrimin may deriv ratio perinat level adult level  concentr stabl sr bone children   year old demonstr differ adult except one area carlisl strike except london south east england chang perinat adult level occur nd year life particular chang first  month london south east england pattern chang age quit differ progress rise sr level short birth end st year time adult level reach conclud geograph differ need taken account make physiolog deduct turnov bone salt chang age level stabl sr children south east england rest unit kingdom compar seem broad invers correl level stabl sr sr detail analysi perinat result one area suggest level stabl sr bone somewhat higher summer winter somewhat higher anatom normal babi babi die gross congenit defect sr show season chang
701  | fibrin thrombosi central nervous system children particular refer congenit hydrocephalus rare metabol degen diseas central nervous system children report great length much common diseas relat vascular incid rare discuss aspect diseas central nervous system relat thrombosi deposit fibrin discuss diseas relat general vascul aneurysm omit condit discuss fall two main categori first presenc thrombosi small blood vessel larg superfici vein drain brain second deposit fibrin either ventricl membran over brain associ thrombot lesion haemorrhag infiltr
702  | hydrocephalus due unrecogn cerebellar astrocytoma treat ventriculoatri shunt four year case  year old girl present prolong palliat sign increas intracrani pressur presum due aqueduct obstruct achiev mean ventriculoatri shunt four year placement shunt sign cerebellar mass becam appar neoplasm cystic astrocytoma subsequ total resect shunt remov air studi demonstr diminut ventricular size within four year period compar
703  | hydrocephalus problem hydrocephalus former hopeless one recent year begun yield clinic research indic new form treatment drawback clear delin discuss lead author field
704  | case unilater hydrocephalus secondari occlus one foramen monro uniqu case unilater obstruct hydro  cephalus secondari occlus one foramen monro gliomatosi  day old infant report
705  | calcif within congenit aneurysm vein galen thirty on case aneurysm vein galen report previ  ousli calcif within wall aneurysm visibl plain skull roent  genogram  number present communic describ addit case calcif aneurysm discov age  year youngest patient heretofor report
706  | ventriculo ven shunt infantil hydrocephalus review  hydrocephal patient treat atrioventricular shunt  year period present discuss function shunt complica  tion procedur revis neces  sitat nonfunct overal  per cent surviv rate  per cent in  fection rate compar seri major caus death pa  tient infect experi date support ob  servat spontan arrest hy  drocephal process occur ventriculo ven shunt estab  lish meticul introduct ventriculo  venous shunt appear present treat  ment choic patient sever hy  drocephalus result satisfactori patient care follow complic recogn treat prompt
707  | congenit malform cns seem small proport malform central nervous system explain simpl genet term depend extent least environment factor natur yet determin dr williamson found matern aunt uncl cousin index case anencephalus spina bifida frequent affect patern relat suggest mother affect children genet factor modifi intra  uterin environ thus predispos embryo malform hypothesi open interest possibl accept one would satisfi higher incid matern relat mere due fact histori obtain case mother
708  | experiment studi cerebrospin fluid flow mix suspens kaolin lyco  podium inject cisterna magna dog blockad csf space produc success   dog   ventricular dilat interme  diat degre observ hydrocephal dog experiment shunt perform either later ventricl lumbar cistern be  tween unilater later ventricl contralater cerebr subarachnoid space uni  direct steadi csf flow averag  ml per hour case former shunt flow averag  ml per hour case latter shunt csf flow rate ventricl toward cerebr subarachnoid space larger intraventricular pressur higher in  creas flow rate parallel increas pres  sure probabl result increas csf absorpt seem upper limit flow rate pressur rais transient reflux csf flow induc jugular abdomin compress follow intraven administr hy  perton solut csf flow rate decreas parallel fall csf pressur re  gain origin valu pressur recov pressur fell low  mm water flow almost stop
709  | dandy walk syndrom dandy walk syndrom specif morbid entiti fourth ventricl grossli dilat congenit malform cerebellar vermi near alway associ atresia foramen magendi mani case atresia foramina luschka also later third ventricl usual dilat figur  illustr specimen condit case present infanc other discov childhood adult life oldest patient record anomali age  year first recogn case publish dandi blackfen  best earli descript condit taggart walker  conclud cerebellar lesion consequ upon atresia foramen magendi  benda propos term dandy walk syndrom
710  | probabl epidem congenit hydrocephalus   peak incid congenit hydrocephalus   describ reason given believ genuin phenomenon though late find caus epidem malform detect prompt incid malform defin popul studi continu epidem popul studi must larg inde
711  | function craniolog aid interpret roentgenogram skull analysi form skull facilit consid compos number function compon roentgenologist purpos divis facial somat skeleton neu  ral skeleton valuabl recognit three function separ portion within calvari bone inner tabl diplo outer tabl base skull por  tion preform cartilag ac  count unusu appear skull achondroplasia addit base appar close relat facial general somat growth neural growth calvari bone form direct membran within cerebr capsul consequ size shape cal  varia direct reflect form grow  ing neural mass inner tabl calvaria age intim relat dura mater direct reflect form dura mater consequ inner tabl re  flect form arachnoid mater usual brain well outer tabl calvaria serv protect brain also anchor mani intrins extrins muscl skull form particular thick skul mammal pig determin demand muscl scalp form brain princip function diplo form lightweight yet rigid separ two osseous tabl addit serv site hematopoiesi reason may tend specif volum given age calvari sutur oppos separa  tion bone calvaria al  low relat motion calvari bone passiv car  rie apart expand cerebr cap  sule growth neural mass area increas deposit bone sutur margin sutur howev function epiphys innat growth potenti remov sutur disturb final skull form calvaria repres ossi  ficat cerebr capsul small neural mass small de  formiti skull secondari chang occur air sinus diplo explain term function cranial compon op  posit chang occur neural mass abnorm larg correl skull size intellig fair presenc brain distinct abnorm size howev may infer plain roentgeno  gram skull prematur closur cranial su  ture may due abnorm form cranial base possibl primi  tive chondrocranium preced abnorm mediat dural fiber tract underli major cal  varial sutur
712  | hydrocephalus chang format absorpt cerebrospin fluid within cerebr ventricl format flow absorpt cerebrospin fluid measur normal progress hydrocephal dog steady st studi ventricular per  fusion format cerebrospin fluid found constant independ hydrostat pressur unaffect develop hydrocephalus normal dog produc  ml cerebrospin fluid min later ventricl  ml cere  brospin fluidmin th ventricl  ml cerebrospin fluidmin sub  arachnoid space intraventricular forma  tion fluid calcul  ml cerebrospin fluidmingm choroid plexus x  ml cerebrospin fluid mincm ependym surfac absorpt cerebrospin fluid found take place within ventricl well subarachnoid space re  sistanc absorpt cerebrospin fluid normal ventricl much higher hydrocephal ventricl decreas resist occur ventricular volum increas ependyma becam flatten chronic hydrocephalus resist signific differ normal dog theori re  strict diffus appli data calcul diffus permeabl crea  tinin urea mean pore radius within ventricl use format cerebrospin fluid data absorpt hydrocephal anim could distinguish normal suffici accuraci suggest use clinic test reason intraventricular pressur alway consid constant fact chang constant problem ventricular enlarg concern abil craniospin content adjust absorb small rapid chang intracrani content occur beat puls
713  | dural sinus pressur normal hydrocephal dog simultan measur cerebro  spinal fluid pressur csfp venous pressur anterior ssvp poste  rior sagitt sinus tvp demonstr normal dog mean pressur relat follow csfpssvptvp statist relationship pres  sure shown poor correl ssvp tvp chang csfp hand hydrocephal dog ssvp rise meet csfp relat fluid pressur  fashion could ex  pect caus non vent acut chang csfp decreas fluid ab  sorption postul mechan ssvp elev partial occlus sinus
714  | intraventricular papilloma case intraventricular papilloma left later ventricl report craniotomi perform remov tumor ac  complish without incid literatur review unusu although perhap relat unim  portant observ report case four five day postop patient  month old femal kept head tilt right time left hospit hold erect unsupport sustain weight satisfactorili feet
715  | five year compar studi hydrocephalus children without oper  case basi  year studi  hy  drocephal children  oper  ate earli ventriculo atri shunt  oper hav  ing studi period similar manner determin mortal morbid intellig relat factor follow  ing conclus justifi program shunt opera  tion done appar give signific advantag children program shunt oper done base life t data project birth  year surviv  per cent compar  per cent number compet children iq  better  per cent vs  per cent number noncompetit children iq   per cent vs  per cent major caus death morbid  iti group infect oper group morbid associ shunt procedur relat obstruct shunt septicemia earli occlus show correl abnorm inflammatori type spinal fluid shunt blood stream late obstruct associ mechan breakag shunt factor growth caus retract cardiac end atrium prompt re establish function shunt possibl instanc period follow  examin irrespect symptom prove invalu earli recognit malfunct shunt septicemia usual requir remov shunt program period evalua  tion includ bubbl ventriculogram studi clearanc risa psycho  logic test correl show intellectu abil seem associ width cerebr mantl width cerebr mantl hydrocepha  lus decreas ventricular pressur  increas pres  sure less prolong shunt cerebrospin fluid give dramat increas width cerebr mantl appar irrespect basic etiolog hydrocephalus intellectu capac could cor  relat basic etiolog hydrocephalus correl in  vers durat increas in  tracrani pressur mani etiolog hydrocephalus requir larg number patient group thorough evalu factor favor studi carri medic center appropri disciplin studi depth prevent ultim goal oper group  patient compens hydrocephal process singl patient demonstr arrest recoveri basic hydrocephalus pro  duce process spite numer attempt demonstr might impli necess life long shunt cerebro  spinal fluid case
716  | hydrocephalus present day definit hydrocephalus loos author would rather adopt concept hydrocephalus abnorm condit character excess amount cerebrospi  nal fluid without enlarge  ment head common caus hydrocephalus arachnoid fol  low congenit anomali neoplasm rare caus ideal surgic procedur placement ventriculo  atrial shunt use either pudenz halter valv valv cannot avail choic conserv wait medic support ventricular tap older surgic shunt procedur like ventriculo periton choroidoplex  ectomi thecal fimbia subarach  noid ureter other
717  | recognit treatment hydrocephalus follow spontan subarachnoid hemorrhag eight adult patient hydrocephalus secondari spontan subarachnoid hem  orrhag present discus  sion diagnosi treatment number possibl mechan develop ventricular dilat condit advanc patholog data present  case
718  | congenit malform clinic communiti consider two signific medic event centuri epidem post rubella anomali australia   pan  demic thalidomid embryopathi europ elsewher   demonstr clear import monitor program record occurr congenit malform group exampl hospit communiti especi citi level principl report  ing malform util data servic program better still prevent new method use vital statist scientif construct surveil  lanc system new also joint endeavor part clinician public health worker basic scien  tist reconstruct epidemiolog deform basi time place person distribut malform primari need stand  ardiz method classifi report congenit malform
719  | famili histori spina bifida cystica famili histori  infant born spina bifida cystica studi index case refer sur  gical treatment select way genet point view intens inquiri made ob  tain complet famili pedigre includ prospect follow up sibl born index case  sibl   gross malform central nervous system spina bifida cystica  anencephali  uncompl hydrocephalus   children born index case     affect progress increas multipl case famili increas famili size sibship five mul  tipl case occur   famili case gross malfor  mation central nervous system known occur among member famili sibl case oc  cur three generat possibl spina bifida cystica might recess inherit condit
720  | pulmonari vascular chang complic ventriculovascular shunt hydrocephalus patient describ pulmonari hypertens cor pulmonal note  year placement ventriculovascular shunt apparatus treatment hypdrocephalus addit histolog section lung tissu obtain  patient hy  drocephalus die various interv follow placement ventriculovascular shunt apparatus review regard vas  cular alter high incid old multipl pulmonari vascular lesion found group compar incid control subject differ attribut oper procedur lesion postmortem materi widespread suggest diagnosi pulmonari hypertens pure histolog ground
721  | etiolog trypan blue induc antenat hydrocephalus albino rat wistar strain albino rat inject  cm  solut trypan blue three type dye use matheson coleman bell chroma gesellschaft high purifi sampl dye inject day    gestat fetus excis day   fix decalcifi necessari embed paraffin serial section stain newborn young treat similar chroma gesellschaft trypan blue without reproduct teratogen effect dose increas dose increas teratogen yield decreas litter size matheson coleman bell trypan blue purifi sampl teratogen frequent neural defect observ hydrocephalus serial section newborn hydrocephal show occlud extrem tenot aqueduct sylvius   section anim fetus collect day   also occlud stenot aqueduct hydrocephal aqueduct stenosi occlus present  day old fetus hydrocephalus conclus demonstr age sixteen day old fetus aqueduct occlus examin stenosi evid conclud defect predispos hydrocephalus young trypan blue treat rat strain aqueduct stenosi occlus
722  | bilater papilloma choroid plexus rare case bilater papilloma choroid plexus five and a half year old hydrocephal girl pre  sent tumor encount autopsi suspect life exist hydrocephalus attribut either cytomegal inclus diseas toxoplasmosi post mortem examin evid hydrocephalus due two factor hypersecret tumor obstruct level sylvian aqueduct delic tens transluc mem  brane interest uncommon addit featur case presenc within choroid papillo  well form haversian bone plea made regular consid papilloma choroid plexus differenti diagnosi hydro  cephalus children earli diagnosi treat  ment might conceiv result total cure
723  | diagnosi hydrocephalus earli diagnosi hydrocephalus imper definit step correct effect transillumin fair accur procedur may offer earliest mean determin whether infant head enlarg howev serial head measur constitut easiest accur method earli detect hydrocephalus chart normal head size full term prematur infant avail aid physician evalu deviat normal condit detect neurosurgeon determin treatment plan oper procedur wide use shunt excess cerebrospin fluid insert spitz holt valv earli detect improv treatment method help prevent irrevers intellectu damag like develop hydrocephalus continu uncheck
724  | infantil hydrocephalus hematoma posterior fossa present case hydrocephalus infant basic caus intracrani hemorrhag perinat period surgic re  moval hematoma posterior fossa give perman relief rais intracrani pressur lumbar air studi stage dis  close inform passag intracerebr cerebrospinal fluid pathway normal wherea extracerebr one still occlud arachnoid condit necessit ventriculo atri shunt
725  | urinari excret i diodrast inject intraventricular communic hydrocephalus aqueduct stenosi nine case expans infantil hydro  cephalus investig inject small amount i diodrast intra  ventricular urinari excret tracer determin first   hour inject cumul excret diodrast csf dif  fer case communic hydro  cephalus stenosi aqueduct investig rapid easili perform produc side effect
726  | gastrointestin ulcer central nervous system lesion real appar in  creas incid sever gastroin  testin ulcer due central nervous lesion increas incid reflect recent devis iatrogen measur includ new drug surgic therapi adult cerebrovascular lesion commonest singl caus acut peptic ul  cerat found autopsi children found  instanc upper gastrointestin ulcer due central nervous system le  sion  autopsi two general ana  tomic categori could recogn acut ulcer malacia varieti causat central nervous sys  tem lesion respons  case commonest bacteri mening caus poliomyel brain tu  mor hydrocephalus etc theori pathogenesi present experi drug surgic therapi need recent develop local freez techniqu offer promis reduct mortal
727  | mansonia crassip natur vector filarioid plasmodium gallinaceum plasmodia fowl ceylon would appear observ crassip natur vector p gallinaceum fowl ceylon possibl speci plasmodium fowl relat avian host one plasmodia crassip fact p lophura first record p lophura part world howev certain whether fowl natur vertebr host p lophura ceylon seen crithidi form midgut engorg wild caught crassip mosquito may therefor prove vector trypanosom well trypanosom differ trypanosoma gallinarum calmettei previous report fowl
728  | filariasi portugues timor observ new microfilaria found man result describ investig filariasi portugues timor two type microfilaria found blood film one wuchereria bancrofti refer timor microfilaria probabl new speci blood survey show w bancrofti timor microfilaria wide distribut territori infect rate usual low clinic lesion mild elephantiasi confin oedema lower limb knee timor microfilaria resembl brugia malayi general stain reaction appear possess two nuclei termin thread differ over al length cephalic spac ratio failur sheath stain giemsa nocturn period rapid remov peripher blood treatment diethylcarbamazin citrat daili dose   mgm per kgm bodi weight   mgm per kgm bodi weight seven day damag fragment adult femal worm recov timor microfilaria found cat dog monkey vector filariasi timor still unknown
729  | dipetalonema obtusa mccoy comb n filarioidea onchocercida colombian primat descript adult microfilaria obtusa mccoy  identifi blood    cebus capucinus c albifron northern colombia found addit  c apella  saimiri sciurea area colombia adult male femal recov peri  esophag connect tissu infect anim describ detail dipetalonema obtusa mc  coy  comb n resembl tetrapetalonema marmoseta faust  smaller right spicul complex simpl
730  | experiment onchocerc ocular lesion chimpanze first attempt produc onchocerc eye lesion microfilaria volvulus chimpanze live microfilaria anterior chamber eye could penetr an  gle anterior chamber iri ciliari bodi choroid vitreous microfilaria inject aliv anterior chamber eye chimpanze die within short time com  parison therefor could made be  tween effect live dead micro  filaria microfilaria debri demonstr within giant cell first time subconjunctiv limbal infiltr incipi pannus inflamm within trabecular meshwork angl anterior chamber extens activ iri  docycl demonstr histolog section although condit clini  calli quiescent posterior segment lesion oncho  cercal chorioretin degener could reproduc subcutan intraven injec  tion worm extract deriv human onchocercoma may contribut onset activ choroid sensit alon without intraocular inject microfilaria effect eye various aspect pathogenesi human onchocerciasi discuss basi present experiment
731  | occur dirofilaria magnilarvatum price brugia sp philippin monkey  macaca philippinensi examin three found infect dirofilaria magnilarvatum price  one infect also speci brugla speci show sub period type microfilari period observ suggest philippin macaqu may serv reservoir sub period b malayi palawan high rate infect found peopl live small villag forest mansonia bonnea found natur infect third stage larva magnilarvatum sug  gest monkey may serv reservoir sub  period b malayi island palawan high rate infect speci observ peopl live small villag forest
732  | filari parasit eastern gorilla congo survey parasit undertaken  mountain gorilla gorilla gorilla beringei eastern congo kivu provinc six full grown two male four femal three adolesc one male two femal eleven young gorilla examin sever consecut month nine autopsi perform protozoa discov blood plasmodium parasit common gorilla chimpanze west africa never found eastern congo primat includ ten gorilla examin previous fifti chimpanze sever diarrhoea balantidiasi pictur develop two young gorilla autopsi reveal howev intens infect oesophagostomum stephanostomum result fatti degenera  tion liver oligotrichida belong genus troglodytella common found intestin tract oesophagostomum stephanostomum egg consist present stool gorilla autoinfect caus death sever young gorilla   week captur mani microfilaria found blood skin pre  liminari communic publish mention exist four differ microfilaria blood gorilla three other dermal layer skin detail studi seven speci identifi describ dipetalonema leopoldi gorilla vanhoofi streptocercum microfilaria binucleata loa loa gorilla nsubsp onchocerca volvulus three worm describ far discov gorilla gorilla name dipetalonema leopoldi gorilla loa loa gorilla two previous known chimpanze name vanhoofi microfilaria binucleata one speci strepto  cercum first discov man later describ chimpan  zee also known gorilla gorilla onchocerca volvulus found one  gorilla examin gorilla gorilla beringei eastern congo might becom close contact man filari vector abnorm accident host streptocercum onchocerca volvulus els might consid origin reservoir filari parasit man
733  | pilot project control filariasi thailand villag kanjanadit district surat thani provinc south thailand field station filariasi studi establish bangkok school tropic medicin blood film examin  person  per cent total popul  two thick film  cmm prepar person stain giemsa found  per cent peopl harbour microfilaria brugia malayi elephantiasi found  per cent popul microfilari period studi  person everi case found mark nocturn blood  cat  dog two monkey also examin b malayi larva recov mosquito caught identifi initi survey  mosquito examin  mansonia spp  dissect b malayi larva stage ii found one uniformi stage iii anoth infect rate uniformi  per cent spray ddt carri hous last phase investig result slight declin number percentag mansonia mosquito caught diethylcarbamazin administ mani villag possibl dose  mgm citrat salt per kgm bodi weight week six week eight hundr eighty eight person receiv drug  per cent popul consider side effect observ near microfilaria carri blood examin repeat one month one year cessat drug found proport microfilaria carri decreas  per cent   per cent respect filariasi infect rate  per cent   per cent mean microfilari densiti film  per  cmm blood   larva b malayi found mosquito dissect one month one year mass therapi
734  | studi loiasi monkey iv  experiment hybrid human simian strain loa cameroon rain forest exist two strain loa appar evolv host vector complex duke wijer  natur simian parasit found abund drill mandrillus leucophaeus character larg somat size adult worm microfilaria nocturn microfilaria period transmit among monkey popul crepuscular canopy dwel chrysop langi c centurioni natur human parasit diurnal period microfilaria transmit day bit anthropophil c silacea c dimidiata bomb form also transmit experiment drill host parasit small somat size maintain diurnal period two strain contrast period maintain drill decid tri cross mat produc hybrid present paper describ method done record characterist hybrid parasit suggest interbreed two strain segreg accord simpl mendelian pattern regard period somat size
735  | develop dirofilaria immiti anophel quadri  maculatus exposur microfilaria freez temperatur blood sampl contain dirofilaria immiti microfilaria store frozen period rang  hr  month thaw  c fed animal deriv bandrod membran laboratory rear anophel quadrimaculatus microfilaria capabl develop third infect larval stage migrat head labium mosquito
736  | advanc filariasi especi concern period microfilaria review given advanc knowledg filariasi past ten year urg investig continu method facilit control filariasi larg popul mean diethylcarbamazine  eg incorpor compound cook salt done chloroquin malaria furthermor step taken protect young peopl filariasi systemat treatment school order understand cyclic disappear microfilaria peripher blood accumul lung movement microfilaria pulmonari capillari studi cinematographi appar accumul lung due mechan retent perhap migrat round round pre capillari network arteriol period microfilaria best consid biolog rhythm appar microfilaria circadian rhythm entrain synchron stimuli circadian rhythm host judg experi monkey contain microfilaria edesonfilaria malayensi effect stimuli host seem rhythmic variat bodi temperatur occur everi  hour
737  | attempt transmit wuchereria bancrofti cat toqu monkey record larval develop wuchereria bancrofti experiment anim attempt transmit period w bancrofti domest cat toqu monkey recov one cat infect larva undergon develop find report preliminari note dissanaik nile  present paper give experiment detail describ larva
738  | period microfilaria x relat circadian temperatur cycl monkey microfilari cycl monkey use whose blood contain microfilaria edesonfilaria malayensi nocturn period artifici lower bodi temperatur daytim caus microfilaria count blood rise artifici rais bodi temperatur night caus fall almost zero ie invers normal circadian temperatur rhythm bodi follow invers microfilari rhythm hypothesi put forward circadian rhythm microfilaria e malayensi probabl microfilaria speci entrain circadian rhythm bodi temperatur thus provid effect stimuli microfilaria respond
739  | period microfilaria ix transfus microfilaria edesonfilaria monkey differ phase circadian rhythm paper report experi microfilaria one phase circadian rhythm transfus host anoth phase circadian rhythm attempt analys relat import rhythm inher microfilaria host product well known period migrat experi perform edesonfilaria malayensi yeh  present macaca monkey thailand
740  | biliari tract morpholog prognosi biliari atresia  infant extrahepat hepat duct present observ use artifici bile duct suggest presenc gallbladd may good prognost signific biliari atresia  long term survivor octob    year age  month use artifici bile duct  babi gallbladd identifi   infant specif factor prolong surviv pattern infant biliari atresia yet identifi although suggest correl among minim hepat fibrosi maxim bile ductul prolifer presenc gallbladd note suspect opportun long term surviv exist infant overcom tragic occurr biliari atresia surgeon avoid trauma hepat pedicl may abl provid guard rather pessimist prog  nosi gallbladd found babi biliari atresia
741  | current concept manag congenit biliari atresia current manag congenit biliari atresia univers cali  fornia los angel review biliari enter decompress perform   patient eight present aliv  figur higher cure rate  previous report describ recent five addit patient extrahepat atresia underw biliari decompress mean hepat lymphaticojejunostomi earli diagnosi biliari atresia im  perat order correct sur  geri may perform advanc biliari cirrhosi develop
742  | congenit atresia extrahepat bile duct congenit atresia extra  hepat biliari tract almost alway fatal except cours becom interest remark histori one infant report  attain age   year three opera  tion good health develop nor  malli free jaundic sinc   year age two opera  tion still free jaundic good health cours sinc  interest
743  | neuroaxon dystrophi congenit biliari atresia neuroaxon dystrophi describ  patient congenit biliari atresia characterist chang includ axon dystrophi mild loss nerv cell variabl degre astrocyt reaction main gracil cuneat trigemin nerv nuclei medulla rare part central nervous system neuroaxon dystrophi patient remark similar patient prolong mucoviscidosi experiment vitamin e defici rat strong suggest neuroaxon dystrophi patient congenit biliari atresia manifest prolong vitamin e defici neuroaxon dystrophi patient also similar seen age bear resembl axon chang encount group heredo degen diseas various form hallervorden spatz diseas patholog similar divers condit warrant investig possibl metabol relationship
744  | extrahepat biliari atresia comment frequenc potenti oper case  year period  infant extrahepat biliari atresia encount twenty eight babi subject surgeri oper liver biopsi discuss although oper lesion detect laparotomi one babi  potenti correct lesion discov  necropsi perform review literatur reveal author discuss necropsi find confirm diagnosi liver biopsi neglect mani case includ claim surgic cure conclud frequenc potenti oper form biliari atresia realli known
745  | metabol excret c label bilirubin children biliari atresia judson g randolph radioact bilirubin inject intraven  children biliari atresia isotop period ten fourteen day recov princip urin sixti per cent label urin found form bili  rubin distribut radioisotop observ princip extravascular form jaundic distribut albumin daili turnov bilirubin sever time greater calcul normal daili product bili  rubin assum due increas hemoglobin breakdown confirm surviv studi cr tag red cell serum half lif intra  venous administ radioact bilirubin may use prognost valu children biliari atresia
746  | central regul enzym activ synthesi embryon adult mammalian tissu activ non specif hexokinas hk solubl fraction particular mitochondria embryon liver much higher adult rabbit decreas prenat period gradual approach adulthood valu postnat fig embryon liver lack specif glucokinas gk  although second half embryon develop occur incret insulin known induc gk synthesi liver alloxan diabet anim  activ glucose  phosph dehydrogenas gp dh solubl liver fraction subject quit similar chang embryon develop
747  | ribonucleas activ hepat nuclei develop mammalian liver undergo mark qualit quantit chang develop embryon adult stage mani event associ derepress repress certain enzym may relat special subcellular activ involv ribonucl acid transcript inform genom construct finish protein molecul prompt studi biosynthesi rna differenti although consider effort regard expend amphibian  avian system well sea urchin  pauciti literatur exist mammalian liver accord investig alter rna metabol occur develop rat embryon liver undertaken report concern fluctuat nuclear ribonucleas hepat develop properti enzym
748  | electron microscop studi develop gall bladder epithelium rabbit gall bladder epithelium adult rabbit consist two type cell first common type show featur associ absorpt notabl microvilli limit pinocytosi lysosom elabor later cell membran intercellular space mitochondria concentr subap band second infrequ type dark rod shap cell unknown function may dehydr epitheli cell foetal epitheli cell lack function adult characterist mito  chondria uniform distribut addit display basal granul apic apocrin bulla epitheli cell damag white cell infiltr occur  day birth birth epitheli cell larg pale smooth outlin other dens display vigor pinocytosi adult characterist acquir immedi birth pino  cytosi subsid believ water resorpt occur function chang allow continu passag water circul
749  | congenit anomali cystic duct phinea rabinovitch anomali cystic duct four differ  ent type report characteris  tic anatom appear embryon develop anomali describ clinic surgic signific discuss
750  | lesion liver hereditari metabol diseas whether various cell liver parenchym stromal receiv genet misinform hereditari diseas caus gene mutat unknown metabol capabl sever cell type divers surpris involv mani diseas demonstr clinic patholog bio  chemic method repetit abnorm liver appar defin diseas caus quantit ie chromosom gene anomali whether produc nondisjunct transloc major delet perhap relat diseas describ result genet determin disord liver survey paper appear result convent singl gene abnorm transmit affect famili men  delian mechan
751  | acid catabol enzym activ relat accessori limb cancer initi amphibia cathepsin acid phosphatas determin liver kidney adult rana pipien triturus viridescen organ specif species  specif differ distribut enzym found well consider differ effect triton x  two enzym heterogen popul lysosom respect enzym content stabil deduc found posit correl cathept activ implant host tissu dissoci acid phosphatas induc featur phenomenon implant induc accessori limb format urodel found posit correl cathept activ resist virus induc renal adenocar  cinoma develop rana pipien
752  | neonatolog consider progress made knowledg bilirubin metabol sinc char  acter direct conjug bilirubin ester glucuronid metabol pathway involv hepat conjug well establish subject excel review sherlock bill sherlock diagrammat represent biliru  bin metabol fig  possibl mecha  nism jaundic fig  reproduc furnish clear pictur serv refer point discuss follow interest re examin current concept etiolog physiolog jaundic dia  gram mind jaundic may occur number reason describ
753  | red cell glucose  phosph dehydrogenas deficiency  a newli recogn caus neonat jaundic kernicterus canada seven male newborn chines greek italian origin present sever hemo  lytic jaundic due red cell glucose   phosphat dehydrogenas g  pd defi  cienci five hemolysi precipi  tate inhal mothbal vapour home kernicterus evid upon admiss six infant fatal four g  pd defici suspect caus jaundic full term male infant ethnic group diag  nosi confirm hospit methemoglobin reduct test area similar toronto canada high risk ethnic group prevail follow  ing measur recommend  detec  tion g  pd defici newborn screen cord blood infant ethnic group  protect affect infant potenti hemolyt agent naphthalen certain vitamin k prepar sulfonamid  ob  servat serum bilirubin level assess need exchang transfus hyper  bilirubinemia
754  | trisomi   syndrom congenit extrahepat biliari atresia congenit amput left foot phenotyp characterist   trisomi syndrom well describ among recent docu  ment case syndrom find agenesi aplasia various bone forearm hand addit classic symptom recent studi case trisomi   syndrom congenit absenc left foot congenit extrahepat biliari atresia
755  | differenti explant fragment earli chick blastoderm ii cultur protein defici medium enrich rna posterior fragment head process blastoderm cultur vitro two day protein defici medium sup  plement various rnas graft chorio allanto membran eight nine day pancreat adult rna enhanc develop entoderm epi  thelium heart adult rna caus hyper  plasia epidermi case keratin papillari project brain embryon rna produc papillomat epidermi giant epi  dermal cyst keratin fibrillar feather format liver embryon rna vis  ibl tissu modif control keratini  zation papillari format epi  dermi epiderm cyst small unkeratin devoid fibrillar organ result discuss term relationship protein brain mus  cle skin
756  | inhibit cell aggreg pure serum protein aggreg embryon chick quail limb bud heart liver cell shaker system investig order elucid mechan cell adhes new method assess aggreg describ evalu method involv measur aggreg kinet found measur kinet agre close floccul kinet provid direct quantit measur adhes term probabl adhes form contact two cell use techniqu confirm aggreg inhibit   c presenc serum absenc kinet aggreg presenc serum  c lack inhibit aggreg   c serum condit presenc cell similar lack inhibitori power serum pre treat antiserum antibodi suggest serum contain factor inhibit aggreg destroy cellular metabol
757  | les icter du nouveau n en dehor de lincompatibilit foeto maternell statist data pull studi  haemolyt neonat icteri link foeto matern incompat  non haemo  lytic neonat icteri among latter two import group malform icteri  case neonat hepat  case difficulti diagnosi frequent rencount two group clear appear compar statist analysi clinic histolog evolut data
758  | immunolog develop human fetus normal human fetus said engag format immuno  globulin immunoglobulin present serum fetus newborn consid matern origin favor opinion observ direct birth serum newborn contain appreci amount igg gm group ident mother   level igg neonat decreas gradual first  month  general explain catabol matern igg wherea format newborn infant still inadequ maintain origin level  best evid transplacent passag almost complet absenc igg serum newborn infant mother agammaglobulinemia  transfer immunoglobulin appear select process   igg readili transfer littl transfer iga igm shown ultracentrifug immunoelectrophoret studi serum     analysi maternally transf antibodi   sensit techniqu doubl diffus test agar quantit immunochem techniqu howev minut amount igm iga detect fetal blood well cord blood matur immatur neonat      sinc larg molecul pass placenta may indic trace amount igm origin fetus transplacent passag complet exclud absenc immunoglobulin format associ absenc plasma cell lymphoid tissu bone marrow normal human fetus newborn report cell appear week birth      howev patholog condit congenit syphili toxoplasmosi human fetus found respond antigen stimulus intrauterin format plasma cell sixth month gestat 
759  | galactosemi congenital observ case congenit galactosemia particular famili incid give opportun brief review subject certain point view must consid galac  tosemia much frequent suppos mani sever case reserv prognosi even slight degre galactosemia diseas must receiv care attent pediatrician
760  | postnat chang portal circul foetal develop larg portion oxygen umbil blood flow umbil recess direct main portal branch accord expos umbil blood pressur wide contrast trunk portal vein narrow probabl small blood flow inact digest tract though pressur approxim umbil vein perhap somewhat higher immedi birth liver depriv substanti umbil blood flow portal venous pressur fall one quart umbil venous pressur birth howev pressur gradient portal vein inferior vena cava remain constant
761  | pattern serum transaminas activ neonat jaundic due cytomegal inclus diseas toxoplasmosi hepat involv pattern serum transaminas ac  tiviti evolv newborn infant congenit toxoplasmosi anoth new  born infant congenit cytomegal in  clusion diseas describ enzymat pattern unlik found infant caus neonat jaundic studi date
762  | impair develop rat liver enzym activ birth irradi utero develop activ three liver enzym birth studi rat re  ceiv  rad x ray day  gestat  day gestat activ lactic glycerophosph dehydrogenas glucose  phosphatas alter subsequ increas enzym activ  day  day gestat  day age   observ control find suggest irradi utero may alter later develop enzym activ perinat period
763  | cytolog cytochem studi hepat cell human embryo chang golgi apparatus mitochondria well content nucleic acid protein polysaccharid lipid iron hepat cell develop human embryo studi data obtain human embryo adult compar found development process chang localis golgi apparatus iron salt take place content rna polysaccharid cytoplasm increas mitochondria form granul reveal throughout embryon period adult essenti alter content dna protein lipid note
764  | risk sever jaundic glucose  phosphate dehydrogenas defici newborn incid g  pd defici neonat jaundic male infant born one year area island lesbo studi  infant test   found g  pd defici hyperbilirubinaemia  mg per  ml observ  g  pd  defici newborn male  normal enzym activity  in half absenc incompat prematur first time high incid sever neonat jaundic report g  pd defici g  pd normal group postul popul lesbo second factor increas incid neonat jaundic especi factor combin g  pd defici
765  | studi b glucuronidas acti  viti bile liver devel  ope chick embryo chick search reason occur  renc unconjug bilirubin biliverdin chick embryo chick bile possibl b glucuronidas function must taken serious con  sider
766  | jaundic infanc caus jaundic infanc discuss empha  sis syndrom sole usual encount neonat infant
767  | absenc cystic duct case congenit absenc cystic duct describ th report case literatur embryogenet basi anomali extrahepat biliari tree discuss method earli oper recognit surgic manag anomali suggest
768  | famili extrahepat biliari atresia fifth famili famili congenit extrahepat biliari describ clinic patholog famili nonfamili biliari atresia similar except predomin male famili condit sex incid associ congenit anomali discuss relat possibl etiolog in  format must correl new fact uncov natur syn  drome known
769  | linfangiografia estudo da filarias linfatica first part present paper studi present lymphangiogram normal african author notic coincid one white indi  vidual second part includ lymphangiograph examina  tion observ lymph circul via risa sever stage lymphat filariasi even asymptomat stage lymphangiographi show ganglial hypertrophi slight fibrosi occa  sional discreet alter lymphat trunk symptomat stage lymphangiograph aspect vari accord diseas differ stage alway relationship durat period symptom chang observ lymphangit frequent alter lymphat trunk ie increas calib extens seg  mentari dilat numer decreas visual anastomos higher permeabl circulatori troubl evi  denc decreas rate lymph flow also mark ganglial retent adenit spite mark ganglial hypertrophi due intens sclerosi may consider altera  tion lymphat risa alreadi show clear circula  tion troubl lead lymphat stasi adenolymphocel obstruct primitive iliac level caus lymph flow deviat pre sacr anastomos reflux inguin gland thus caus dilat format varicos affe  rent lymphat lymphedema lymphangiograph result togeth risa allow us assum pathogeni chiefli influenc three factor lymphat obstruct due lym  phangiti insuffici collater duct ganglial sclerosi
770  | adjuv chemotherapi cancer larg bowel complet report avail  abil continu statist analysi warn advers effect accumul  case year demonstr cooper studi group provid rela  tive quick assess new approach treatment cancer larg bowel hope studi begun januari  use  fluorodeoxyuridin adjuv adequ excision surgeri may demon  strate drug known produc object remiss  per cent group unresect case colon carcinoma five year surviv rate curat resect may improv
771  | cancer chemotherapi prolong arteri infus current experi report  patient treat prolong arteri infus chemotherapi patient pre  sent varieti far advanc cancer un  suitabl convent surgic roent  gen therapi antimetabolit solut either methotrex fluorin pyrimidin inject continu small plastic cathet unobstruct arteri provid high region drug concentr day week patient receiv drug infus  day cours follow  month treatment methotrex antidot therapi system administr citrovorum fac  tor use preferenti patient fluorin pyrimidin common  fluoro  deoxyuridin prefer hepat arteri infus liver metastas
772  | montgomeri tube palliat hypopharyng cancer three case advanc incur cancer hypopharynx present instanc simpl procedur insert  ing avail prothesi serv effect palliat otherwis difficult hopeless situat
773  | adjuv cancer chemotherapi develop dosag schedul adjuv cancer chemotherapi surgic case account given develop dosag schedul adjuv can  cer chemotherapi surgic patient treatment administ two purpos adjuv radic surgeri reduc risk blood born metastas palliat measur non ra  dical oper inoper pa  tient purpos  dosag level fix maximum toler dose ad  juvant therapi maximum toler dose pa  renter palliat therapi maximum toler dose oral palliat therapi treatment author use  antimitot sp i sp g podophyllin deriv
774  | surgic palliat lung cancer result resect incur lung cancer effort improv termin cours small number patient briefli present compar studi in  ferenc conclus justifi regard choic form therapi palliat prefer form palliat ther  api howev believ termin cours patient lung cancer bene  ficial effect remov primari tumor whenev technic feasibl
775  | manag advanc endometri adenocarcinoma medroxyprogesteron acet basi progestin therapi patient advanc endometri adenocarcinoma present criteria select patient hormon therapi sched  ule administr medroxyprogester  one provera discuss evalu patient object chang ie visual palpabl histolog roentgeno  logic mean reveal complet partial remiss signific palliat   patient  per cent respons me  droxyprogesteron therapi appar re  late degre differenti pri  mari neoplasm well differenti le  sion respons document tumor effect serial biopsi treatment provid index histolog chang progestin produc suscep  tibl case effect therapi upon serial urinari hormon excret rate document sever patient basi experi treat  ment patient advanc endometri adenocarcinoma potent progestin medroxyprogesteron seem justifi
776  | chemotherapi breast cancer major cancer patient refer chemotherapi far advanc stage diseas difficulti deliver  ing effect dose oncolyt agent involv area may limit result treatment unless patient tumor un  usual respons one variabl re  spons appar similar case cancer cell type becom in  creas evid puzzl fact  per cent patient breast cancer live  year treatment decis choic chemother  api hormon therapi well choic chemotherapeut agent employ may difficult experi increas use chemotherapi treatment cancer becom increas appar also be  come appar chemotherapi cannot regard curat procedur advanc cancer even though occasion patient ap  pear cure howev valu oncolyt agent prolong use surviv time amelior mani dis  tress symptom associ cancer provid physician extra tool posit program care cancer patient establish
777  | clinic experi palliat metastat adenocarcinoma  fluorouracil chemotherapi chemotherapi solid tumor becom help therapeut tool probabl within year chemother  api becom firm establish ad  junct primari treatment solid tumor perhap someday cancerocid chemic devis actual act antibiot bacteria reason import surgeon interest treatment cancer tri keep abreast recent ad  vanc field chemotherapi surgeon also begin use technic palliat incur patient drug ad armamentarium primari treatment cancer familiar various technic mode action drug  fluorouracil  fu extens clin  ical use produc signific palliat breast colon cancer third patient receiv palliat five six month
778  | pelvic perfus carcinoma rectum method region chemotherapi isol pelvi present subject near termin stage time perfus surviv time degre palliat en  courag
779  | carcinoma esophagus survey fifty seven patient cancer esophagus occur twenti year period present present complaint diseas method diagnosi char  acterist diseas discuss three equal treatment group consist treat  ment x ray treatment surgic resect compar result extrem poor one patient three group sur  vive longer two year con  clusion support opinion other x ray therapi gave best palliat case surgic resect cure use suitabl pa  tient
780  | carcinoma bladder cobalt therapi    patient receiv radiotherapi carcinoma bladder radi  cal therapi cobalt  done  case patient receiv tumor dose excess  rad  week  pa  tient follow  year radic treatment  aliv sixteen  patient stage b c tumor aliv  pa  tient surviv  tumor grade   broder four  survivor cystectomi perform none show residu diseas bladder lymph node com  plicat radiotherapi present consid excess believ radiotherapi initi treatment patient infiltr carcinoma bladder surviv pre  sent  year better quot radic cystectomi whitmor marshal use bladder function preserv major survivor reserv cystectomi specif indic
781  | polyposi colon seen privat practic famili polyposi colon may present varieti clinic en  titi case discuss paper follow form may enu  merat  asymptomat phase dis  crete polyposi  mild asymptomat stage diffus polyposi  premalign phase car  cinoma situ  grossli malign phase char  acter anemia carcinomatosi possibl multicentr origin secur complet cure im  perat clinician discov surgeon treat diseas pre  malign state worthwhil palliat result may obtain surgeri incur case extens resect primari lesion subsequ resect recurr metastasi whether local distant second third look necessari special emphasi paid emot problem patient encourag sympathet attitud part surgeon essenti reward
782  | system chemotherapi cns metastas solid tumor  case studi remiss ob  tain eight  remiss rate signific number variabl present howev believ chemother  api type patient indic sup  port report data result suggest blood suppli solid tumor differ tumor associ hematopoi  etic disord latter respond poor system therapi although abl measur central nervous system cns lesion exact regress cns symptomatolog signific pa  tient demonstr metastat diseas lesion also regress evid feel patient metastat cns lesion even recent result paralysi seizur con  sider system chemotherapi
783  | combin  fluorouracil supervoltag radiat therapi palliat manage  ment advanc gastrointestin cancer pilot studi malcolm colbi margaret holbrook  fluorouracil combin supervoltag radiat therapi employ palliat treatment  pa  tient advanc gastrointestin carcinoma total dose   mg per kilogram bodi weight  fluorouracil given rapid intraven inject onset radiat therapi found relat safe toler larger dose associ excess toxic mortal suffici number patient achiev object subject palliat justifi control studi possibl addit synergist role  fluorouracil may combin radiat therapi
784  | palliat radiotherapi purpos radiotherapi manag cancer lung first cure diseas second prolong use comfort exist  enc third provid comfort relief suffer symptomat in  curabl cancer lung vari quit wide respons radiat glandular origin adenocarcinoma often modest suscept sometim quit resis  tant undifferenti so cal oat  cell cancer often exquisit sensit re  spond irradi almost like lymphoma cancer lung howev squamous cel carcinoma may consid moder radiosensit much order magnitud squamous cel carcinoma skin cervix larynx theori curabl mean degre unfor  tunat date found true reason princip two first foremost time diagnosi made cancer lung often estim  spread beyond site origin thus make cure effect mean present avail unlik second substrat cancer grow lung toler radiat less well tissu surround high radiocur epitheli cancer carcinoma skin cervix larynx thus make un  favor therapeut ratio
785  | chlorambucil prednisolon therapi dissemin breast carcinoma   year period  patient dissemin breast cancer treat combin alkylating agent cortico  steroid therapi chlorambucil pred  nisolon drug choic agent administ oral produc serious disagre toxic effect twen  ty four patient  object regress six month durat long  er averag surviv time therapi  month result statist similar obtain sex steroid endocrine abl therapi presum  abli three modal similar mechan action ie suppres  sion andor erad endogen estrogen
786  | recent advanc treatment cancer esophagus whether combin surgeri supervoltag radiat therapi notic improv  year surviv rate carcinoma esopha  gus remain seen encourag howev observ time oper previous irradi esophagus firm encas fibrous tissu give impress danger dissemin tumor time resect diminish addit fibrosi sug  gest tumor spread local beyond limit surgic excis may destroy
787  | cyclophosphamid manag advanc bronchial carcinoma forti patient suffer advanc bronchial carcinoma treat cyclophospha  mide review select effect drug tumour oat cel type note suggest relaps occur patient oral mainten therapi may control intraven cours cyclophosphamid full clinic statist detail patient refer paper avail applic author
788  | esophag obstruct use endoscop insert tube care esophag carcinoma experi suggest en  doscop insert intralumin tube provid relat simpl reason  abli safe method deal problem aris man  agement patient esophag car  cinoma tube would appear particular use handl prob  lem obstruct regurgit patient incur tumor may also help prepar sever debilit patient esophag car  cinoma withstand rigor opera  tion radiat therapi
789  | palliat radiat therapi care patient incur cancer may direct physician various background per  suasion physician littl experi care prone influenc still preval atti  tude therapeut futil equal unjustifi prematur claim wide public method recent scene surgeri radiat therapi remain domin treatment forc patient cancer unfortun lack demonstr good radiat therapi led unjustifi condemn method rather user result loss patient welfar obtain maxim benefit radiat therapi must allow indic contraind like therapeut modal must respons therapeut radiologist applic realist stringent indic contraind lessen use accomplish avoid unnecessari morbid wast time money effort delay seek suitabl treatment
790  | carcinoma middl ear result radiotherapi relat larg number case carcinoma middl ear report crude  year surviv rate  case  differ surviv case preliminari mastoidectomi use megavoltag x ray probabl increas surviv rate
791  | sustain palliat ovarian carcinoma manag  case advanc ovarian carcinoma analyz attempt made compar valu radiat valu chloram  bucil use salvag time sustain pal  liation end point chlorambucil outpati oral medi  cation appear efficaci ra  diation advanc ovarian carcinoma chlorambucil may use irradi therapi pleural periton effus respond favor chlorambucil  time possibl use differ dosag schedul discuss
792  | clue deal cancer patient clear patient cancer chang pattern communic differ stage diseas pattern communic basi clue doctor paramed personnel consid make total care effect bedsid clinician past day knew clue instinct wise ministr thank gift social worker made manifest help us deal cancer perhap chronic relentless diseas
793  | radon radioact seed volum implant extens recurr vaginal pelv cancer radioact seed volum implant extens recurr vaginal pelv cancer result extend control otherwis untreat diseas immedi earli reaction practic nonexist late complic also rare serious sever hemorrhag cystiti  author  patient
794  | termin cancer nurs home perhap difficult part mrs brown ill knew nurs work life awar deterior process carcinoma time cours would tri deceiv say  ing alway hope someth new way treatment would turn life would worth live
795  | advanc cancer breast treat primarili irradi five year result  patient treat primarili irradi cancer breast most late stage analyz case initi intent control x radiat alon primari tumor involv breast entir lymphat drainag irradi remain essenti sole method treatment  case postirradi mastectomi perform  patient initi consid inoper plan treatment consist singl continu cours radiat ther  api protract period seventy  five one hundr day administ  close integr phase tissu dose superfici deep must brought highest level requir maximum biolog effect within toler structur involv immedi effect irradi alon remark re  gression neoplast manifest breast palpabl node degre heal ulcer carcinoma incid recurr re  cord assess determin efficaci treatment
796  | manag dissemin cancer breast mammari cancer spread tissu beyond breast axilla diseas incur present day method howev patient may great help tumor growth retard skill sympathet applic irradi surgic ablat hormon ad  ministr chemotherapi given conjunct analges sedat ataract drug measur frequent reduc disabl pain prolong period use comfort life
797  | toilet train autist eight year old condit therapi case report oper condit techniqu success use treatment wide varieti be  havior problem includ hyster blind bradi lind  tic barrett  psychot symptom lindsley    read disabl rachman  stutter flanagan et al  enuresi mowrer mowrer  lovibond  b encopresi neal  madsen  neal  success treat three four encopret children use oper train techniqu case one  yr old boy  month histori encopresi go toilet reward candi prais record event special book boy presenc soil inadvert reward eg attent punish boy would given clean pair pant without comment neal report respons treatment rapid complet  month toilet train relaps bowel habit procedur similar use neal use case report posit small number instanc negat reinforc use toilet train  yr old boy diagnos child psychiatristneurologist infantil autism
798  | incid symptom earli infantil autism subsequ hospit psychiatr patient studi concern relationship occurr dur  ing first two year life symptom earli infantil autism retrospective  ly report mother ss subsequ adjust mother  unmarri young hospit psychia  tric patient interview deter  mine presenc absenc  differ sign contain check list sign repres characterist featur report often found conjunct earli infantil autism control  mother high school student resid communiti present signific adjust prob  lem question regard item result indic signific symptom report patient normal find appli overal number symptom well sever subcate  gori symptom item classifi head social withdraw appear sensit dif  ferenti group also found   sign distinguish be  tween patient normal except one occur frequent former group conclud signific relationship exist report presenc symptom often associ sever earli ego impair subsequ status mental hospit patient studi provid direct answer ques  tion proport children infantil autism later abl make adequ adjust outsid mental hospit
799  | eeg abnorm earli childhood schizophrenia double blind studi psychiatr distrub normal children promazin sedat eeg trace promazin sedat obtain  children autist symbiot childhood psychosi comparison eeg done ident condit  group children  chronic undifferenti schizophrenia  non psychot children sever acting out behavior disord  neuros  psychiatr normal children final clinic diagnos made without knowledg eeg read determin studi eeg place random order read without knowledg clinic diagnosi eeg abnorm ac  cept focal slow focal spike paroxysm spike wave par  oxysm spike wave independ spike among  patient  abnorm record none psychiatr normal children eeg abnorm except neurot eeg abnorm qualit quantit sim  ilar psychiatr patient frequent abnorm ir  regular paroxysm spike wave com  plex often best seen transit wake sleep  patient  complex either alon independ spike although complex frequent au  tistic symbiot group incid statist signific differ higher perform chronic undiffer  entiat schizophren communi  cativ speech non psychot children acting out behavior disord  autistic symbiot children  seizur similar  seizur incid remain  psy  chiatric patient whether cerebr dysfunct im  pli studi primari disord secondari factor effect prolong anxieti bodi chem  istri cannot decid time never  theless organ concomit demonstr  psychiatr disturb children increas amount time includ eeg sam  ple incid electr abnorm might even higher
800  | earli infantil psychosi symbiot autist syndrom conclus wish state core child psychosi must sought one describ distort sym  biotic phase first case lay heart psychot dis  turbanc mark emot unavail mother altern pure physic extrem close breast feed situat particular destruct mother unpredict rage attack contrast experi drove child autist ward human contact de anim world realiti constitut factor could case evalu degre accuraci second case contrast mother ever pres creat unendur instrus upon interfer structur bud ego constitut perhap predisposit may vulner made imposs infant experi normal altern gratification frustr sequenc pace also made process individu separation individu period one beset abysm panic instanc see primarili sever dis  tortion normal symbiosi child psychosi root
801  | autopathyfollow up case public two paper recent acta paedopsychiatrica arn van krevelen subject autist psychopathi stimul author present  case appear conform descript valu brief contribut lie fact follow least  year may give idea eventu result type case
802  | sensori domin autist imbecil children control previous experi hermelin oconnor  found autist control imbecil children respond frequent light stimulus condit bimod simultan stimul howev role relat intens level stimuli remain determin present experi light sound light verbal command present simultan various intens combina  tion respons irrespect stim  ulus made reward autist mongol nonmongol imbecil children test addit tendenc visual domin result show independ modal high intens affect group nonmongol imbecil children also respond signific frequent verbal sound stimulus two group
803  | dream sleep autist twin  year old ident autist twin observ one spontan night sleep session electroencephalogram eye movement heart rate chin muscl potenti record autist twin show similar pattern amount dream sleep report normal children age
804  | twin discord earli infantil autism pair heterozyg twin discord earli infantil autism report relev literatur review although mani  fest organ factor rule twin physic develop differ spe  cific emot etiolog demon  strat avail twin studi offer find consist hypothesi genet factor relev develop  ment childhood autism evid also present impair acquisit lan  guag may hereditari determin second set probabl homozyg twin report also discord autism second case suggest although genet factor may play part case syndrom infantil autism appear revers one view set twin kanner sibl data role genet factor remain obscur twin studi proper document blood type need
805  | evalu treatment plan autist children infantil autism consid re  action part immatur organ primit undifferenti stage ego develop littl choic defens reaction avail possibl sub  limat exist even though object relationship gradual develop mother still child primari object vulner develop  mental stage wide rang patholog circumst rang sever famili psychopatholog adventi  tious physiolog traumata un  fortun malign circumst may constitut acut cumul cata  strophic stress primit organ tend respond overwhelm stress paranoid reaction direct mother regardless actual etiologi  cal variabl mother still child primari object believ child respond autist reaction show vari degre simpl with  drawal obsession behavior magic de  lusion thought process consequ disrupt development skill speech relationship other mani famili make everi effort counter paranoid reaction child respond reject counterreject counterwithdraw child autist symptom may abat without formal treatment yet sinc mother famili primari object child paranoid attitud felt formal therapeut intervent necessari modifi paranoid core autist reaction
806  | twenty f year view therapeut result thus group ten patient show complet rang chronic schizophrenia bright pseudoneurot never hospit inaccess patient chronic hospit  year physiolog therapi form metrazol induc convuls given cours puberti schizophren psychosi help make access total treat  ment program hospit rais margin toler suffici could live home attend public school least time best indefinit sever regress deterior patient state hospit mani year brought back level meaning live current drug therapi program still im  prove determin sinner may mani believ mother alway sinner schizophrenogen other believ individu sinner sinc one whose behavior fantasi schizophren howev mani attend fifty second annual meet american psychopatholog associ judg speaker sinner given wealth clinic ma  terial without chart graph statist evalu
807  | group psychotherapi preschool psychot children collater group therapi parent preliminari report first two year group approach treatment preschool ag psychot children report autism defens loss symbiot partner group children penetr defens form group ego constitut one pole new therapeut symbiosi separation individu occur
808  | autist reaction earli childhood differenti diagnost consider term autism frequent use today differenti diagnosi sever emot disturb earli childhood howev label child autist present formid problem regard definit term specif etiological diagnost implic treatment consider given child design purpos paper briefli review histor psychiatr background term autism recent ramif clinic experi field
809  | infantil autism famili approach autist child appear unabl integr respond stimuli intern sourc bodi well extern sourc human contact note children residenti treatment center preliminari period us appear unawar bodi give impress insensit pain display littl autoerot behavior inflict injuri hit head object bite bodi littl outward display distress work children therapi one guidepost chang growth display child part increas bodi awar autoerot behavior exampl one child develop polio earli stay clinic resid communic anyon made known observ child drag one leg memori guid  anc clinic  later abl point bodi indic pain anoth child first seem quit unawar other concurr grow display affect express toward therapist also manifest pleasur genit stimul quit ticklish injur would display area pain quit readili
810  | analysi languag fourteen schizophren children fourteen schizophren autist children studi mean detail behaviour histori observ languag record histori observ protocol analys compar avail data normal children schizophren children grossli retard languag develop measur correl high previous overal clinic assess sever ill strike abnorm languag children studi stereotyp repetit utter appropri earlier development level previous environment context accompani lack normal express curios respons chang environment cue
811  | behaviour electroencephalograph studi autist children short biographi given  children age   year diagnos suffer kanner syndrom earli infantil autism analysi made free field acti  viti children compar group normal children similar age electro  encephalograph studi also carri  children two possibl carri simultan behaviour eeg observ mean telemetri children observ three minut period four environ vari complex empti room b room toy wooden block present c block plus passiv adult block plus activ adult except visual fixat manipulatori activ signific shorter durat autist children normal lack clear cut off point show relat littl variabl environ autist children whole show virtual construct play contrast normal though time spent contact play materi social environ chang time spent locomot gestur block play manipul object environ show autist children acut respons chang environ includ presenc social stimulus autist children subdivid characterist show stereotypi latter sub group show behaviour structur similar normal wherea stereotypi sub group clear differenti normal children non stereotypi sub group eight autist children wake eeg record character low voltag irregular activ without establish rhythm one child record contain irregular alpha anoth unstabl theta activ two children flat laboratori eeg show rhythmic higher voltag record eeg telemetr environ also show less stereotyp behaviour environ b show pro  gressiv irregular eeg activ stereotypi hypothesi advanc autist children chronic high state physio  logic arous find present studi worker discuss respect hypothesi
812  | autist child school school nurs teacher respons autist children demonstr persist pattern retreat realiti appar children categor normal psychologist establish caus symptom autist child extrem anxieti forc withdraw social contact anxieti report initi occurr age rang one five year sens secur consid es  sential child gain overt manifest love care approv adult close associ need satisfi child attempt self real esteem deter thwart state anxieti may result sever anxieti may forerunn schizophren disord condit develop child adolesc adult schizo  phrenia serious mental ill consid major caus admit patient mental institut anoth school thought place infantil autism categori disturb result abnorm develop intrauterin period congenit condit categor mental retard yet anoth concept autism conceiv problem absenc innat abil capac develop meaning contact peopl detach vari degre persist human contact concern
813  | autist child condit frequent mistaken autism speech disord brain damag mental defici promin symptom psychot child care his  tori close observ disclos symp  tom withdraw lack ego compuls same display intellig give incomplet clue diagnosi etiolog autism uncertain sev  eral factor seem signific import role organ damag brain under  score coincid epilepsi eeg neurolog abnorm chil  dren seri seizur various type occur  eeg abnorm  minor neurolog deficit  case environment factor quit obvious import mani instanc emot behavior pattern par  ent toward infant often incrimin separ inattent cold reject etc found mani situat fa  milial incid psychos low autism sibl
814  | shadow therapi shadow therapi develop sunland train center gainesvill florida communica  tion difficulti disturb psychot children con  jectur subject would reveal anxieti conflict readili simul night situat therapi conduct darkroom projector light use produc silhouett accompani shadow addit stimuli twelv subject attend articl reaction child autist sever disturb use illustr subject reaction playroom exhibit static behavior darkroom re  gressive transcendenti behavior also transcend usual level vocal social
815  | languag train treatment autist child function retard level preliminari studi determin effect languag speech therapi develop communic lessen un  related group non verb autist children function retard level report basi re  sult studi suggest inclus languag speech therapi techniqu consid develop treatment program children
816  | converg interact visual auditori tactil respons human nonspecif cortex relat electr respons human brain mental process integr associ perhap chal  leng problem face neurophysiologist today quit recent prospect unifi physiolog psycholog concept electro encephalograph eeg techniqu seem reced baffl complex intrins electr rhythm difficulti still overcom intrigu time elus properti rhythm although often remark constant variat respect time fluctuat also much less regular manner within three dimension space brain continu analysi display phenomenon present serious difficulti method yet given entir satisfactori result incent construct adequ equip design per  form crucial experi undoubt limit uncertainti whether inform like obtain way essenti understand brain mechan experiment imagin would suffici
817  | infantil autism schizophrenia paper publish  entitl au  tistic disturb affect con  tact report children psychi  atric servic john hopkin hospit observ  children  boy  girl common pattern be  havior previous consid strike uniqu symptom view combin extrem alone  ness begin life anx  iousli obsess desir preserv same conclud discuss say must assum chil  dren come world innat inabl form usual biologi  calli provid affect contact peopl children come world innat physic intellectu handi  cap assumpt correct studi children may help furnish concret criteria regard still diffus notion constitut compon emot reactiv seem pure cultur exampl inborn au  tistic disturb affect contact search appropri designa  tion decid  much grope term earli infantil autism thus accentu time first manifesta  tion children limit access
818  | autist children autism form childhood schizophrenia sudden separ mother traumat shock earli life caus child reject world nor  mal relationship lead back origin traumat situat part treatment describ articl
819  | gill de la tourett syndrom autist child case gill de la tourett syndrom present earli infantil autism describ treatment appli outlin
820  | psychodrama disturb children psychodrama especi adapt treat  ment mental ill children evok degre spontan involv difficult attain mani group therapi offer situa  tion children particip actor observ competit restrict minim child come natur in  deed much children natur play form dramat activ make believ how  ever intens act child becom person thing pretend fireman indian hors tiger
821  | speech languag abil emot disturb children speech languag disord sever disturb children divid two categori relat type psychiatr disturb autistic schizophren children use bizarr form languag use communic languag non  autistic schizophren neurot primari behaviour disord minim brain damag children group similar speech languag problem normal children sever frequent natur problem predomin area speech languag develop  ment articul rate speech fluenci children primari be  haviour disord sever speech languag problem
822  | studi childhood schizophrenia earli infantil autism part i  descript sampl follow period observ three month durat group twelv autist schizophren children se  lect treatment program group select criteria would allow reason chanc suc  cess treatment group homo  geneous enough allow statist con  sider valid younger age averag intellectu func  tion presenc intact famili near metropolitan toronto firm diagnosi autist schizophrenia limit factor rather distinct differ note treatment group oppos larger observ group dis  tinguish characterist undoubted  ly speech abnorm present
823  | discuss sur les pseudo tumeur osseus des hemophil doctor queneau josso describ one case pseudo tumour calcaneum analag describ trillat favre gilli demonstr x ray dr alagill refer haemophil cyst maxilla dr favre gilli cyst perineum dr kugler seen case erron diagnosi osteosarcoma made
824  | effect joint posit pressur intra articular effus known joint symptomat effus held spontan characterist posit movement joint increas pain studi report correl made hydrostat pressur joint effus joint posit result indic possibl relationship intra articular pressur pain
825  | haemophil blood cyst mongol boy ten known haemophiliac seen orthopaed depart southmead hospit may  swell left foot parent awar steadi increas size sinc swell first notic two month examin cystic swell seen occupi forefoot skin dorsum stretch duski red colour fig  radiograph show destruct proxim two third third metatars bone appear consist thought destruct within expand lesion fig  diagnosi haemophil blood cyst made
826  | treatment prevent chronic haemorrhag arthropathi contractur haemophilia orthopaed treatment joint deform thirteen patient haemophilia review period seven year form treatment discuss includ open oper manipul general anaesthesia continu traction splintag physiotherapi amount intraven therapi requir form treatment indic discuss prevent joint deform histori eighteen patient taken account conclud initi painless haemarthros provid main threat joint deform haemophilia best prevent treatment earli immobilis follow prolong splintag physiotherapi intraven therapi antihaemophil factor play less import role form haemorrhag evid present joint deform sever haemophilia often entir avoid
827  | osteopatia emofilia aa present case materi literatur one person remark extrarticular osteopathi hemophilia examin anatom clinic pictur ill import less known peculiar dwell upon curat medico surg problem affect
828  | la plasmatherapi minima dan le traitement de la douleur des hemarthros hemophiliqu fifti clinic similar case hemophil hemarthrosi immobil either treat placebo plasma perfus els corticoid analges small quantiti plasma suffici stop pain follow hour attempt give physio patholog explan would seem accord pathogen studi hemophiliac r marx et al
829  | effet analgesiqu immediat des inject de plasma pour hemarthros recent du genou des hemophil singl inject  ml lyophil fresh plasma per kg bodi weight propos treatment recent case knee hemarthrosi import distens capsul achiev hemostasi reduc evolut period pain alway acut perman case hemarthrosi subsid plasma inject immedi afterward
830  | hip disarticul patient hemophilia disarticul hip hemophiliac patient perform sever osteomyel involv entir right femur lifesav follow suggest hemotolog man  agement  infect wound hemophiliac pa  tient left open initi  electro  cauteri use infect wound hemophiliac patient  safe fibrinogen prepa  ration potent antihemophil factor avail countri high signific advanc surgic treatment hemophilia
831  | haemophilia sweden vii incid treatment prophylaxi arthropathi musculo skelet manifest haemophilia b clinic materi consist   known haemophiliac b sweden investig includ clinic examin major joint   patient sever haemophilia   patient moder haemophilia   patient mild haemophilia roentgen examin practic joint found abnorm clinic examin addit inform  patient sever haemophilia  moder haemophilia  mild haemophilia obtain questionnair degre arthropathi grade    classifi larg accord depalma cotler  evalu general disabl made regard abil manag walk dress eat toilet with  help latter evalu compris also extra articular manifesta  tion haemophilia
832  | interet de la radiotherapi dan les hemarthros recidivant du genou chez lhemophil radiotherapi deliv dose  r repeat   time  knee haemo  philiac children present recur arthropathi irradi harm effect growth patient benefici two third case reduc consider number per annum haemarthrosi onset one third patient show signific result number onset follow year total averag infirmari stay due knee haemarthrosi  day year radio  therapi  day follow year author think result justifi therapeut method
833  | discuss sur les donne radiologiqu dan les arthropathi des genoux professor marchal act moder dr le coeur wonder fring appear condyl realli patholog signific appear could normal young children opinion dr queneau seem patho  logic older children seem dr favre gilli dr queneau scalariform trait occur frequent haemo  philiac children normal one dr le coeur thought fibrillari decalcif ultim stage decalcif wherea dr favre gilli impress repres haemophiliac subject earli stage anterior homogen decalcif accord brinkhous densif synovi membran result infiltr joint cartilag due haemosideraemia also opinion dr favre gilli dr izarn dr izarn ask geod caus intra  osseous haemorrhag necros dr queneau dr de mourgu think anatom data con  cern haemophiliac subject insuffici question answer
834  | etud radiographiqu des genoux de  hemophil de   an radiograph examin knee syste  matic perform  haemophiliac subject age   year  bilater haemarthrosi  one knee affect  uninjur intra articular opacif observ  knee correspond recent haemarthrosi densif synovi membran ob  serv  knee correspond iron deposit interlinear pinch present  knee eros articular surfac especi fre  quent  knee homogen  knee hypertrophi condyl knee cap broaden intercondylian space crush intern tibial disk genu valgum posterior sublux tibia osseous deform encount atrophi femur diaphysi explain frequenc fractur femur aspect seem occur earli inter  linear pinch eros surfac other tardier geod decalcif relat intens abnorm radio  logic find sever sequela alway exist one observ major radio  logic alter major bio  logic disturb
835  | blood vascular disord connect nose throat ear disord includ  lesion primarili nose throat ear  produc symptom sign nose throat andor ear part symptomatolog involv organ well con  sider lesion connect nose throat ear separ
836  | volkmann ischaemia volkmann ischaemia name given sequenc event origin describ volkmann  basic condit consist replac limb flexor muscl fibrous tissu follow injuri occlus main arteri suppli blood muscl condit rare fortunately  main improv method prevent flexor muscl toe sometim affect commonest group muscl damag flexor muscl forearm total arteri occlus limb sever hour usual caus frank gangren partial total occlus shorter period may give rise ischaem contractur muscl depriv blood suppli die sub  sequent replac fibrous tissu like scar fibrous tissu contract produc complet pictur volkmann ischaem contractur forearm thin wast finger held flexion owe overal shorten flexor muscl sever case nerv also affect entir muscl mass replac fibrosi finger may total paralys well
837  | klinik der polyarthrosen among degen affect joint symptom arthrosi joint finger heberden nod bouchard nod inter  digit joint polyarthrosi   subject cost foresti wrote describ lffb   arthropathi chronic gout thorough discuss rare condit arthrot chang hemo  philia psoriasi metabol disord mention wider area dedic differenti degen inflammatori diseas refer  red gout often occur day one forc calcul year ago also refer signific serolo  gical reaction differenti diagnosi import diseas enumer belong degen polyarticular affect joint often get mix
838  | major surgic procedur includ amput hemophiliac various surgic procedur hemo  philia patient includ amput knee report human cohn fraction fibrinogenahg use ensur normal hemostasi patient abil form firm clot within normal time measur treatment prescrib accord serial studi thrombelastograph
839  | prevent crippl haemophil children children sever affect haemo  philia christma diseas suffer repeat haemorrhag joint muscl trivial injuri episod bleed produc cumul crippl haemarthros tend recurr episod produc damag joint surfac immobl con  valesc lead muscl weak thus recoveri joint becom increas liabl renew bleed deep muscl haematomata produc crippl actual destruct muscl tissu pressur import nerv arteri contractur develop heal failur resolut origin haematoma lead chronic cyst format
840  | throat nose surgeri patient constitut haemostat defect success surgeri patient defect haemostasi becom possibl inter  est detail problem encount nose throat surgeri
841  | hemophil arthropathi jaromir priborski zora antalovska author report experi joint diseas  patient suffer hemo  philia  case hemophilia  hemophilia b  patient children age  year bleed joint occur  patient age group  year case bleed joint frequent  age group  year  differ bleed joint serious articular chang case hemophilia hemo  philia b case bleed joint began th th year age bleed joint first manifest hemophil condit occur  patient case hemophil manifest preced spite fact joint manifest often wrong diagnos tubercul arthriti rheumat fever progress arthriti treat accord usual larg joint knee elbow ankl affect bleed chang also serious joint halv bodi affect uniform case sever joint affect monoarticular local observ  serious articular chang depend main number repeat bleed one joint although factor weight bear joint complex joint treatment may decis import individu case well accord clinic especi function point view x ray criteria articular find classifi three group first group function joint preserv second limit third practic extinguish follow laboratori test carri erythrocyt sediment reaction latex test rheu  matoid factor c reactiv protein mecoprotein tyrosin weltmann coagul test find normal even case irrepar articular chang unless acut bleed joint local complic disord present simultan therapi hemophil arthropathi remain troublesom owe especi frequent occurr articular bleed close cooper hematologist rheumatologist orthopedist may con  tribut improv fate patient
842  | prevent treatment joint deform haemophilia experi treat establish joint deform  patient prevent develop deformtiy  younger patient last  year shown two type haemorrhag requir differ treatment prevent chronic deform
843  | haemophil pseudotumour haemophil subperiost haematoma case histori haemophiliac larg haematoma thigh treat amput limb describ examin avail radiograph histolog led conclus cyst subperiost origin evid present support hypothesi haemophil pseudotumour alway associ subperiost haemorrhag haemophil cyst confin muscl littl effect adjac bone
844  | actinomycin respons parathyroid hormon actinomycin inhibit effect parathyroid hormon upon bone measur ca mobil without alter effect upon renal excret phosphat ca rat
845  | aspect circadian period chang phosphorus metabol mice kinet studi p content mous brain phosphorus fraction follow intraperiton inject p label orthophosph perform two select segment  hour time scale result studi suggest circadian period relat specif activ brain phospholipid probabl consequ variat extent p incorpor brain inorgan phosphat indic period rate intermediari phospholipid metabol data postinject time cours specif activ plasma inorgan phosphat liver inorgan phosphat liver phospholipid suggest similar explan circadian period chang relat specif activ liver phospholipid circadian rhythm inorgan phosphat concentr mous plasma demonstr consider mathemat model suggest observ within day variat p distribut circadian period phospholipid relat specif activ liver brain consequ period plasma phosphat content signific within day variat total phosphorus content liver observ disturb mice incid p inject mark effect plasma content inorgan phosphat corticosteron
846  | specif inhibit tubular phosphat reabsorpt certain amino acid inhibit tubular phosphat reabsorpt certain amino acid high specif one differenti close relat compund l isom clear possibl
847  | local phosphatur effect parathyroid hormon nephron dog renal mechan tubular site phosphatur action parathyroid hormon investig clearanc stop flow techniqu one intact seven thyroparathyroidectom dog administr hormon caus signific increas excret phosphat without increas filter load stop flow analysi indic absenc parathyroid hormon filter phosphat reabsorb proxim tubul hormon increas rate phosphat excret inhibit reabsorpt mechan p inject stop flow show signific transport across renal tubul despit presenc excess parathyroid hormon signific p activ appear stop flow collect simultan appear new filtrat evid parathyroid hormon mediat secretori process phosphat excret
848  | regul growth hormon secret present communic summar investig control secret hgh use radioimmunoassay measur plasma gh assumpt impli throughout present chang secretori rate respons acut chang plasma concentr hgh appear reason sinc fluctuat plasma hgh concentr often rapid caus sole alter hormon degrad excret slower chang plasma hgh concentr howev alter rate remov hormon bodi fluid might play contributori role howev evid import chang occur rate remov hgh circul except patient develop antibodi hgh follow treatment hgh
849  | earli infantil autism receptor process syndrom earli infantil autism examin function deviat near dist receptor usag receptor deviat compar normal receptor hierarchi develop near distanc receptor domin avail inform consist view earli infantil autism involv earli sensori depriv sensori depriv result interact constitut defici inhibit certain reticular arous function mother tend understimul treatment young autist child suggest includ stimul communic via avail near receptor system framework sensori develop direct studi earli diagnosi treatment indic
850  | studi compensatori renal hypertrophi effect unilater ureter ligat transect data present compar relat rate compensatori renal hypertrophi hyperplasia control kidney rat follow either unilater ureter transect ligat nephrectomi growth control kidney unoper side strike slower ureter transect ligat compar result remov one kidney progress hydronephrosi observ oper side follow ureter transect ligat pronounc latter degre hypertrophi control kidney show close correl degre durat hydronephrosi kidney oper side observ interpret indic oper control system regul kidney growth respons chang way relat kidney size
851  | studi chang growth dna synthesi rat kidney experiment induc renal hypertrophi high rate accumul newli synthes dna kidney folic acid inject compar small increas first day unilater nephrectomi larg increas water content kidney folic acid occur unilater nephrectomi chang wet dri weight rna dna content kidney compar administr folic acid unilater nephrectomi unilater nephrectomi follow folic acid  hr later attempt studi natur differ unilater nephrectomi steadi increas wet weight dri weight rna content kidney paramet reach   normal  day time dna content increas  increas rate dna synthesi found   day return almost normal  day folic acid inject larg increas wet weight  rna content  dna content  first  day accompani smaller increas dri weight  thereaft paramet declin relat bodi weight return almost normal  day rate dna synthesi great increas earli  hr inject reach much higher level found unilater nephrectomi return normal level  day unilater nephrectomi follow  hr later folic acid inject increas weight nucleic acid content rate dna synthesi greater correspond time either treatment alon mark differ found label indic kidney cell either unilater nephrectomi folic acid inject latter treatment result larg increas three zone kidney wherea unilater nephrectomi respons cortex outer medulla much lower signific increas inner medulla treatment combin respons remain kidney similar though exagger normal kidney folic acid inject
852  | renal adren relationship compensatori hyperplasia compensatori renal hyperplasia normal follow unilater nephrectomi abolish bilater adrenalectomi rat maintain fresh drink water restor salin drink water provid anim inject doca adren also import increas prolifer caus unilater hydronephrosi experi suggest role adren cortex renal hyperplasia may secret mineralocorticoid promot retent sodium therebi stimul cell divis kidney
853  | genet studi neonat obstruct jaundic  children extrahepat biliari atresia  intrahepat biliari atresia  neonat hepat analys concern diagnost criteria natur histori famili clinic patholog data extrahepat biliari atresia evid famili tendenc influenc matern age birth order disturb foetal develop neonat hepat  consanguin parent suggest mutant autosom gene homozyg form infant genotyp neonat hepat may manifest mild sever form diagnosi made appar excess male femal may anoth evid failur manifest genotyp neonat hepat may manifest one diseas neonat hepat birth weight show mark decreas perhap sequenc disturb liver function foetus
854  | parathyroid extract induc chang oxid citrat succin organ acid liver parathyroid extract pte partial purifi parathyroid hormon administ vivo mark alter oxid vitro rabbit liver minc citrat  keto glutarate c succinate c fumarate c lactat ca  present incub medium minc pte treat anim produc co greater consumpt control minc stimul due part least rapid declin metabol activ control tissu ca absent total metabol increas tissu deriv pte treat anim less activ control tissu effect detect earli  hr inject  ukg could elicit littl  u  hr action pte could duplic inject cacl anim data suggest one effect treatment general inhibit oxid stimul metabol could consequ inhibit separ unrel alter
855  | actinomycin erythropoiesi product erythropoietin mice bdf femal mice singl dose  actinomycin suppress normal erythropoiesi fe erythrocyt uptak polycythem mice  enough prevent stimulatori effect  unit erythropoietin curv suppress recoveri versus time support hypothesi erythropoietin act short time earli stage erythropoiesi earli stage develop cell longer sensit actinomycin recoveri even repeat dose rapid adequ amount actinomycin adequ abolish erythropoiesi prevent new appear erythropoietin plasma hypox mice
856  | ultrastructur histopatholog histochemistri parathyroid gland pregnant nonpregn cow fed high level vitamin parathyroid gland pregnant nonpregn cow studi light electron microscopi follow daili feed  million unit vit  day compar untreat control pregnant nonpregn cow parathyroid gland becam mark atroph diminut amount parenchyma compar untreat control vit feed number activ secret dark intermedi chief cell reduc percentag inact light atroph chief cell increas parathyroid gland vit d fed nonpregn cow domin sever atroph chief cell cell character high irregular shape shrunken nucleus cytoplasm widen intercellular space travers numer cytoplasm process increas electron densiti secretori granul inact ergastoplasm golgi complex atroph chief cell present untreat control predomin cell type parathyroid vit d fed pregnant cow inact chief cell contrast atroph chief cell larger regular shape relat straight cell membran compar electron transpar contain glycogen fewer secretori granul organell concern protein synthesi packag secretori unit poor develop inact chief cell observ occasion parathyroid gland untreat pregnant cow activ secret dark intermedi chief cell predomin
857  | effect heparin parathyroid extract acid phosphatas bone test theori heparin might stimul acid phosphatas bone young rat heparin pte combin inject appropri time interv acid phosphatas activ bone treat anim compar control found heparin enhanc pte stimul acid phosphatas activ calvaria metaphysi diaphysi possibl relat fact presenc lysosom osteoclast discuss
858  | isol thyrocalcitonin studi effect rat thyroid secret polypeptid hormon thyrocalcitionin effect lower plasma calcium phosphat hormon extract thyroid rat dog pig goat ox monkey isol hormon pig thyroid combin salt fraction gel filtrat describ one microgram pure materi activ rat thyrocalcitonin remain effect parathyroidectomi nephrectomi overdosag vitamin vitamin defici calcium magnesium defici action prevent prior administr actinomycin singl inject chang soft tissu calcium infus  hr lower cardiac muscl calcium conclud new thyroid hormon act bone probabl play import role normal physiolog
859  | effect actinomycin parathyroid induc chang bone kidney actinomycin amd antibiot known inhibit dna direct rna synthesi use studi parathyroid induc chang ca mobil vivo vitro well renal excret ca phosphat rat intact parathyroidectom rat subject periton lavag administ amd chang ca p mg lavag serum examin amd consist lower ca transfer periton rins intact parathyroidectom anim although drop ca acut anim pretreat subcutan inject amd amd administ compon rins pretreat lavag anim amd prevent expect increas osteoclast number distal metaphysi femur effect administ compon periton rins incub femora remov intact parathyroidectom anim result media ca level signific lower  hr incub amd ad vitro howev transfer recent inject ca incub medium anim treat amd increas addit parathyroidectomi anim subsequ administr amd still result expect chang ca p urin although amd signific increas p excret intact parathyroidectom anim conclud endogen parathyroid hormon requir continu product enzym ultim respons action bone kidney action necessarili relat direct product m rna
860  | inhibit actinomycin bone resorpt induc parathyroid hormon vitamin actinomycin inhibit cell prolifer control cultur embryon rat bone prevent stimul bone resorpt parathyroid horom pth vit dose  ml actinomycin pth effect partial inhibit inhibit overcom increas dose pth find suggest agent act competit
861  | j clin endocr     antagon parathyroid extract adren cortic steroid man metabol balanc studi done  patient hypoparathyroid receiv hydrocortison prednison administr parathyroid extract administr prednison associ phosphat retent decreas urinari ca decreas serum ca citrat glycoprotein concentr increas serum phosphat excret parathyroid activ urin  patient uninfluenc administr prednison conclud antagonist effect adren cortic steroid express biochem site action parathyroid extract bone kidney steroid reduc parathyroid secret administr probabl result degrad inactiv hormon
862  | tissu distribut electrolyt ca mg experiment hyper  hypoparathyroid effect experiment hyper  hypoparathyroid plasma tissu distribut electrolyt tissu exchang ca mg studi dog follow acut renal pedicl ligat hyperparathyroid plasma concentr mg inorgan p well ca increas greater accumul ca occur tissu lesser accumul other acut hypercalcemia compar sever fraction rate exchang tissu ca  rapid control acut hypercalcem dog bone exchang ca signific increas cell mg concentr appreci alter hyperparathyroid except signific  decreas myocardium fraction rate exchang tissu mg increas acidsolubl p concentr decreas  tissu na c concentr decreas    tissu hypoparathyroid addit decreas plasma ca increment plasma inorgan p usual occur renal pedicl ligat  less control dog cell ca concentr decreas   fraction rate exchang tissu ca unalt although cell mg concentr unalt  increas occur exchang skelet muscl mg tissu na c concentr decreas   tissu previous report hypercalcemia increas cell ca concentr rais extracellular ca concentr gradient evid also present hypercalcemia direct inhibit cell influx mg na cell efflux k alter parathyroid activ  type effect observ depend upon abnorm extracellular ca concentr appear due intrins effect parathormon cell cation transport present data compat hypothes parathormon stimul bidirect transport cell ca p stimul cell influx mg oppos effect hypercalcemia cell transport unival ion
863  | inhibit respir phosphoryl kidney mitochondria parathyroid hormon administ vivo parathyroid hormon administ vivo rabbit produc metabol alter kidney cortex mitochondria evidenc diminish respiratori rate respiratori control po ratio seri substrat includ pyruv plus fumar succin ketoglutar malat citrat isocitr adenosin triphosphate inorgan phosphat exchang reaction rate decreas adenosin triphosphatas activ increas compar control mitochondria chang becom appar  hr inject undiminish  hr could elicit littl  usp unit hormon ident condit liver mitochondria unaffect diphospho  triphosphopyridin nucleotid combin frequent elev respir parathyroid tr mitochondria close control level citrat isocitr remain substrat effect respiratori control substrat effect hormon could duplic elev maintain otherwis normal rabbit serum ca concentr twice normal level  hr conclud effect produc parathyroid hormon kidney multipl natur relat ca rais potenc prepar
864  | sudden hypocalcemia normal hypoparathyroid subject serum calcium concentr sudden decreas  normal  hypoparathyroid subject infus  mgkg disodium edta    minut interv return rate pre infus valu serum calcium concentr group serum phosphat show mark transient decreas  min infus normal individu hypoparathyroid hypophosphatemia follow mark increas phosphat clearanc normal group decreas hypoparathyroid group urin phosphat urin creatinin x  upuc x  urin phosphat urin osmol x  upuo x  ratio also reflect increas phosphat excret  group simpl clinic measur parathyroid function suggest determin upuo x  upuc x  ratio   hr intraven infus disodium edta
865  | parathyroid function chronic renal failur statist survey plasma biochemistri azotaem renal osteodystrophi collect made  person publish case azotem osteodystrophi adequ inform avail concern patholog state bone measur avail plasma calcium plasma phosphat blood urea nitrogen case plasma bicarbon plasma protein repres sampl plasma level calcium phosphat whole seri  case relat reciproc correl direct data analyz alloc case either  sub group accord type patholog lesion present bone one group evid defect miner skelet tissu form either ricket osteomalacia plasma calcium found statist sub norm group primari defect miner lesion general osteiti fibrosa present plasma calcium statist normal signific correl plasma level calcium phosphat either sub group plasma phosphat signific higher group higher plasma calcium level data indic patient renal osteodystrophi contrari general belief plasma calcium vari independ plasma phosphat sinc result impli differ parathyroid function among patient azotem osteodystrophi survey also made record parathyroid weight chronic renal failur general osteiti fibrosa accompani normal level plasma calcium associ greater parathyroid hypertrophi found case chronic renal failur case defect miner various data interpret relat known metabol disturb natur histori azotem osteodystrophi analog state simpl vitamin defici suggest hypocalcemia relat unrespons calcem action parathyroid hormon relat acquir resist vitamin group case statist normal plasma calcium prove parathyroid gland function effect patient chronic renal failur irrespect level plasma phosphat size gland effect sub tot parathyroidectomi patient group suggest normal plasma calcium result increas product parathyroid hormon advanc renal failur normocalcem compar hypocalcem case could mean develop effect degre secondari hyperparathyroid function durat renal diseas seem like parathyroid respons suffici overcom effect vitamin resist also entail develop general osteiti fibrosa heal defect miner increas liabil metastat calcif
866  | albright hereditari osteodystrophi report famili studi bone remodel two member singl famili repres differ form albright hereditari osteodystrophi present kindr pattern similar report famili consist sex link autosom domin mode inherit import cours intramuscular parathyroid extract proof parathyroid hormon resist emphas biopsi specimen rib label vivo tetracyclin studi microscop new observ indic cellular defect bone remodel share propositus case  may explain low rate bone turnov found immunolog studi establish presenc substanc antigen similar parathyroid hormon parathyroid tissu propositus pathogenesi albright hereditari osteodystrophi atyp form parathyroid hormon resist hypocalcemia discuss
867  | acut hyperparathyroid surgic emerg acut hypercalcem crisi hyperparathyroid surgic emerg diagnosi often difficult polymorph charact symptom variabl clinic featur syndrom describ emphas frequent occurr gastrointestin symptom especi duoden ulcer recur pancreat anteced histori well better known occurr renal skelet manifest preced crisi case despit variabl clinic manifest total syndrom form distinct pattern recogniz known previous report case review addit case report differenti diagnosi aid identif tumor prospect effect control hypercalcemia discuss present time earli surgic remov tumor effect treatment
868  | actinomycin inhibit intestin transport calcium vitamin action actinomycin inject inhibit action vit increas concentr transport ca across intestin wall vitro rais serum ca concentr fast vit d defici rat actinomycin block transport ca across mucos surfac vit defici well vit d treat rat action ca transport system rather stimulatori effect vit inhibitori effect actinomycin ca transport present within  hr c inject less mark  hr suggest direct interact ca transport system condit actinomycin influenc transport  tyrosin across intestin wall vitro
869  | studi hydroxyprolin excret corticosteroid induc dwarfism treatment human growth hormon two children receiv larg dose corticosteroid year grow retard rate treat human growth hormon growth rate increas   fold urinari hydroxyprolin excret initi low increas normal level treatment stop growth rate hydroxyprolin excret decreas prompt
870  | comparison human placent lactogen hpl human growth hormon hgh hypopituitari patient conclus base studi report placent lactogen hpl dose level  mg day induc posit nitrogen balanc two hypopituitari subject addit lactogen augment nitrogen retain effect growth hormon given dose  mgday
871  | radiat necrosi brain acromegali radiat therapi pituitari tumor caus necrosi brain  case report particulari care consid schedul dosimetri exceed error due repeat cours treatment rapid administr cerebr lesion develop latent period month progress often fatal appropri pituitari surgeri prefer multipl treatment radiat
872  | experi hgh treatment twelv hypopituitari dwarf period vari   month report patient consid hypopituitar birth four hereditari type four possibl due traumat birth neonat asphyxia four unknown caus six patient detail inform concern growth first year life could obtain patient degre growth retard one year age consid rule rather except pituitari dwarfism import diagnost evid mark degre growth retard accompani pronounc delay skelet matur case sign secondari hypothyroid increas insulin sensit poor respons metopyron administr none patient pass normal age puberti matur sexual twelv patient respond well hgh therapi first year treatment averag height increment  cm catch up growth continu treatment normal rate growth  cmyear obtain disproportion acceler skelet matur patient none far becom resist hgh administr oldest patient reach normal height whether possibl moder sever also sever case pituitari dwarfism yet state possibl use human gonadotroph hormon attempt produc sexual matur patient discuss briefli
873  | treatment retard growth human growth hormon result treatment human growth hormon follow  case discuss femal hypopituitari dwarf  yr grew  cm  mth boy  yr constitut retard growth growth rate increas case primordi dwarfism girl  yr growth curv unaffect treatment
874  | genet pituitari dwarfism high serum concentr growth hormon new inborn error metabol descript given three sibl hypoglycemia clinic laboratori sign growth hormon defici abnorm high concentr immunoreact serum growth hormon sinc exogen growth hormon activ patient endogen secret abnorm growth hormon molecul postul
875  | growth hormon defici man isol recess inherit defect defici human growth hormon associ pituitari defici observ midget sexual ateliosi form dwarfism inherit autosom recess trait bodi proport sexual develop birth weight postpartum lactat normal syndrom
876  | treatment short statur children adolesc human pituitari growth hormon raben experi thirty f case human pituitari growth hormon raben evalu longitudin studi growth therapeut agent treatment short statur clinic signific increas growth rate achiev   hypopituitari patient signific improv linear growth rate note dose  mg  time week children whose short statur due condit advers reaction note thyroid adren gonad activ observ growth stimul probabl without undu increas bone age though point demand continu scrutini owe limit suppli materi recommend use case document growth failur protocol evalu therapeut respons discuss though panacea treatment short statur human growth hormon fulfil uniqu invalu role replac therapi hypopituitari dwarf
877  | develop bilater adenomat adren hyperplasia case cush syndrom eighteen year durat case cush syndrom  year durat present diseas began patient  year old partial control pituitari radiat  howev clinic evid indic low grade continu adrenocort activ next  year probabl suppress gh secret increas steroid level growth period provid reason explan dwarfism patient administr  mg dexamethason per day fail decreas urinari steroid excret bilater nodular hyperplasia found surgeri suggest evid present patient diseas began first primari pituitari process long durat acth secret evolv one autonom function bilater nodular hyperplasia
878  | hypopituitar studi growth hormon endocrin function pituitari function evalu  adult evid hypopituitar enlarg sella turcica growth hormon secretori function measur radioimmunoassay plasma sampl taken insulin induc hypoglycemia standard test growth hormon reserv patient exhibit signific defect growth hormon secret indic failur hormon rise normal level respons hypoglycemia order frequenc hormon loss growth hormon gonadotropin adrenocorticotrop hormon thyroid stimul hormon pattern defici characterist particular etiolog hypopituitar one patient asymptomat enlarg sella turcica accident discov isol loss growth hormon secretori capac two patient seri demonstr intrins defici thyroid well pituitari secret elev liter antithyroid antibodi studi repres first direct evalu radioimmunoassay growth hormon function seri hypopituitari adult demonstr remark high preval growth hormon loss suggest growth hormon respons hypoglycemia may one sensit test diagnosi hypopituitar
879  | hypoglycemia dwarfism associ isol defici growth hormon author studi  year old dwarf boy histori sever recurr hypoglycem episod sinc age  retard bone age hepat adren thyroid function normal demonstr fast hypoglycemia blood sugar   mg ml sensit l leucin show insulin sensit hypoglycem unrespons glycogenolysi respons adrenalin glucagon appropri fast plasma gh level less  gml normal   rise seen insulin induc hypoglycemia similar low gh level rise   hr glucos toler test treatment hgh revers alter carbohydr metabol conclud patient suffer isol gh defici result dwarfism alter carbohydr metabol
880  | effect growth hormon hypothalamo pituitari dwarfism metabol effect human growth hormon human growth hormon isol raben method given   mg daili dose period   day  patient pituitary hypothalam dwarfism metabol effect follow nitrogen retent variabl reduct blood urea plasma amino acid concentr alter im inject hormon fast accompani retent intracellular compon proport requir protoplasm format isoton expans extracellular compart without chang plasma electrolyt concentr retent phosphorus sometim rise plasma phosphat increas intestin calcium absorpt hypercalciuria alter plasma calcium increas plasma citrat citrat urinari excret calcium phosphat retent revers stop treatment mobilis fat store lipid catabol accompani well mark increas nefa concentr hour hormon inject fast state period hypoglycaemia low nefa level complex biphas action glucos metabol fast blood sugar level alter glycaemia various test fast insulin inject tolbutamid administr intestin hyperglycaemia acceler intermedi metabol increas blood citrat concentr  hour urinari excret  ketoglutar acid one test fast blood citrat increas  hour hormon inject oral load sugar blood citrat  ketoglutar acid concentr alter progress gain weight found treatment part revers stop treatment correl intracellular nitrogen retent expans extracellular space despit mobilis fat reserv
881  | serum chorion growth hormone prolactin serum pituitari growth hormon mother fetus term chorion growth hormone prolactin cgp pituitari hgh measur matern fetal blood obtain simultan term  pregnant women fetus util sensit radioimmunoassay procedur mean concentr serum cgp matern venous blood  gml sem wherea umbil venous serum mean concentr  gml sem   fold differ contrariwis mean concentr serum hgh matern serum  gml sem  umbil venous serum level  gml sem  ratio serum cgphgh matern venous serum  contrast  umbil venous serum find strong suggest cgp secret syncytiotrophoblast almost exclus unidirect manner matern circul unlik appreci exchang hgh occur matern fetal circul data support view growth hormone lik metabol chang observ pregnanc attribut effect cgp consist hypothesi cgp import metabol hormon pregnanc exert action mother possibl placenta indirect fetus
882  | effect abdomin oper glucos toler serum level insulin growth hormon hydrocortison abdomin oper moder sever follow high fast blood glucos level reduc toler intraven glucos persist least  hour oper fast plasma insulin level rais surgeri intraven glucos produc much higher level serum insulin growth hormon immedi postop period corticotrophin infus increas plasma hydrocortison level reduc glucos assimil greater extent oper effect serum insulin growth hormon level
883  | plasma growth hormon concentr rat determin radioimmunoassay influenc sex pregnanc lactat anesthesia hypophysectomi extrasellar pituitari transplant assay use describ detail sever experiment condit studi valid method determin factor regul gh secret speci fast sprague dawley rat weigh   g mean plasma gh concentr femal   male   gml gh level lactat rat determin normal rang femal therebi provid evid assay detect prolactin gh level elev pregnant rat hypophysectomi led fall detect level gh intraocular pituitari transplant fail rais gh level hypophysectom host gh level male femal rat depress brief period ether anesthesia find result pituitari transplant experi evid nervous system involv regul gh secret
884  | clinic featur alali russian term alali appli various state absenc insuffici develop speech children result defect develop affect speech center develop speech clinic studi possibl distinguish sever form motor sensori semant alali sign amnesia caus multipl trauma perinat cerebr hemorrhag inflammatori process metabol disord develop speech alimentari trophic disord alali show vari degre sever children suffer alali neurolog sign demonstr right side indic organ natur condit presenc local symptom various form alali often associ sign indic involv adjac region cerebr hemispher patholog process would explain alali often complex charact alali depend function disord result lesion frontal anterior motor tempor pariet region domin cerebr hemispher patient alali often show neurot reaction result disord process inhibit excit cerebr cortex subcort format earli treatment alali drug combin logoped pedagog measur give good result
885  | unusu form acquir aphasia children unusu form acquir aphasia both recept execut describ occur  children  girl  boy onset occur   yr age one epileptiform attacks which repeated but follow degre hear loss later improv failur comprehend spoken languag final loss impair execut speech examin csf peg yield normal result eeg abnorm main tempor lead disord appear self limit throughout non verb intellig impari
886  | childhood echolalia delay psychot neuropatholog speech pattern linguist analyt procedur preliminari find control tape record sampl group echolal children report togeth clinic experiment rational investig subject echolal  yr old group young clinic referr repres varieti patholog condit variabl select studi includ proport echo non echo silenc qualiti appropri non echo speech amount stimulus echo natur trigger stimulus deviat echo pattern stimulus pattern pitch loudness tim variat child chronolog mental age earli quantit result yield similar echo non echosil percentag echolalia repres mean  convers experiment group
887  | speech landmark develop attempt demonstr observ children speech languag develop may serv valuabl indic general physic intellectu emot progress speech lag breakdown may corrobor suspect area develop may point way speech languag disord seldom origin mouth idea must preced speech speech direct correl intellig
888  | applic individu program instruct educ deaf children verbal behavior learn behavior guid principl learn behavior parent role main help young deaf child conceiv languag social process help shape languag behavior toward use verbal symbol teacher role deaf child progress languag user includ  help child discov structur languag oper  guid process acquir clear concept learn languag high individu process requir thousand hour practic effici languag teach deaf general achiev tradit method teacher deaf need extra help order provid individualist kind teach insur verbal over learn child self tutor program materi offer help program construct child proceed program step step probabl maximum success constant feedback correct respons younger children use machin seem desir older children program may appear book form film strip visual medium well construct program correl classroom instruct
889  | impact individu differ languag learn matrix extrins intrins factor affect languag learn prelingu deaf child consid particular emphasi place effect parent attitud emot stabil home provis restrict experi
890  | oral languag perform prematur children control fifty on prematur children born   compar  normal born subject birth weight  gram test tap pattern auditori memori span auditori discrimin word recognit languag comprehens articul resist articul disintegr word find stori tell number word use mean length  longest sentenc sentenc elabor grammat error definit categori mean age group  prematur children perform inferior children born term
891  | speech read problem childhood follow communic disord discuss function articul defect delay speech develop stutter hear loss cleft palat neurolog disord read disord disord rare singl caus result intermingl mani factor physiolog psycholog resid within child parent environ general delay defect speech caus great concern parent teacher public health worker listen attent sympathet ear may allay anxieti thus help foster healthi emot develop child exist serious condit under present communic problem even sens parent frequent deni public health worker assist parent pain process face fear child communic problem still child public health worker simpli reflect parent advis normal child rais practic help child children speech deviat expos overabund well intent speech correct home ineffect unfortun harm worker may posit offer specif advic particular child manner parent teacher handl child communic problem explor damag practic possibl elimin fact may diagnost treatment center child refer vitiat public health worker role public health physician public health nurs valuabl contribut make help parent school child accept chronic natur disord
892  | disord communic young children normal develop spoken languag outlin causat differenti diagnosi individu assess manag development disord communic young children briefli discuss
893  | acquir aphasia children report concern case  boy  girl studi period sever year rehabilit carri general conclus fall  head  symptomatolog compar aphasia adult  cours disord  prospect level intellectu perform futur children  case cerebr damag result traumat contus  case intracrani nontraumat hematoma vascular malform aneurysm angioma  case aphasia follow oper cerebr astrocytoma  case occlus left middl cerebr arteri occur remain  case precis diagnosi made
894  | caus delay develop speech speech develop parallelli simultan psychophys develop child aris intern need influenc extern factor children given chanc develop favor condit pass phase develop without injuri various possibl child may injur hamper develop speech discuss test sens hear children cleft palat also included out  case cleft palat  case decreas sens hear exceed  db addit injuri child cleft palat remain unnot may make treatment speech abnorm difficult necess diagnost team investig treatment children speech disturb emphas
895  | concept learn cultur disadvantag children function verbal pretrain research indic verbal pretrain posit influenc discrimin learn perform subject normal intellig compar influenc shown type conceptu task retard subject purpos experi investig effect stimulus pretrain concept learn subject high risk classifi mental retard futur time group  higher risk  lower risk subject random divid  pretrain group verbal label attent control subsequ pretrain stimuli use transfer task  subject group present concept learn task transfer task  reach criterion learn transfer task  subject present second new concept learn task analysi data reveal signific perform differ risk group pretrain signific posit effect perform
896  | concept develop languag instruct author describ factor relat error may occur concept develop children contribut languag deaf child conceptu develop stress includ review concept psycholog exampl concept may present educ classroom
897  | formal speech characterist diagnost aid childhood psychosi frequenc use various grammat unit spontan convers speech adult children note mani author fair stabl hypothesi idiosyncrat distribut might found certain specif disord ego function test relationship childhood psychosi support found well contemporari psycholog psychoanalyt interpret phenomena seen childhood psychosi
898  | cerebr domin speech acquist deaf children examin predict left cerebr domin index hand sight prefer posit accompani speech learn individu whose cerebr speech area like left hemispher found   year period formal educ right handed right sight deaf student consist earn higher speech grade right handed left sight right handed mixed sight counterpart match basi hear loss find support hypothesi cerebr mechan relev speech acquisit simplifi facilit andor less prone interfer control speech hand eye local primarili  hemispher brain
899  | color test measur antibodi non acid form human mycoplasma speci metabol inhibit test measur growth inhibit antibodi non acid produc human mycoplasma speci describ test base upon abil organ metabol arginin result alkalin shift ph medium alkalin shift inhibit specif antiserum labil accessori factor present unheat guinea pig serum potenti inhibitori effect antiserum test sensit specif measur antibodi mycoplasma rabbit immun human convalesc serum
900  | serolog epidemiolog studi pneumonia demonstr hemagglutinin inhibit antibodi new direct specif hemagglutin reaction live pneumonia describ requir presenc natur antibodi red cell hors serum employ diluent although vervet monkey erythrocyt general employ human rabbit cell may use hemagglutin inhibit specif antibodi heat inactiv sera requir whether human anim origin antibodi persist mani year passiv transfer fetus micro variat devis test use diagnost epidemiolog studi revers util rapid serolog identif new isol method limit present pneumonia
901  | serolog epidemiolog studi pneumonia ii preval antibodi sever popul preval antibodi pneumonia determin  popul mean new serolog test among member popul normal famili one age  antibodi none latter acquir infect follow year  children home  antibodi  cottag mate one children acquir infect remain uninfect group  elder person   antibodi similar proport  person attend rheumat fever prophylaxi clinic posit popul demonstr antibodi could persist undiminish titer least  yr  point barrow resid  antibodi age  rate approxim  two compani naval recruit similar posit antibodi rate begin train acquir antibodi rather diverg pattern  one  pneumonia infect seem sporad produc epidem infrequ civilian popul
902  | growth surviv mycoplasma neurolyticum liquid media maxim growth neurolyticum   colony form unitsml obtain  day incub  c broth media contain  agama hors serum whole hors serum use medium complement medi inhibit observ inhibit could detect growth follow daili plate count maxim growth delay  hr hors serum inhibit spontan revers temperatur incub penicillin g also found temporari inhibitori effect detect littl  unitsml maxim growth delay th day incub  unitsml present th day  unitsml present surviv neurolyticum undetect level cultur incub period present eclips phenomenon explain recrudesc growth cultur late incub period illustr event may occur mycoplasma isol clinic materi prolong incub presenc inhibitor surviv data show neurolyticum greatest stabil ph  reduc viabil ph     order data growth stabil suggest close relationship speci mycoplasma studi bacteria
903  | hela cell resist bromodeoxyuridin defici thymidin kinas activ mutant sublin hela cell resist growth inhibit bromodeoxyuridin budr isol resist cell line hela bu  hela bu  hela bu  hela bu  hela bu  prolifer presenc    mgml budr respect extract hela bu  hela bu  hela bu  cell exhibit   thymidine h deoxyuridine h bromodeoxyuridine h phosphoryl activ parent hela cell hela bu  hela bu  cell extract also defici thymidin kinas activ yield approx   respect thymidin kinas activ parent hela cell defici thymidin kinas activ hela bu  cell due negat feedback inhibit high level budr interfer thymidin kinas assay inhibitor compet enzym hela bu  cell extract follow  week passag media lack budr hela bu  cell exhibit increas thymidin kinas activ moreov mixtur extract hela hela bu  cell display thymidin kinas activ equival sum activ extract prepar respect hela hela bu  cell radioautograph studi shown hela cell incub  hr thymidine h   nuclei heavili label radioact howev fewer hela bu  cell display label nuclei nuclei light label hela bu  cell extract contain normal amount thymidyl synthetas thymidil kinas uridin kinas activ follow infect vaccinia virus high level thymidin kinas activ induc hela bu  cell
904  | note taxonom status strain like campo hitherto classifi mycoplasma homini type  classif strain similar mycoplasma strain pg  campo myc homini type  withdrawn strain identifi myc arthritidi
905  | chromosom studi human cell infect utero vitro rubella virus cytolog studi metaphas chromosom undertaken determin damag genet apparatus human cell may induc rubella virus whether damag produc patholog seen newborn mother infect earli pregnanc fibroblast cell strain initi vitro embryon materi obtain therapeut abort fetus rubella infect mother embryon materi spontan non rubella therapeut abort yield similar cell strain infect vitro result type studi follow virus shed cell strain obtain type organ cultiv indic wide dissemin virus fetus rubella infect mother b chronic infect could readili establish vitro infect cytopath effect note c although mani strain continu shed virus throughout month vitro cultiv chang growth properti occur except infect strain lung tissu show limit growth capac observ  metaphas neither obvious chromosom rearrang non disjunct chang observ strain infect natur experiment e among  rubella abortion deriv cell strain mark elev frequenc chromosom breakag  instanc    f correl virus shed vitro increas chromosom breakag note although complet g combin averag frequenc chromosom breakag one set  rubella abort strain  set  abortus strain  h similar slight signific elev averag chromosom break frequenc  obtain four cell strain experiment infect vitro rubella virus uninfect cell  although effect upon chromosom demonstr restrict slight general elev frequenc breakag normal valu high increas break sporad appear like general fetal abnorm associ rubella infect vivo result possibl effect virus upon growth rather effect upon chromosom howev studi restrict fibroblast cultur vitro effect type cell may greater implic question
906  | fine structur staphylococcc l form l form staph aureus bacteri cell process techniqu electron microscopi ultrathin section allow comparison structur unit indic staphylococc l form unit size lack rigid cell wall compact fibrillar nuclear area bacteri cell l form unit bound typic trilamellar membran compar describ mycoplasma speci nuclear area staphylococc l form present diffus appear could correl size particular structur unit mani small unit seen within larg bodi possibl involv reproduct process evid divis format septa pinch cytoplasm fragment obtain electron micrograph
907  | respiratori virus vaccin ii mycoplasma pneumonia eaton agent vaccin purifi concentr formalin kil vaccin prepar pneumonia propag serum fre artifici medium vaccin aqueous incorpor alum emulsifi peanut oil adjuv  adjuv two  differ concentr mycoplasma includ prepar serum neutral cf antibodi respons measur hamster monkey institution person follow  sometim  vaccin prepar high antigen anim man alum vaccin better aqueous vaccin adjuv  appear give best result although bleed time alway optim demonstr maxim effect person without detect antibodi initi thus would vulner infect gave better respons vaccin pre exist antibodi alum vaccin accept formul use man  dose vaccin necessari induc neutral antibodi  person initi without detect antibodi local system reaction clinic consequ note person vaccin recent unpublish find indic high degre effect alum vaccin stimul antibodi preschool children protect children adult natur diseas mention
908  | isol mycoplasma pneumonia adult respiratori infect isol mycoplasma organ sputum attempt  patient various syndrom respiratori diseas isol obtain   patient pneumonia  patient chronic bronchial diseas treat tetracyclin  person acut upper respiratori infect differ statist signific indic nonpathogen role pharyngi salivarium strain frequent isol highest frequenc isol male   yr age isol pneumonia requir one  weekstherefor use rapid diagnosi also underestim preval infect especi patient receiv tetracyclin serolog test complement fix cf specif growth inhibit test tri sensit signific relat atyp pneumonia  test may measur differ antibodi pneumonia serum cold agglutinin develop mani case pneumonia poor discriminatori etiolog diagnosi pneumonia infect occur minimum  maximum  civilian patient hospit pneumonia season studi serolog evid pneumonia rare lobar pneumonia nonlobar pneumonia pneumonia account etiolog   case incid pneumonia infect constant differ season greatest relat occurr pneumonia fall spring
909  | color test measur antibodi t strain mycoplasma metabol inhibit techniqu measur antibodi t strain mycoplasma develop base upon abil t strain mycoplasma metabol urea concomit product ammonia abil specif antiserum inhibit ammonia product phenol red ad medium serv indic ph chang result ammonia product specif antiserum t strain mycoplasma t  prepar t strain organ shown serolog distinct recogn large coloni mycoplasma antibodi mycoplasma strain t  human sera demonstr metabol inhibit techniqu
910  | effect mycoplasma interferon product interferon assay cell cultur influenc mycoplasma product action interferon studi cultur l human embryon kidney hek cell homini  negroni agent f mycoplasma use infect l cell homini  pneumonia inocul hek cell strain capabl multipl cultur system employ none produc detect level interferon respons cell induct interferon virus remain unalt infect mycoplasma impair sensit cell action interferon replic vesicular stomat virus notic diminish
911  | recoveri character herpes lik virus dog kidney cell cultur transmiss agent recov primari dktc develop spontan cpe character serolog studi virus indic virus new member herp virus group
912  | immunopatholog chang rheumatoid arthriti synovium synovi tissu  children  adult rheumatoid arthriti examin local immunoglobulin complement three case found c immunoglobulin within cytoplasm synovi cell four case discret local within connect tissu stroma remain  case demonstr larger weak stain collect found diffus throughout synovium immunoglobulin complement local present   addit patient form joint diseas rheumatoid arthriti correl result clinic find joint fluid c assay made
913  | electron microscop studi mycoplasma pplo strain  artifici medium tissu cultur mycoplasma strain  isol leukem patient studi broth cultur sever cell cultur line strain exhibit consider pleomorph size intern structur shape includ form filament project common form observ   diamet nuclear area fibrillar strand probabl dna cytoplasm organ contain ribosome lik granul flatten vacuol indent nuclear area various form includ elementari bodi diamet electron dens tissu cultur line cell grew monolay mycoplasma close associ cell surfac occasion seen membrane lin cytoplasm vacuol cell line attach glass mycoplasma fewer attach cell surfac although ultrastructur strain similar previous describ strain differ detail structur may relat either growth condit use characterist strain various form organ consist suggest mycoplasma may sever mechan reproduct growth intracellular mycoplasma may protect antibiot would part explain difficulti erad mycoplasma infect cell cultur
914  | long term prognosi respons schizophren children drug therapi control studi trifluoperazin evid studi treatment control group must match sever ill sinc affect respons pharmacolog well type treatment use double blind techniqu guarante well control studi comparison  treatment regim may mislead group match match base critic factor studi respons nonpharmacolog aspect treatment type respons drug relat initi sever languag impair thus major development defect determin long term outcom schizophren children group also predict immedi respons treatment within  major prognost subgroup young schizophren children speech without children differ profil disord develop differ pattern asset handicap
915  | long term treatment psychot child psychiatr hospit descript one phase long term psychotherapi  yr old psychot boy within framework mental hospit first part deal briefli lay out structur new unit emot disturb children underlin well known import therapeut milieu treatment care mental ill particular import patient children child present diagnos admit case sever childhood psychosi autist type unusu rich data dispos obtain non verb communic child languag nevertheless express clear play gestur analysi precious clinic materi focus discuss exist qualiti object relationship preced psychosi import earli unusu sensit format prematur fragil ego method choic treatment childhood psychos
916  | comment case infantil psychosi account given case infantil mutism depend much upon true autism withdraw defenc danger threaten environ spectacular unusu improv symptomatolog psychotherapi
917  | problem infantil autism psychiatr nosolog psychiatr literatur syndrom earli infantil autism divid sever subgroup instanc subgroup kanner subgroup asperg assign differ mental condit schizophrenia psychopathi neurosi distinct classif thought controversi long etiolog earli infantil autism unknown psychiatr school claim right concept schizophrenia sinc etiolog schizophrenia yet discov particular pre scientif situat psychiatri seem promis analyz individu mental case concentr clinic symptomatolog instead discuss arbitrari nosolog entiti
918  | famili children earli childhood schizophrenia emot disturb children divid  group basi diagnos  autism symbiosi  chronic undifferenti schizophrenia  form emot disturb  group compar statist follow demograph measur  educ level parent  occup level father  preval broken home  male femal ratio patient group  ordin posit among sibl  ordin posit among sibl sex  age parent birth child result indic famili children diagnos autist symbiot show mani similar diagnosi chronic undifferenti schizophrenia general parent  group better educ employ high rate occup parent otherwis disturb subject broken home preval group disturb nonschizophren children autist chronic undifferenti schizophren group male femal ratio signific differ among  group autist group specif  data reveal trend ordin posit
919  | childhood psychosi descript given diagnost criteria put forward creak associ  call schizophren syndrom childhood psychot reaction childhood group  childhood schizophrenia  organ state psychosi  mental subnorm psychosi  sensori depriv  neurosi  manic depress psychosi suggest generic term psychosi best avail classif present discuss
920  | psychot reaction childhood experi mental retard pilot project clinic team evalu present group  psychot children initi thought mental retard emphasi place consider mani aspect total pictur possibl diagnosi result synthesi individu piec inform caution suggest regard interpret incomplet psycholog test find especi regard prognosi result studi offer guidelin differenti diagnosi psychosi result primari emot disord psychosi superimpos chronic brain syndrom children question rais earli infantil autism unitari syndrom basi etiolog need better comprehens diagnost classif psychot reaction infanc earli childhood stress must develop valid comparison treatment prognost consider made among group clinician work field
921  | modif autist behavior lsd  lsd  appear offer use adjunct psychotherapi autist children posit effect area close relat process psychotherapi pair ident male autist twin period administ  lsd  observ behavior chang control drug observ made subject place seri standard test situat refer social test social isol test peek a boo pat a cak face to fac hand hold follow test divers behavior record area self stimulatori behavior social interact affect record made use esterlin angus multipl pen record behavior measur total time appear plot percent time appear consist behavior chang result lsd subject demonstr increas eye to fac contact increas laughter smile behavior decreas self stimulatori behavior
922  | influenc organ emot factor origin natur outcom childhood psychosi group  children diagnos child psychosi one synonym follow averag  yr none parent schizophren   parent psychiatr treatment neurosi  children sib transient autist episod none sib adult type schizophrenia find felt milit view child psychosi part schizophren group among  children  iq       iq found general good predictor later perform mental retard regard primari compon clinic pictur evid brain damag conclus  children  show epilept attack develop  follow up speech disord outstand manifest five children confirm recept aphasia  other show evid  speak children echolalia note  abnorm deliv spoken word view reduct speech due social withdraw reject psychogen factor parent attitud found relev etiolog psychosi consid primarili emot origin although emot relationship well educ manag consider influenc outcom diseas
923  | complianc resist condit autist children exploratori studi twelv autist children   yr age ask choos red object squar object stimulus array ten subject made correct choic signific less often chanc avoid emit correct respons subject given  condit trial choic either red squar object reinforc attain either concept subsequ perform perfect ask produc red squar concept subject continu give fewer than ch correct respons thus condit trial elicit subject increas tendenc compli experiment instruct result suggest attent paid distinct respons autist children unabl make respons unwil make
924  | etiolog autist syndrom children examin treatment  children youth autist syndrom earli childhood period ten year led impress disord primari organ syndrom manifold etiolog view support mani relev clinic experi data discuss detail
925  | acquisit imit speech schizophren children two mute schizophren children taught imit speech within oper condit framework train procedur consist seri increas fine verbal discrimin children reward closer closer reproduct attend adult speech found reward deliv conting upon imit necessari develop imit furthermor newli establish imit shown acquir reward properti children
926  | hallucin children state hospit hallucin children referr upon admiss state hospit studi review random select chart current patient signific differ incid hallucin boy girl racial group schizophren children   children diagnos psychosi convuls disord highest incid hallucin  diagnos childhood schizophrenia incid  children diagnos primari behavior disord lowest incid  specif auditori visual olfactori hallucin describ natur hallucin boy girl similar psychot children tend bizarr hallucin nonpsychot children differ natur hallucin among differ group psychot children although popul consist sever disturb depriv children high incid hallucin hallucin simpl content organ delusion system
927  | treatment childhood schizophrenia three year comparison day residenti treatment care design studi  day treat children match individu  residenti children present case diagnosi schizophrenia care confirm basi impair human relationship disturb person ident resist chang unusu preoccup perceptu cognit disord panic reaction age rang   children select result match regard age onset cultur famili organ intact famili structur requir residenti treatment impli round the clock therapeut interact child  day week  mth year day treatment consist   pm care  day week  mth year staff distribut ident  group day car group teacher assum larger relat posit world establish child children match ego status begin experi mean wisc psychiatr evalu chang status measur wisc metropolitan achiev test seri result indic signific improv either day resid schizophren children admiss unscor wisc test sever impair ego structur among children scorabl wisc organ group day residenti treatment show equival degre progress non organ children resid gave evid improv match children day treatment
928  | visual versus tactual receptor prefer normal schizophren children receptor prefer visual tactual stimuli measur schizophren normal children  pair standard choic situat visual tactual stimuli use time engag either stimulus constitut prefer measur schizophren children age   compar age normal children group retard use control schizophren signific lower visual prefer age normal age trend increas visual prefer found normal sampl retard show greater visual prefer schizophren compar implic theori schizophrenia discuss
929  | effect folic acid growth deoxyribonucl acid synthesi rat kidney effect singl inject folic acid  mgkg bodi wt growth rat kidney studi pattern respons found essenti similar anim age  wk  mth maximum valu kidney weight nucleic acid content relat bodi weight found  day folat administr increas wet dri weight time approx   resp control weight percentag dri matter kidney signific lower normal period  day rna content kidney also maxim  greater control valu dna content  day increas  wherea dna valu  wk old rat slight lower   day  day  mth old anim small increas observ  day suggest prolong dna synthesi older anim autoradiograph studi dna synthesi thymidine h shown great increas label index zone kidney follow folat inject maximum valu observ  hr cortic zone pattern chang medulla less well defin label indic kidney  mth old rat remain normal longer period  wk old rat result concur evid increas dna content kidney older rat   day folat
930  | renal renin unilater nephrectom hypertens rat juxtaglomerular index renal pressor activ width zona glomerulosa normal unilater nephrectom hypertens rat maintain normal sodium intak increas subject sodium deplet decreas receiv  salin indic renin format secret like result sodium state anim rather loss renin stimul agent contralater unclip kidney failur sodium influenc degre hypertens unilater nephrectom hypertens rat milit direct quantit relationship blood pressur renin angiotensin aldosteron system
931  | hypertens vascular diseas produc homolog renin administr rat renin uninephrectom rat reproduc chang hypertens vascular diseas hypertrophi zona glomerulosa adren found partial constrict renal arteri taken evid renal pressor system play major role pathogenesi renal hypertens
932  | effect hypophysectomi growth hormon renal compensatori hypertrophi rat effect hypophysectomi renal compensatori hypertrophi rch observ unilater nephrectom rat receiv therapi receiv replac therapi compar rch attain non hypophysectom unilater nephrectom rat    day latter group initi rapid rch seen day  continu slower rate day  hypophysectom group without replac therapi also initi rch first  hrs howev instead rch continu regress kidney size  day subsequ chang  day hypophysectom group receiv hormon replac initi rch compar  group renal enlarg  day much less non hypophysectom anim result experi report studi impli exist renotrop factor produc pituitari requir intact pituitari full effect
933  | extraren fibromuscular hyperplasia clinic radiolog patholog studi  patient lesion extraren arteri resembl fibromuscular hyperplasia describ  patient fibromuscular hyperplasia present renal arteri patient involv celiac arteri one symptom viscer ischemia fibromuscular hyperplasia intern carotid arteri observ  patient  symptom cerebr ischemia nine patient fibromuscular hyperplasia carotid renal arteri intracrani aneurysm  other intracrani hemorrhag develop absenc demonstr aneurysm histolog similar intracrani aneurysm type aneurysm appear patient fibromuscular hyperplasia frequenc intracrani aneurysm patient extracrani fibromuscular hyperplasia similar sex age incid suggest common etiolog origin
934  | specul natur signific development small kidney renal hypoplasia renal hypoplasia may take sever form among best known perhap renal dysplasia parenchyma maldevelop form hypoplasia renal parenchyma normal form mere diminish amount exist may sever clinic consequ find postmortem examin anatom small kidney children suffer excess unexplain dehydr prompt thought renal tubular insuffici may result renal hypoplasia
935  | studi induc renal hyperplasia use autoradiographi establish base line futur autoradiograph investig compensatori renal hyperplasia studi use tritiat thymidin label cell infrequ tubular tissu control kidney kidney remain unilater nephrectomi    fold increas cortex    fold increas medulla label tubular cell number seen control tissu find obtain agreement observ made earlier investig routin method stain mitot observ
936  | compensatori structur function chang kidney radiograph assess renal size factor influenc renal hypertrophi discuss import compensatori hypertrophi prognost signific emphasis chang correl renal function measur glomerular filtrat rate renal plasma flow
937  | bilater renal hypoplasia pig bilater renal hypoplasia pig describ compar previous descript defect observ  piglet total  born  litter sire one larg white boar twelv affect piglet die soon birth  die age   day inherit simpl autosom recess factor suggest evid grossli condit character vari degre hypoplasia persist fetal lobul microscop domin featur poor develop collect tubul system conclud basic defect failur develop mesonephr mesenchym
938  | effect nortestosteron phenylpropion compensatori hypertrophi remain kidney unilater nephrectomi forty eight hr unilater nephrectomi non castr castrat male mice relat dri weight remain kidney increas signific compensatori hypertrophi signific stimul earli  hr oper treatment  nortestosteron phenylpropion  npp time oper percentu increas kidney weight approxim non castr castrat mice absolut initi valu well result valu  hr oper higher non castr male mice castrat anim number cell dna concentr per g tissu decreas period non stimul compensatori hypertrophi group anim npp caus still decreas concentr dna per cell chang follow non stimul compensatori hypertrophi chang rna concentr per g tissu per cell castrat mice non castr mice concentr increas npp caus approxim percentu increas rna concentr non castr castrat anim period compensatori hypertrophi differ group mice rna concentr remain kidney follow stimul compensatori hypertrophi npp statist signific
939  | thyroid pituitari gland activ compensatori renal hypertrophi autoradiograph studi tritiat thymidin show increas synthesi dna cellular prolifer thyroid pituitari compensatori renal hypertrophi
940  | influenc thyroid hormon renal function cours compensatori hypertrophi cours compensatori hypertrophi kidney glomerular filtrat renal plasma flow increas less extent thyroidectom anim control anim secretori capac renal tubul thyroidectom anim increas insignific compensatori hypertrophi increas mark administr thyroid hormon
941  | kidney cell prolifer unilater nephrectomi relat age effect unilater nephrectomi number cortic kidney cell undergo dna synthesi mitosi measur tritiat thymidin autoradiographi weanl adult rat among unoper control anim weanl rat group show base line label index  adult anim one  respons unilater nephrectomi result peak valu  weanl anim  adult anim occur  hr mitot indic  weanl control anim  adult peak   resp  hr separ count tubul stromal cell cortex reveal maximum increas  label cell occur later stromal cell tubul cell stromal cell reach maximum  hr nephrectomi find indic although relat prolif activ much lower adult anim similar respons qualit obtain group unilater nephrectomi
942  | influenc adren gland dna synthesi normal compens kidney role adren gland control synthesi dna normal compens kidney rat given salin drink fluid studi use tritiated thymidin radioautographi adrenalectomi alon increas signific label renal cortex medulla otherwis intact rat two day follow unilater nephrectomi rat intact adren gland number label nuclei remain kidney increas factor   cortex medulla respect adrenalectomi moder decreas hyper plast respons cortex remain kidney increas still label index medulla  day unilater nephrectomi rat intact adren gland neither cortex medulla remain kidney exhibit mark hyperplast respons adrenalectom anim also unilater nephrectomi caus slight increas label indic cortex medulla remain kidney
943  | auto radiograph studi protein metabol singl kidney nephrectom rat rat subject unilater nephrectomi follow protein metabol kidney exert compensatori activ studi h label l phenylalanin differ interv hr  wk two phase enhanc incorpor amino acid cell convolut tubul found one maximum  hr time uptak limit cytoplasm nd maximum th day nucleus equal involv cours nd phase enhanc amino acid uptak also increas mitot index epithelia tubul collect tubul one phase enhanc amino acid uptak maximum th day also coincid increas mitot index increas number cell kidney determin studi variat mitot index mean multipl factor begin amount  protein metabol increas  time increas volum factor  increas protein metabol per unit volum factor  hypertroph kidney result total increas protein metabol  time adapt process complet residu kidney approxim protein metabol  normal kidney
944  | two brother nephrogen diabet insipidus patient  year old  year old boy suffer polydypsia polyuria sinc age  yr physic mental retard hyperchloremia lower kidney concentr power observ patient resist pitressin consid suffer nephrogen diabet insipidus caus recess hered factor
945  | studi sweat renal diabet insipidus treatment saluret descript  month old boy suffer famili diabet insipidus sweat well mother increas nacl content chlorthalidon fursemid differ effect quantiti nacl content sweat singl dose chlorthalidon decreas nacl content short time increas quantiti sweat  day fursemid given intermitt produc decreas sweat nacl also interv increas quantiti sweat howev contraregul interv quantiti sweat decreas time urea content increas isoton serum filtrat sweat gland ho nacl reabsorb duct urea concentr increas reabsorpt ho nacl go parallel therefor sweat hypoton regul alter diabet insipidus therefor high valu nacl without chang osmolar na exchang k mechan accentu na concentr high
946  | diabet insipidus treat synthet lysin vasopressin case diabet insipidus associ eosinophil granuloma  year old child partial control symptom achiev pitressin tannat oil  u im altern day synthet lysin vasopressin im control urin output dose  u  hour prepar well toler therefor given nasal rout  month period diabet control dose  u tds
947  | action vasopressin renal diabet insipidus water retain action antidiuret hormon elimin renal diabet insipidus step na transport separ determin vasopressin induc prompt increas freewat clearanc urinari volum well delay increas sodium clearanc suggest vasopressin bring stimul sodium reabsorpt ascend limb henl loop suppos physiolog action antidiuret hormon   antidiuret sodium act effect   becom oper two differ place nephron synergist produc maximum concentr urin
948  | pituitari diabet insipidus associ progress urinari tract dilat case pituitari diabet insipidus associ obstruct urinari tract chang describ patient treat surgic correct lower tract obstruct well control diabet revers anatom chang  year followup period demonstr
949  | antidiuret effect angiotensin diabet insipidus effect angiotensin val  hypertensinii asp   amid studi  children diabet insipidus  yr old boy diabet insipidus neuro hormonali  yr old girl diabet insipidus renali clearanc inulin pah na urea osmolar free wat clearanc examin angiotensin produc prompt antidiuresi combin gross decreas na clear osmol urin increas slight free wat clearanc becom negat effect contrari seen vasopressin antidiuresi antinatriuresi produc salt load salt depriv state furosemid revers effect angiotensin clearanc urea chang angiotensin long glomerular filtrat rate remain normal
950  | polyuria children twelv polyur children investig present report etiologico clin aspect classifi four broad group first group diabet insipidus syndrom includ  case    idiopath type one acquir varieti due hand schuller christian diseas  case second group nephrogen diabet insipidus investig diagnos renal acidosi  case renal tubular syndrom multipl defect  case hypokalaem nephropathi  case third group polyuria due chronic renal failur exemplifi one case fourth group  case compuls water drink probabl etiolog addit illustr case histori practic diagnost approach context physiopatholog normal urin excret recommend
951  | treatment diabet insipidus synthet lysin vasopressin nasal solut twenti patient vasopressin defici diabet insipidus treat nasal solut synthet lysin vasopressin use nasal spray   time daili control polyuria patient without recurr side effect occasion observ posterior pituitari prepar anim origin one pregnant patient well control term without undesir uterin stimul eas administr absenc signific water retent use judici freedom potenti serious allerg reaction foreign protein synthet prepar recommend clinic use
952  | synthet lysin vasopressin nasal spray treatment diabet insipidus thirteen patient diabet insipidus satisfactorili conveni treat synthet lysin vasopressin nasal spray materi administ   time per day total daili dosag rang   u transient decreas effect note period upper respiratori infect allerg rhiniti advers effect nasal spray consist minor nasal irrit  patient increas frequenc bowel movement one child increas dose effort concentr restrict urin volum hydrat normal subject lysin vasopressin administ sc  time effect nasal spray prepar
953  | diabet insipidus treatment  lysin vasopressin nasal spray synthet  lysin vasopressin administ nasal spray  patient diabet insipidus result excel control one  valu therapi supplement pitressin tannat oil patient adequ control spray therapi alon requir spray everi  hr day none night
954  | salt water distribut hereditari induc hypothalam diabet insipidus rat salt water metabol distribut na k water gastrocnemius aorta measur spontan hereditari hypothalam surgic induc diabet insipidus rat degre sever  type diseas estim term salt water handl water turnov  hr equal bodi weight hereditari diseas  bodi weight induc diseas skelet muscl na increas  famili diseas gain involv cell environ correspond loss k similar chang lesser degre note induc diseas degre na accumul appear partial depend durat diseas
955  | antidiuresi induc saluret diabet insipidus hypothalamus pituitari less regular nephrogen diabet insipidus diuret caus fall diuresi main due reduc excret free water adh lik action correl extent natriuret action salt deplet depend direct effect drug water permeabl distal tubul suppress cortison maxim thiazid deriv diminish progress mercuri compound spirolacton triamteren order absent acetazolamid reduct glomerular filtrat increas proxim reabsorpt na follow salt deplet induc diuret less import irregular appear
956  | congenit hydronephrosi histolog studi renal parenchyma case hydronephrosi guid surgic treatment renal parenchyma reduc thick  mm less lead complet atrophi thick  mm conserv procedur justifi
957  | neurohypophysi principl rat famili hypothalam diabet insipidus brattleboro strain antidiuret oxytoc assay perform tissu  femal rat famili hypothalam diabet insipidus di  normal femal oxytoc activ slight lower pituitari di rat antidiuret activ pituitari  di rat expect content oxytocin thus pituitari appear contain oxytocin arginin vasopressin hypothalami  rat show minim antidiuret activ might due oxytocin vasopressin pituitari third di rat contain antidiuret activ could due oxytocin antidiuret respons extract pituitari hypothalamus rat resembl produc arginin vasopressin pituitari appear contain  normal amount vasopressin sinc vasopressin inhibit diuresi di rat would appear specif defici endogen arginin vasopressin
958  | famili renal diabet insipidus renal diabet insipidus known  yr first german report case appear  nevertheless diseas appear frequent also germani report given  infant  famili verifi diagnosi one famili  case featur diseas polydipsia polyuria low sg urin famili anamnest studi reveal  case
959  | evalu  year experi treatment hydrocephalus infant total  infant examin   till   infant examin  oper  group analyz laurenc opinion favor spontan evolut agre merit surgic treatment prove dynam form hydrocephalus oper infant shown patient oper suffer diseas combin macrocephali must distinguish hydrocephalus spontan arrest process observ  children eg  compar laurenc  caus patholog find analyz  infant oper   great discrep time onset first symptom time oper found diseas manifest  infant first month life averag age infant time oper  mth  infant oper first month thirteen oper procedur use  yr review introduct deviat csf jugular vein cardiac atrium  infant surviv  yr oper sinc introduct procedur surviv rate infant  spite late oper  surviv children show averag mental develop surgic treatment dynam hydrocephalus advoc consid method mean help infant present
960  | cerebrospin fluid dynam arnold chiari malform method use radio iodin serum albumin measur volum ventricular system rate disappear csf later ventricl describ newborn infant rate flow less  ml  hr surgic repair myclomeningocel develop progress hydrocephalus requir ventriculo atri shunt test use detect patenc ventriculo atri shunt may allow safe remov shunt select patient
961  | coexist cranial spinal defect hydrocephalus five infant etiolog signific craniolacunia defect clinic roentgenograph etiolog factor  infant vari cranial defect craniolacunia craniofenestra cranial meningocel hydrocephalus spinal defect meningocel myelomeningocel describ infant expir bacteri complic etiolog factor signific cranial defect coexist malform central nervous system review
962  | hydrocephalus myelomeningocel central nervous system infect seri  incid cns infect  patient hydrocephalus myelomeningocel summar gram posit organ occur frequent caus infect result mortal  gram neg organ induc infect result mortal  near  infect occur patient shunt procedur done staphylococcus caus two third infect patient shunt situ obvious portal entri could demonstr major patient  patient receiv nonspecif prophylact therapi ooz myelomeningocel  surviv  given prophylact therapi one surviv combin kanamycin sodium methicillin chloramphenicol appear vitro effect gram posit cocci combin chloramphenicol kanamycin polymixin b appear vitro effect combin gram neg bacilli
963  | myelomeningocel hydrocephalus first year  patient fifti infant hydrocephalus myelomeningocel treat comprehens team specialist patient evalu death first birthday whichev occur first twenti patient die  bacteri infect thirteen survivor classifi noncompetit thought poor prognosi base development quotient less  seventeen patient judg competit case latest development quotient  urinari tract irrevers decompens development quotient base motor develop adapt behavior languag develop personal soci develop report progress report longitudin studi comparison previous survey group result seem encourag current data  older patient follow   yr show  competit survivor  noncompetit survivor  death
964  | pneumoencephalograph chang cavum septi pellucidi clinic signific pneumoencephalograph appear clinic problem associ communic non commun cavum septi pellucidi discuss basi  case non commun csp may lead intermitt headach due variat intracrani pressur obstruct flow csf rare case repres special etiolog group foramina monro aqueduct may narrow communic csp general associ mild moder symmetr intern hydrocephalus author opinion case direct result cavum sinc fluid continu form cavum communic rest ventricular system establish condit resembl hypersecretori hydrocephalus reason author reject view communic csp clinic signific case possibl combin cavum cerebr malform must consid
965  | posterior scallop vertebr bodi uncontrol hydrocephalus two case extens posterior scallop vertebr bodi present men age   year long stand hydrocephalus two addit case scallop one lumbar vertebra partial control hydrocephalus present shorter time also note previous associ entiti record suppos increas intraspin pressur must present first  patient mani year present near time closur epiphysi junction arch bodi caus widen spinal canal also excav vertebr bodi scallop vertebr bodi describ  neoplasm neurofibroma meningioma glioma hemangio endothelioma hemangioma lipoma  intraspin cyst intradur arachnoid cyst tarlov perineur cyst thorac extradur cyst kyphosi dorsali juvenili  congenit anomali spine cord fusion defect myelodysplasia hydromyelia absenc singl vertebr pedicl meningocel  neurofibromatosi without thorac meningocel
966  | electroencephalograph pictur infantil hydrocephalus   case congenit hydrocephalus eeg examin normal asymmetri eeg record common abnorm encount congenit acquir hydrocephalus none children examin reveal focal neurolog symptom conclud eeg examin could use differenti congenit acquir hydrocephalus normal eeg record suggest congenit natur condit
967  | consecut hydrocephalus report  case two patient  consecut hydrocephal newborn report consanguin present famili genet basi hydrocephalus suggest
968  | fanconi anaemia hydrocephalus thyroid abnorm case describ girl suffer dwarfism due congenit hypoplasia pituitari congenit malform pancytopenia manifest age  yr resist combin corticosteroid testosteron treatment unusu find case congenit hydrocephalus hypoplast spleen hypoplasia thyroid togeth persist high pbi serum level without appar chang thyroid function
969  | dandy walker taggart syndrom case report dandy walker taggart syndrom  month old girl substanti correl clinic patholog featur  exit foramina th ventricl fail open result sever cystic dilat ventricl hypoplast distort posterior midlin cerebellar structur
970  | hydrocephalus due smallpox occur fetal period  case hydrocephalus year    found whose mother contract variola rd month pregnanc base person case spars data literatur clinic epidemiolog radiograph skull biolog histopatholog aspect present  fatal case histopatholog examin could demonstr hydrocephalus occur manifest diseas involv fetus caus variola infect gestat infer given eeg examin liquor
971  | air pantopaqu ventriculographi congenit hydrocephalus myelomeningocel studi csf pathway combin pantopaque air ventriculographi infant congenit hydrocephalus myelomeningocel present advantag method discuss combin pantopaqu air ventriculographi provid demonstr extent hydrocephalus also exact locat caus obstruct infant myelomeningocel permit disclosur unmanifest hydrocephalus coexist intracrani malform earli detect latter import complet evalu manag prognosi introduct pantopaqu ventricular system infant produc immedi reaction precipit deterior clinic status retent small amount pantopaqu later ventricl interfer function bypass procedur
972  | two case dandi walker syndrom dandi walker syndrom refer particular kind malform hydrocephali character anatom associ less consider agenesi cerebellar vermi imperfect foramina luschka magendi dysgenet natur pictur obvious pathogenesi hydrocephali simpl etiolog remain obscur malform compens less quick life subject clinic pictur hydrocephali tumor posterior fossa diagnosi must carri x ray examin ventriculograph imag pathognomon extrem eas surgic restor passag flow effect time oper emphas interest syndrom turn rare kind curabl malform hydrocephali author report  unpublish case respect  yr old children first alreadi go back sever year  unfavor postoper result second  recov complet without sequela resect posterior wall cyst
973  | incid treatment post meningit hydrocephalus newborn incid mening first week life higher compar period life even case associ spina bifida cystica exclud graviti prognosi even sinc introduct mani power antibiot drug frequent emphas among  case occur matern unit  eventu made complet recoveri group  infant develop postmeningit hydrocephalus refer either still activ mening postmeningit state  infant could treat ventriculocav shunt infant  other die later  survivor  recov without sequela spite extrem hydrocephalus demonstr air studi oper degre hydrocephalus matter sever contraind oper
974  | compar valu thick drop concentr method detect filaria infect blood drawn finger vein  student  pm  compar diagnost efficaci thick drop method vis a vi concentr method infect rate found  method  student harbour infect found posit method infest rate concentr method higher  per slide  per slide thick drop method
975  | filariasi relat bo mn kell duffi rhesus blood group secretor factor  filariasi patient studi bo blood group  duffi kell rhesus blood group  secretor factor  mn blood group find associ filariasi blood group associ whatsoev found blood group studi filariasi
976  | polyethylen tube cultur method diagnosi parasit infect hookworm relat nematod studi made amami island bangkok compar diagnost effici direct microscop examin test tube cultur newli devis polyethylen tube cultur method detect filariform larva result show new techniqu number advantag method sensit other detect case slight infect great reduc risk overlook small number larva polyethylen tube extrem cheap compact light easili dispos use
977  | observ effect vivo vari ambient temperatur filari worm snake new inform obtain biolog filari worm experi use constrictor constrictor mexicanus boa infect macdonaldius oschei worm microfilaria oschei aperiod respect light cycl fluctuat sharpli densiti day day maximum minimum level occur approx  day apart microfilaria larger variabl size day maximum densiti day minimum densiti suggest smaller microfilaria day low parasitemia born recent enlarg follow  hr enter peripher capillari low ambient temperatur littl effect upon oschei exposur host ambient temperatur  c period   hr appear suffici kill adult oschei microfilaria appar die within  hr temperatur slight infect disappear blood altogeth within period microfilaria infect  time sever howev elimin circul prior death host  hr although observ either decompos distort appar dead indic temperatur serv limit factor parasit point sever degre lower postul host speci probabl correl nocturn habit host
978  | preliminari report leucoconcentr techniqu appli studi microfilaraemia case filariasi due wuchereria bancrofti routin leucoconcentr techniqu use demonstr steinberg neoplas cell circul blood appli method make possibl obtain consider enrich demonstr filaria perform daylight materi obtain prepar specif antigen make possibl immunolog diagnosi may carri
979  | concentr techniqu sanguicol microfilaria techniqu describ concentr sanguicol microfilaria modifi harri summer method
980  | patholog schistosoma japonicum taiwanes monkey macaca cyclopi comparison formosan japanes strain ii effect pass formosan strain japanes snail near equal recoveri rate adult worm taiwanes monkey macaca cyclopi infect formosan japanes strain sch japonicum record worm recoveri rate monkey low comparison made high suscept laboratori rabbit signifi partial suscept formosan strain granuloma liver contain fewer egg consider sever extens japanes strain granuloma possibl larg atyp granuloma could reaction young degener formosan worm discuss altern hypothesi explain dissimilar reaction formosan strain egg stronger tissu irrit japanes strain propos ii formosan strain sch japonicum pass japanes snail intermedi host oncomelania nosophora  consecut generat progress rise rate snail infect mortal record result laboratori strain formosan schistosom use infect taiwanes monkey monkey infect natur formosan strain natur japanes strain serv control worm recoveri rate similar  group granulomat respons liver produc laboratori strain compar larg atyp granuloma natur formosan strain convent granuloma natur japanes strain new formosan strain appear alter toward characterist possess japanes strain
981  | review immunolog method diagnosi filariasi author review histor applic skin test cft precipitin test haemagglutin bentonit floccul prausnitz kuestn test diagnosi various filari infect man anim discuss area requir studi opinion standard techniqu immunolog method made furnish reliabl mean diagnosi notwithstand past unreli method bibliographi arrang chronolog order list  paper cover period   supplementari list refer includ  recent paper general aspect subject
982  | schultz dal reaction sera eosinophil lung patient   preliminari report schultz dal test indic specif antibodi metabolit product microfilaria present serum e l patient diethylcarbamazin concentr     requir caus percept cessat contract intestin strip use suffici test yet complet indic consist relationship particular filari speci eosinophil lung diseas
983  | evalu bentonit floccul indirect hemagglutin test diagnosi filariasi indirect haemagglutin test bentonit floccul test util salin extract dirofilaria immiti evalu test reactiv sera individu infect acanthocheilonema perstan show higher titr symptomat patient microfilaria blood group  symptomat patient   microfilariae posit patient   microfilariae neg patient show posit serolog test group  asymptomat individu microfilaria blood  posit group  asymptomat microfilariae neg individu  sera  posit test  sera  normal missionari  normal american  individu various parasit bacteri infect overal non specif respons  obtain util follow criteria posit serolog test  haemagglutin titr  higher posit floccul  higher  haemagglutin titr  negat floccul reaction sera  patient helminth diseas show non specif rate  high rate due cross react trichinosi sera  schistosomiasi  ascariasi  sinc schistosomiasi ascariasi sera individu born area endem filariasi reaction may repres serolog respons past experi filariasi   sera individu non helminth diseas   sera normal individu posit
984  | filariasi mountain provinc luzon republ philippin endem focus w bancrofti mountain provinc luzon calaccad valley discuss  microfilaremia rate found parasit probabl brought area origin human migrat recent immigr came non infect area infect found children  yr age correl spray area sinc  howev peopl live unspray hous children may becom infect come road develop urban culex p fatigan move undoubt increas transmiss current anophel minimus flavirostri import local vector aed finlaya niveus probabl also vector
985  | immunolog studi filariasi iii isol purif antigen intraderm skin test antigen intraderm skin test extract homogen dirofilaria immiti phosphat buffer ph  purifi sephadex g  gel filtrat cm cellulos chromatographi deae sephadex a  column chromatographi final purifi antigen fscd protein small amount carbohydr  gave relat broad band electrophoresi cellogel film aminoacid detect high voltag paper electrophoresi acid hydrolyz antigen lysin arginin glycin alanin glutam aspart acid valin wheal erythema appear within  min inject antigen   prove filariasi patient cross reaction examin patient p westermani japonicum hookworm lubricoid e vermiculari weak skin reaction notic case protein natur antigen prove fact proteolyt enzym destroy antigen activ consider extent
986  | human filariasi identif speci basi stain morpholog characterist microfilaria new stain procedur human microfilaria describ morpholog detail characterist speci illustr appar greater clariti previous obtain simpl key human microfilaria outlin base criteria clear demonstr stain
987  | immunolog studi filariasi iii fraction purif antigen intraderm skin reaction filariasi report antigen tca obtain adult worm dirofilaria immiti produc notic reaction filariasi patient whose blood microfilaria could demonstr fraction purif antigen attempt order studi substanc respons skin reaction obtain reliabl antigen high sensit specif fraction fs obtain treatment similar describ previous report use parent materi gel filtr sephadex g  column chromatographi antigen fs antigen fsi produc notic reaction filariasi patient obtain high reactiv antigen fsi separ  fraction vizfsc  fsc  fsc  fsc  fsc  fsc  cm cellulos chromatographi  antigen test  protein compon level patient infect wuchereria bancrofti antigen fsc  contain  protein  carbohydr per ml activ next fraction antigen fsc  deae sephadex column chromatographi carri yield  antigen vizfscd  fscd  fscd  fscd   antigen test  protein compon level filariasi patient antigen fscd  produc notic skin reaction patient elimin protein compon antigen fscd  attempt nagas proteolyt enzym pronas obtain antigen fscdn fscdp  antigen test patient prove filariasi reaction produc inject antigen weaker produc antigen fscd  may infer studi substanc respons skin reaction protein
988  | identif canin microfilaria import microfilari identif diagnos canin filariasi emphas compar signific infect due differ speci person experi analysi publish report found modifi knott method simplest practic reliabl method use improv new morpholog criteria differenti microfilaria microfilari concentr peripher blood number natur infect dog determin averag count  dog infect dirofilaria immiti  rang    per ml blood compar averag  rang    per ml  dog infect dipetalonema reconditum  dog inappar infect immiti  microfilari concentr within rang found infect reconditum male femal dog reconditum similar concentr microfilaria
989  | chemotherapi metastat gastro intestin cancer cancer digest tract commonest caus death neoplast diseas unit state larg number patient form incur cancer may candid specif anti tumor drug therapi criteria employ select patient system region chemotherapi review method treatment outlin system chemotherapi use fluorin pyrimidin antifol methotrex alkyl agent cytoxan found signific practic valu   patient receiv anticanc drug protract hepat arteri infus chemotherapi patient primari secondari hepat neoplasm tumor biliari system result object tumor respons associ clinic benefit  patient treat length surviv prolong patient advanc metastat liver cancer primari tumor colorectum conclud system region cancer chemotherapi select case contribut practic manag patient incur cancer gastrointestin tract
990  | palliat treatment osseous metastas carcinoma breast carcinoma prostat radio act phosphorus testosteron fifty thre patient suffer pain aris boni metastas carcinoma breast prostat discuss method palliat treatment outlin result report
991  | region chemotherapi prolong arteri infus head neck tumor methotrex inject superfici tempor superior thyroid arteri perfus  mg dropsmin everi day  day area irrig decid preliminari perfus patent blue violet  result  inoper patient death  failur  improv  total regress  pain reliev  patient
992  | intra arteri infus emphas treatment malign neoplasm review english medic literatur summar signific paper concern intra arteri infus techniqu cancer therapi effect palliat mani advanc primari recurr cancer patient head neck cancer patient form largest group patient treat easili access arteri howev almost involv organ infus extern approach femor brachial common carotid oncolyt chemotherapeut agent given via intra arteri rout notabl increas dosag except fudr partial complet regress mani tumor obtain present day chemotherapeut agent   mth best therapeut result patient head neck pelvic tumor current infus techniqu use small mobil pump unit permit patient ambulatori cours anti tumor therapi complic intra arteri infus usual minor serious complic occur embol phenomena cns intern carotid infus aplast bone marrow drug toxic hemorrhag tumor degener technic complic infus may life threaten frequent prematur termin therapi continu interest form therapi appear inevit
993  | prolong intra arteri chemotherapeut infus cancer therapi indic limit review articl  refer principl cancer treatment use continu intra arteri chemotherapi describ select patient oper techniqu complic dealt two case present infus methotrex   mg partial complet object remiss woman  carcinoma amygdaloid fossa man age  reticulosarcoma rhinopharynx
994  | intra arteri chemotherapi cancer metastat liver twenty two patient cancer metastat liver treat intra arteri infus cancer chemotherapeut agent drug introduc direct hepat arteri  patient aorta level celiac axi  patient signific differ result observ  group  patient receiv cancer chemotherapi via hepat arteri one remain aliv  mth treatment  die immedi posttreat period  surviv   mths treatment averag surviv  mth  patient treat intra aort administr cancer chemotherapi die  patient die immedi posttreat period surviv time remain  averag  mth object signific shrinkag metastas liver observ  patient  treat intra hepat arteri rout  via aorta last   mth subject palliat observ  patient  treat intrahepat arteri rout  intra aort rout major complic note leukopenia lesser degre hepat failur patient poor metabol reserv receiv chemotherapi irradi immedi past complic sever need critic screen proper select patient candid cancer chemotherapi discuss
995  | cancer chemotherapi continu intra arteri infus experi veteran administr surgic adjuv cancer chemotherapi infus studi group two hundr fifty on patient advanc cancer treat  cours intra arteri cancer chemotherapi techniqu complic result analyz discuss object respons obtain  patient treat best result obtain epidermoid carcinoma head neck poorest primari brain tumor intra abdomin adenocarcinoma ten per cent patient receiv least  cours therapi avail evalu obtain worthwhil palliat  month ten patient satisfactori result period   month conclud arteri infus chemotherapi may benefit palliat patient convent method fail contraind frequenc serious complic suggest present form therapi use individu group special interest experi chemotherapi much studi type cancer treatment need various area investig suggest
996  | treatment cancer bacteri toxin initi experi toxin therapi sarcoma melanoma report  group patient toxin use adjunct oper potenti curabl patient palliat treatment metastat tumor toxin therapi supplement radiotherapi local symptomat tumor mass experi encourag first  group   patient rd group mark object remiss tumor subsequ irradi studi indic use radiotherapi follow prime bacteri toxin inject
997  | radiotherapi malign rectal anal tumor method result  case result given treatment  patient  case anal  rectal carcinoma convent deep therapi ultrahigh kilovoltag irradi total  year surviv rate  surgic treatment accord survey literatur made reifferscheid  accord gulek   accord ottenheim  total  patient receiv irradi question radic surgeri  patient receiv palliat irradi palliat surgeri case anus praeter perform altogeth  patient receiv palliat irradi without surgeri  patient receiv irradi recurr appar radic surgeri  patient receiv irradi metastas appar radic surgeri  patient metastas palliat surgeri ultrahigh kilovoltag radiat treatment show better result convent deep therapi irradi   r site surgeri stage c case give higher  year surviv rate accord duke henschkestearn et al
998  | manag advanc cancer patient incur cancer may receiv substanti relief disabl mental physic symptom constant continu medic manag usual limit valu certain measur specif anticanc therapi nonspecif support therapi may reliev symptom sustain patient moral general support measur valu various cancer chemotherapeut compound techniqu administr drug review standpoint patient select practic applic various form cancer limit agent patient advanc cancer
999  | evalu ileal conduit palliat procedur  yr period end juli   ileal conduit oper perform citi hope medic center treatment carcinoma bladder pelvic organ charact extent lesion describ detail detail surgic procedur discuss complic includ pyelonephr uremia enter urinari fistula wound infect thrombophleb common twenty eight  patient die postop period fifty nin  surviv patient known die most result recurr uncontrol carcinoma procedur consid palliat  patient  patient lesion remov conduit establish one stage  patient die  surviv  patient tumor control averag term surviv  mth procedur carri  stage  case  patient die nd stage  surviv patient live    mth respect ileal conduit alon establish  patient  die oper averag time surviv  mth  patient aliv  mth conclud ileal conduit conjunct total cystectomi  stage indic palliat procedur sever intract symptom exist patient care select procedur poor toler older person
1000  | cancer chemotherapi continu intra arteri infus methotrex continu intra arteri infus methotrex use treatment  patient malign diseas head neck  patient advanc cancer pelvic organ  malign lesion lower limb  patient epidermoid lesion head neck complet regress local tumor thirty thre patient benefit treatment vari period time remain  show respons eight patient die immedi treatment advanc cancer head and neck region mean total dose methotrex given patient respons signific less partial regress tumor suggest greater total dose methotrex toler greater chanc benefici respons role continu intra arteri chemotherapi manag malign diseas discuss
1001  | manag advanc ovarian carcinoma life graph present purpos illustr result treatment patient ovarian carcinoma eventu die diseas includ patient regardless initi stage diseas histolog tumor therapi employ seri select one type patient refer medic oncolog servic demonstr almost  patient die within  yr diagnosi patient receiv activ aggress anti tumor well support therapi although formal protocol patient manag might possibl employ standard therapeut approach irradi indic entir abdomen dose rang  rad follow judici use current avail anticanc drug diseas recurs to produc modest increas  year surviv figur sinc seri show approxim  patient ovarian carcinoma stage iii iv first diagnos attent might direct earlier diagnosi import field investig method facilit earli diagnosi appar moment control trial adjuv therapi stage ii diseas approxim  recurr seen expand might consist instil radioact chemic agent abdomin caviti use system chemotherapi immedi oper infus drug abdomin aorta stage iii iv control trial drug alon sequenti combin subsequ irradi seem indic final effort find effect anticanc drug must continu
1002  | liver resect embol metastas cancer colon rectum two patient underw resect left lobe liver embol metastas primari cancer colon rectum report intern anatomi liver relat technic terminolog resect review case liver resect perform embol metastas cancer colon rectum found extens review medic literatur classifi result analyz resect either half liver hemihepatectomi embol metastasi cancer colon rectum rare cure patient carri high oper mortal rate seldom ever justifi lesser oper left lobectomi right lob metastasectomi often perform simultan primari oper occasion follow freedom recurr period  yr justifi metastasi situat favor liver complet remov primari lesion appear curabl
1003  | palliat treatment nonresect lung cancer upper hemibodi perfus chlorimin short act alkyl agent experi five case method discuss provid palliat treatment patient nonresect lung cancer mean administ short act alkyl agent upper half bodi temporarili occlud circul lower half bodi proper select patient awar potenti complic procedur appear safe effect
1004  | congenit extrahepat biliari atresia success oper case ductus hepaticus obstruct author briefli review histori anatom manifest genesi congenit extrahepat biliari atresia associ abnorm collect  case literatur ladd first success oper case end year  public found  theoret correct case  recov   person case perform success hepatico duodenostomi  week old girl four year later girl develop normal absolut without symptom sign author discuss differenti diagnost problem stress diagnost valu gradual increas direct serum bilirubin propos term ex juvantibus differenti allud differenti diagnost evalu time pass surgic explor also emphas need early latest age  week performed surg explor accord administr vit k advantag suppos caus postop dehisc oper wound lie metabol chang result icterus author case reliev drainag bilio digest anastomosi solv help polyethylen nasal tube could safe remov surgeon statist data author person case author point correct case occur  case one may hope success oper averag  case  correct one fatal complic author believ reduc earli surgeri
1005  | icterus neonatorum simplex studi  guinea pig demonstr birth activ glucuronyltransferas birth activ gradual increas reach highest level rd day life hereaft gradual decreas shown suggest made glucuronyltransferas adapt enzym result support hypothesi neonat jaundic caus inabl liver newborn excret bilirubin
1006  | import steroid hormon hyperbilirubinemia icterus newborn administr natur occur steroid estriol pregnanediol cortison th th day life increas bilirubin level newborn administr steroid progesteron nurs mother result hyperbilirubinemia infant fact explain pathogenesi neonat jaundic interpret experiment clinic find lead conclus high amount steroid hormon must excret neonat period conjunct relat insuffici neonat liver respons inabl conjug bilirubin glucuron acid steroid hormon probabl compet bilirubin enzym substrat necessari conjug function capac neonat liver high enough conjug bilirubin steroid excret placent steroid suffici conjug bilirubin becom possibl furthermor pregnanediol appear inhibit enzym glucuronyl transferas mechan show import steroid hormon pathogenesi neonat jaundic import aggrav factor develop jaundic due erythroblastosi newli develop concept may therapeut implic author report later date
1007  | problem neonat obstruct jaundic critic analysi  case neonat obstruct jaundic led conclus proper diagnosi determin studi liver biopsi low percentag surgic correct lesion among patient neonat obstruct jaundic serious high mortal case hepat treat hazard oper stress conserv manag recommend  mth age even later serial fall bilirubin note
1008  | clinic studi histolog studi liver hepat infant classif find clinic studi histolog studi liver hepat infant japanes clinic observ histolog studi liver biopsi hepat infanc e obstruct jaundic unknown caus infant made histolog hepat infanc divis  type  giant cell format observ general slight degener liver cell necrosi inflammatori chang stasi bile characterist  so cal giant cell hepat characterist  specif type present pictur cholangiol histolog chang liver biliari stasi scanti specif chang could clinic differenti  type found type serum bilirubin sgot sgpt activ slight characterist point clinic laboratori studi type  valu relat low type  mark high type  sgot activ within normal rang histolog characterist liver type  necrosi liver cell format acidophil granul balloon cell cellular infiltr glisson capsul biliari stasi liver cell fine bile duct morpholog find viral hepat observ type  liver tissu replac mani multinuclear giant cell extrem distort cord liver cell cellular infiltr glisson capsul lobul note mark biliari stasi capillari bile duct liver cell characterist prolifer bile duct bile plug found consist giant cell hepat craing land type  degener liver cell necrosi inflammatori chang slight biliari stasi hepat lobul conspicu histolog find similar cholangiolit hepat due drug poison observ
1009  | patholog giant cell hepat earli infanc  month old male infant admit hospit acut cardiac circulatori failur autopsi reveal macronodular liver cirrhosi splenomegali left ventricular dilat heart hydrothorax ascit histolog liver show giant cell hepat portal area widen foci erythropoiesi histiocyt infiltr liver cell show vacuolar degen chang giant cell present margin regener area well degener lobul irregular border vari size   ft nuclei larg sometim bizarr basophil cytoplasm show granul iron pigment also found normal hepat cell promin kupffer cell connect tissu spleen prolifer connect tissu scatter area erythropoiesi well pigment deposit pulpa iron pigment also found pancrea salivari gland islet langerhan hyperplast etiolog giant cell hepat still unknown pathogenesi may due malform immunolog respons type antibodi inborn error iron metabol viral infect suggest giant cell transform respons immatur liver cell varieti stimuli case interest predomin giant cell   nuclei presum intermedi stage variant hepat
1010  | surgeri infantil obstruct jaundic result suruga yamazaki procedur  case congenit biliari duct atresia report postop anorexia diarrhea edema due circulatori disturb upper extrem found oper oper technic difficult postop fat protein electrolyt metabol problem order obtain better result diseas differenti earli period long term follow up continu studi problem requir
1011  | transient famili neonat hyperbilirubinemia syndrom transient famili neonat unconjug hyperbilirubinemia due known caus describ  infant  unrel healthi caucasian mother four infant develop kernicterus begin nd trimest pregnanc sera  mother newborn infant inhibit direct react bilirubin o aminophenol glucuronid format rat liver slice homogen respect   time observ sera control group pregnant women infant serum inhibitori factor women unidentifi fact inhibitor occur pregnanc serum suggest probabl progest steroid inhibit glucuronyl transferas activ liver neonat mechan respons increas serum inhibitor factor activ women unknown requir studi
1012  | hepat virus neonat liver diseas liver biopsi specimen  babi neonat hepat  extrahepat biliari atresia studi presenc hepat virus cultur yield posit result  babi neonat hepat  infant biliari atresia
1013  | neonat hepat liver biopsi find clinic featur  infant clinic diagnosi neonat hepat histolog examin liver made needl biopsi relat clinic cours investig histolog find classifi provision  type type show giant cell slight damag hepat cell promin intracellular cholestasi type ii character occurr numer giant cell specif type character centrolobular cholestasi without inflammatori reaction laboratori examin reveal increas serum transaminas bilirubin greater type ii type specif type increas serum transaminas direct hyperbilirubinemia histolog sequela result serial biopsi reveal type hepat damag heal almost complet type ii giant cell disappear within  yr case hepat cirrhosi result prognosi neonat hepat may said good type poor type ii undetermin specif type
1014  | spherocyt anemia earli deglobulis crisi avitaminosi birth  homozyg male twin seri hemolyt crise caus low crythrocyt count jaundic one hand xerophthalmia probabl owe exist proven liver biopsi complic obstruct biliari syndrom
1015  | neonat hepat famili neonat obstruct jaundic four sibl boy chronic obstruct jaundic describ onset jaundic vari  day  week birth two boy  girl famili healthi although one  case patholog find neonat hepat giant cell hepat possibl could exclud describ hitherto giant cell hepat appear morpholog pictur must sever caus conclud find  patient one possibl caus so cal giant cell hepat inborn error metabol
1016  | hypoplasia intrahepat bile duct descript  case  boy  day old atresia small intestin pneumonia slight enlarg liver faint green color histolog examin reveal numer collaps bile duct solid ductular cell sprout reach liver cell minor smallest bile duct empti  girl  yr  mth increas jaundic sinc birth autopsi reveal hypoplast common bile duct howev open probe mark green color liver also case bile duct narrow solid ductular cell sprout reach liver cell type bile duct correspond stage ontogenesi show sign prolifer may consid form hypoplasia size number primordi bile duct reduc present anlag show regular connect liver cell hypoplasia distinguish atresia long surviv second case explain great compensatori capac liver
1017  | fetal neonat hepat consequ author report  fatal case observ infant  week  year old case jaundic appear birth first day life persist stool sometim discolor blood incompat pictur similar congenit biliari atresia patholog studi reveal  group  patholog chang hepat  case liver enlarg flabbi icter microscopi show dissoci cell cord polymorph hepat cell necrot cell balloon cell giant cell transform giant cell show vacuol erythrocyt lipid acidophil materi cytoplasm sign regener collaps stromal framework prolifer mesenchym cell bile retent cell erythrocyt seri scatter periport space eosinophil leucocyt lymphocyt histiocyt  fibrosi cirrhosi  case liver green firm nodular granular surfac extra hepat biliari tree normal spleen enlarg microscopi show bile stasi pericholangiolit fibrosi prolifer bile ductul periport interlobular intralobular fibrous tissu increas show cellular infiltr architectur liver disturb presenc pseudolobuli regener area suggest case due congenit viral hepat result intrauterin infect also featur fetal hepat secondari pericholangiolit post necrot liver cirrhosi neonat giant cell hepat consid result cytotox action virus author consid also possibl viral etiolog case biliari atresia basi morpholog similar congenit viral hepat
1018  | metabol excret bilirubin c experiment obstruct jaundic bile duct ligat carri seri rhesus monkey time requir serum bilirubin stop rise achiev relat stabl level averag serum bilirubin reach parallel close seen clinic serum bilirubin level stop rise steadi state reach radioact bilirubin inject iv radioisotop distribut princip extravascular ratio albumin form jaundic daili turnov bilirubin found doubl anticip normal hb breakdown suggest increas bilirubin product obstruct jaundic anim follow  wk near  inject radioact excret urin indic obstruct jaundic kidney take entir liver function bilirubin excret
1019  | major surgeri sever hemophiliac lesson manag three case pseudotumor thigh requir surgic amput one case open pericardi drainag cardiac tamponad briefli report sever hemophiliac first case hemostasi follow amput produc patient die septicemia secondari proxim infect tissu level amput therefor proxim grossli infect tissu second case infect massiv pseudotumor left thigh  separ oper procedur perform last procedur elect revis skin flap hip disarticul site applic knowledg gain previous experi result complet uncompl postop cours dint time surgic procedur relat control infect loss plasma fast judici use antibiot direct curr electrocoagul therapi plea made avoid use plasma ahg therapi hemophilia trivial reason consid patient surgic procedur earli cours complic demand surgeri time patient still respons hematolog therapi prior onset infect area hematoma felt second signific hemorrhag particular site constitut bona fide indic surgic intervent long time surgeri consid last resort physician patient famili although author believ surgeri hemophiliac taken light endors prevail nihilist attitud result tempor delay guarante fatal outcom
1020  | immunolog demonstr factor viii protein plasma hemophiliac valu insight hemophilia immun rabbit one obtain antisera human factor viii action immunsera determin use modif thromboplastingener test factor viii neutral test antibodi factor viii equal absorb either normal hemophilia plasma observ show hemophilia plasma contain much factor viii protein normal plasma normal hemophilia serum one find lower level similar concentr factor viii analog cross react substanc crm bacteria mutant hypothesi made accord author deal product genet alter synthesi factor viii product function less activ possess antigen determin normal factor viii inhibitor properti hemophilia plasma explain competit inhibit made possibl similar structur fact inhibitor discov mammen factor viii similar properti support hypothesi theori author accord plasma hemophiliac contain normal amount normal factor viii block specif inhibitor pathogenet agent hemophilia reject genet consider acceler appear ether treatment hemophilia plasma ident factor viii
1021  | haemophil pseudotumour  case  first case haemophil pseudo tumour  adult affect haemophilia report remark account clinic latenc intertrochanter local third haemophiliac b extens accompani mark clinic symptom tumour extens femor gap subjac imag osseous infarct progress turgid tumour iliac wing side literatur data stress discrep progress charact verit tumour absenc sign histolog malign
1022  | protein los enteropathi complic prolong bleed hemophilia gastrointestin bleed sever hemophiliac continu  day  pint fresh blood replac treatment eaca steroid factor viii rich fibrinogen control bleed mark hypoproteinemia develop th day bleed protein los enteropathi suspect basi x ray find mucos thicken alter motil discontinu steroid protein replac result appear normal small bowel mucos pattern coincid cessat bleed
1023  | bilater hemophil pseudotumor calcaneus cuboid treat irradi case report case present bilater pseudotumor calcaneus cuboid  year old boy appar classic hemophilia respond prompt deep x ray therapi relief pain subsequ disappear tumor without recurr  yr  mth treatment although previous report effect radiotherapi pseudotumor conflict result case dramat
1024  | bone lesion cours blood diseas special refer format boni callus treatment fractur patient suffer blood diseas preliminari remark embryolog physiolog bone marrow mechan coagul blood author pass consider genesi boni callus treatment fractur patient suffer blood diseas account given basi exampl patholog fractur also traumat fractur subject affect various kind blood diseas solitari myeloma polyosteot plasmocytoma waldenstroem syndrom coagulopath syndrom structur defect fibrin coagulum hemophilia fractur patient blood diseas character abnorm cours effeci cure necessari make accur diagnosi regard pre exist blood diseas re establish hemostasi chang prevent hemorrhag correct plasma defect may present reflect format boni callus
1025  | studi antihemophil factor ahf factor viii produc von willebrand diseas confirm person autosom ahf defici von willebrand diseas produc larg quantiti ahf transfus ahf defici plasma person hemophilia occur despit fact complement occur vitro one predict model suggest x locus ahf structur autosom locus regulatori ahf appear von willebrand diseas transfus structur normal ahf obtain condit test method result fulfil predict may impli model correct hand predict may fulfil reason perhap wrong paramet examin larg standard error test mask real differ test obvious need one feel reason certain mutat regulatori gene basi von willebrand diseas examin person sex link autosom ahf defici use antibodi prepar wild type ahf might illumin also transfus studi carri person homozyg von willebrand diseas person found failur obtain new synthesi homozygot would throw great doubt model impli reduc ahf level von willebrand diseas heterozygot due entir reduct effector substanc neutral repressor x chromosom operon direct code ahf molecul
1026  | tumor lik bone lesion hemophilia report deal clinic radiolog find hemophil pseudotumor femur observ period  yr pathogenesi treatment radiolog differenti diagnosi discuss
1027  | concurr hemophilia christma diseas one famili studi present number generat famili two member christma diseas three hemophilia suspect preced generat must afflict hemophilia ab mutat x chromosom gene respons type hemophilia must occur grandmoth famili daughter gene respons hemophilia ab segreg children grandchildren inherit one type hemophilia ie hemophilia christma diseas relev genet consider briefli review
1028  | albin associ angiohemophilia report case case present rare associ albin angiohemophilia occur man  bone marrow contain cell resembl proper reticulum cell contain larg basophil granul
1029  | major surgeri classic hemophilia use fraction experi twelv oper review literatur therapeut regimen provid hemostasi hemophiliac major surgeri without requir laboratori control establish factor viii concentr effect regimen fraction therapi evalu major surgeri  sever defici  moder defici hemophiliac analysi clinic result made combin  oper seri  major oper procedur hemophiliac record english literatur fraction sole major sourc factor viii therapi dental nondent surgeri analyz separ special problem blood cyst although over al mortal rate follow major surgeri hemophiliac present   use factor viii concentr problem still remain includ continu high incid abnorm postop hemorrhag variat factor viii potenc differ lot fraction late develop serum hepat hemolyt anemia due contamin isoantibodi high cost adequ amount product effici method prepar purer potent factor viii concentr could elimin difficulti
1030  | lengthen thrombin time anti equin antithrombin hyperthrombocyt myelosi report given patient treat numer im inject thrombas equin thrombin chronic gingivorrhagia caus hyperthrombocyt myelosi ineffect antithrombin specif equin thrombin develop caus specif disturb intrins coagul observ compar two case haemophilia antithrombin also develop repeat inject equin thrombin
1031  | epsilon aminocapro acid e aca therapeut agent base  year clinic experi experi treatment  patient e aca suggest use prepar indic follow situat  fibrinolyt haemorrhag associ deliveri  acut system fibrinolysi associ surgeri main major oper thorax pancrea prostat liver genit organ complic fibrinolysi fibrinolyt bleed occur oper  acut system fibrinolysi patient cancer particular cancer prostat pancrea  system fibrinolyt state complic various disord especi leukaemia liver cirrhosi boeck sarcoid  antidot thrombolyt therapi  local fibrinolyt activ urinari tract follow situat prostatectomi e aca substanti reduc blood loss follow prostatectomi especi treatment continu urin becom macroscop clear b haematuria prostat cancer prostat hyperplasia prolong haematuria traumat injuri kidney haematuria haemophilia coagul defect so cal essenti haematuria  ulcer coliti drug equal effect whether given oral intraven state increas system fibrinolyt activ dose  g per kg bodi weight everi   hour recommend inhibit local fibrinolyt activ urinari tract dose  g three time day prove suffici side effect consist dizzi nausea diarrhoea toxic effect drug ecg blood pictur npn liver function test observ even case receiv  g e aca postmortem examin  case reveal sign toxic effect sign intravascular coagul connect e aca therapi observ incid thromboembol complic prostatectomi patient treat e aca seri control ident judg author experi materi e aca act agent induc thrombosi
1032  | femor neuropathi hemophilia six new case femor neuropathi hemophil patient describ syndrom begin sever pain groin inferior aspect thigh deep hip region follow pronounc contractur hip flexion extern rotat tender swell appear iliac fossa groin depress center correspond inguin ligament final flaccid paralysi quadricep femori diminut absenc sensat anteromedi aspect thigh proxim portion leg depress absent patellar reflex discov author propos syndrom result hemorrhag iliopsoa muscl musculotendin junction beneath iliacus fascia femor nerv becom compress beneath unyield inguin ligament superior iliopectin ligament medial treatment consist bed rest analges freshfrozen plasma acut phase convalesc phase hess long brace use protect knee hemarthrosi function return quadricep femori occur date valid theori femoral nerv palsi result iliopsoa hemorrhag musculotendin junction compress femor nerv beneath inguin ligament verifi author anticip day see non hemophil patient traumat iliacus hemorrhag femor neuropathi opportun present explor beneath poupart ligament may show femor nerv compress thus confirm propos caus clinic pictur
1033  | hemorrhag episod hemophilia  year prospect studi medicosoci studi hemophilia particular clinic import allow assess like cours diseas differ age differ grade sever provid knowledg complic caus disabl loss educ earn capac also overcom distort clinic impress diseas aris recurr admiss sever affect hemophiliac owe consider individu variat number sever complic differ hemophiliac accur individu prognosi never given general howev number spontan episod per year decreas age sever individu episod tend increas least age  yr general agreement bulk hospit hemophil admiss due hemarthros hemophil arthropathi involv knee joint increas time spent hospit per episod later life part least due develop relat unstabl weight bear joint due hemophil arthropathi associ muscl atrophi thus correct manag individu hemarthros childhood consider import present time littl known best possibl treatment episod littl known patholog mechan hemophil arthropathi whether presenc blood presenc tension lead joint destruct thus opinion differ concern routin admiss hemarthros hospit regardless sever also advis joint aspir attempt avoid develop destruct arthropathi individu variat patient chang pattern diseas age difficulti obtain suitabl control patient question answer longterm prospect medicosoci studi
